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Bacteria evolved the ability to uptake and degrade sialic acid as an alternative source of carbon, nitrogen 
and energy to colonise and persist in environments rich in sialic acid within the human host. The 
expression of the genes that are responsible for utilisation of this amino sugar are controlled by the 
transcriptional regulator NanR. The interplay between gene regulation and metabolism of sialic acid is 
important for efficient growth of the bacterium and to establish infection within the human host. The gap 
in our knowledge is that the mechanism of this gene regulation is poorly understood at the molecular 
level. To address this gap, I studied two types of sialic acid gene regulators, which are the RpiR-type NanR 
from the Gram-positive pathogen Streptococcus pneumoniae and the GntR-type NanR from the Gram-
negative pathogen Escherichia coli.  
In the first body of work, I explored the uncharacterised yjhBC operon from E. coli, which encodes two 
proteins that are transcriptionally regulated by the GntR-type NanR and that is hypothesised to function 
in the uptake and processing of less common forms of sialic acid. To test this hypothesis, a thorough in 
silico characterisation suggested YjhB is a sugar-ion symporter within the major facilitator family and 
identified amino acid residues that may be of functional importance. Using a protein-GFP fusion system, 
I optimised an overexpression protocol for YjhB, which will be useful for purifying the membrane protein 
in future biophysical studies. I demonstrated that YjhC is broadly involved in carbohydrate metabolism, 
through in vivo knockout studies. To understand this function further, I solved the crystal structure of YjhC 
to 1.35 Å, in complex with the cofactor nicotinamide adenine dinucleotide. This verifies the role of YjhC 
as an oxidoreductase/dehydrogenase, within the Gfo/Idh/MocA family. Using differential scanning 
fluorimetry and in silico docking experiments, which are guided by the structure, I identified several 
promising leads that suggest YjhC is involved in sialic acid catabolism. 
In the second body of work, I found that RpiR-type NanR from S. pneumoniae adopts an extended dimeric 
assembly in solution. This conformation changes to bind DNA, forming a dimeric protein-DNA hetero-
complex with a 2:1 binding stoichiometry, as demonstrated by sedimentation velocity and small angle X-
ray scattering experiments. This provides the first molecular understanding of the stoichiometry for the 
RpiR-type NanR-DNA hetero-complex. Multiphase ab initio modelling suggested this protein-DNA 
interaction occurs between the N-terminal DNA-binding domain of NanR to form a binding cleft. To 
understand the DNA-binding affinity of this interaction, I conducted a kinetic analysis, which revealed a 
low micromolar affinity. I also demonstrated that the sialic acid pathway metabolite, N-
acetylmannosamine-6-phosphate binds S. pneumoniae NanR and completely abolishes DNA binding. This 
iv 
 
supports the hypothesis that N-acetylmannosamine-6-phosphate is the effector that attenuates gene 
repression.  
In the final body of work, I demonstrated that the GntR-type NanR from E. coli binds as a dimer to a total 
of three direct GGTATA repeats that make up the DNA recognition site, forming a hexameric protein-DNA 
hetero-complex, with a 6:1 binding stoichiometry. Interestingly, this interaction is cooperative, mediated 
by a unique 32 residue N-terminal extension, likely through protein-protein interactions. To understand 
how DNA binding is attenuated by the effector, I solved the structure of E. coli NanR to 2.1 Å in the 
presence of N-acetylneuraminic acid and in complex with a zinc ion. This supports the hypothesis that N-
acetylneuraminic acid is an effector molecule and identifies zinc as an additional effector. The structure 
is asymmetrical, with N-acetylneuraminic acid and zinc only present in one monomer, informing the 
molecular choreography that occurs following binding of the effector that attenuates DNA-binding 
affinity. Notably, the structure of the NanR dimer and DNA hetero-complex was refined to 3.9 Å using 
cryo-electron microscopy, which is the first known structure of a NanR gene regulator in complex with 
DNA. In addition, these experiments provided structural evidence of the multimeric assembly process to 
support the stoichiometry observed in solution. This multimeric protein-DNA assembly is unique to E. coli 
NanR, among known members of the GntR superfamily.  
Importantly, this body of work gives the first molecular insight into the mechanism of the NanR-DNA 
interaction for both a RpiR-type and GntR-type transcriptional regulator, while additionally providing the 
first structural and functional investigation for both the YjhB and YjhC proteins. Together, this new 
knowledge enhances our understanding of sialic acid gene regulation and improves our overall grasp of 




















This form is to accompany the submission of any thesis that contains research reported in co-authored 
work that has been published, accepted for publication, or submitted for publication. A copy of this 
form should be included for each co-authored work that is included in the thesis. Completed forms 
should be included at the front (after the thesis abstract) of each copy of the thesis submitted for 




Please indicate the chapter/section/pages of this thesis that are extracted from co-authored work and 
provide details of the publication or submission from the extract comes:  
 
Chapter Two – Manuscript – ‘On the structure and function of Escherichia coli YjhC: an 
oxidoreductase involved in bacterial sialic acid metabolism’  
(Submitted to Proteins: Structure, Function, and Bioinformatics, 2019) 
 
Chapter Five – Manuscript – ‘The cooperative assembly and disassembly of the GntR-type                   
sialoregulator NanR from Escherichia coli’ 
 
 
Please detail the nature and extent (%) of contribution by the candidate:  
 




Certification by Co-authors: 
If there is more than one co-author then a single co-author can sign on behalf of all 
The undersigned certifies that: 
▪ The above statement correctly reflects the nature and extent of the PhD candidate’s contribution 
to this co-authored work  




Name: Christopher Horne         Signature:                                                          Date: 26/06/2019 
Deputy Vice-Chancellor’s Office 





First and foremost, to my supervisor Professor Renwick Dobson. Thank you for your guidance and for 
sharing your creative support over the last four years. Thank you for providing me so many amazing 
opportunities to expand and get the most out of my research. But most importantly, thank you for sharing 
your incredible passion for science, your unique enthusiasm and always encouraging me to do my best.  
A big thankyou to all the members of the Dobson Lab, past and present, for your support and friendship. 
Special thanks to Jen, Kat and Rachel for your guidance from day one and to the Boyo’s (and Serena) of 
Room 625 for the endless banter or sport related chat. Thanks to Grant Pearce for your insight and wit. 
Thank you to the extended labs of Level 6, including Callaghan Innovation for your support and sound 
advice over the years. You are all an incredible bunch of people!  
Thank you to Professor Borries Demeler and Deede for hosting me in Canada and providing the guidance 
to teach me the skills needed to conduct the essential experiments for my project. Thank you to Amy 
Henrickson for your technical support and for the extended members of the Demeler or Patel Labs for 
your support while in Canada. Thank you to the MX and SAXS beamline scientists at the Australian 
Synchrotron for your technical support and guidance over the years. Special thanks to Dr Santosh Panjikar 
for your assistance in MX and to Dr Hari Venugopal at Monash University for your assistance in Cryo-EM 
data collection and refinement. Thanks to Dr Janet Newman for your creative assistance.  
Thank you to the organisations who have financially supported me over the last four years. The University 
of Canterbury for a Doctoral Scholarship. The Freemasons NZ for a Postgraduate Scholarship. The 
Biomolecular Interaction Centre, the Royal Society of New Zealand, and the New Zealand Society for 
Biochemistry and Molecular Biology for your support to attend conferences in New Zealand and Australia. 
Thank you to the Maurice Wilkins Centre for funding my research trip to the University of Lethbridge, 
Canada.  
A huge thankyou to my Mum, Dad, Michael, other family and friends outside Uni, for your understanding 
and support. Thank you for always showing interest in my work, even though you really had no idea what 
a ‘protein crystal’ or a ‘NanR’ was.  
Most importantly, thank you to Anna. Thank you for your love, understanding, endless patience and 




Table of contents 
  





Chapter One: Introduction ..…………………………………………………….………………………….………….………………….1 
1.1 Overview ..……………………………………………………………………………………….……………………………………….……….1 
1.2 Sialic acid ..………………………………………………..………………………………………………………………………….…..…..….1 
1.3 Significance of sialic acid in eukaryotes ..………………………..…………………………………..……………….….………..2 
1.4 Significance of sialic acid in bacteria ..…………………………………………………….….…………………………..………...3 
1.5 Uptake of sialic acid by bacteria ………………………………………………………………………………………………..….….4 
 1.5.1 Uptake of sialic acid across the outer membrane ……………………………………….………….….….….5 
 1.5.2 Sugar-proton symporters ………………………………………………………………..…………………....….……..6  
 1.5.3 Sodium Solute Symporters ……………………………………………..…………………..…………………………….8 
 1.5.4 ATP-binding cassette transporters …………………………………………………..……………………..…...…..8 
 1.5.5 Tripartite ATP-independent periplasmic transporters …………………………………….………..……...9  
1.6 Cell-surface sialyation in bacteria ……………………………………………………………………………………………………11 
 1.6.1 De novo biosynthesis ……………………………………………………………………………………….…..………...12 
 1.6.2 Donor scavenging …………………………………………………..……………………………………………………….12 
 1.6.3 Trans-neuraminidase activity ………………………………………………………………………………………….12 
 1.6.4 Precursor scavenging ………………………………………………………………………………………………………12 
1.7 Catabolism of sialic acid by bacteria ………………………………………………………………………………………..……..13 
1.7.1 N-Acetylneuraminate lyase ………………………………………...…………………………………….……………15 
1.7.2 N-Acetylmannosamine kinase ………………………...…………..………………………………………………….15 
1.7.3 N-Acetylmannosamine-6-phosphate 2-epimerase ………………..………………………………………..16 
1.7.4 N-Acetylglucosamine-6-phosphate deacetylase …………………..…………………………………………16 
1.7.5 Glucosamine-6-phosphate deaminase ……………………………..…………………………………………....17 
1.7.6 Supplementary enzymes of sialic acid catabolism …………………............................................17 
viii 
 
1.7.7 The catabolism of sialic acid is a viable target for antimicrobial development ……………..…18 
1.8 Regulation of sialic acid catabolism …………………………………………………………………………………………………19 
1.8.1 The structural architecture of NanR transcriptional regulators ……………………………………….20 
1.8.2 The protein family classification of NanR transcriptional regulators ……………………………….21 
1.8.3 Allosteric mechanism of NanR transcriptional regulators ……………………………………………….22 
1.9 Research Aims ………………………………………………………………………………………………………………………………..25 
1.10 Chapter References ………………………………………………………………………………………………………………………26 
 
Chapter Two: On the structure and function of the proteins encoded by the yjhBC operon  
- Part One ..……………………….…………………………………………………………………………………………………………………33 
 
2.1 Introduction ………………………………………………………………………………………..………………….………………………33 
 2.1.1 yjhBC operon ……………………………………………………………………………………………………….….………33 
 2.1.2 Gfo/Idh/MocA protein family …………………………………………………………………….…………………...34 
2.2 Chapter overview ……………………………………………………………………………………………………………….…………..37 
2.3 Manuscript – ‘On the structure and function of Escherichia coli YjhC: an oxidoreductase 
involved in bacterial sialic acid metabolism.’ ….………………………………….……………………………………….….38 
2.4 Chapter Summary ………………………………………………………………………..…………………………….…………………..74 
2.5 Chapter References ..………………………………………………………………………………………………………………………74 
 
Chapter Three: On the structure and function of the proteins encoded by the yjhBC operon  
- Part Two ……………………………………………………………………………………………………………………………………………75 
 
3.1 Introduction …………………………………………………………………………………………………………………….……………..75 
3.1.1 The Major Facilitator Superfamily of permeases .…………………………………………….……….…….75 
3.1.1 The putative permease YjhB …………………………………………………………………………………….……..77 
3.2 Chapter overview ………………………………………………………………….……………………………………………..……..….77 
3.3 Results and Discussion …………………………………………………………………………………………………………………….76 
 3.3.1 Cloning and overexpression trials of Escherichia coli YjhB ……………………………………………….76 
 3.3.2 In silico comparison and structural modelling of YjhB ……..………………………………………………81 
3.4 Chapter Summary ..…………………………………………………………………………………………………………………………92 





Chapter Four: Towards a structural and functional understanding of the RpiR-type sialoregulator 
from Streptococcus pneumoniae ..…………………………………………………………………………..97 
4.1 Introduction ……………………………………………………………………………..…………………………………………………….97 
 4.1.1 RpiR family of transcriptional regulators …………………….……………………………………………….….97 
4.1.2 The RpiR-type sialoregulators ………………………………………………………………………………..……....99 
 4.1.3 S. pneumoniae NanR …………………………………………………………………………………………………..…101 
4.2 Chapter overview ……………………………………………………………………………………………………………………….…102 
4.3 Results and Discussion ……………………………………………………………………………………………………………….…103 
4.3.1 Cloning, expression and purification of S. pneumoniae NanR ………………………………………..103 
 4.3.2 The thermal stability of S. pneumoniae NanR ……………………………………………………………..…105 
 4.3.3 Sequence comparison with other RpiR-type sialoregulators …………………………………………107 
 4.3.4 The quaternary structure of S. pneumoniae NanR …………………..……………….……….………….109 
 4.3.5 Electrophoretic mobility shift assays demonstrate DNA binding activity……………..…………110 
4.3.6 Defining the stoichiometry of the S. pneumoniae NanR-DNA hetero-complex ..…………...112 
 
4.3.7 Crystallisation studies of S. pneumoniae NanR ……………………….………………..….……………….116 
4.3.8 Small angle X-ray scattering of S. pneumoniae NanR ………………..………………..…………….….118 
4.3.8.1 The solution structure of S. pneumoniae NanR ………………………..……………………119 
4.3.8.2 The solution structure of S. pneumoniae NanR-DNA hetero-complex .……….…120 
4.3.8.3 Multiphase ab initio model of the S. pneumoniae NanR-DNA  
hetero-complex ……………………………………………………………………………………………….….……123  
 
4.3.8.4 Comparison with Vibrio vulnificus NanR structure …………………………………………125 
4.4 Chapter summary and model mechanism of regulation for S. pneumoniae NanR ……………….……….126 
4.5 Chapter References ……………………………………………………………………………………………………………..……….128 
 
Chapter Five: Defining the DNA-binding mechanism of the GntR-type sialoregulator from 
Escherichia coli - Part One …………………………..……………………………………………………………………….…………131 
5.1 Introduction …………………………………………………………………………………………………………………………….……132 
5.1.1 GntR family of transcriptional regulators ………………………………………………………………………132 
5.1.2 Interaction of GntR family members with DNA ……………………………………………………………..134 
5.1.3 Allosteric regulation mechanism of GntR family member ……………………………………….…….135 
5.1.4 Regulation of sialic acid catabolism in Escherichia coli .………………..……………….………………136 
5.1.5 Previous studies of E. coli NanR ………………………………………………………………………….………...137  
x 
 
5.2 Chapter overview ….…………………………………………………....…………………………………………………….…………138 
5.3 Manuscript ‘The cooperative assembly and disassembly of the GntR-type sialoregulator NanR from 
Escherichia coli.’ ……………………..……………………………………………………………………………………..…………………..139 
5.4 Chapter Summary ……………………………………………………………………………………..…………………………….……184 
5.5 References …………………………………………………………………………………………………………………..….……………184 
 
Chapter Six: Defining the DNA-binding mechanism of the GntR-type sialoregulator from 
Escherichia coli - Part Two .……………………………………………..……………………………………………………….……..187 
 
6.1 Chapter overview ………………………………………………………………………………..………………………………….......187 
6.2 Results and Discussion …………………………………………....…………………………………………………………………...188 
6.2.1 The thermal stability of E. coli NanR …………………………………………………………..…………..….…188  
6.2.2 Analysing the distance between GGTATA binding repeats using electrophoretic mobility 
shift assays ……………………………………………………………………………………………………………….……………191 
 
6.2.3 Sedimentation velocity analysis on the E. coli NanR-DNA interaction ……………………………193 
6.2.3.1 Single-wavelength sedimentation velocity analysis using two GGTATA  
binding sites ..…………………………………………………………………………………………..……………….194 
 
6.2.3.2 Single-wavelength sedimentation velocity analysis using three GGTATA  
binding sites ………………………………………………………………………………………………………………197 
 
6.2.3.3 An introduction to multi-wavelength sedimentation velocity analysis …………..200 
6.2.4 The C-terminal domain sub-structure of E. coli NanR used to phase the native  
structure …………………………………………………………………………………………………………………………….….203 
 
6.2.5 Crystallisation trials of E. coli NanR in the presence of DNA …………………………….…………...205 
6.2.5.1 Crystallisation trials with full-length NanR …………………………………………………….205 
6.2.5.2 Crystallisation trials with the N-terminal DNA-binding domain ……………………..206 
6.3 Chapter Summary ……………………………………………………………................................................................209 
6.4 Chapter References ……………………………………………………………………………………………..……………………….210 
 
Chapter Seven: Conclusions and future perspectives ………………………………………………………………….211 
7.1 The interplay between gene regulation and metabolism in pathogenic bacteria ………………………....211 
7.2 The first molecular insight into the yjhBC operon ………………………………………………………………………...212  
xi 
 
7.3 Structure and functional insight into the RpiR-type sialoregulator from S. pneumoniae …………….…213 
7.4 The cooperative assembly of the GntR-type NanR from E. coli ………………………………………………….….214 
7.5 Chapter References ………………………………………………………………………………………………………………………216 
 
Chapter Eight: Methods and Materials …………………………………………………………………………………………219 
8.1 Experimental consumables …………………………………………………………………………..………………………………219 
 8.1.1 Chemical consumables ………………………………………………………………………………………………….219 
 8.1.2 Biological consumables …………………………………………………………………………………………….…..219 
 8.1.3 General consumables ………………………………………………………………………………………………..….219 
8.2 General Methodology …………………………………………………………………………………………………………………..220 
 8.2.1 Mass Spectrometry ……………………………………………………………………………………….………………220 
 8.2.2 DNA sequencing ……………………………………………………………………………………………….…………..220 
 8.2.3 pH measurement ………………………………………………………………………………………………..………..220 
 8.2.4 Centrifugation ……………………………………………………………………………………………………………….221 
 8.2.5 Autoclave …………………………………………………………………………………………………………...…………221 
 8.2.6 Visualisation of macromolecular structures ………………………………………………………………….221 
8.3 Microbiology …………………………………………………………………………………………………………………………….....222 
 8.3.1 Bacterial strains ………………………………………………………………………………………..…..………..…….222 
 8.3.2 Constructs used in this thesis ………………………………………………………………………….…………….222 
 8.3.3 Media …………………………………………………………………………………………………………………….……..223 
  8.3.3.1 Luria Bertani media ……………………………………………………………….………..…………….223 
  8.3.3.2 Terrific Broth media ………………………………………………………………………………..…….223 
8.3.3.3 LB agar ………………………………………………………………………………….……………………….223 
8.3.3.4 Super optimal broth with catabolite repression media ………………....……….…….223 
 8.3.4 Antibiotics ………………………………………………………………………………………………………………...….224 
xii 
 
 8.3.5 Preparation of competent cells ………………………………………………………………………………..…..224 
 8.3.6 Transformation of competent cells ……………………………………………………………………..………..224 
 8.3.7 Preparation of glycerol stocks ..………………………………………………………………….…..…………….225 
8.4 Biomolecular techniques ………………………………………………..…………………………….……………………………...225 
 8.4.1 Determination of protein and DNA concentrations ………..……..…………………….……..………..225 
  8.4.1.1 Bradford protein assay …………………………………………………..……………………………..225 
  8.4.1.2 Quantitation of proteins using ultra-violet spectroscopy………………………………226 
  8.4.1.3 Quantitation of DNA using ultra-violet spectroscopy ..………………….………………226 
 8.4.2 DNA preparation ……………………………………………………………………………………………………….…226 
 8.4.3 Plasmid preparation ……………………………………………………………………………………………………..227 
 8.4.4 In-Fusion Cloning …………………………………………………………………………………..……………….…….227 
  8.4.4.1 Primers ………………………………………………………………………..……………………..…………227 
  8.4.4.2 Polymerase Chain Reaction ……………………………………………………………..……….…..228 
  8.4.4.3 Restriction enzyme digest ……………………………………………………………………………..228 
  8.4.4.4 DNA gel extraction …………………………………………………………..……………………………229 
  8.4.4.5 Ligation-independent recombination ……………………………………..………………….…229 
8.5 Electrophoresis ……………………………………………………………………………………………………………..……….…….230 
 8.5.1 Electrophoresis buffer solutions ………………………………………………………………..…………..……..230 
 8.5.2 Agarose gel electrophoresis …………………………………………………………….…………………….……..230 
 8.5.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) ………………………231 
8.6 Experimental methods …………………………………………………..……………………………………………………………..231 
 8.6.1 Experimental methods for Chapter Three ……………………………………….....………………………..227 
8.6.1.1 Cloning and expression trials of the E. coli YjhB construct …………..………………..231 
8.6.1.2 Whole-cell fluorescence ……………………………………………………………………….………232 
8.6.1.3 In-gel fluorescence ..………………………………......……………………………………………….233 
xiii 
 
  8.6.1.4 Bioinformatic analysis of E. coli YjhB ……………………......………..……………….……….233 
  8.6.1.5 De novo 3D structure prediction ………………………………......……………………………..233 
 8.6.2 Experimental methods for Chapter Four …………………………………………………………..……….…233 
  8.6.2.1 Cloning of the Streptococcus pneumoniae NanR expression construct ………….233 
  8.6.2.2 Expression and purification of S. pneumoniae NanR ……………………………...........234 
  8.6.2.3 Ligand screening using differential scanning fluorimetry ………….......................235 
  8.6.2.4 Bioinformatic analysis with other RpiR-like sialoregulators ………………………..….235 
8.6.2.5 Analytical ultracentrifugation of S. pneumoniae NanR ……………………………..……236 
8.6.2.6 Analytical ultracentrifugation of S. pneumoniae NanR in the presence 
of DNA …………….………………………………………………………………………………………………………..236 
 
8.6.2.7 Electrophoretic mobility shift assay with S. pneumoniae NanR …….………..….….237 
8.6.2.8 Crystallisation and data collection of S. pneumoniae NanR ….…….……………......237 
8.6.2.9 Small angle X-ray scattering of S. pneumoniae NanR …………….…..………………….238 
 8.6.3 Experimental methods for Chapter Six………………………………………………….…………………...….238 
  8.6.3.1 Thermal stability of E. coli NanR ………………………………………………………………..….238 
  8.6.3.2 Circular dichroism spectroscopy ……………………………………………………………..…….239  
  8.6.3.3 Electrophoretic mobility shift assay with E. coli NanR ………………………………..….239 
8.6.3.4 Analytical ultracentrifugation of E. coli NanR and the N-terminal DNA-binding 
domain in the presence of DNA …………………………...…………………………………………….…….239 
8.6.3.5 Crystallisation and data collection of E. coli NanR in the presence of DNA …….240 
8.6.3.6 Cloning of the E. coli NanR N-terminal DNA-binding domain………………………….241 
8.6.3.7 Expression and purification of the E. coli NanR N-terminal DNA-  
binding domain …………………………………………………………………………..…………………………….241 
 
8.6.3.8 Crystallisation of E. coli NanR N-terminal DNA-binding domain in the presence of 
DNA …………………………………………………………………………………………………………………….…….242 





ABC  adenosine triphosphate binding cassette transporter 
ADP  adenine diphosphate 
ADPS  Adaptive Poisson-Boltzmann Solver 
ATP  adenine triphosphate 
AUC  analytical ultracentrifuge  
BLAST  basic local alignment search tool 
C2  carbon position 2 or equivalent 
CD  circular dichroism  
cm  centimetre  
c(M)  continuous mass distribution 
c(S)  continuous sedimentation coefficient distribution 
CMP  cytidine monophosphate 
Cryo-EM cryo-electron microscopy 
D  diffusion coefficient 
Da  dalton 
DBD  DNA binding domain 
Dmax  maximum inter-particle dimension 
DNA  deoxyribonucleic acid 
DSF  differential scanning fluorometry 
DTT  dithiothreitol 
EBD  effector binding domain 
EDTA  ethylenediaminetetraacetic acid 
EMSA  electrophoretic mobility shift assay 
EMDB  electron microscopy data bank 
f/f0  frictional ratio 
FN  normalised fluorescence 
g  gram 
GFP  green fluorescent protein 
GntR  gluconate (gnt) operon transcriptional regulator 
Gfo/Idh/MocA glucose-fructose oxidoreductase/inositol dehydrogenase/rhizopine catabolism family 
xv 
 
His-tag  hexanucleotide histidine tag 
hr  hour 
HTH  helix-turn-helix 
I0  forward scattering value at zero angle 
IMAC  immobilised metal affinity chromatography 
IPTG  isopropyl β-D-1-thiogalactopyranoside 
KD  dissociation constant 
kDa  kilodalton 
L  litre 
LB  Luria Bertani 
LOS  sialylated lipooligosaccharides  
LPS  lipopolysaccharides 
M  molar  
MC  Monte Carlo 
MD  molecular dynamics 
MFS  major facilitator superfamily 
mg  milligram 
min  minute 
mM  millimolar 
mm  millimetre 
MRE  mean residue ellipticity 
MWL-SV multi-wavelength sedimentation velocity 
NAD  nicotinamide adenine dinucleotide 
NADP  nicotinamide adenine dinucleotide phosphate 
Nag   N-acetylglucosamine catabolic genes 
Nan  N-acetylneuraminic catabolic genes  
NagA  N-Acetylglucosamine-6-phosphate deacetylase 
NagB  Glucosamine-6-phosphate deaminase 
NanA  N-Acetylneuraminate lyase 
NanE  N-Acetylmannosamine-6-phosphate 2-epimerase 
NanK  N-Acetylmannosamine kinase 
NanR  N-Acetylneuraminate repressor 
Neu5Ac  N-Acetylneuraminic acid 
xvi 
 
nM  nanomolar 
nm  nanometer 
OD600  optical density at 600 nm 
PCR  polymerase chain reaction 
PDB  protein data bank 
PEG  polyethylene glycol 
P(r)  real space distance distribution function 
Rfactor  residual factor 
Rfree  free Rfactor 
RFU  relative fluorescence unit 
Rmerge  symmetry ideality 
Rg  radius of gyration 
RMSD  root mean square deviation  
RpiR  ribose-5-phosphate rpiB transcriptional regulator 
Rpm  revolutions per minute 
ROK  repressor, open-reading frame, kinase superfamily 
S  sedimentation coefficient (Svedberg) 
s  second 
SASBDB  small angle scattering biological data bank 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEC  size exclusion chromatography 
SIS  sugar isomerase domain 
SSS  sodium solute symporter 
SatA  periplasmic binding protein A 
SatB/C  integral membrane permease domains  
SatD  adenosine triphosphatase domain 
SAXS  Small angle X-ray scattering 
SiaP  sialic acid binding protein 
SiaQ  small transmembrane domain  
SiaM  large transmembrane domain 
TB  terrific broth 
TBE  tris-borate-EDTA 
TLS  translation-libration-screw 
xvii 
 
Tm  melting temperature 
TRAP  tripartite adenosine triphosphate independent periplasmic transporter 
Tris  2-amino-2-hydroxymethyl-propane-1,3-diol 
UDP  uridine diphosphate 
v/v  volume to volume 
w/v  weight to volume 
wHTH  winged helix-turn-helix 
2DSA  two-dimensional spectrum analysis 
2rDNA  two GGTATA binding site DNA 
3D  three-dimensional 
3rDNA  three GGTATA binding site DNA 
%  percentage 
°  degree 
°C  degree Celsius 
σ  sigma 
λ  wavelength 
Å  angstrom 
µg  microgram 
µL  microlitre 
µM  micromolar 














































The overall focus of this thesis is the gene regulation of sialic acid catabolism. A broad overview of sialic 
acid and its importance in bacteria is provided in this introduction. A more detailed review of the 
literature is presented in the experimental chapters that follow.  
 
1.2 Sialic acid 
 
Sialic acids are a family of nine-carbon amino monosaccharide units (1; 2) that includes more than 50 
naturally occurring and structurally distinct variants (3; 4). Structurally, sialic acids contain a carboxylate 
group, which is deprotonated at physiological pH, resulting in an overall negative charge for the 
molecule (5). This net negative charge governs the physiochemical properties of sialic acids (1). The 
arrangement of this carboxylate group (and hydroxyl group) about C2 defines the stereochemistry of 




Figure 1.1 Sialic acid. A) N-Acetylneuraminic acid (Neu5Ac) is the most abundant and widely studied of the sialic 
acids. Carbons are labelled one through to nine. The N-acetyl group (C5) and the C4, C7, C8 and C9 hydroxyl groups 
that are subject to substitution/ modification are labelled with a red asterisk. The stereochemical difference at the 
C2 position defines the α- and β-anomer (grey box). B) N-Glycolylneuraminic acid is the second most abundant 




The most common form of sialic acid across all organisms is N-acetylneuraminic acid, herein abbreviated 
to Neu5Ac (Figure 1.1A) (3; 7; 8). The second most abundant form of sialic acid is N-glycolylneuraminic 
acid (Figure 1.1B). Although, this hydroxylated version of Neu5Ac is not present in humans as the 
hydroxylase gene required for modification is absent (6). Variants are generated through substitutions 
at the C5 position and modification of the hydroxyl groups at C4, C7, C8 and C9 by acetylation, 
methylation, sulfation, or in some circumstances the formation of intramolecular esters (lactones) (1; 
3). Unlike other derivatives of sialic acid, the lactone variant, formed between the carboxylate and C7 
does not carry a net charge or exhibit any defined stereochemistry (Figure 1.1C). 
 
1.3 Significance of sialic acid in eukaryotes 
Mammalian cell surfaces are decorated with a complex array of glycoconjugates (9; 10). Located at the 
termini of many cell surface glycoconjugates are sialic acids (Figure 1.2), where they can mediate cellular 
interactions, recognition and adhesion processes through immunoglobulin-like lectins, called ‘Siglecs’ 
which bind sialic acid (1; 6; 11-13). These processes are fundamental to the pathophysiology of the 
eukaryotic cells and can act as a defence against infection (2; 13). Overall, the significance of sialic acids 
in eukaryotes is driven by their distinct chemical diversity (13).  
  
Figure 1.2 | Sialic acids are the terminal sugar on glycoconjugates that coat the surfaces of mammalian cells. Shown 
is a representation of complex glycoconjugates bound to the surface of the cell, forming a glycolipid and a 
glycoprotein. Sialic acid (red and insert) is the terminal sugar of these complex glycoconjugates, while sub-terminal 
sugars (beige) can include N-acetylglucosamine, N-acetylgalactosamine, glucosamine, galactose, mannose, and 
fucose (14).  
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Within the human host, sialic acids are most abundant in the brain where they are utilised in the central 
nervous system. Their presence in the brain was first discovered by Ernest Klenk over 70 years ago and 
accounts for the origin of ‘neuraminic’ (15). The name ‘sialic acid’ is derived from the Greek word sialon, 
meaning saliva, following the discovery of sialic acid in salivary mucin by Gunnar Blix in a similar era (15). 
Mucin is a high molecular weight glycoconjugate, present within the mucosal epithelia of the respiratory 
and gastrointestinal tract (16). Over 65% of terminal glycans are known to contain sialic acid (17; 18) 
and are believed to provide proteolytic protection to underlying cell surface machinery (19) or serve as 
the first interaction point for bacteria (9; 10).  
 





While rich in sialic acid, the respiratory and gastrointestinal tract in humans tend to be glucose-limited 
and therefore presents an inopportune environment (20; 21). To overcome this limited nutrient 
availability, bacteria evolved the ability to scavenge sialic acids produced by the human host (7), which 
are a source of carbon, nitrogen and energy (22). Utilising sialic acid from the human host offers 
bacteria, such as Escherichia coli, a competitive advantage to colonise and persist within the host (23; 
24). 
In order to utilise sialic acid, bacteria rely on the actions of neuraminidases (25), which hydrolyse the 
glycosidic linkage of terminal sialic acid residues from glycoconjugates and release them into the 
surrounding environment. This allows bacteria to scavenge free sialic acid (26; 27). Neuraminidases that 
release sialic acid are produced endogenously by the host during inflammation (28; 29) or exogenously 
by neuraminidase-expressing bacteria, such as Streptococcus pneumoniae (30) and Pasteurella 
multocida (31). The role of these neuraminidases is essential, since the concentration of sialic acid in 
the human host within these heavily sialylated niches is relatively high (~2 mM), the majority is 
inaccessible, locked within complex glycoconjugates (32).  
Once the terminal sialic acid is hydrolysed, bacteria can now utilise host-derived sialic acid in a variety 
of different ways. Primarily, once imported into the cell, sialic acid is catabolised as an alternative 
nutrient, providing a source of carbon, nitrogen and energy (7; 33). This catabolism of sialic acids also 
yields precursors for peptidoglycan biosynthesis, such as N-acetylglucosamine (34; 35), which is 
essential for bacterial growth. In addition to sialic acid catabolism, pathogenic bacteria can also decorate 
their own cell surfaces with host-derived sialic acids. This strategy is known as molecular mimicry and 
serves as a camouflage mechanism against the host innate immune system (6; 26; 36). Thus, the 
utilisation of sialic acid in pathogenic bacteria can serve two purposes, by providing a source of nutrition 
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and playing an important role in the establishment of infection. As a result, sialic acid can act as a 
virulence factor and play an integral role in pathogenesis (37; 38).  
 
1.5 Uptake of sialic acid by bacteria 
 
The transport of sialic acid into the bacterial cell is an essential process and is required to utilise sialic 
acid from the surrounding environment (6). This is understood following the discovery that sialic acid 
uptake is dependent upon a functional transporter in the bacterial pathogens E. coli (36), Haemophilus 
influenzae (39) and Salmonella enterica (40). Therefore, sialic acid transporters present an attractive 
target for the development of antimicrobial development towards these pathogenic bacteria. 
Once imported, pathogenic bacteria are required to make a choice: catabolise sialic acid as a source of 
nutrition, or sialylate their cell surface to evade the host innate immune system. Exercising a fine 
balance between these choices is essential for bacteria to survive and persist within the human host.  
The uptake of sialic acid in bacteria is facilitated by multiple transporter families, which vary between 
different species. These bacterial transporters can be organised into four major types: Secondary proton 
symporters (36; 41); sodium solute symporters (40; 42); ATP-binding cassette transporters (43); and 
tripartite ATP-independent periplasmic transporters (39; 44-46).  
Generally, the transport of sialic acid is driven by using an energy source or coupling the uptake of sialic 
acid with the movement of an ion down an electrochemical gradient (47). However, Gram-negative 
bacteria pose an additional barrier for the uptake of sialic acid with their outer cell membrane. Here, 
import is governed by the specific porin NanC (48; 49), a bi-partite outer membrane protein complex 
NanOU (50; 51) and the non-specific porins OmpF and OmpC (52). Collectively, the sialic acid 
transporters in the outer and inner membrane are discussed below, while their diversity is illustrated in 
Figure 1.3. 
In the bacterial pathogens E. coli (36), Haemophilus influenzae (39) and Salmonella enterica (40), the 
uptake of sialic acid is dependent upon a functional transporter. This discovery demonstrates that these 
pathogens utilise a dedicated transporter, specific for the import of sialic acid across the inner plasma 







Figure 1.3 | Overview of sialic acid uptake in bacteria. Located in the outer membrane of Gram-negative bacteria, 
the influx of sialic acid (depicted as a red hexagon) is driven by the specific porin NanC, NanOU, part of the bi-
partite complex and the non-specific porins OmpF and OmpC. Located in the inner membrane are four sialic acid-
specific transport systems: NanT and the sodium solute symporter (SSS) transporters both consist of a single 
transmembrane spanning domain and couple the uphill movement of sialic acid with the movement of an ion 
down its electrochemical gradient; ATP-binding cassette (ABC) transporters consist of a sialic acid-binding protein 
(SatA), two transmembrane spanning domains (SatBC) and two cytoplasmic nucleotide-binding domains 
responsible for binding and then hydrolysing ATP to drive the translocation of sialic acid (SatD). In some ABC 
transporters SatC can be fused with SatD; Tripartite ATP-independent periplasmic (TRAP) transporters consist of 
a sialic acid-binding protein (SiaP), a small transmembrane spanning domain (SiaQ) and a large membrane 
spanning domain (SiaM), which can be fused in some TRAP transporters where translocation of sialic acid is driven 
by an ion motive force.  
 
1.5.1 Uptake of sialic acid across the outer membrane  
The outer membrane acts as the first line of defence for Gram-negative bacteria, serving as a semi-
permeable barrier to large, charged molecules (53). Therefore, in order to utilise host-derived sialic acid, 
Gram-negative bacteria must first uptake this resource across the barrier. This influx is controlled 
specifically by porins through facilitated diffusion or active transport mechanisms (Figure 1.3) (47). The 
first identified system for the specific uptake of sialic acid across the outer membrane was the E. coli 
NanC porin, encoded by the nanCMS operon (49). Although the mechanism is not well understood, the 
crystal structure identified that the translocation pore is lined by two parallel strings of basic amino 
acids—this feature is believed to be fundamental for the transport of sialic acid (48).  
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In Bacteroides fragilis and Tannerella forsythia, a more complex transport system NanOU, has been 
discovered, which uses active transport to drive the uptake of sialic acid across the outer membrane. 
This bi-partite complex is comprised of NanO, a TonB-dependent porin and NanU, an extracellular-
binding protein with a high-affinity for sialic acid (KD ≈ 0.4 µM). Through structural and functional 
studies, NanU is believed to first bind sialic acid and then deliver it to NanO before being actively 
transported into the periplasmic space (50; 51).  
Inside the periplasmic space, various processing enzymes have been identified in Gram-negative 
bacteria to modify sialic acid and mediate its delivery to the inner membrane transporters. Those that 
modify sialic acid include a sialate mutarotase (nanM), which catalyses the periplasmic conversion of 
the α-anomer of Neu5Ac to the thermodynamically favourable β-anomer (Figure 1.1A) (54), and a 9-O-
acetylated Neu5Ac esterase (nanS) that permits growth on this derivative of sialic acid (55; 56). 
Conversely, periplasmic-binding proteins can bind sialic acid with high-affinity and deliver this resource 
to the ATP-binding cassette and tripartite ATP-independent periplasmic transporters (Section 1.4.4-
1.4.5) (43; 57; 58).  
In addition to these sialic acid-specific outer membrane transporter systems, influx of sialic acid can also 
be achieved through simple diffusion, mediated by the general porins, OmpF and OmpC (49). Together, 
these porins allow an influx of a large variety of molecules and therefore present a broad substrate 
specificity (52). Within a nutrient limiting environment, these non-specific porins become inefficient. To 
combat this, pathogenic bacteria evolved these sialic acid-specific transport systems to sustain their 
survival and persistence within the human host (47).  
 
1.5.2 Sugar-proton symporters  
 
Placed in the major facilitator superfamily, NanT from E. coli was the first sialic acid transporter to be 
discovered (36). Today, NanT is the most common sialic acid transporter amongst Enterobacteriaceae 
and Bacteroidetes bacterial pathogens (Figure 1.3) (7; 47). Encoded by the nanT gene, this bacterial 
transporter is predicted to be a sugar-proton symporter. To facilitate the transport of sialic acid across 
the inner membrane, NanT couples the movement of a proton down an electrochemical gradient to 
facilitate the uphill movement of sialic acid against its electrochemical and/ or concentration gradient 
in the same direction (59).  
The membrane topology of NanT, based on the amino acid sequence is predicted to comprise a total of 
14 transmembrane helices. This differs from the traditional 12 transmembrane helices observed among 
transporters in the major facilitator superfamily. Located centrally, these additional transmembrane 
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helices (7 and 8) within NanT, are hypothesised to form an amphipathic helix and play a role in the 
substrate specificity of the transporter (41). The remaining 12 transmembrane helices contain residues 
that are conserved between members of the major facilitator superfamily (6; 47). Interestingly, a 
sequence homolog to NanT has been identified in E. coli, referred to as YjhB. In Chapter Three, I will 
investigate the role this transporter may play in sialic acid catabolism.  
While the structure of NanT has yet to be solved, the closest structural and biological candidate to NanT 
with a sequence identity of only 16-23% is the recently reported sugar-proton symporter, XylE from E. 
coli—a D-xylose transporter within the major facilitator superfamily (60). These transporters, among 
other members of the major facilitator superfamily are proposed to function via an alternating access 
mechanism (59). The N- and C-terminal domains rock back and forth between an inward- and outward-
facing open conformation, where the substrate binding site acts as the pivot point only accessible to 
either the cytoplasmic or periplasmic side of the membrane. This process is known as the ‘rocker-switch’ 
mechanism (Figure 1.4) (61; 62).  
 
 
Figure 1.4 | The ‘rocker-switch’ mechanism. In this mechanism the N-terminal (beige) and C-terminal (blue) 
domains rock back and forth between an inward- and outward-facing open conformation, where the substrate 
binding site acts as the pivot point only accessible to either the cytoplasmic or periplasmic side of the membrane. 
Initially, in an outward-facing open conformation a proton binds from the periplasmic side of the membrane 
(Position 1). Following the binding of a proton, the substrate binds in a central cavity (Position 2). The binding of 
the substrate triggers a conformational change, initially through an intermediate occluded state (Position 3), 
through to an inward-facing open conformation where the proton can exit into the cytoplasm (Position 4). Finally, 
the substrate is translocated and released into the cytoplasm, completing the cycle (Position 5). While some of 






1.5.3 Sodium solute symporters  
In contrast with sugar-proton symporters, the Sodium Solute Symporter (SSS) family of secondary 
transporters couple the transport of sodium ions down their electrochemical gradient to facilitate the 
movement of sugars, amino acids, inorganic ions, or vitamins into the cell (63). This dependency on 
sodium ions for co-transport is where the family name, SSS originates. Among members of the SSS 
family, the symporter SiaT has been linked to the genes encoding the processing enzymes for sialic acid, 
and thus is understood to be a specific transporter for sialic acid.  
In 2018, the structure of SiaT from Proteus mirabilis was solved (42)—this is the first known structure 
of a sialic acid transporter. Comprised of 13 transmembrane helices, SiaT adopts a fold analogous to the 
sodium-leucine symporter, LeuT (42; 64). Interestingly, the structure was solved in the outward-facing, 
open conformation bound to sialic acid and two sodium ions. While, the binding site for one of these 
sodium ions is conserved, the other sodium ion binds at a new position and is believed to allosterically 
stabilise sialic acid. Analogous to the alternating access mechanism (as described for members of the 
major facilitator superfamily), transport in SiaT also involves the rearrangement of transmembrane 
helices to translocate sialic acid with the addition of a gating mechanism (42).  
 
1.5.4 ATP-binding cassette transporters 
 
The ATP-binding cassette (ABC) transporters are a ubiquitous superfamily of membrane transporters 
that couple the energy attained from ATP hydrolysis to transport a variety of different solutes across 
the outer and inner membranes (65; 66). Within this superfamily, ABC transporters function as both 
importers and exporters (67). Their typical architecture consists of four domains, which include: two 
transmembrane domains (forming the translocation pathway), and two cytoplasmic nucleotide-binding 
domains (responsible for binding and then hydrolysing ATP) (68). These domains can either be fused, 
which is characteristic of ABC exporters, or can exist as separate domains in ABC importers (65; 69). In 
addition to this domain architecture, ABC importers can employ substrate-binding proteins to sequester 
their preferred substrate with high affinity and deliver it to the membrane component (70). These 
substrate-binding proteins can either be found tethered to the inner membrane in Gram-positive 
bacteria, or free to scavenge in the periplasmic space (71).  
The first report of a bacterial ABC transport system for the uptake of sialic acid was discovered in 
Haemophilus ducreyi, encoded by the genes satABCD (43). These genes express a periplasmic-binding 
protein (SatA), two integral membrane permease domains (SatB/SatC) and an ATPase domain (SatD). 
Together, these components are named Sat for sialic acid transport. Unique to H. ducreyi, the SatC 
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integral membrane domain is fused with one of the SatD domains (Figure 1.4) (43)—this feature 
highlights the diversity of the ABC transporter superfamily. Remarkably, the periplasmic-binding protein 
SatA, is known to demonstrate nanomolar affinity for negatively-charged sialic acid through a process 
driven by entropy, hydrogen-bonding and electrostatic interactions (72). However, the molecular 
exchange of sialic acid between SatA and the membrane component, SatBCD is yet to be confirmed. A 
second class of Sat-type ABC transporters have been identified in several other bacteria, including the 
pathogen S. pneumoniae (73; 74). While this system contains a SatABC domain architecture, it was 
shown to lack the SatD ATPase domain. Here, ATPase activity is alternatively driven by MsmK, an ATPase 
responsible for stimulating multiple carbohydrate ABC transporters by interacting with SatABC to 
energise the translocation of sialic acid (58).  
 
1.5.5 Tripartite ATP-independent periplasmic transporters 
 
The tripartite ATP-independent periplasmic (TRAP) transporters are a unique group of specific solute 
transporters that only occur in bacteria and archaea and not eukaryotes, making this class of 
transporters a viable target for antimicrobial development (71). TRAP transporters are known to 
translocate a range of substrates, including C4-dicarboxylates, α-keto acids, amino acids and various 
aromatic compounds (75). To drive this translocation, TRAP transporters couple the movement of an 
ion down an electrochemical gradient to thermodynamically drive the uphill movement of the substrate 
in the same direction, as opposed to harnessing the energy of ATP (71)—by definition this mechanism 
is defined as secondary transport.  
Structurally, TRAP transporters are composed of three protein domains in a ‘PQM’ system. These 
include either a membrane-anchored or periplasmic substrate-binding protein (‘P’ domain), a large 
transmembrane spanning domain (‘M’ domain) consisting of 12 transmembrane helices, believed to 
form the translocation pore and a small transmembrane spanning domain (‘Q’ domain) consisting of 4 
transmembrane spanning domains (76). This ‘Q’ domain is poorly conserved and although shown to be 
essential for transport, its function is largely uncharacterised (46).  
The first sialic acid TRAP transporter to be characterised was from the human pathogen, H. influenzae 
(39; 45; 75). Here, the substrate-binding protein (SiaP) delivers sialic acid to the membrane component 
(SiaQM), where translocation of sialic acid is driven by a sodium motive force (Figure 1.4). Moreover, 
the SiaQM membrane component is genetically fused in H. influenzae (46). Although this feature is not 
uncommon in TRAP systems, an extra transmembrane domain is required to link the two 
transmembrane domains—this results in a total of 17 transmembrane helices for H. influenzae SiaQM. 
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Despite identifying a dependency on sodium ions for symport in the H. influenzae TRAP transporter, 
further characterisation is required to define the ion specificity of sialic acid TRAP transporters (46).  
SiaPQM TRAP transporters have also been identified in P. multocida (77; 78), Vibrio vulnificus (79) and 
Vibrio cholerae (44). Among these, the sialic acid-binding protein, SiaP has been structurally and 
functionally characterised (80-82). These sialic acid-binding proteins have two domains (Figure 1.5). 
Between these domains, sialic acid is known to bind with low micromolar to nanomolar affinity within a 
conserved binding site (72). This binding triggers a conformation change between domains to clamp 
down on the substrate, mediated through a conserved α-helix hinge region. Comically, this mechanism 
has been likened to a ‘Pac-Man’ motion or action of the Venus Fly Trap (83; 84). Like the ABC 
transporters, the protein-protein interactions and inherent dynamics involved in the exchange of sialic 
acid between SiaP and SiaQM is yet to be elucidated.  
 
Figure 1.5 | The periplasmic sialic acid-binding protein, SiaP. The left panel presents the structure of the periplasmic 
sialic acid-binding protein SiaP in its open conformation. Highlighted is the hinge region and binding cavity. The 
right panel presents the structure of SiaP in its closed conformation, induced through binding of sialic acid—this 
mechanism has been likened to a ‘Pac-Man’ motion or action of the Venus Fly Trap (83; 84). To help illustrate this 
mechanism, the molecular surface has been mapped to each structure, where both open and closed 





1.6 Cell-surface sialyation in bacteria 
Cell-surface sialyation is a prominent feature of eukaryotic cell surfaces (85). Surprisingly, some 
pathogenic bacteria have evolved the ability to decorate their own cell-surface with sialic acid to mimic 
the host cell, masquerading themselves in order to evade the host innate immune response (34; 86), 
and serve as a virulence factor. This process is achieved by incorporating sialic acid into 
lipopolysaccharides (LPS) of Gram-negative bacteria; sialic acid-containing polysaccharide capsules, or 
the flagellum (87). The selective advantage of this process is so prominent that at least four separate 
strategies of cell-surface sialylation have evolved in pathogenic bacteria (6; 34). These strategies 
include: de novo biosynthesis; donor scavenging; a trans-neuraminidase mechanism; and precursor 
scavenging. Collectively, this diversity is illustrated in Figure 1.6.  
 
 
Figure 1.6 | The mechanisms of cell surface sialylation in bacteria. Presented is a bacterial cell (oval) with both 
intracellular (grey) and extracellular (white) environments. The four mechanisms of cell surface sialylation are: A) 
De novo biosynthesis; B) Donor scavenging; C) Trans-neuraminidase activity; and D) Precursor scavenging. The 
specific enzymes and membrane transporter (rectangle) involved in these strategies are coloured blue. Sialic acid 
is depicted as a red hexagon on the surface of the cell, or at the terminal position of a glycoconjugate (glycan), 
while sub-terminal sugars are coloured beige.  
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1.6.1 De novo biosynthesis 
 
Several bacteria including E. coli K1, Neisseria meningitidis and Campylobacter jejuni can synthesise their 
own sialic acid from simple metabolites (Figure 1.6A) (6). This biosynthetic pathway is thought to begin 
with the enzymatic conversion of the cell wall precursor uridine diphosphate (UDP) N-
acetylglucosamine, through to sialic acid, via several enzymatic steps (88; 89). Once synthesised, sialic 
acid is converted into cytidine monophosphate (CMP) sialic acid, an activated form of sialic acid, which 
is subsequently added to appropriate acceptors by linkage-specific sialyltransferases and exported to 
the cell surface (34). Here, appropriate acceptor molecules include lipopolysaccharides (LPS), sialylated 
lipooligosaccharides (LOS) and sialic acid-containing polysaccharide capsules (86). 
 
1.6.2 Donor scavenging 
 
In a second strategy, Neisseria gonorrhoeae also utilises linkage-specific sialyltransferases and CMP-
sialic acid to sialylate their cell surfaces. However, N. gonorrhoeae contain a significantly truncated 
sialylation pathway, deficient in the genes responsible for sialic acid biosynthesis. Therefore, CMP-sialic 
acid must be scavenged exogenously from the host, rather than synthesised endogenously using UDP 
N-acetylglucosamine (90)—a strategy termed donor scavenging (Figure 1.6B). 
 
1.5.3 Trans-neuraminidase activity  
 
This cell surface sialylation strategy identified within Trypanosoma cruzi is unique as this organism 
neither scavenges, nor synthesises sialic acid. Alternatively, T. cruzi has a trans-neuraminidase 
mechanism, which has both neuraminidase and sialyltransferase activity (Figure 1.6C) (91). While the 
neuraminidase activity is responsible for hydrolysing the glycosidic linkage of terminal sialic acid, the 
sialyltransferase activity is responsible for directly transferring the cleaved sialic acid to the cell surface 
of the organism, without requiring activated sialic acid (6; 86).  
 
1.6.4 Precursor scavenging  
 
The most recently discovered strategy of cell-surface sialylation, termed precursor scavenging (Figure 
1.6D), was identified in the bacterial pathogen H. influenzae (92). Like N. gonorrhoeae, H. influenzae has 
a truncated sialylation pathway and is incapable of synthesising sialic acid from the simple metabolite 
UDP-N-acetylglucosamine. As a consequence, it must scavenge host-derived sialic acid by importing 
directly into its cell (86). Once internalised, the host-derived sialic acid is subsequently converted to 




1.7 Catabolism of sialic acid by bacteria 
 
Once host-derived sialic acid is made bioavailable to the pathogenic bacteria, enabling transport into 
the cell, it is then faced with the choice to sialylate their cell-surface and evade the host innate immune 
system, or utilise the sialic acid as a source of nutrition by degrading it into a supply of carbon, nitrogen 
and energy (86; 92). This catabolic process is facilitated by six key steps.  
The first four steps of the sialic acid catabolic pathway involve a sialic acid-specific transporter, 
responsible for the uptake of sialic acid into the bacterial cell (Section 1.5), and three catalytic enzymes 
(22): N-acetylneuraminate acid lyase; N-acetylmannosamine kinase; and N-acetylmannosamine-6-
phosphate 2-epimerase—a suite of proteins collectively known as the N-acetylneuraminate acid (Nan) 
cluster. This cluster has been identified in over 46 bacterial species, with the majority represented by 
human pathogenic bacteria (7).  
Following flux through the Nan cluster, the final steps in the catabolic pathway are facilitated by two 
enzymes, N-acetylglucosamine-6-phosphate deacetylase and glucosamine-6-phosphate deaminase. 
Together, these enzymes are known as the Nag enzymes (N-acetylglucosamine).  
Although clustered, the distribution of the nan genes is variable, where the order of the genes encoding 
these enzymes is known to vary both among and within bacterial families (6; 7). In comparison, the 
genes encoding the Nag enzymes are not clustered and are scattered amongst the genome. The only 
reported exception is within H. influenzae where these genes are closely associated with the Nan cluster 
(6). Taken together, the diversity in sialic acid-specific transporters, the difference in gene organisation 
and the limited distribution of the essential catabolic genes is indicative of ‘mosaic evolution’ (6; 7). Put 
simply, the observed diversity and lack of synteny among bacteria is driven by an individual pressure to 
adapt to their respective hosts and surrounding environment in order to survive.  
Collectively, the metabolic overlap of these enzymes fabricates the core catabolic pathway that 
functions to degrade sialic acid into fructose-6-phosphate, in order to drive the glycolytic cycle (6), or 
yield precursors for peptidoglycan biosynthesis, such as N-acetylglucosamine (34; 35). An illustrative 
overview of this catabolic pathway is presented in Figure 1.7, followed by a summary of each key 
enzyme to emphasise the complexity of this degradative process. Aside from this core catabolic 
pathway, additional genes have been identified or hypothesised to be involved in the catabolism of sialic 





Figure 1.7 | Overview of sialic acid catabolism in bacteria. In brief, the degradation of sialic acid within bacteria is initiated 
by NanA, an enzyme that catalyses the retro-aldol cleavage of sialic acid to yield N-acetyl-D-mannosamine and 
pyruvate via a Schiff base intermediate. This retro-aldol reaction constitutes the first committed step of the 
degradation pathway. N-Acetyl-D-mannosamine is then phosphorylated at the C6 position by NanK, an ATP-
dependent reaction to yield N-acetyl-D-mannosamine-6-phosphate and ADP. Thereafter, NanE inverts the 
stereochemistry of N-acetyl-D-mannosamine-6-phosphate in a reversible epimerisation reaction, generating N-
acetyl-D-glucosamine-6-phosphate. Next, the acetyl group from N-acetyl-D-glucosamine-6-phosphate is 
subsequently removed by NagA, yielding glucosamine-6-phosphate. Finally, the enzyme NagB, catalyses the two-
step isomerisation and deamination of glucosamine-6-phosphate to generate fructose-6-phosphate, which can 
then enter central metabolism via the glycolytic pathway. The reverse reaction is catalysed by glutamine-fructose-
6-phosphate aminotransferase (GlmS). Here, glucosamine-6-phosphate can also yield cell wall precursors for 
peptidoglycan biosynthesis, or surface polysaccharides for poly-N-acetylglucosamine biosynthesis (shown in grey). 
The chemical structure of Neu5Ac and each catabolite along the sialic acid catabolic pathway is shown.  
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1.7.1 N-Acetylneuraminate lyase 
 
Once sialic acid is imported into the cell through one of the dedicated transporters, N-
acetylneuraminate lyase (NanA) is responsible for catalysing the primary and committed step in the 
catabolism of sialic acid (36). Through an aldol condensation via a Schiff base intermediate, N-
acetylmannosamine and pyruvate is formed (93; 94). This aldolase activity is reversible (93) and was 
first identified over 45 years ago in a study by Nees and Schauer using C. perfringens (95).  
NanA enzymes are well characterised across the bacterial pathogens, C. perfringens (95), E. coli (93; 94), 
H. influenzae (96), and S. aureus (97), which revealed a preference for the α-anomer of Neu5Ac (Figure 
1.1A), over the more thermodynamically favourable β-anomer (22; 94). This stereoselective preference 
is a hallmark feature of lyase/ aldolase enzymes (98). Structurally, NanA enzymes display a characteristic 
(β/α)8-barrel domain architecture and present a tetrameric assembly (97; 99), which is essential for 
function (100). Owing to their stability and reversible chemistry, NanA enzymes have been successfully 
utilised in large-scale production of sialic acid for industry  (101). 
 
1.7.2 N-Acetylmannosamine kinase 
 
N-Acetylmannosamine kinase (NanK) is the second enzyme in the core catabolic pathway for sialic acid. 
NanK catalyses the transfer of a phosphate moiety from ADP to the C6 position of N-acetylmannosamine 
to form N-acetylmannosamine-6-phosphate. NanK is a member of the repressor, open-reading frame, 
kinase (ROK) superfamily of proteins and contains an N-terminal adenosine-nucleotide binding domain, 
a zinc-binding domain, and a conserved arginine residue in the active site. This architecture is conserved 
and serves as a trademark for this family (102; 103). Overall, these two domains form a dimeric, 
butterfly-shaped architecture connected by a hinge region. This hinge is believed to facilitate catalysis 
by mediating the movement between an open and closed conformation upon substrate binding (104). 
Among ROK members, the zinc ion has been hypothesised to stabilise the active site (102). However, 
this binding site is absent in all reported NanK enzymes (105; 106), apart from E. coli which coordinates 
zinc predominantly via cysteine residues. This general absence has yet to be explained. 
Structurally, the current understanding of NanK is limited to methicillin-resistant S. aureus (105) and 
Fusobacterium nucleatum (106), with only deposited coordinates of an E. coli and Listeria 
monocytogenes NanK (PDB ID 2AA4 and 4HTL, respectively). Consequently, our mechanistic 
understanding is based on the human bifunctional homolog UDP N-acetylglucosamine 2-epimerase/ N-
acetylmannosamine kinase (102). 
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1.7.3 N-Acetylmannosamine-6-phosphate 2-epimerase 
 
Following the phosphotransferase activity of NanK, the final enzyme of the Nan cluster, N-
acetylmannosamine-6-phosphate 2-epimerase (NanE) catalyses the epimerisation of N-
acetylmannosamine-6-phosphate to form N-acetylglucosamine-6-phosphate (107-109), inverting the 
stereochemistry at the C2 position.  
Mechanistically, carbohydrate-based epimerases can facilitate this epimerisation through five different 
strategies: deprotonation/ re-protonation, carbon-carbon bond cleavage, nucleotide elimination, via 
formation of a transient keto intermediate and mutarotation (110; 111). Supported by proton-NMR 
kinetic experiments, the current understanding is that this mechanism employs the deprotonation/ re-
protonation strategy, mediated via an enolate intermediate (109). However, for this strategy to be 
possible it relies on the substrate undergoing a 180° flip about a carbon-carbon bond. While this has 
been reported in other carbohydrate-based epimerases (112; 113), the molecular determinants in NanE 
has yet to be confirmed, and therefore the true epimerisation strategy remains unclear.   
Structurally, NanE belongs to the triose-phosphate isomerase barrel superfamily, where by virtue the 
domain architecture of NanE contains a (β/α)8-barrel domain, which forms a dimeric assembly through 
an exchange of C-terminal α-helices (107-109). Together, this forms a helix-swapped interface. 
Furthermore, while NanE is conserved among bacteria, it shares no structural homology with human 
UDP-N-acetylglucosamine 2-epimerases. This observation implicates NanE as a viable target for the 
development of novel antimicrobial drugs. 
 
1.7.4 N-Acetylglucosamine-6-phosphate deacetylase 
 
N-Acetylglucosamine-6-phosphate deacetylase (NagA) catalyses the deacetylation of N-
acetylglucosamine-6-phosphate to form glucosamine-6-phosphate, via process that utilises water and 
releases an acetate moiety (114). Although this reaction is the penultimate in the sialic acid catabolic 
pathway, it alternatively serves as the first committed step in the production of cell wall precursors for 
peptidoglycan biosynthesis, or surface polysaccharides for poly-N-acetylglucosamine biosynthesis (34; 
35). This branch point (Figure 1.7) is essential for responding to the metabolic needs of the cell and to 
prevent the futile cycling of amino sugars (115). Importantly, this feature has warranted attention of 
NagA as a viable target for the developmemt of novel antimicrobial drugs (35; 116). 
NagA belongs to the metal-dependent amidohydrolase superfamily and consists of two domains: a 
(β/α)8-barrel domain; and a small β-barrel domain (116). Enclosed by the (β/α)8-barrel domain, the 
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active site is reported to contain one or more divalent metal ions, including Fe2+, Zn2+, Cu2+ and Co2+ 
(117). This metal ion specificity varies between species due to different coordination motifs. The 
presence of these divalent metals ions is essential for activity, where they play a role in stabilising the 
acetate carbonyl oxygen, and the attacking nucleophile, while in the tetrahedral transition state (116). 
Among the NagA enzymes, the majority form a dimeric assembly (35; 118), although E. coli NagA is a 
tetramer in solution (117). 
 
1.7.5 Glucosamine-6-phosphate deaminase 
 
Following the deacetylation of N-acetyl-D-glucosamine-6-phosphate, glucosamine-6-phosphate 
deaminase (NagB) catalyses the final step in the sialic acid catabolic pathway, facilitating the 
isomerisation and deamination of glucosamine-6-phosphate to form fructose-6-phosphate and release 
ammonia. Importantly, fructose-6-phosphate can be directly fed into central metabolism as a glycolytic 
precursor (35; 119). Like NagA, NagB is also a branch point enzyme that determines the metabolic fate 
of glucosamine-6-phosphate. If the intracellular pool of amino sugars is low, glucosamine-6-phosphate 
can be formed from fructose-6-phosphate via the reverse reaction. This is catalysed by glutamine-
fructose-6-phosphate aminotransferase, a process that utilises glutamine and releases glutamate (35; 
120). However, high levels of ammonia have been reported to facilitate the reverse reaction, which is 
catalysed by NagB alone (121; 122).  
NagB is classified in the aldose-ketose isomerase class of proteins, which characteristically catalyse the 
removal of a proton from the C2 position of the aldose and proton transfer to the C1 position of the 
ketose via a cis-enediol intermediate (123). Structurally, the domain architecture of NagB resembles a 
α/β-type Rossmann fold (124), while the quaternary assembly has been observed to vary between 
species. The majority of NagB enzymes display a monomeric assembly (119; 124), although E. coli NagB 
is reported as a hexamer (123), while S. aureus NagB is reported to be dimeric (35). Interestingly, only 
the E. coli hexamer exhibits allosteric regulation by its substrate glucosamine-6-phosphate (123), which 
raises questions about its physiological relevance between NagB homologs.  
 
1.7.6 Supplementary enzymes of sialic acid catabolism  
 
 
In addition to the nan and nag genes, several other genes have been identified as part of the Nan cluster 
in E. coli, which are hypothesised to be involved in the catabolism of sialic acid and provide support to 
the core catalytic pathway (22). Firstly, these include the genes encoded by the nanCMS operon, which 
include the outer membrane porin (NanC); the sialate mutarotase (NanM); and the 9-O-acetylated 
18 
 
Neu5Ac esterase (NanS). Introduced earlier, these genes function to uptake sialic acid across the outer 
membrane (48; 49), catalyse the periplasmic conversion of Neu5Ac to the thermodynamically favoured 
β-anomer (54), and permit growth 9-O-acetylated Neu5Ac (55; 56), respectively. Secondly, encoded by 
the nanATEK-yhcH operon, YhcH is hypothesised to function as an epimerase for N-glycolylneuraminic 
acid, on the basis of the crystal structure solved for this enzyme (125). Furthermore, encoded by the 
yjhBC operon, YjhB and YjhC are hypothesised to function as a permease and oxidoreductase, to uptake 
and process less common forms of sialic acid, respectively (22). However, no experimental evidence 
exists to support this hypothesis. To address this, the uncharacterised yjhBC operon will be investigated 
in Chapter Two and Chapter Three of this thesis.  
 
 
1.7.7 The catabolism of sialic acid is a viable target for antimicrobial development 
 
The human gastrointestinal tract is heavily populated by bacteria (126). As such, this environment is 
largely glucose-limiting and thus is unfavourable for invading pathogenic bacteria to colonise and 
establish infection within the human host (127). To overcome this bottleneck, pathogenic bacteria 
evolved the catabolic machinery necessary to utilise host-derived sialic acid as an alternate source of 
nutrition and gain a competitive advantage over neighbouring microbial residents (23; 128).  
The ability to utilise host-derived sialic acid was first identified within C. perfringens (95) and has since 
been identified in B. fragilis (129), E. coli (24; 36), H. influenzae (39; 92), S. aureus (130), S. enterica 
serovar Typhimurium (7), V. cholerae (23), V. vulnificus (127), and 27 other pathogenic bacteria, 
confined to the Gamma-Proteobacteria class and the Firmicutes phylum (7; 131). Knocking out this 
catabolic machinery in vitro resulted in the inability for these pathogens to grow on sialic acid as a sole 
source of nutrition, suggesting these enzymes serve the only pathway for sialic acid to be degraded (36; 
127; 130). This was demonstrated in vivo using mouse models, where knocking out the nanA gene in E. 
coli and V. cholerae, significantly affected each respective pathogens ability to colonise and persist 
within the host (23; 24). Taken together, this highlights the importance of sialic acid utilisation in 
pathogenic bacteria, which is intimately linked to their fitness and survival within the human host.   
Consequently, the sialic acid catabolic machinery is identified as a viable target for the development of 
novel antimicrobial therapeutics. Drug development could target the uptake of sialic acid across several 
sialic acid-specific transporters, which are unique to bacteria or one of the catabolic enzymes within the 
Nan cluster, such as the lyase (NanA) which catalyses the first committed step in the pathway. The 
dependency on the activity of this enzyme within pathogenic bacteria has been well documented across 
numerous in vitro and in vivo studies. With greater insight into the sialic acid-specific transporter 
proteins, this drug development to could be jointly targeted at both sialic acid transport and catabolism. 
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1.8 Regulation of sialic acid catabolism   
Given the importance of sialic acid to the survival and persistence of pathogenic bacteria, it comes as 
no surprise that its catabolic pathway is regulated to ensure maximum efficiency and provide the 
pathogen a competitive advantage in glucose-limiting environments. The response to altered nutrient 
sources or an inopportune environment is most commonly controlled at the genetic level by 
transcriptional regulators. Here, expression of the catabolic machinery only occurs when the substrate 
is detected at levels that will ensure a sufficient metabolic return for it be utilised as a source of nutrition 
(Figure 1.8) (132; 133)—this is referred to as carbon catabolite repression (134). Without sufficient 
levels of the substrate, expression of the catabolic operon is switched off by the binding of a 
transcriptional regulator to the promoter region, which blocks the activity of RNA polymerase (135).  
 
 
Figure 1.8 | Sensing nutrients in the environment. Bacteria selectively import and catabolise a wide variety of 
nutrients by processes that are tightly regulated in order to efficiently match the environment that the bacterium 
inhabits. However, the immediate environment can rapidly change and thus the ability to quickly adapt to these 
environmental signals (lightning bolt) provide bacteria with a competitive advantage. Mediated by transcriptional 
regulators, this process is achieved through changes in gene expression to upregulate the metabolic enzymes that 
are required to metabolise the available nutrient, such as sialic acid.  
 
The gene expression of the sialic acid catabolic machinery is mediated by a transcriptional regulator that 
is referred to as the N-acetylneuraminic repressor, or herein abbreviated to NanR. In general, NanR 
functions as a gene repressor to negatively control the expression of the Nan cluster, which includes the 
sialic acid-specific transporter and the catabolic enzymes NanA, NanK and NanE (22). As NanR-mediated 
regulation is a feature of this thesis, a general introduction to the domain architecture, protein family 
and mechanism is presented below.  
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Conversely, the expression of the nag genes, which encode the Nag enzymes is controlled by the 
transcriptional regulator, NagC (115; 136). In addition, NagC activates the expression of the glmUS 
operon, which encodes the enzyme machinery to drive peptidoglycan biosynthesis (137). Together, 
regulation of these genes is essential for coordinating amino sugar metabolism in bacteria and to 
prevent futile cycling (115). While there is a limited molecular understanding of this NagC-mediated 
regulation, this was beyond the scope of this thesis.  
Transcriptional regulation aside, catabolic pathways can also be regulated through a feedback 
mechanism, whereby catabolites within the pathway can influence flux through the pathway itself by 
controlling the activity of one or more enzymes by allostery (138). Interestingly, allostery does not 
appear to be a feature of the sialic acid catabolic pathway, as only the E. coli NagB hexamer has exhibited 
allosteric regulation by its substrate, glucosamine-6-phosphate (123).  
 
1.8.1 The structural architecture of NanR transcriptional regulators   
 
In general, NanR is comprised of two domains, which include an N-terminal DNA-binding domain and a 
C-terminal effector-binding domain (Figure 1.9) (22; 139). The N-terminal domain binds DNA with high 
affinity to the promoter region of the catabolic operon, through a helix-turn-helix motif This is a 
common DNA-binding motif amongst bacterial transcriptional regulators, which is defined by a tight tri-
helical structure, where the third α-helix is often referred to as the ‘recognition helix’ (Figure 1.10A), as 
it interacts directly with the major groove of the DNA through electrostatic interaction (140; 141).  
 
Figure 1.9 | Cartoon overview of the sialoregulator NanR. The N-terminal DNA-binding domain (beige) binds DNA 
with high affinity to a specific binding site on the catabolic operon. The binding of an effector molecule (red) to 
the C-terminal domain (blue) propagates a conformational change via a linker region to facilitate a change in 
activity of the repressor, through allosteric regulation.  
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By contrast, the C-terminal domain forms the oligomerisation interface and propagates conformational 
changes upon binding of an effector that decrease the affinity for DNA (derepression), or in some cases 
increase the affinity for DNA (activation) (22; 142). Allosteric regulation is a trademark of bacterial 
transcriptional regulators allowing them to serve as molecular switches, switching gene expression on 
or off (143). The factors that facilitate allosteric regulation in NanR are discussed in more detail below.  
 
1.8.2 The protein family classification of NanR transcriptional regulators   
 
Encoded by the nanR gene, NanR has been identified across a range of bacteria, including E. coli (144), 
H. influenzae (145), S. aureus (130), S. pneumoniae (146) and V. vulnificus (139), where it functions as 
repressor to negatively control the gene expression of sialic acid catabolic machinery in the absence of 
this alternative nutrient.  
Surprisingly, given this overall function, NanR is annotated in two separate protein families, including 
the RpiR family of transcriptional regulators and the GntR family of transcriptional regulators (22; 144). 
While most pathogens contain a RpiR-type NanR, Enterobacteriaceae encode a NanR that belongs to 
the GntR superfamily, one of the most widespread families of transcriptional regulators that regulate 
gene expression through allostery upon binding to metabolites (142).  
There are two main differences between the RpiR and GntR family of transcriptional regulators. Firstly, 
in comparison with RpiR family members, the helix-turn-helix motif of GntR family members is 
characterised by an additional ‘wing’ that interacts with the minor groove of DNA to provide additional 
specificity (Figure 1.10B). This ‘wing’ is formed by a small loop, with two short β-strands following the 
canonical tri-helical structure (147). Secondly, in addition to regulating the Nan cluster, the GntR-type 
NanR has been shown to control the expression of two other operons: 1) nanCMS, responsible for outer-
membrane transport and periplasmic processing; and 2) yjhBC, whose function is currently undefined, 
but is investigated in Chapter Two. This coordinated regulation of multiple operons is known as the 
sialoregulon and is only present in E. coli (144). This unique regulation of sialic acid catabolism will be 









Figure 1.10 | Cartoon overview of the helix-turn-helix and the winged-helix-turn-helix motif. A) The canonical helix-
turn-helix motif. Structurally, this motif is defined by a tight tri-helical structure, where the third α-helix (α3 in red) 
is often referred to as the ‘recognition helix’, as it interacts directly with the major groove of the DNA through 
electrostatic interaction. B) The winged-helix-turn-helix variant of the canonical DNA-binding motif. Structurally, 
this is characterised by an additional ‘wing’ that interacts with the minor groove of DNA to provide additional 
specificity. For clarity, both major and minor DNA grooves are highlighted. 
 
1.8.3 Allosteric mechanism of NanR transcriptional regulators  
 
Allostery plays a critical role in the function of NanR transcriptional regulators (142). This process is 
driven by the binding of an effector molecule to the C-terminal effector-binding domain, which 
propagates a conformation change through the protein to elicit a change in DNA-binding affinity. The 
effector molecule that mediates the activity of NanR is most commonly a degradation product of the 
sialic acid catabolic pathway (148), such as N-acetyl-D-mannosamine-6-phosphate, which has been 
identified as the inducer molecule for NanR from V. vulnificus (149) and S. aureus (130). Although, as an 
exception, sialic acid has been implicated as the inducer molecule in E. coli (144; 148).  
The ability to attenuate the expression of this catabolic machinery on and off is essential for the bacterial 
pathogen to gain a competitive advantage in the human host. Furthermore, constitutive expression of 
the sialic acid-specific transporters would be metabolically unfavourable for the bacterium, resulting in 
undue stress on an already crowded membrane environment. Thus, gene expression is only induced 
when the signal (effector) is present. Some authors believe cytoplasmic accumulation of sialic acid to 
high levels is toxic, inhibiting growth (36), while others provide contradictory evidence (127). Hence, 
further investigation is required to understand this notion. Toxicity aside, the ability to respond rapidly 
to an environmental change is essential in order to utilise sialic acid as a source of nutrition and avoid 
futile cycling.  
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To better understand the allosteric mechanism, the availability of high-resolution structures that 
capture the repressor in different complex states (effector-free, effector-bound, and DNA-bound) is 
essential to map any conformational changes that occur (150). Traditionally, X-ray crystallography has 
been an invaluable tool to characterise these conformations that allow bacterial transcriptional 
regulators to serve as molecular switches (143). In the GntR superfamily, the common feature that 
alleviates the interaction with DNA is a large displacement of the N-terminal DNA-binding domains when 
an effector molecule binds (142; 151; 152). This mechanism is illustrated in Figure 1.11 to provide a 
model for allosteric regulation in NanR.  
 
Figure 1.11 | Cartoon overview for allosteric regulation in the GntR superfamily. A) To regulate the gene expression 
of catabolic enzymes, GntR family members interact with the operator site of the respective catabolic operon. 
When bound to DNA, the repressor prevents the binding of RNA polymerase. B) Upon effector binding (red 
hexagon) to the C-terminal domain (large blue oval), a large structural displacement in the N-terminal DNA binding 
domain (small blue oval), leads to an attenuation of DNA-binding activity.  
 
Among NanR transcriptional regulators, allosteric regulation is poorly understood as there is only a 
single crystal structure solved (Figure 1.12)—the 1.9 Å structure of V. vulnificus in complex with its 
allosteric effector, N-acetyl-D-mannosamine-6-phosphate (PDB ID - 4IVN). This RpiR-type NanR is 
believed to form a dimeric assembly, where DNA is hypothesised to bind between the monomers in an 
arched tunnel-like cavity, mediated by positively charged residues (139). This data allowed the authors 
to propose the mechanism for the transcriptional regulation of sialic acid catabolism. However, 
interpreted from negative stain transmission electron microscopy data and crystal symmetry mates, the 
dimer interface of their functional regulator is unconvincing, as is formed by only four hydrogen bonds 
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and buries less than 3% of the accessible surface area (Figure 1.12). Together, these features would 
support a very weak and transient oligomeric assembly. Moreover, these authors had previously 
demonstrated that V. vulnificus NanR adopts a hexameric assembly in solution (149), as opposed to a 
dimer. Therefore, the active DNA bound conformation and true oligomeric assembly of RpiR-type NanR 
has yet to determined. This open question will be addressed in Chapter Four for the RpiR-type NanR 
from S. pneumoniae.  
 
Figure 1.12 | Crystal structure of the V. vulnificus NanR. The left panel presents the proposed dimeric assembly for 
V. vulnificus RpiR-type NanR in its ‘active state’, in complex with the N-acetyl-D-mannosamine-6-phopshate 
(ManNAc-6P) effector molecule (sticks). Highlighted is the arched, tunnel-like DNA-binding cavity. The right panel 
presents a top view of the transcriptional regulator, where the insert highlights the four hydrogen bonds that form 
the dimeric interface—these are formed between residues, D161-G135 and H163-ManNAc-6P. This figure was 







1.9 Research Aims 
The overall aim of this research is to develop a molecular understanding of sialic acid gene regulation in 
bacteria and investigate the biological role of the uncharacterised yjhBC operon in sialic acid catabolism. 
Despite a number of groups addressing bacterial sialoregulation around the world, surprisingly little 
structural and biophysical data exists to elucidate how the transcriptional regulator functions.  
 
Chapter Two tests the hypothesis that the functional role of the E. coli yjhBC operon is to import and 
process the less common derivatives of sialic acid. This work explores the biological role of E. coli YjhC 
placed in the Gfo/Idh/MocA family of oxidoreductases. Here, a biophysical characterisation and 
structural analysis are presented, highlighting several sialic acid and closely related variants are potential 
substrates for YjhC.  
 
Chapter Three expands the investigation of the E. coli yjhBC operon and aims to understand the function 
of E. coli YjhB. This work describes the overexpression trials of this membrane protein and an in silico 
characterisation to deduce regions of functional importance.  
 
Chapter Four provides a comprehensive study of S. pneumoniae NanR, a member of the RpiR family of 
transcriptional regulators. This chapter describes the purification, reports the binding kinetics, and 
presents novel structural data in solution. Together, this is a substantial step towards structurally and 
functionally understanding how these RpiR-like family of regulators control gene expression.  
 
 
Chapter Five thoroughly investigates the GntR-type NanR from E. coli, reports the first crystal structure 
of a GntR-type sialoregulator and presents a model for the DNA-bound conformation to near atomic 
resolution using cryo-electron microscopy. Through collaboration with Professor Borries Demeler 
(University of Lethbridge), this thesis confirms the stoichiometry of DNA-binding using novel multi-
wavelength sedimentation velocity experiments, which I designed, conducted and analysed. Excitingly, 
this work provides a detailed molecular understanding of how NanR regulates gene expression and 
reveals an unusual mechanism of cooperativity that drives protein-DNA hetero-complex formation.  
 
Chapter Six provides supplementary information to support the model for gene regulation in E. coli. This 
work reports the thermal stability of NanR, describes the attempts at crystallisation of this 
transcriptional regulator with DNA and provides a background for the novel multi-wavelength 
sedimentation velocity experiments used to define to the stoichiometry of the system.  
To summarise, these data enhance our understanding of bacterial sialoregulation, contributes to a 
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2.1.1 yjhBC operon 
 
The E. coli sialoregulon (Figure 2.1) contains three operons that are transcriptionally regulated by the 
GntR-type NanR from E. coli. NanR specifically recognises and binds to tandem repeats of the nucleotide 
sequence GGTATA within the promoter region of these operons controlling their expression (61; 62).  
 
Figure 2.1 | The Escherichia coli sialoregulon. In E. coli, the transcriptional regulator, NanR negatively controls the 
expression of the core operon, nanATEK-yhcH along with the nanCMS operon and uncharacterised yjhBC operon. 
 
The nanATEK-yhcH operon encodes the core catabolic genes responsible for the import and catabolism 
of Neu5Ac—the most common form of sialic acid (63; 64). The genes nanA, nanT, nanE and nanK encode 
a lyase, a sialic acid-specific sugar-proton symporter, an epimerase and a kinase, respectively (64-66). 
While these enzymes are well characterised in E. coli, little is known about the YhcH protein. Although, 
recent studies within Haemophilus influenzae, hypothesise that YhcH functions as an epimerase to 
process the glycolyl form of sialic acid known as N-glycolylneuraminic acid (67); a hydroxylated 
derivative of Neu5Ac common in most mammals, but not synthesised by humans (68; 69).  
The nanCMS operon encodes an outer membrane porin (nanC), responsible for the selective uptake of 
sialic acid (70; 71), a sialate mutarotase (nanM) that facilitates the conversion of the α-anomer of 
Neu5Ac to the thermodynamically favourable β-anomer (72), and a 9-O-acetylated Neu5Ac esterase 
(nanS), which permits growth on this sialic acid derivative (73; 74).  
Although the biological role of the E. coli nanATEK-yhcH and nanCMS operons in sialic acid metabolism 




Bioinformatic analysis places YjhB in the major facilitator superfamily, comparable to the sugar-proton 
symporter NanT, while YjhC is a member of the Gfo/Idh/MocA family of enzymes. Taken together, the 
regulation of yjhBC by the transcriptional repressor NanR suggests that the biological function of these 
genes is involved in sialic acid catabolism, where it been hypothesised they function to catabolise less 
common forms of sialic acid (75). As discussed in Chapter One, Section 1.6, the suite of enzymes that 
catabolise Neu5Ac are excellent candidates for antimicrobial drug development, targeting pathogenic 
bacteria who exploit this nutrient source (76-79). Hence, the structural and functional characterisation 
of these genes will both enhance our understanding of sialic acid catabolism and inform rational drug 
design to this viable target. YjhC is addressed in this chapter, while YjhB is investigated in Chapter Three.  
 
2.1.2 Gfo/Idh/MocA protein family 
 
Through bioinformatic analysis, YjhC is placed in the glucose-fructose oxidoreductase/inositol 
dehydrogenase/rhizopine catabolism (Gfo/Idh/MocA) family of enzymes that utilise nicotinamide 
adenine dinucleotide (NAD) or nicotinamide adenine dinucleotide phosphate (NADP) as a cofactor 
(Figure 2.2) for an oxidoreductase/ dehydrogenase functionality (80). This cofactor plays a key role 
during catalysis by either accepting a hydride ion (oxidation reaction) from, or donating a hydride ion 
(reducing reaction) to the substrate from the C4 position of the nicotinamide ring (80). Typical 
substrates of the Gfo/Idh/MocA family oxidoreductases are pyranose sugars (81-84). Although, some 
members show catalytic activity towards other compounds, such as biliverdin; a product of heme 
catabolism (85) or trans-dihydrodiols; an aromatic hydrocarbon (86). Together, this highlights the 
diverse substrate specificity within the protein family.  
Figure 2.2 | Structures of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide 
phosphate (NADP) cofactors. The additional phosphate group of NADP on the 2’ position of the adenine ribose 
moiety is coloured red. The C4 position of each nicotinamide ring (grey box), which is essential for hydride transfer 




The typical architecture for this protein family consists of two domains; an N-terminal Rossmann fold 
(87), which facilitates the binding of NAD/NADP, and a C-terminal α/β-domain believed to share a role 
in both substrate binding and oligomerisation through a long, predominantly antiparallel β-sheet (Figure 
2.3A) (80). The Rossmann fold is one of the most common and widespread structural motifs within the 
proteome comprising an alternating series of β-strands and α-helices (87; 88). The glycine-rich residues 
located in a turn between the first β-strand and α-helix can serve as a fingerprint for cofactor specificity, 
interacting with the pyrophosphate bridge of NAD(P) (Figure 2.3B) While NAD binding enzymes normally 
possess a GxGxxG consensus sequence after the first β-strand (89), a GxGxxA motif usually correlates 
with NADP binding by the enzyme (90; 91).  
 
 
Figure 2.3 | Typical architecture of the Gfo/Idh/MocA protein family and the Rossman fold. A) The N-terminal 
domain contains the distinctive Rossmann fold which facilitates the binding of the NAD/NADP cofactor (grey). The 
C-terminal α/β-domain believed to share a role in both substrate binding and oligomerisation (blue). The long, 
predominantly antiparallel β-sheet is a feature of this protein family. B) The β1- α1- β2- α2 segment forms the 
Rossmann fold. The glycine-rich loop that specifically recognises either NAD or NADP is highlighted in yellow, 
located between the first β-strand and α-helix (blue) of the Rossmann fold. The GxGxxG motif recognises NAD, 
while a GxGxxA motif binds NADP. Together, these motifs serve as the fingerprint for cofactor specificity within 
the Rossmann fold. The monomeric subunit is modelled from the Caulobacter crescentus aldose-aldose 
oxidoreductase (PDB 5A02), a member of the Gfo/Idh/MocA family as a representative structure. 
 
Despite numerous crystal structures of Gfo/Idh/MocA protein family members (defined by the Pfam ID: 
PF01408) within the PDB, most of these structures are part of structural genomics projects where only 
the coordinates are reported. Unfortunately, those linked to publications are rarely in complex with 




catalytic reaction. However, the consensus motif AGKHVxCEKP has been identified as a fingerprint of 
sugar dehydrogenases (92), where the second lysine residue (in bold) has been suggested to play a 
fundamental role in the catalytic reaction (82). As an example in the myo-inositol dehydrogenase from 
Bacillus subtilis, this lysine residue is involved in a catalytic triad (93), where it assists in positioning the 
substrate for catalysis and is part of a proton relay system between neighbouring residues. When this 
lysine residue was mutated to valine, all dehydrogenase activity was abolished, supporting that lysine 
performs an integral role in the catalytic mechanism (93). Moreover, surrounding residues coordinate 
the substrate and additionally may play a role in the catalytic mechanism, dependent upon the 
chemistry (80). 
While Gfo/Idh/MocA family members all have similar tertiary structure, their quaternary assembly is 
seen to vary predominantly between a dimeric and tetrameric assembly (80), although a monomeric 
structure has been reported (94). Further, the sequence identity between proteins is typically below 
20%—a consequence of their diverse functionality. Of the dimeric structures, the most common 
assembly reported is formed by packing the long, flat-faced β-sheet of the C-terminal domain against 
the opposing monomer to form a rigid, sandwich-like structure, mediated by face-to-face hydrophobic 
interactions (Figure 2.4A) (81). Alternatively, a similar interface has been observed between opposing 
monomers, although another face of the β-sheet is utilised (Figure 2.4B) (83). In the tetrameric 
structures, two different interface assemblies are also observed. One of these is comparable to the most 
prevalent dimeric interface, although an additional dimer interacts alongside the other to form an 
extensive, flat-faced β-sheet in what can be described as a dimer of dimers (Figure 2.4C). The glucose-
fructose oxidoreductase from Zymomonas mobilis is an example of this tetrameric assembly.  
Interestingly, this enzyme contains an N-terminal extension, which protrudes into the neighbouring 
monomer, assisting in the stabilisation of the assembly and coordination of the cofactors adenine 
moiety—a novel feature of this protein (82). Conversely, the other tetramer forms a weaker, more 
transient assembly utilising the face of the N-terminal domain as opposed to the long, flat-faced β-sheet 





Figure 2.4 | The quaternary structure is observed to vary between Gfo/Idh/MocA family members. A) The most 
common dimeric assembly is formed by packing the long, flat-faced β-sheet of the C-terminal domain against the 
opposing monomer to form a rigid, sandwich-like structure, mediated by face-to-face hydrophobic interactions 
through face (PDB ID 5A02). B) This dimeric assembly utilises another face of the β-sheet (PDB ID 1DPG). C) 
Analogous to A, this tetrameric assembly is formed by an additional dimer interacting alongside the other to form 
an extensive long, flat-faced β-sheet in what can be described as a dimer of dimers. Note the novel N-terminal 
extension that protrudes to the neighbouring monomer in the glucose-fructose oxidoreductase from Z. mobilis 
(PDB ID 1H6D). D) This tetrameric assembly utilises the face of the N-terminal domain as opposed to the long, flat-
faced β-sheet within the C-terminal domain (PDB ID 3O9Z). 
 
2.2 Chapter overview 
 
This chapter will investigate the hypothesis that the yjhBC operon functions to import and process the 
less common derivatives of sialic acid by presenting a functional and structure-based approach to 
address whether YjhC is a bona fide oxidoreductase and is truly involved in sialic acid catabolism. 










On the structure and function of Escherichia coli YjhC: an oxidoreductase involved in bacterial 
sialic acid metabolism. 
Short title: 
 
On the structure and function of E. coli YjhC.  
Authors: 
Christopher R. Horne a, Laura Kind b, James S. Davies a, Renwick C.J. Dobson a,c,* 
 
Author Affiliations: 
a) Biomolecular Interaction Centre and School of Biological Sciences, University of 
Canterbury, PO Box 4800, Christchurch 8041, New Zealand. 
b) Department of Biomedicine, University of Bergen, Bergen 5020, Norway. 
c) Bio21 Molecular Science and Biotechnology Institute, Department of Biochemistry and 
Molecular Biology, University of Melbourne, Parkville, Victoria 3010, Australia. 
 
Acknowledgements: 
This work was supported by the following funding to R.C.J.D: 1) the New Zealand Royal Society Marsden 
Fund (contract UOC1506); 2) a Ministry of Business, Innovation and Employment Smart Ideas grant 
(contract UOCX1706); and 3) the Biomolecular Interaction Centre (University of Canterbury). This work 
was also supported by funding from the Canterbury Medical Research Foundation to C.R.H. We 
acknowledge the Australian Synchrotron, the staff at the MX2 beamline and Dr Nigel Kirby and Dr Tim 
Ryan for provision of synchrotron facilities along with their assistance in using the beamlines. This 
research was undertaken in part using the MX2 beamline at the Australian Synchrotron, part of ANSTO, 
and made use of the ACRF detector. We thank Professor Antony Fairbanks and Dr Stewart Alexander 
for the chemical synthesis of the sialic acid 1,7 lactone. We thank Dr Rachel North for her insight on 






Human pathogenic and commensal bacteria evolved the ability to scavenge host-derived sialic acids and 
subsequently degrade them as a source of nutrition. Expression of the Escherichia coli yjhBC operon is 
controlled by the repressor protein nanR, which regulates the core machinery responsible for the import 
and catabolic processing of sialic acid. The role of the yjhBC encoded proteins is not known—here we 
demonstrate that the enzyme YjhC is an oxidoreductase involved in bacterial sialic acid degradation. 
First, we demonstrate in vivo using knockout experiments that YjhC is broadly involved in carbohydrate 
metabolism, including that of N-acetyl-D-glucosamine, N-acetyl-D-galactosamine and N-
acetylneuraminic acid. Differential scanning fluorimetry demonstrates that YjhC binds N-
acetylneuraminic acid and its lactone variant, along with NAD(H), which is consistent with its role as an 
oxidoreductase. Next, we solved the crystal structure of YjhC in complex with the NAD(H) cofactor to 
1.35 Å resolution. The protein fold belongs to the Gfo/Idh/MocA protein family. The dimeric assembly 
observed in the crystal form is confirmed through solution studies. Ensemble refinement reveals a 
flexible loop region that may play a key role during catalysis, providing essential contacts to stabilize the 
substrate—a unique feature to YjhC among closely related structures. Guided by the structure, in silico 
docking experiments support the binding of sialic acid and several common derivatives in the binding 
pocket with an overall positive charge distribution. Taken together, our results verify the role of YjhC as 
a bona fide oxidoreductase/dehydrogenase and provide the first evidence to support its involvement in 
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Mammalian cell surfaces are decorated with a complex array of glycoconjugates (1; 2). Located at the 
termini of many cell surface glycoconjugates are sialic acids—a family of nine-carbon amino 
monosaccharide units (3) that are comprised of more than 50 naturally occurring and structurally 
distinct variants (4). The most common form of sialic acid is N-acetylneuraminic acid, herein abbreviated 
to Neu5Ac (Figure 1A) (3; 4), while other common variants include the lactone (between carbon 1 and 
7) and the 9-O-acetylated derivatives of Neu5Ac (Figure 1B). Given their terminal location on 
glycoconjugates, these negatively-charged amino sugars mediate a diverse array of cellular interactions 
(recognition and adhesion processes), through carbohydrate-binding proteins and their associated 
receptors (1; 2). 
 
Figure 1 | Structure of common sialic acids and overview of the Escherichia coli sialoregulon. A) N-Acetylneuraminic 
acid. The most abundant and best studied of the sialic acids. Carbons within the chemical structure are labelled 
one through to nine. Substitutions at various hydroxyls (red asterisk) with acetyl moieties or less commonly, 
phosphate, lactate or succinyl moieties leads to over 50 naturally occurring and structurally distinct derivatives. B) 
The 9-O acetylated derivative and the sialic acid 1,7 lactone derivative are the second and third highest detected 
sialic acid derivatives in the human gut (5; 61). C) Regulation of sialic acid catabolism. In Escherichia coli, the 
transcriptional regulator, NanR negatively controls the expression of the core operon nanATEK-yhcH, along with 
the nanCMS and yjhBC operons; collectively this is termed the sialoregulon. 
 
Pathogenic and commensal bacteria evolved the ability to scavenge host-derived sialic acids (3), which 
are a source of carbon, nitrogen and energy (5). In addition, the catabolism of sialic acids yields 
precursors for peptidoglycan biosynthesis, such as N-acetylglucosamine (6; 7). Lastly, some bacteria can 
decorate their cell surfaces with host-derived sialic acids to camouflage themselves against the host 




utilization offers pathogenic bacteria and commensals, such as Escherichia coli, a competitive advantage 
to colonize and persist within the human host (1; 9; 10).  
In E. coli, the nanATEK-yhcH operon encodes a lyase (nanA), a sugar-proton symporter (nanT), an 
epimerase (nanE), and a kinase (nanK), which together are essential for the utilization of Neu5Ac (5; 6; 
8). The expression of these enzymes from the nanATEK-yhcH operon is controlled by a transcriptional 
regulator, NanR, which is in turn regulated by the presence of sialic acids (11). In addition to this core 
operon, NanR also regulates the nanCMS and yjhBC operons, collectively termed the sialoregulon 
(Figure 1C) (11). The nanCMS operon encodes an outer membrane porin (nanC), which is responsible 
for the selective import of sialic acid (12; 13), a sialate mutarotase (nanM) that catalyses the periplasmic 
conversion of the α-anomer of Neu5Ac to the thermodynamically favourable β-anomer (14), and a 9-O-
acetylated Neu5Ac esterase (nanS) that permits growth on this sialic acid derivative (15). Although the 
biological role of both the E. coli nanATEK-yhcH and nanCMS operons in sialic acid metabolism is 
reasonably well understood, the biological role of the yjhBC operon has yet to be established—here we 
focus on the role of yjhC.  
YjhC is hypothesized to function as an oxidoreductase for less common forms of sialic acid (5). Our 
bioinformatic analysis places YjhC in the Gfo/Idh/MocA family of oxidoreductase/ dehydrogenase 
enzymes that use nicotinamide adenine dinucleotide (NAD) or nicotinamide adenine dinucleotide 
phosphate (NADP) as a cofactor. This analysis was achieved via a sequence homology search (see 
Materials and Methods). Typical substrates of the Gfo/Idh/MocA family oxidoreductases include 
pyranose sugars (16; 17), although some members have shown catalytic activity towards other 
substrate types, such as biliverdin; a product of heme catabolism (18) or trans-dihydrodiols; an aromatic 
hydrocarbon (19).  
Here we address two research questions: 1) Is YjhC involved in amino sugar catabolism? and 2) Is YjhC 
a bona fide oxidoreductase/dehydrogenase? To address these questions, we used BiOLOG Phenotype 
Microarrays (20) to report on the biological role of YjhC, along with thermal shift assays to screen 
potential substrates for binding. Further, we have solved the crystal structure of E. coli YjhC in complex 
with the cofactor NAD(H) at a resolution of 1.35 Å. Guided by the structure, the substrate-binding pocket 
was examined, and using in silico docking experiments, we support the binding of the acidic sugar, 
Neu5Ac in its cyclized and open-chain forms, along with the sialic acid 1,7 lactone and the 9-O-







Materials and Methods 
 
Bioinformatics  
To search and compare protein sequences for YjhC, the basic local alignment search tool (BLAST) 
program and BLASTp (21) was used. The DALI server (22) was used for protein structure comparison. 
Multiple sequence alignments of YjhC homologues with known atomic structures were generated using 
Clustal Omega (23) and visualized using ESPript 3.0 (24). Amino acid sequences and atomic structures 
of homologues were sourced from the UniProt database and Protein Data Bank (PDB), respectively. 
Cloning of the YjhC expression construct 
The gene encoding YjhC from E. coli (UniProt-P39353) was synthesized commercially by GenScript and 
supplied in a cloning vector, designated pUC57. In order to use a N-terminal His-tag, the yjhC gene was 
digested from pUC57 using the high-fidelity restriction enzymes BamHI and HindIII (New England 
Biolabs), gel purified and ligated with T4 DNA ligase (Takara) to generate pET30ΔSE/yjhC. The pET30ΔSE 
expression vector, conferring kanamycin resistance was kindly supplied by Dr Hironori Suzuki. The 
recombinant expression vector was transformed into DH5α competent cells, purified using a DNA-Spin™ 
Plasmid DNA Purification Kit (iNtRon Biotechnology), and verified by DNA sequencing (Macrogen). 
Expression and purification of recombinant YjhC 
The pET30ΔSE/yjhC construct was transformed into E. coli BL21(DE3) competent cells (Agilent) and 
grown in Luria Broth (LB) supplemented with kanamycin (30 mg mL-1) at 37 °C, with shaking at 220 rpm. 
Expression of YjhC was induced mid-log phase (OD600 ≈ 0.6) by the addition of isopropyl β-D-1-
thiogalactopyranoside to 1 mM and incubated overnight at 26 °C. Cells were harvested by centrifugation 
(Thermo Sorvall RC-6-Plus centrifuge) at 8,000 rpm for 10 min and resuspended in buffer A (20 mM 
Tris−HCl (pH 8.0), 500 mM NaCl, 40 mM imidazole). The cells were lysed by sonication (Hielscher UP200S 
Ultrasonic Processor) on ice, and cellular debris was pelleted by centrifugation at 16,000 rpm for 30 
min. 
Purification of YjhC was conducted via a two-step procedure: immobilized-metal affinity 
chromatography (IMAC) and size-exclusion chromatography (SEC). For IMAC the soluble cell lysate was 
applied onto a His-Trap FF Crude 5 mL column (GE Healthcare) pre-equilibrated with buffer A. The 
column was washed with buffer A until a steady baseline absorbance was observed. YjhC was eluted 
using buffer B (20 mM Tris−HCl (pH 8.0), 500 mM NaCl, 400 mM imidazole). Fractions were analyzed by 
SDS-PAGE and the protein containing fractions were pooled. The sample was spin-concentrated to 500 
µL, filtered through a 0.2 µm filter to remove aggregate, and loaded onto a Superdex 200 Increase 




NaCl), for further purification and removal of any aggregates. YjhC was purified to near homogeneity as 
visualized by SDS-PAGE (Supplementary Figure 1). The absorbance at 280 nm (A280) of the purified 
protein was measured using a Cary 100-Bio UV-Vis spectrophotometer (Agilent Technologies) and the 
concentration estimated using a molar extinction coefficient of 42,400 M-1 cm-1 at 280 nm, as calculated 
by ProtParam (25). All purification steps were carried out at 4 °C. Purified YjhC was flash-frozen in liquid 
nitrogen for storage. 
BiOLOG Phenotype MicroArray 
Commercially available BiOLOG Phenotype MicroArray plates were used to explore the biological role 
of YjhC. For this experiment, the BL21(DE3) strain was used as the wild-type, while the chromosomal 
yjhC knockout strain, defined as ΔyjhC:kan strain was obtained from the E. coli Genetic Stock Centre. 
The 96-well Phenotype MicroArray plates were pre-configured with a variety of compounds and a 
tetrazolium redox dye, which enabled the phenotypic reaction of growing cells to be monitored in a 
high-throughput system. Both PM1 and PM2A carbon Phenotype Microarrays were used in this 
experiment.  
For preparation of the inoculum, cells were initially streaked and grown overnight at 37 °C on LB-agar 
plated media supplemented with 30 mg mL-1 kanamycin. After incubation, cells were resuspended in IF-
0a inoculating fluid to an OD600 of 0.035 using a Cary 100 Bio UV/Vis spectrophotometer (Agilent 
Technologies). This inoculum was then combined with the tetrazolium redox dye according to the 
manufacturer’s instructions. Carbon sources were rehydrated by adding 100 µL of the inoculum solution 
to each plate well (position A1 did not have a carbon source and therefore served as a 
reference/negative control) and incubated aerobically without shaking at 37 °C. Metabolism of the 
various carbon sources was monitored spectrophotometrically at 570 nm using a SpectraMax M5 plate 
reader (Molecular Devices) over a 48 h period. The reduction of the tetrazolium dye caused a purple 
color to develop, which is indicative of active respiration and metabolism of the respective compound. 
For analysis, the OD570 for the reference (position A1) was subtracted from each well and then plotted 
against each strain to generate a kinetic growth curve. Here, a major phenotypic change between strains 
was defined as a difference in the rate of respiration by more than 50% after 24 h growth (late log 
phase), on the same carbon source. The entire experiment was performed in duplicate for both wild-
type and ΔyjhC:kan bacterial strains. The kinetic growth curves for the PM1 and PM2A plates are 
presented as supplementary data, along with the contents of each plate (Supplementary Figure 2 and 
3). The IF-0a inoculating fluid, tetrazolium dye mix, and carbon utilization plates (PM1 and PM2A) were 





Ligand screening using differential scanning fluorimetry 
The QuantStudio 3 real-time PCR system (ThermoFisher Scientific) was used to record the thermal 
stability of the purified protein with and without potential substrates. Reactions consisted of 10 µM 
protein, 5x SYPRO Orange (prepared as a 50x stock) and the desired concentration of potential substrate 
(Carbon source = 40 mM, NAD(P) = 5 mM) in a final reaction volume of 25 µL. Samples were heated 
from 4 °C to a 95 °C at a ramp rate of 0.05 °C, taking fluorescent readings at each time point. Triplicate 
measurements were performed for each sample. To validate the experiment, one positive control using 
a well-characterized melting curve (lysozyme at 10 µM) , along with two negative controls (protein only 
and dye only) were conducted. Data analysis was performed using Protein Thermal Shift software 
(version 1.3–Applied Biosystems), where an apparent melting point (Tm) of each sample in °C was 
obtained from the lowest point of the first derivative plot. A summary of all Tm is shown in 
Supplementary Table 1. 
Crystallization, data collection and structure determination of YjhC  
Initial crystallization trials for E. coli YjhC were performed in-house using the PACT premier, Clear 
Strategy 1, and Clear Strategy 2 commercial screens (Molecular Dimensions). Trials were conducted 
using the sitting-drop vapor-diffusion method at 20 °C with droplets consisting of 400 nL protein solution 
and 400 nL reservoir solution. Purified YjhC was concentrated to 12 mg mL-1 in buffer C, supplemented 
with 5 mM of the cofactor NAD, which was identified using differential scanning fluorimetry (Figure 2 
and Supplementary Table 1). The crystals were cryo-protected by soaking in 85% reservoir solution and 
15% glycerol-ethylene glycol (50:50 mix) prior to being flash-frozen in liquid nitrogen. Condition A1 (1.5 
M ammonium sulfate, 0.1 M sodium acetate pH 5.5) from Clear Strategy 2 produced large crystals after 
four weeks growth. The crystals produced in this condition were suitable for diffraction. Diffraction data 
were collected (λ = 0.9537 Å) using the MX2 beamline at the Australian Synchrotron with the EIGER X 
16 M detector. Data was processed using XDS (26) and AIMLESS from the CCP4 program suite (27).  
Details of the data collection statistics are summarized in Table 1.  
The structure of YjhC was initially solved using Auto-Rickshaw (28) to 1.94 Å resolution, in the 
spacegroup P212121. Crystallographic phases were determined by molecular replacement using chain A 
of PDB entry 5A02; an aldose-aldose oxidoreductase from Caulobacter crescentus (17) with a sequence 
identity of 24%. Diffraction data was collected without the use of cryo-protectant, using litho-loops. The 
refined output model at 1.94 Å from Auto-Rickshaw (28) was used as a search model for molecular 
replacement to solve the structure of YjhC at 1.35 Å using PHASER (29). The model was refined using 
REFMAC5 (30) from the CCP4 program suite, and PHENIX REFINE (31). To eliminate model bias, 




including the addition of ligand and water molecules were performed in COOT (32). Water molecules 
were manually assessed to fit to the observed density and for hydrogen bonding partners. Final 
refinement was performed using translation-libration-screw (TLS) refinement to produce a final model 
of E. coli YjhC refined to a Rwork and Rfree value of 14.98% and 16.87%, respectively. Model validation was 
performed using MOLPROBITY (33). Details of the structural refinement and model validation are 
summarized in Table 1. To capture possible substrate leads (Neu5Ac and sialic acid 1,7 lactone) in the 
binding cavity of YjhC, crystals from condition A1 were soaked in cryo-protectant containing 80% 
reservoir solution, 10% glycerol-ethylene glycol (50:50 mix), and 10% of either Neu5Ac or sialic acid 1,7 
lactone, each at a final concentration of 20 mM prior to data collection.  
Ensemble refinement  
Ensemble refinement was used to evaluate the dynamics and model sources of disorder simultaneously 
within the final atomic model. Following TLS refinement in PHENIX REFINE (31), all missing residues or 
truncated side chain atoms (due to insufficient electron density) were added using COOT (32). Any 
alternative conformations within the model are automatically removed, while all occupancies are set to 
one. An ensemble of structures was generated by time-averaged refinement using PHENIX ENSEMBLE 
REFINEMENT (34). The averaging time (τx) of structure factors used during the refinement was selected 
based on the resolution of the diffraction data. Harmonic restraints were applied to all three sulfate 
ions to prevent stochastic displacement—two were placed at the interface and one closer to the active 
site. To model the contribution of intramolecular disorder an overall TLS model was applied using one 
group per chain (34) with a pTLS of 0.8, which defines the number of atoms included in the TLS 
refinement. A total of 100 ensemble structures were reported where the Rwork and Rfree values decreased 
by 1.9% and 0.9%, respectively. Refinement statistics are presented in Supplementary Table 2. 
Analytical ultracentrifugation  
Sedimentation velocity experiments were performed with a XL-I analytical ultracentrifuge (Beckman 
Coulter) using double sector quartz cells and epon center-pieces in an An-50 Ti 8-hole rotor. Data was 
obtained at 45,000 rpm using 380 µL protein at three different concentrations (7, 14 and 20 µM) in 
buffer C as the sample, and 400 µL buffer C as the reference. A total of 100 scans were collected at 20 
°C using radial absorbance scans at 280 nm and a step size of 0.003 cm. All data were analyzed using 
UltraScan 4.0, release 2578 (35). Sedimentation data were evaluated by the two-dimensional spectrum 
analysis (2DSA) (36), which affords an unbiased hydrodynamic model, where the sedimentation 
coefficient and frictional ratio (f/f0) can be floated independently. Furthermore, 50 Monte-Carlo 
iterations were performed on the 2DSA data set providing 95% confidence intervals for all measured 




buffer viscosity and an estimate of the partial specific volume of the protein sample based on the amino 
acid sequence were determined using UltraScan. Data analysis are summarized in Table 2.  
Small angle X-ray scattering 
Small angle X-ray scattering (SAXS) data were collected on the SAXS/WAXS beamline equipped with a 
Pilatus 1M detector (170 mm × 170 mm, effective pixel size, 172 μm × 172 μm) at the Australian 
Synchrotron. A sample detector distance of 1600 mm was used, which provided a q range of 0.006-0.5 
Å-1. 50 µL of purified YjhC protein (8 mg mL-1) was injected onto an inline Superdex S200 Increase 5/150 
GL SEC column (GE Healthcare), equilibrated with 20 mM Tris–HCl (pH 8.0), 150 mM NaCl, 
supplemented with 5% (v/v) glycerol and 0.1% (w/v) sodium azide, using a flow rate of 0.45 mL min-1. 
Coflow SAXS was used to minimize sample dilution and maximize signal to noise (37). Scattering data 
was collected in one second exposures (λ = 1.0332 Å) over a total of 400 frames, using a 1.5 mm glass 
capillary, at 12 °C. 2D intensity plots were radially averaged, normalized to sample transmission, and 
background subtracted using the Scatterbrain software package (Australian Synchrotron).  
Analysis of the scattering data was performed using the ATSAS software package (version 2.8.4) (38).  
PrimusQT (39) was used to perform the Guinier analysis and to generate the pairwise distribution 
function P(r), calculated using an indirect Fourier transform. Molecular mass was estimated using the 
SAXS-MoW2 package (40), while CRYSOL (41) was used to evaluate the solution scattering from the 
known atomic coordinates of YjhC (solved in this study) by fitting to the experimental scattering data. 
Data collection and analysis are summarized in Table 2.  
In silico docking experiments 
The molecular interactions that may occur between a small molecule and a protein were predicted using 
the web service SwissDock (42) interfaced with the CHARMM package (43).To initiate docking, we 
defined a search space around the center of mass of our suspected binding cavity as a set of x, y and z 
coordinates (x center/size = -13.76/17.57; y center/size = 1.11/15.70; z center/size = -19.20/17.85). 
Secondly, the target protein and ligand were processed to remove the solvent, repair any truncated 
sidechains using a rotamer library, add hydrogens, assign partial charges and convert all files to a Mol2 
file format. Binding modes were then scored using their estimated binding free energy and full fitness, 
which is defined as the total energy of the system along with a solvation term. All docking results were 
visualized in UCSF Chimera (44) using ViewDock. The binding modes are summarized in Supplementary 






NAD kinetic assay 
Kinetic analysis of YjhC was performed using a Cary 100 Bio UV/Vis spectrophotometer (Agilent 
Technologies), where the reaction was observed by measuring the increase in absorbance at 340 nm 
due to the consumption of NAD+. Assays were performed in duplicate, using acrylic cuvettes with a path 
length of 1 cm. All assay mixtures were equilibrated at 25 °C for 20 min using the heat-controlled Peltier 
module, prior to measurement. All other stock solutions were kept on ice. The assay mixture consisted 
of: 20 mM Tris–HCl pH 8.0, 150 mM NaCl, 2 mM NAD+ (Sigma-Aldrich) and Neu5Ac (Carbosynth), which 
varied from 5 mM to 60 mM (980 µL total). The assay was initiated following the additional of 20 µL 
YjhC at a final concentration of 0.05 µM. The assay was repeated using sialic acid 1,7 lactone as the 
substrate and 0.2 mM NADH (Sigma-Aldrich). In this experiment, the reaction was observed by 
measuring the decrease in absorption at 340 nm due to the conversion of NADH to NAD+. Controls 
without enzyme were performed to measure the background turnover of NAD+/NADH in solution. All 
initial rate data were analyzed and fitted with the Michaelis-Menten model using Prism 8.2.0 (GraphPad 
Software, La Jolla California USA).  
 
Results and Discussion 
 
YjhC is involved in amino sugar catabolism  
 
A protein’s primary sequence is often used to predict its function. However, it is estimated that 
approximately one-third of all bacterial proteins have such low sequence similarity to do this accurately, 
meaning many databases annotate protein sequence with an incorrect function (45; 46). This is often 
the case with homologous proteins that have diverse substrate specificities (47), such as the 
Gfo/Idh/MocA family. To investigate the function of the oxidoreductase YjhC and its predicted role in 
sialic acid catabolism, two approaches were taken.   
First, we examined the phenotypic consequence of knocking out the yjhC gene of E. coli, when grown 
in a range of different carbon sources by using the BiOLOG Phenotype MicroArray system. In this 
experiment, the overall metabolic activity of the yjhC knockout was significantly reduced compared with 
the wild-type when grown in 15 different carbon sources (Figure 2A). These were L-arabinose, D-
arabinose, N-acetyl-D-glucosamine, D-trehalose, D-mannose, D-mannitol, D-fructose, α-D-glucose, 
maltose, α-D-lactose, N-acetyl-D-galactosamine, maltotriose, N-acetylneuraminic acid, β-D-allose, and 
D-galactonic acid-γ-lactone. Interestingly, most of these carbon sources are carbohydrates (Figure 2B), 
where the pyranose sugars displayed the most pronounced catabolic divergence to the wild-type, as 




the metabolic activity of the yjhC knockout was observed for four different carbon sources; D-saccharic 
acid, mucic acid, D- malic acid and L-malic acid, when compared with the wild-type (Figure 2A)—the 
reason for this increase was not clear. Phenotype MicroArrays measure respiration, not growth. As such, 
where there is reduced metabolism for the yjhC knockout compared to the wild-type, the cells may be 
incapable of converting these sole carbon sources into the downstream metabolites required for cell 
division, thus leading to potential false negatives (48). Overall these data support the annotation of YjhC 
within the Gfo/Idh/MocA family, with a pyranose sugar as their likely substrate. 
 
Figure 2 | In vivo (BiOLOG Phenotype MicroArray) and in vitro (Thermal shift) experiments argue that YjhC is involved 
in amino sugar metabolism.  A) The metabolic activity of the yjhC gene knockout is significantly reduced (shown in 
blue) for 15 different carbon sources, when compared with the wild-type. Comparatively, an increase in metabolic 
activity (shown in orange) of the yjhC gene knockout is observed for four different carbon sources. B) The carbon 
sources that significantly affect metabolic activity are presented in categories. Here, carbohydrate-based carbon 
sources provide the greatest metabolic divergence when the yjhC gene is knocked out. C) The thermal stability of 
YjhC in the presence of NAD+ (52.4 ± 0.2, colored in dark blue) and together with Neu5Ac (55.2 ± 0.1, colored in 
orange). D) The thermal stability of YjhC in the presence of NADH (53.5 ± 0.1, colored in light blue) and together 
with the sialic acid 1,7 lactone derivative (54.4 ± 0.1, colored in purple). The thermal stability of YjhC without any 
substrate is 46.5 ± 0.1 (colored in red). The unfolding temperature (Tm) is calculated from the first derivative of 
the relative fluorescence units (RFU) of the SYPRO Orange dye as a function of temperature (°C). Here, the Tm is 




Next, we used differential scanning fluorimetry to test whether the compounds implicated in the 
Phenotype MicroArray experiment bound directly to YjhC. Binding is indicated by a positive or negative 
thermal shift of the unfolding temperature for the protein (Tm) (49). To verify the role of YjhC as a bona 
fide oxidoreductase, the cofactors NAD+ and NADP+ were screened. The addition of NAD+ produced a 
positive thermal shift of 5.85 °C (Figure 2C), whereas NADP+ had no significant change (0.12 °C). NADH 
produced a similar shift to the oxidized cofactor of 6.94 °C (Figure 2D). Within the Gfo/Idh/MocA family, 
members who modify carbohydrates typically catalyze their respective reactions via a ping-pong 
mechanism, where the cofactor binds first, followed by the substrate (16; 17; 50). In the absence of 
NAD+/NADH, the carbon compounds tested gave only small thermal shifts, within a range of 0.06-0.37 
°C, which we did not consider significant (Supplementary Table 1). However, in the presence of 
NAD+/NADH, both Neu5Ac and the sialic acid 1,7 lactone had a significant effect on the thermal stability 
of YjhC with an additional thermal shift of 2.86 and 0.98 °C, respectively (Figure 2C-D). The remaining 
carbon compounds did not significantly affect the thermal stability and only produced thermal shifts 
between 0.01-0.48 °C (Supplementary Table 1).  
Taken together, our Phenotype MicroArray and differential scanning fluorimetry experiments suggest 
that Neu5Ac or analogous sialic acid variants could be the biologically relevant substrate of YjhC. 
Moreover, we show that YjhC can preferentially bind the cofactor NAD(H) over the cofactor NADP(H), 
















YjhC adopts a common oxidoreductase architecture 
 
To add further weight to the hypothesis that YjhC is a bona fide oxidoreductase, as predicted from the 
bioinformatic analysis and thermal shift assays, the structure was solved at a resolution of 1.35 Å (Table 
1). The structure is in complex with NAD(H) and has two monomers in the asymmetric unit that associate 




Figure 3 | Structure of E. coli YjhC in complex with NAD(H). A) The dimeric assembly present in the asymmetric unit 
(spacegroup P 212121). The disordered region (residues 288-301) is shown as a yellow dotted line. Chains A and B 
are shown in blue and green, respectively. NAD(H) is shown in a stick representation. The omit map corresponding 
to NAD(H) in chain A is shown as an insert (black dotted line). Here, the 2Fo-DFc electron density map (1.0 σ, blue 
mesh) and the mFo-DFc omit electron density map (3.0 σ, green mesh) is shown. B) Monomeric subunit structure 
of E. coli YjhC in complex with NAD(H). Colors are assigned based on secondary structure. The N-terminal domain 
(residues 1-117) containing the distinctive Rossmann fold is colored yellow, red and green. The C-terminal α/β 
domain (residues 118-268) is colored magenta, cyan and pink. Alpha (α) helices and beta (β) strands are labelled 
sequentially. C) Close-up view of the active site and NAD(H) binding pocket. Residues within ~3.2 Å of the cofactor 
are shown (colored as in B) and hydrogen bonding interactions are highlighted by black dashed lines. Ordered 
water molecules are represented by yellow spheres. The C4 position of the cofactor nicotinamide ring is 





Table 1 | Data collection statistics and refinement parameters a. 
Structure E. coli YjhC in complex with NAD(H) 
Data collection statistics  
X-ray wavelength (Å) 0.9537 
Temperature (K) 100 
Detector EIGER X 16 M (Dectris) 
Crystal-to-detector distance (mm) 200 
Space group P 21 21 21 
a, b, c (Å) 51.51, 84.67, 188.12 
α, β, γ (°) 90, 90, 90 
Resolution range (Å) 45.18-1.35 (1.398-1.35) 
Volume fraction of solvent 50.39 
Vm (Å3/Da) 2.49 
CC1/2† 0.999 (0.552) 
Multiplicity 12.8 (7.8) 
Wilson B-factor (Å) 18.70 
Total No. of reflections 2,315,217 (154,583) 
No. of unique reflections 181,008 (17,796) 
Rmerge 0.08 (2.11) 
Data completeness (%)  99.0 (99.3) 
Average I/σ (I) 14.2 (1.0) 
Refinement statistics  
Resolution (Å) 45.18-1.35 (1.398-1.35) 
Reflections used in refinement 180,786 (17,762) 
Reflections used for Rfree 9103 (915) 
Total number of residues  710 
Total non-H atoms 6629 
Protein/ Water 5593/ 933 
Ligands 103 
Average temperature factors (Å2)  
Overall 27.48 
Protein/ Water 25.76/ 38.49 
Ligands 28.18 
Rwork (%) 14.98 
Rfree (%) 16.87 
Geometric RMSD   
Bond (Å) 0.008 
Angle (°) 1.061 
MolProbity statistics ‡  
Rotamer outliers (%) 0.83 
Clashscore 2.13 
Ramachandran plot  
Favoured/allowed/disallowed regions (%) 97.58/2.42/0.0 
PDB Code     6O15 
a Values in parentheses are for the highest resolution shell 
† CC1/2 is the correlation between random half-sets of data 
‡ MolProbity is a structure-validation web service (33)  







The monomer of YjhC shares a typical architecture to other Gfo/Idh/MocA protein family members and 
consists of two domains (Figure 3B). The N-terminal domain (residues 1-117) adopts the distinctive 
Rossmann fold of six β-strands (51), alongside five neighboring α-helices. The C-terminal α/β domain 
(residues 118-368) consists of an eight-stranded β-sheet and seven α-helices. This long β-sheet 
predominately contributes to a flat-faced dimer interface and is a common feature of this protein family 
(47). The two monomeric chains of YjhC are nearly identical with a root mean square deviation (RMSD) 
of 0.128 Å (Cα positions). 
Within the N-terminal domain, the first residues of a glycine-rich motif in the turn between the first β-
strand and α-helix serve as a fingerprint for cofactor specificity, interacting with the pyrophosphate 
bridge of the cofactor NAD(P). While NADP(H) binding enzymes normally possess a GxGxxA consensus 
sequence after the first β-strand (52; 53), a GxGxxG motif typically correlates with the binding of 
NAD(H)—the latter is observed in YjhC between residues G8 and G13. Most residues were well defined 
in the electron density map, except the sequence 288SEMDGAIAYGHPGK301 within the C-terminal 
domain, which was disordered in both chains (yellow dotted line in Figure 3A-B). Furthermore, three 
residues at the C-terminus were disordered and thus not modelled in the final refined structure. 
However, using electrospray ionization mass spectrometry we verified that the full sequence (residues 
1-372) was expressed and purified.  
 
Cofactor binding  
 
The crystal structure was solved in complex with the cofactor NAD(H). As shown in Figure 3A (insert), 
electron density for NAD(H) was unambiguously observed for the entire cofactor. NAD(H) was bound 
within a crevice formed between the loop regions of β-strands, β1 and β4 of the Rossmann fold within 
the N-terminal domain in which there was a change in the direction of the β-strand order (Figure 3B). 
The binding motif at this region, 8GxGxxG13 confers cofactor specificity for NAD(H) over NADP(H) (54). 
Specifically, the cofactor was recognized by the side chains of residues F12, D33, N36, N70, H73, K91, 
W160 and K161, through an interaction that was mediated by an ordered water molecule 
(Supplementary Figure 5). Further, the cofactor was recognized by the main chain atoms of residues 
G10, Y11 and G13, through an ordered water molecule (Supplementary Figure 5). The side chain of 
residue D33 was observed to form a bifurcated hydrogen bond with the ribose of the adenine moiety. 
In addition to an increased thermal stability of the protein, which was observed in the presence of NAD+ 
over NADP+ (Supplementary Table 1), the locality of residue D33 provided further evidence for specificity 
towards the cofactor NAD(H) as it would sterically hinder the access of the 2’-phosphate group of 
NADP(H). The oxygen of the primary amide group, located within the nicotinamide moiety, was 




residue G117, through an ordered water molecule (Supplementary Figure 5). In addition to this extensive 
hydrogen-bonding network, the nicotinamide ribose moiety was in an anti-C2’-endo conformation, 
which was stabilized through an aromatic edge-to-face interaction, or a C-H-π hydrogen bond with 
residue F12 (55). The adenine ribose moiety also existed in an anti-C2’-endo conformation, and was 
predominately stabilized through a hydrophobic patch, which was formed by residues Y32, W68, P69, 
and L72 (Supplementary Figure 5). There was no observed difference between chains A and B with 
respect to the cofactor binding network. This observation was reinforced in the ensemble structure with 
residues G10, Y11, F12, G13, D33, N36, N70, H73, K91, and W160, along with NAD(H) itself, displaying 
little to no movement (Figure 4C). The only observed differences in the ensemble model was residue 
K161, which displayed increased flexibility relative to neighboring residues, and residue D90, which 
formed a hydrogen bond with the nitrogen of the amide group of NAD(H). Taken together, the well-
ordered cofactor binding network highlights how tightly bound NAD(H) is within the crevice formed at 
the C-terminal edge of the Rossmann fold. Lastly, this binding mode is analogous to Gfo/Idh/MocA 
family members who bind NAD(H).  
 
Ensemble refinement demonstrates mobile active site loops 
 
To evaluate the disordered regions of YjhC we combined molecular dynamics simulations with 
crystallographic data, and generated an ensemble of models by time-averaged refinement, using 
PHENIX ENSEMBLE REFINEMENT (34). This refinement strategy extracts the local molecular motion and 
samples the global disorder within the protein, through which it can provide more insight into dynamic 
regions that are functionally important, rather than just an averaged ‘snap-shot’ of the atomic structure. 
In this study, the ensemble refinement generated a Boltzmann-weighted population of 100 structures, 
with a significant reduction of the mFo-DFc electron density differences and improved Rwork and Rfree 
factors by 1.9% and 0.9%, respectively (Supplementary Table 2).  
Overall, the ensemble model revealed that, while YjhC displayed a well-ordered core, four loop regions 
(Figure 4A-B) along with the C-terminus displayed varied degrees of flexibility. The four flexible loop 
regions; L1-L4 are identified through the root mean square fluctuation (RMSF) for the backbone of both 
chain A and B, which is displayed in Figure 4A. While these loop regions are situated on the surface of 
the protein, they center around the substrate- and cofactor-binding cavities (Figure 4B). The flexibility 
in loops L1 and L3 may function to facilitate the diffusion of substrates to the binding cavity, with L3 
capping the active site during catalysis—this suggested link between protein flexibility and catalysis has 







Figure 4 | Ensemble refinement of E. coli YjhC. A) Plot displaying the root mean square fluctuation (RMSF) 
calculated per residue for all backbone atoms in chain A (green) and chain B (blue). B) Ensemble structure of the 
YjhC monomeric subunit colored by RMSF, ranging from 0 to 10 Å (from blue to red). Colored regions, deviating 
from blue to red highlight regions of high flexibility, which include the N- and C-terminal regions and four flexible 
loops, spanning residues 150-167 (L1), 198-212 (L2), 288-301 (L3) and 321-335 (L4). C) The binding network within 
the cofactor binding pocket. A representative set of 25 ensemble models are presented, displaying the dynamical 
fluctuations within the pocket. Key residues (colored as in Figure 3C) along with NAD(H) (in black) are shown, 
highlighting the well-ordered binding network of the cofactor within the pocket. The 2Fo-DFc electron density map 
(blue mesh) is contoured to 1.0 σ. Figures were produced using PyMOL(62) and UCSF Chimera (44). 
 
E. coli YjhC is a dimer 
 
Within the Gfo/Idh/MocA family the oligomeric assemblies of solved structures are predominately 
dimeric or tetrameric, although in one case a monomeric structure was reported (58). The structure of 
E. coli YjhC contained two molecules in the asymmetric unit, which form a dimeric assembly (Figure 3A), 
supported by a long, open flat-faced β-sheet in an antiparallel arrangement and via a two-fold rotation 
axis. Using the PDBePISA server (59), we determined that approximately 1666 Å2 of accessible surface 
area was buried against the interface of the opposing monomer, while the total estimated ΔGint value 
of the dimer interface was approximately -62.3 kcal mol-1. Collectively, this formed a rigid, sandwich-
like structure that was stabilized through face-to-face hydrophobic interactions, interdigitation of side 




(Supplementary Figure 6). In addition, two sulfate ions were modelled at this interface, where were both 
coordinated to residue R354 of chain A and B. Given their external location and a feature of the 
crystallization condition, these sulfate ions are unlikely to be of functional relevance.  
To assess whether this dimeric assembly in the crystal structure was biologically relevant in solution, we 
used analytical ultracentrifugation and small angle X-ray scattering. Using analytical ultracentrifugation, 
three protein concentrations were analyzed (7, 14 and 20 µM) to assess if the dimeric assembly showed 
any signs of self-association. Following 2DSA-Monte Carlo analysis, all three concentrations were 
consistent with a single peak and supported a homogenous species in solution (Figure 5A). These data 
were consistent with the observation in SEC experiments, which showed a single monodisperse species 
(Supplementary Figure 1). The sedimentation coefficient of 5.60 S (95% confidence interval is 5.49- 5.72) 
was consistent with a dimeric species, while the frictional ratio (f/f0) of 1.26 (95% confidence interval is 
0.79-1.73), suggested that the molecule was slightly elongated. Further analysis using UltraScan 
predicted a molecular mass of 88.6 kDa, which was consistent with the calculated dimeric mass of 86.1 
kDa (Table 2).  
 
Figure 5 | Solution structure of YjhC. A) 2DSA-Monte Carlo model displaying the sedimentation coefficient (S) 
distribution of YjhC for three concentrations (7, 14 and 20 µM, colored orange, blue and purple, respectively). The 
data was best fit to single 5.6 S species, where no sign of self-association is observed. The residuals, shown top 
right all display randomly distributed noise. B) Small angle X-ray scattering data of YjhC is consistent with 
theoretical scattering of the atomic structure (red line, X2 value of 0.62). The fit residuals are shown below in red. 
The Guinier plot shown as an insert, highlights linearity at low q—this provides confidence that the data is free of 
any significant amount of aggregation or interparticle interference. C) Pairwise distribution plot displaying the 




Small angle X-ray scattering data were also consistent with a dimer in solution (Figure 5B, SASBDB 
accession code: SASDFZ3), when analyzed by the online server SAXS-MoW2 (40). Measured on a relative 
scale, the molecular weight was 84.5 kDa, which was within 2% of the calculated dimeric mass (86.1 
kDa). As shown in Figure 5B, the theoretical scattering profile, which was generated from the crystal 
structure of YjhC, fit the data well to high q, with a reduced X2 value of 0.62. This supported that the 
dimeric assembly of YjhC, which was observed in the crystal structure was consistent with our solution 
structure. Guinier analysis produced a linear plot with a radius of gyration (Rg) of 31.14 Å and a forward 
scattering value (I0) of 0.049 (Table 2). The linearity of the Guinier plot further supported a single 
monodisperse species in solution, which was free of any significant amount of aggregation or 
interparticle interference. An indirect Fourier transform of the scattering data gave a maximum 
interparticle dimension (Dmax) of 107.1 Å (Figure 5C). This value agreed with the maximum interparticle 
dimension of ~107 Å, which was determined from the crystal structure. Overall, these data propose E. 
coli YjhC is a tight dimer, where the crystal structure closely models the solution structure.  
Table 2 | Summary of data collection and analysis from the solution study of YjhC.  
Sedimentation velocity analysis  
Sedimentation coefficient (×10−13 S) 5.61 (5.51, 5.71) 
Frictional ratio (f/f0) 1.24 (0.97, 1.52) 
Molecular weight (kDa) 8.67 (5.96, 11.38) 
Partial specific volume of YjhC (mL/g) 0.7329 
Buffer density (g/cm3) 1.0009 
Buffer viscosity (cp) 1.0086 
SAXS data-collection parameters  
Instrument Australian Synchrotron SAXS/WAXS beamline 
Detector PILATUS 1M (Dectris) 
Wavelength (Å) 1.0332 
Maximum flux at sample 8 x 1012 photons per second at 12 keV 
Camera length (mm)  1600 
q range (Å-1)  0.006-0.5 
Exposure time Continuous 1 second frame measurements 
Sample configuration SEC-SAXS with co-flow 
Sample temperature (°C) 12 
SAXS data analysis  
Guinier analysis  
I(0) (cm-1) 0.049 ± 0.00081 
Rg (Å)  31.14 ± 0.36 
P(r) analysis  
I(0) (cm-1) 0.049 ± 0.00014 
Rg (Å)  31.80 ± 0.13 
Dmax (Å) 107.08 
Porod volume (Å-3) 130000 
CRYSOL analysis (X2 value) 0.62 
SAXS-MoW2a  (Estimated molecular weight (kDa) 84.5 




Structural comparison with other Gfo/Idh/MocA family members 
 
A search of the PDB using the DALI server (22) was used to gain insight into the overall folding, structural 
features and possible catalytic functions of YjhC. The numerous search hits were reduced to seven by 
excluding PDB coordinate entries without a publication available and excluding PDB coordinate entries 
of identical protein sequence (Table 3). A multiple sequence alignment was generated using these seven 
homologs to investigate consensus regions to and identity characteristic features that may uncover 
potential catalytic residues (Supplementary Figure 7). Figure 6A presents the sequence conservation 
among the search hits mapped onto the monomeric structure of YjhC using UCSF Chimera, while Figure 
6B presents a structural superimposition of the monomeric assembly for each protein. All seven 
homologs were found to catalyze redox reactions with carbohydrate-based substrates. However, 
despite sharing a similar overall tertiary fold, the sequence identity between each structure was low 
compared to YjhC (<25%). This trend was observed across the Gfo/Idh/MocA family, which likely reflects 
their diverse catalytic function (47).  
Table 3 | Result of structural homology search using the DALI server.  
 
The multiple sequence alignment of these structural homologs identified that YjhC contains the 
sequence 83NKKHVFCEKP92, which closely resembles the consensus motif AGKHVxCEKP—a fingerprint of 
sugar dehydrogenases (50). Interestingly, within this motif we identified a conserved cis-peptide 
between the lysine and proline residue for all homologs including YjhC (residues K91 and P92). This cis 
conformation orientates the lysine residue towards the cofactor, where it can form a cation-pi 
interaction with the nicotinamide ring or hydrogen bond to the 2’-hydroxyl group of the nicotinamide 
ribose. Together, these interactions likely play a crucial role in maintaining the nicotinamide ring in the 
correct conformation during the catalytic reaction. In addition, this lysine residue is hypothesized to act 
as a molecular switch, preventing substrate rebinding by moving closer to the nicotinamide ring when 
the cofactor is reduced (16; 60).  
Protein (abbreviation) Cofactor 
Quaternary  
structure 









NAD Tetramer 37.4 2.3 22 3Q2K 61 
Levoglucosan dehydrogenase (LGDH) NAD Tetramer 37.4 2.2 21 6A3I 62 
Scyllo-inositol dehydrogenase (IDH) NAD Tetramer 37.1 2.3 19 5YA8 63 
1,5-anhydro-D-fructose reductase 
(AFR) 
NADP Dimer 36.4 2.3 23 2GLX 64 
Aldose-aldose oxidoreductase (AAOR) NADP Dimer 34.9 2.5 24 5A02 17 
Glucose-fructose oxidoreductase 
(GFOR) 
NADP Tetramer 34.4 2.6 24 1H6D 16 
C-3’-ketoreductase (KijD10) NADP Tetramer 31.2 2.6 18 3RC2 65 





Figure 6 | Structural comparison of Gfo/Idh/MocA family members. A) Mapping of amino acid sequence 
conservation on YjhC monomeric structure, based on multiple sequence alignment of the seven DALI-server search 
hits in Table 3. Depending on the extent of conservation, the residues are colored from red, for the highest 
conservation, to blue, for variable or non-conserved residues. The insert shows the binding pocket where key 
residues involved in cofactor binding are well conserved are highlighted.  B) Structural superimposition of YjhC and 
all seven DALI-server search hits in Table 3. Overall the tertiary structure is very similar between enzymes. C) 
Surface representation of the binding pocket of PDB 5A02 (17) (in wheat) and YjhC (in blue). While the pocket is 
open in PDB 5A02 (similar across all other search hits), the pocket in YjhC is partially occluded by the disordered 
loop ‘L3’ (see Figure 4B) (in grey). Figures were produced using UCSF Chimera (44). 
 
Structural comparison of the binding cavity of these homologous proteins demonstrated that the 
binding cavity was open (Figure 6C), whereas in YjhC the binding cavity was found to be occluded (Figure 
6C), primarily by disordered loop L3 within the C-terminal domain, which is highly flexible (Figure 4B). 
This loop may have a catalytic role and provide essential contacts to stabilize the substrate—a unique 





Insight into YjhC substrate specificity at the binding cavity 
 
Electrostatics play a key role in substrate binding, so we mapped the electrostatic potential onto the 
molecular surface of the substrate binding cavity for E. coli YjhC (Supplementary Figure 8A). Situated 
between the N- and C-terminal domains, this cavity had a positive charge distribution that would 
support the binding of acidic amino sugars, such as Neu5Ac and its derivatives.  This observation was 
consistent with our data analysis using differential scanning fluorimetry (Figure 2C-D). Typically, within 
the Gfo/Idh/MocA family the catalyzed reaction precedes via a ping-pong mechanism, in which the 
bound cofactor is required for the substrate to bind. Following binding, the substrate is either oxidized 
or reduced (47). To initiate the transfer of the hydride ion, the C4 position of the nicotinamide ring must 
be positioned near the substrate (~3.5 Å), while surrounding residues, depending upon the specific 
chemistry, can assist in the catalytic reaction. 
Interestingly, we observed ambiguous density in the mFo-DFc map of the crystal structure that was close 
to the C4 position of the nicotinamide ring (Supplementary Figure 8B) and close enough to interact with 
the neighboring K91 and H176 residues. However, no molecule was modelled into this density, as 
nothing within the crystallization condition appeared to fit the density when refined. Perhaps this could 
be an artifact from the expression and purification of the protein, with variable occupancy (<1.0).  
To help deduce what the unmodelled density was and further identify potential substrates we 
performed in silico docking experiments using SwissDock (42), interfaced with the CHARMM package 
(43) on Neu5Ac and several other sialic acid derivatives. These were selected based on their relative 
distribution in the human gastrointestinal tract, and within the small and large intestine of mice (5). 
Neu5Ac and its open chain form, along with the 1,7 lactone and 9-O-acetylated sialic acid variant all 
presented favorable binding modes in which they were: 1) nestled within the binding cavity with 
favorable electrostatic interactions; 2) positioned close to the C4 position of the nicotinamide ring, 
poised for hydride transfer; and 3) orientated in a way that a redox reaction would be chemically 
plausible (Figure 7). These potential ligands were scored based on their estimated ΔG, number of 
hydrogen bonding partners, and full fitness (Supplementary Table 3), which was defined as the total 
energy of the system, along with a solvation term (43). As a control, to illustrate the efficiency of the 
docking strategy, NAD(H) was docked into YjhC with an RMSD difference to the crystal structure of less 









Figure 7 | In silico docking experiments of potential substrates. Molecules (light blue sticks) that presented favorable binding modes in proximity to NAD(H) (in black sticks) are 
presented below. A) Key residues within the binding cavity are shown (beige). Hydrogen bonds formed between the substrate and neighboring residues are highlighted (black 
dash). B) Depicts the carbon position of the substrate that is in proximity to the C4 position of the nicotinamide ring. C) The substrate is shown in the binding cavity mapped by 





Interestingly, the C4 position of Neu5Ac and the 9-O-acetylated variant were poised for hydride transfer 
and may suggest the position in which the hydride would be removed (oxidation) or added (reduction) 
during the catalytic reaction. In contrast, the open chain form of Neu5Ac, and the sialic acid 1,7 lactone 
variant both presented different carbon positions, relative to the nicotinamide ring. The positioning of 
the open chain Neu5Ac (C7 position) and the sialic acid 1,7 lactone (C1 position), although not modelled 
as closely to the C4 position of the nicotinamide could likely be reoriented during conformational 
changes that inherently may occur during initial binding. In this case, disordered loop L3 (Figure 5B) may 
be involved in stabilizing the lactone during catalysis. Unfortunately, none of the compounds that were 
modelled in Supplementary Figure 8, fit the ambiguous density, which supported our hypothesis that 
this molecule was likely an artifact from the expression and purification of the protein. 
Following the identification of several promising leads through docking experiments and differential 
scanning fluorimetry, attempts were made to co-crystallize the protein with the potential substrates 
(Neu5Ac and sialic acid 1,7 lactone), or alternatively soak the protein crystals with these molecules in 
the presence of the cofactor. Unfortunately, following data collection, these was no difference in the 
electron density within the binding cavity. However, ambiguous density was still observed close to the 
C4 position of the nicotinamide ring, as illustrated in Supplementary Figure 8B. We believe the presence 
of this unknown molecule(s) potentially hindered the binding of both Neu5Ac and sialic acid 1,7 lactone.  
In addition, we have kinetically tested these promising leads using a spectrophotometric NADH assay, 
by measuring the change in absorbance at 340 nm upon addition of each molecule. Interestingly, this 
presented a very small rate for Neu5Ac and gave an apparent Km of 68.8 mM (Supplementary Figure 9). 
No observable rate was measured in the absence of YjhC (control), or when using sialic acid 1,7 lactone 
as the substrate. It is probable that the low observable rate reflects the ambiguous density observed in 




Here, we report the characterization of YjhC from E. coli in an effort to elucidate its role in amino sugar 
metabolism. The results from our in vivo (BiOLOG Phenotype MicroArray) and in vitro (differential 
scanning fluorimetry assays) experiments argue that YjhC is involved in sialic acid metabolism.  The 
structure of the protein, the presence of NADH in the active site, and binding studies demonstrate that 
the enzyme binds NAD(H) as a cofactor, consistent with its role as an oxidoreductase/dehydrogenase 
from the Gfo/Idh/MocA family. Unfortunately, we were unable to identify the substrate(s) for the 
enzyme, despite several promising leads, although sialic acid and closely related variants are potential 
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Supplementary Figure 1 | YjhC purification. Size exclusion trace of YjhC highlights a homogeneous, monodisperse 
species. Shown as an insert - SDS-PAGE gel of YjhC purification. A) Lane 1: Novex Sharp Pre-Stained Protein 
Standard ladder (molecular weights are shown in kDa). B) Lane 2: cell free supernatant. C) Lane 3: pooled fractions 
following elution in immobilised nickel ion His-trap chromatography. D) Lane 4: pooled fraction following size 




Supplementary Figure 2 | PM1 Phenotype Microarray. Kinetic growth curves for the wild-type (blue) and yjhC gene 
knockout (orange) strains. Each curve contains plots of metabolism (due to dye reduction) against time (0-48 h) 






Supplementary Figure 3 | PM2A Phenotype Microarray. Kinetic growth curves for the wild-type (blue) and yjhC 
gene knockout (orange) strains. Each curve contains plots of metabolism (due to dye reduction) against time (0-






Supplementary Figure 4| BiOLOG MicroArray raw data. Duplicate experiments were performed for each plate, 
while time points were collected at 0, 3, 6, 12, 24, 36 and 24 hrs. The mean and standard deviation are presented. 
A major phenotypic change between strains is defined as a difference in the rate of respiration by <50% after 24 
h growth (late log phase), on the same carbon source. 
 
 
Supplementary Figure 5 | LigPlot highlighting the interactions that stabilise the cofactor NAD(H) in the substrate 
binding pocket. The hydrogen bonded network is depicted with dashed lines with the distance between partners 
labelled. Key water molecules are coloured in light blue, while hydrophobic interactions which stabilise NAD(H) 





Supplementary Figure 6 | Molecular surface representations of the E. coli YjhC dimer interface. Each monomer is 
separated and rotated by 60° to expose features of their molecular surface in more detail.  A) Two interacting 
monomers are shown juxtaposed with the monomer as a protein cartoon. Interface residues that form 
hydrophobic interactions are highlighted in red for both chains, while residues that form hydrogen bonding 
interactions or salt bridges are highlighted in blue and green from chain A and B, respectively. B) Two interacting 







Supplementary Figure 7 | Multiple sequence alignment performed using Clustal Omega (23) and generated using 
ESPript 3.0 (24). The top seven search hits from the DALI server (Table 3) were used in the sequence alignment, 
identified by their PDB I.D. Red background highlights identical residues, red coloured font indicates similar 
residues. Secondary structure elements depicted above the alignment were generated from the crystal structure 






Supplementary Figure 8 | Binding cavity of YjhC. A) The substrate binding cavity mapped by electrostatic potential 
depicts primarily, a positively charged pocket rendering using the Adaptive Poisson-Boltzmann Solver (ABPS) 
plugin. Colored from red (negative) to blue (positive). B) Electron density map highlighting the unmodelled, 
ambiguous mFo-DFc difference density (3.0 σ, green). The 2Fo-DFc electron density map (1.0 σ, blue mesh) is shown 
around conserved residues within the binding cavity and the bound cofactor, NAD(H) (C4 position is labelled). 





























Supplementary Figure 9 | Neu5Ac kinetic assay. Using a spectrophotometric NAD+ assay, YjhC activity in the 
presence of Neu5Ac was observed by measuring the change in absorbance at 340 nm. This gave a small rate for 
Neu5Ac across a mM concentration range and an apparent Km of 65.1 mM (R2 = 0.9637). The experiment was 
performed in duplicate, where initial rates (red spheres) were analyzed and fitted with the Michaelis-Menten 










Supplementary Table 1 | Differential scanning fluorimetry of YjhC with potential carbon sources. Thermal shift 
assays were repeated in triplicate for each carbon source alone and in the presence of NAD(P). The average 
melting temperature (Tm) is presented for each condition along with the standard deviation. Significant increases 
in melting temperature are highlighted in bold; these are presented in Figure 2.   
Molecule 
Tm (°C) 
-Cofactor + NAD+ +NADH +NADP+ 
YjhC 46.51 ± 0.10 52.36 ± 0.21 53.45 ± 0.10 46.39 ± 0.18 
N-Acetylneuraminic acid 46.68 ± 0.25 55.22 ± 0.10 56.23 ± 0.02    X † 
N-Acetylmannosamine 46.53 ± 0.20 52.54 ± 0.27 53.71 ± 0.14 X 
N-Acetylglucosamine 46.54 ± 0.18 52.60 ± 0.18 53.44 ± 0.05 X 
N-Acetylgalactosamine 46.42 ± 0.38 52.61 ± 0.18 53.61 ± 0.08 X 
Sialic acid lactone 46.50 ± 0.15 52.19 ± 0.29 54.41 ± 0.10 X 
Arabinose 46.60 ± 0.10 52.48 ± 0.21 53.50 ± 0.16 X 
Trehalose 46.53 ± 0.20 52.84 ± 0.28 53.62 ± 0.07 X 
Mannose 46.54 ± 0.32 52.60 ± 0.18 53.62 ± 0.09 X 
Mannitol 46.54 ± 0.18 52.60 ± 0.32 53.66 ± 0.02 X 
Glucose 46.58 ± 0.13 52.66 ± 0.10 53.44 ± 0.11 X 
Maltose 46.60 ± 0.10 52.60 ± 0.18 53.55 ± 0.02 X 
Galactonic acid-γ-lactone 45.99 ± 0.19 52.53 ± 0.47 53.49 ± 0.09 X 










Supplementary Table 2 | Ensemble refinement statistics a. 
Refinement statistics  
Final single-structure model  
Rwork (%) 14.98 
Rfree (%) 16.87 
Geometric RMSD  
Bond (Å) 0.009 
Angle (°) 1.310 
Ensemble refinement model  
Rwork (%) 13.08 (-1.90) 
Rfree (%) 15.93 (-0.94) 
τx (ps)  1.0 
Number of ensemble structures 100 
Geometric RMSD (centroid distribution) †  
Bond (Å) 0.009 
Angle (°) 0.984 
Geometric RMSD (per model distribution) ‡  
Bond (Å) 0.016 
Angle (°) 1.758 
a Values in parentheses in the change in R factors between the ensemble and single model 
† Calculated for the whole ensemble where restraints represent an oscillation around the ideal value 
‡ Calculated for each model separately and then averaged across the whole ensemble 
RMSD = root mean square deviation 
 
 








N-Acetylneuraminic acid (β-anomer) -5.98 -1906.47 2 
N-Acetylneuraminic acid (Open chain) -7.08 -1929.16 3 
Sialic acid 1,7 lactone -5.41 -1896.51 2 














2.4 Chapter summary 
 
This chapter developed a structural and functional understanding of E. coli YjhC to address the 
hypothesis that the functional role of this previously uncharacterised protein was to process the less 
common derivatives of sialic acid. 
Phenotype MicroArrays and differential scanning fluorimetry experiments demonstrated that E. coli 
YjhC is sensitive to carbohydrate-based substrates and identified Neu5Ac and derivatives of sialic acid 
as promising leads. Solution studies using sedimentation velocity experiments and SAXS verified that 
YjhC adopts a dimeric architecture in solution.   
The reported high-resolution structure of E. coli YjhC, solved in the complex with the cofactor NAD(H) 
is consistent with its role as an oxidoreductase/dehydrogenase from the Gfo/Idh/MocA family. Further 
ensemble refinement identified a flexible loop region that may play a key role during catalysis. A 
structural comparison suggested this flexible loop was a unique feature to YjhC among closely related 
structures. Using in silico docking, Neu5Ac and various sialic acid derivatives were screening in order to 
identify molecules that presented favourable binding modes. This reinforced Neu5Ac as a promising 
lead and further established the lactone derivative and the 9-O-acetylated derivative of sialic acid as 
potential substrates. 
This study provided the first characterisation of YjhC, indicating an involvement in sialic acid catabolism, 
which was consistent with the hypothesis in the literature (15), and verified its role as an 
oxidoreductase/ dehydrogenase. Together, this knowledge expands our understanding of bacterial sialic 
acid catabolism and provides a foundation towards antimicrobial drug development for this enzyme.  
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On the structure and function of the proteins encoded by the 




3.1.1 The Major Facilitator Superfamily of permeases  
 
The major facilitator superfamily (MFS) is a diverse group of permeases that permit the uptake of small 
solutes, such as sugars, amino acids or drugs across the cytoplasmic membrane within archaea, bacterial 
and eukaryotic species (1; 2). Based on their mode of uptake, members of the MFS are further classified 
as secondary symporters, secondary antiporters or uniporters (3). Secondary symporters facilitate 
transport by coupling the movement of a proton/ion down an electrochemical gradient to entropically 
drive the small solute against an electrochemical and/ or concentration gradient. Secondary antiporters 
facilitate a similar coupled process, although pump the different solutes in opposing directions. In 
contrast, uniporters simply utilise the electrochemical gradient of the small solute to entropically 
facilitate transport (4; 5). These transport modes are illustrated in Figure 3.1.  
 
Figure 3.1 | Transport modes catalysed by members of the major facilitator superfamily.  This model presents the 
secondary symporter, secondary antiporter and uniporter modes of uptake across the plasma membrane. The 





MFS permeases are characterised by a topology of 12 transmembrane α-helices that are shared 
between a structurally similar N- and C-terminal domain (6; 7). Exceptions to this trademark feature 
include a member with six transmembrane α-helices, which likely functions as a dimer (1), and a 
member with 24 transmembrane α-helices that is likely the result of a gene duplication and fusion (1; 
8). In addition, other members of the MFS have been identified to contain 14 transmembrane α-helices. 
An example is the sialic acid-proton symporter NanT, where the additional transmembrane helices, 
located centrally are hypothesised to form an amphipathic helix and play a role in the substrate 
specificity of the transporter (9).  
Despite a difference in transport modes (Figure 3.1), MFS members are proposed to function via a 
common mechanism, which is described as the ‘rocker-switch’ model. In this model, transporters are 
known to alternate between an inward- and outward-facing conformation to move molecules across a 
membrane, where their respect substrate-binding site is only accessible to either the cytoplasmic or 
periplasmic side of the membrane (Figure 3.2) (10; 11). The substrate-binding site or translocation 
pathway is located at the domain interface between the N- and C- α-helical bundles. This alternating 
access between two conformations in order to facilitate transport has been well characterised in the 
Escherichia coli glycerol-3-phosphate inorganic phosphate antiporter (11) and the E. coli lactose 
permease sugar proton symporter (10).  
 
Figure 3.2 | The ‘rocker-switch’ model of transport within the major facilitator superfamily. In this mechanism the 
N- and C-terminal domains (coloured in beige and blue, respectively) rock back and forth between an inward- and 
outward-facing open conformation, where the substrate-binding site acts as the pivot point, accessible at either 
the cytoplasmic or periplasmic side of the membrane at a given time. Initially, in an outward-facing open 
conformation a proton binds from the periplasmic side of the membrane (Position 1). Following the binding of a 
proton, the substrate binds in a central cavity (Position 2). The binding of the substrate triggers a conformational 
change, initially through an intermediate occluded state (Position 3), through to an inward-facing open 
conformation where the proton can exit into the cytoplasm (Position 4). Finally, the substrate is translocated and 
released into the cytoplasm, completing the cycle (Position 5). [Figure adapted from (12)]. 
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3.1.2 The putative permease YjhB  
 
Encoded by the yjhBC operon, YjhB is placed in the MFS and is hypothesised to function as a permease, 
playing a role in sialic acid catabolism (13). This hypothesis follows the identification that the yjhBC 
operon contains three direct repeats of the nucleotide sequence GGTATA, which is specifically 
recognised by NanR, the transcriptional regulator of sialic acid catabolism in E. coli (14). Furthermore, 
YjhB is comparable to the sialic acid-proton symporter NanT (13). This suggests that YjhB is not the main 
transporter for sialic acid, as studies have shown that NanT knockouts prevent growth on sialic acid (15) 
and therefore supports the hypothesis that YjhB functions to import less common derivatives of sialic 
acid (13). However, there is no structural or functional data to verify this hypothesis. 
 
3.2 Chapter overview 
 
To expand on the characterisation of the yjhBC operon (Chapter Two), this chapter investigates the 
putative permease YjhB. The results presented here show the overexpression trials conducted for YjhB 
and conclude an optimised protocol for expression. Furthermore, in silico comparison against sequence 
homologs was used to identify potential amino acid residues important for function. Following 
reconstruction of a de novo 3D model, these amino acid residues were mapped to the structure. 
Together, Chapter Two and Three provide invaluable insight into this uncharacterised operon.  
 
3.3 Results and Discussion 
 
3.3.1 Cloning and overexpression trials of Escherichia coli YjhB 
 
The structural and functional characterisation of proteins is increasingly dependent on purifying high 
amounts of pure and stable protein, where some problems are related to gene expression (16; 17). The 
overexpression of membrane proteins is often toxic to the host, caused by saturating the protein 
secretion machinery and membrane protein biogenesis (18; 19). Thus, efficient methods aimed at 
controlling the expression of membrane proteins and preventing toxicity are used to obtain sufficient 
quantities of pure protein required for their structural and biophysical characterisation. These methods 
utilise expression systems with a tightly regulated promoter, avoiding systems driven exclusively by the 
bacteriophage T7-ribonucleic acid (RNA) polymerase, for example, the E. coli BL21(DE3) strain, which 
can result in leaky expression (20).  
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To optimise expression of the yjhB gene, the E. coli Lemo21(DE3) strain was utilised. This is a T7-RNA 
polymerase-based platform for the overexpression of challenging targets, such as membrane proteins, 
proteins with solubility issues or toxic proteins (21). This strain was developed from the E. coli BL21(DE3) 
strain, one of the most extensively used platforms to recombinantly overexpress protein in E. coli (18). 
Governed by the isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible lacUV5 promoter, protein 
overexpression is driven by T7-RNA polymerase to transcribe messenger RNA approximately five times 
faster than the E. coli RNA polymerase (18). This feature, although attractive to routine protein 
expression is not well suited to challenging targets, such as membrane proteins. To address this obstacle 
the derivative strain of E. coli BL21(DE3), known as Lemo21(DE3), was developed to control the rate of 
expression by using T7 lysozyme, a natural inhibitor of T7-RNA polymerase. Encoded on a separate 
plasmid identified as pLemo, the expression of T7 lysozyme is governed by the titratable rhamnose 
(rhaBAD) promoter (Figure 3.3) (22). The rationale behind this titratable system is that varying the 
amount of L-rhamnose controls the amount of protein expressed and reduces the risk of saturating the 
protein secretion machinery and membrane protein biogenesis (18; 19).  
 
Figure 3.3| The E. coli Lemo21(DE3) strain and pWarf(-) expression vector allow for tunable expression of yjhB. The 
presence of IPTG governs the expression of T7-RNA polymerase under the lacUV5 promoter (PlacUV5). The activity 
of T7-RNA polymerase is controlled by its natural inhibitor, T7-lysozyme (T7Lys). Present on the pLemo plasmid, 
the expression of T7Lys is governed by the titratable rhaBAD promoter (PrhaBAD) using L-rhamnose. Ultimately this 
controls the overexpression of yjhB located on the pWarf(-) expression vector, governed by the T7 lac promoter 
(PT7lac). The pWarf(-) expression vector is shown [Figure adapted from (18)]. 
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To monitor the overexpression of membrane proteins, the E. coli Lemo21(DE3) strain was used in 
combination with the commercially available low-copy pWarf(-) expression vector. The vector carries a 
C-terminal human rhinovirus 3C protease (HRV3C) cleavage site, a C-terminal green fluorescent protein 
(GFP) and a C-terminal 8x histidine affinity tag (Figure 3.3) (23). The GFP fusion tag permits the levels of 
overexpressed membrane protein to be monitored by using whole-cell fluorescence, a high-throughput 
method to decipher the optimal expression conditions of the target protein compared to traditional and 
more tedious approaches such as immunoblotting. Put simply, the higher the fluorescence, the more 
stable the protein expressed. If no fluorescence is observed, the target protein is not correctly folded 
and expression conditions need to be revised. As a consequence, the E. coli Lemo21(DE3) strain and 
pWarf(-) expression vector allow for the tunable expression of yjhB. Utilisation of pWarf(-) is only 
possible if the C-terminus of the protein is intracellular, as GFP is only fluorescent in the cytoplasm. If 
the C-terminus is extracellular or positioned in the periplasm, the expression vector pWarf(+) can be 
utilised, which repositions the C-terminus to the cytoplasm using a Glycophorin A protein fusion (23). 
The sub-cloning of E. coli yjhB into the pWarf(-) expression vector and subsequent transformation into 
E. coli Lemo21(DE3) is described in Chapter Eight, Section 8.6.1.1. 
Using a high-throughput screen developed by Drew et al. 2006, YjhB was subjected to a total of 48 
different expression variables in order to find the optimal overexpression conditions for the protein (24). 
These small-scale expression trials were carried out in terrific broth (TB) media, where a range of L-
rhamnose concentrations (0-2000 µM), induction temperatures (18 and 26 °C) and IPTG concentrations 
(0.1, 0.4, 0.7 and 1 mM) were explored. All conditions had a total induction time of 16 h. As a negative 
control, empty pWarf(-) was included in the expression screen as the presence of a target gene is 
required for GFP to be expressed. The expression of each variable was analysed by whole-cell 
fluorescence (Chapter Eight, Section 8.6.1.2), where the best range of overexpression conditions were 
visualised by in-gel fluorescence using gel electrophoresis (Chapter Eight, Section 8.6.1.3). The whole-
cell fluorescence measurements for each expression screen are presented in Figure 3.4A, where the 
highest whole-cell fluorescence was observed with 250 µM L-rhamnose and 0.1 mM IPTG, at 26 °C. In 
addition, the second highest whole-cell fluorescence was observed with 250 µM L-rhamnose and 1.0 
mM IPTG, at 26 °C. Both of these overexpression conditions displayed a relative fluorescence unit (RFU) 
above 15, which represents the minimum level of expression required to isolate a suitable yeild of 
protein (at least 1 mg L−1) for structural and biophysical studies (23). When visualised using in-gel 
fluorescence, YjhB appeared at approximately 40 kDa (Figure 3.4B), although the predicted weight of 
the YjhB-GFP fusion protein is 73.4 kDa. This anomalous gel migration is commonly observed in SDS-
PAGE when running membrane proteins and is believed to be attributable to the binding of detergent 
molecules to the transmembrane regions (25). Of the conditions analysed using in-gel fluorescence, the 
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most intense band correlates with 250 µM L-rhamnose and 0.1 mM IPTG, at 26 °C (Figure 3.4B), which 
was the best optimisation condition as determined by whole-cell fluorescence. The same 
overexpression condition is shown side-by-side to an uninduced sample (resuspended cell pellets), in 
order to illustrate the difference between the inherent fluorescence of E. coli and the fluorescence 
observed with overexpression of the YjhB-GFP fusion (Figure 3.4C). Taken together, this condition is 
suitable for protein overexpression at a larger scale, due to having an RFU above 15.  
 
Figure 3.4 | Whole cell fluorescence and in-gel fluorescence of YjhB in different expression conditions. A) Whole cell 
fluorescence for two induction temperatures (18 and 26 °C) reported in relative fluorescence units (RFU). YjhB 
was subjected to four different IPTG concentrations (0.1, 0.4, 0.7 and 1.0 mM), across a range of L-rhamnose 
concentrations (0, 100, 250, 500, 1000 and 2000 µM). Each IPTG concentration is coloured and grouped with each 
respective L-rhamnose concentration. The standard deviation was calculated from the duplicate measurements 
and shown as error bars. The horizontal dashed line highlights 15 RFU representing the minimum level of 
expression required to isolate a suitable amount of protein (at least 1 mg L−1). B) In-gel fluorescence of YjhB from 
the best overexpression range at 26 °C using an IPTG concentration of 0.1 mM, as determined by whole-cell 
fluorescence. Lane 1 – 0 µM L-rhamnose; Lane 2 – 100 µM L-rhamnose; Lane 3 – 250 µM L-rhamnose; Lane 4 – 
500 µM L-rhamnose; Lane 5 – 1000 µM L-rhamnose; Lane 6 – 2000 µM L-rhamnose; and Lane 7 – BenchMark 
Fluorescent Protein Standard (kDa). Although a tiny amount of free GFP is observed in the gel, the YjhB-GFP fusion 
protein is detected at levels that are sufficient for structural and biophysical studies (conditions that are above 15 
RFU) C) The difference between the inherent fluorescence of E. coli (uninduced) and the fluorescence of the best 
overexpression condition, 250 µM L-rhamnose and 0.1 mM IPTG, at 26 °C. 
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Although not addressed in this thesis, the next step towards characterising YjhB would be to optimise a 
protein purification protocol. To initiate this process, the membrane fraction must be harvested by 
ultracentrifugation and subsequently solubilised using detergents. Identifying a suitable detergent that 
will mimic the native membrane environment for the protein is a major bottleneck in obtaining stable 
and monodisperse protein (23). Traditionally, this process was lab intensive and required microgram to 
milligram quantities of purified protein (23). However, fluorescence-detection size-exclusion 
chromatography (FSEC) has recently emerged as an efficient strategy to identify the optimal detergent 
that renders the protein stable in solution by exploiting the GFP-fusion tag and using only nanogram 
quantities (26). As a result, crude membrane extract can be solubilised in a range of detergents and 
subjected to FSEC, equilibrated in the respective detergent-containing buffer. At this point, using 
fluorescence spectroscopy, both the stability and monodispersity of the GFP-fusion protein can be 
analysed for each respective detergent by monitoring the elution profile over time. Here, a single, 
symmetrical peak represents stable, monodisperse protein, while in contrast multiple or largely 
asymmetric peaks are reflective of an unstable and polydisperse protein (23; 26). The ideal detergent 
will present a stable elution profile over a 24 to 48 h period.  
 
3.3.2 In silico comparison and structural modelling of YjhB 
 
Since YjhB is yet to be purified, bioinformatics were used to provide structural and functional insight for 
this uncharacterised permease. To achieve this, various tools were employed to search for appropriate 
templates, construct a de novo 3D model, predict how this model may embed within the lipid bilayer 
and identify potential residues that are important to its biological function. 
Initially, a sequence-based homology search was conducted using the BLASTp web server to verify the 
annotation of YjhB in the MFS of permeases. Of the homologs producing significant alignment with YjhB, 
the sialic acid-proton symporter NanT was most closely related. Interestingly, E. coli YjhB presented the 
highest sequence identity to NanT from Yersinia species (37.1%), followed closely by Salmonella enterica 
sub-species (35.2%), rather than E. coli NanT, which was third highest (35.0%). The top five results of 
this homology search from the UniProt database are presented in a multiple sequence alignment (Figure 
3.5). Collectively, these all represent NanT from various bacterial species, while the other homologs with 
a sequence identity less than 30% represent an assortment of putative sugar-, amino acid- and 
metabolic-proton symporters (27-30). This reinforces the annotation of a permease made previously 






Figure 3.5 | Amino acid sequence alignment of YjhB compared to NanT homologs from five different species of 
bacteria. Species include Yersinia pestis, Salmonella enterica, E. coli, Shigella flexneri and Citrobacter koseri—all 
gram-negative bacteria. Strictly conserved residues are highlighted (*), conservation between residues with 
strongly similar properties are shown (:) and conservation between residues with weakly similar properties are 
shown (.). Residues implicated in the two additional and unique transmembrane helices of NanT are highlighted 
with a blue box. 
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The multiple sequence alignment of these transporters identified numerous regions of sequence 
conservation, including the DXXXGRR/K and E------R/Q motifs, which have been determined to play a 
crucial role in the well-characterised E. coli D-xylose sugar porter, XylE (31). One obvious difference is 
the extra 49 residues located halfway through the alignment for all NanT homologs. These residues 
likely comprise the two additional transmembrane helices that are unique to NanT (9). To confirm this 
assumption, the membrane topology of YjhB was predicted using the TOPCONS server 
(topcons.cbr.su.se/). Given an amino acid sequence, five different prediction algorithms are employed 
to specify the orientation of the transmembrane helices. Collectively, their predictions are supplied to 
the TOPCONS Hidden Markov Model, which provids a consensus prediction, coupled with a reliability 
score for the membrane topology (32). Based on the amino acid sequence, E. coli YjhB was predicted to 
comprise a total of 12 transmembrane helices, where both the N- and C-termini are located on the 
cytoplasmic side of the membrane (Figure 3.6). This is a characteristic feature of the major facilitator 
superfamily (33) and essential prerequisite for the pWarf(-) expression vector.  
 
 
Figure 3.6 | The predicted membrane topology for YjhB. Using the TOPCONS server (32), the consensus prediction 
for the orientation of the transmembrane helices is presented. Transmembrane helices are numbered from 1 to 
12, where their respective orientation is labelled. The reliability score is stated for each amino acid position in the 
sequence—a score of 1.0 reflects the highest quality. The N- and C- termini for YjhB are both predicted to be on 
the inside (or cytoplasmic side) of the plasma membrane.  
 
To facilitate the characterisation of membrane proteins and identify functionally important features, 
the determination of the proteins 3D structure is essential, especially if the protein of interest is targeted 
for the development of therapeutics. Although membrane proteins constitute at least 20-30% of the 
total proteome for most organisms (34), they are severely under-represented in the PDB, currently at 
only 1-2% (2723 membrane proteins/ 150145 total PDB entries, March 2019). This paucity reflects the 
inherent challenges with protein overexpression, protein stability, method of reconstitution (i.e. 
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detergent, SMALPS, nanodiscs etc.) and simply obtaining well-ordered crystals for X-ray crystallography 
(18; 35). While the ‘resolution revolution’ in single-particle cryo-electron microscopy signals the 
beginning of a new area in structural biology (36; 37), this will still present challenges to membrane 
proteins, particularly with the difficulties in sample preparation and to a certain extent, image 
classification (38). As a result of these inherent challenges, computational approaches that predict the 
structure of membrane proteins still have a role in their characterisation (39; 40). Homology modelling 
is one computational approach to predict the structure of proteins through a template-based method, 
using closely-related atomic structures in the PDB (41). While this can be effective with soluble proteins, 
its success can be limited with membrane proteins due to their poor representation in the PDB, as 
mentioned above. An alternative is de novo protein structure prediction.  
De novo protein structure prediction, as opposed to homology modelling constructs a 3D model from 
sequence or first principles, without the use of closely related structures or templates (42). To achieve 
this, two main approaches are commonly used; contact-assisted ab initio folding and fragment-based 
ab initio assembly. The contact-assisted approach aims to predict the spatial relationship between 
amino acid residues within a protein through a combined machine learning or evolutionary-coupled 
analysis (40; 43). Amino acid residues identified to have a spatial relationship, driven by a multiple 
sequence alignment, are used to generate a contact map and distance matrix. Combined with secondary 
structure information, these spatial relationships can then be used to construct a 3D model of the target 
protein (44). However, the accuracy of these models can be limiting when sequence homologs are 
lacking (45).  
Alternatively, fragment-based assembly utilises small fragments of experimentally determined 
structures to construct an ab initio 3D model—a process driven by conformational sampling (46; 47). In 
comparison to soluble proteins, which display huge structural diversity, membrane proteins can be 
constrained to a conformational search space within the lipid membrane and present a simplified 
structural diversity of either α-helical bundles or β-barrels (48). Therefore, in the absence of structural 
homologs these small peptide fragments can be exploited where high local sequence identity is 
observed, in order to drive ab initio structure prediction with the assistance of simulated annealing and 
a scoring function to favour structures with protein-like features or folds (39; 49). This approach is fully 
implemented in the Rosetta software package (47; 50). However, the success of this strategy is 
dependent on a sequence identity of ≥30% and access to several structural homologs in the PDB (51). 
As the highest sequence identity was 23% for the structural homolog, D-xylose transporter XyIE from E. 
coli (PDB ID - 4GBY) (31), the contact-assisted de novo strategy was chosen over the fragment-based, 
comparative modelling strategy. 
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To construct a contact-assisted de novo 3D model for YjhB, the PredMP server was employed. This is a 
new state-of-the-art prediction method, which utilises a Deep Transfer Learning method, along with the 
latest features of the RaptorX web portal for protein structure and function prediction (52). Its workflow 
follows three modules: 1) prediction of secondary structural elements from the target amino acid 
sequence using the RaptorX-Property server, including any disordered regions (53); 2) the spatial 
relationship between residues are predicted through Deep Transfer Learning generating a contact map 
and distance matrix. This information is then combined with the predicted secondary structure to 
construct a de novo 3D model using the RaptorX-Contact server (40); and 3) The de novo 3D model is 
embedded into a lipid membrane, guided by a prediction of the membrane topology. A summary of this 




Figure 3.7 | De novo structure prediction workflow for PredMP. To construct a de novo 3D model the PredMP server 
initially requires the input of an amino acid sequence, which is used to construct a multiple sequence alignment 
with homologs. This sequence alignment is applied to a workflow of three modules: 1) prediction of secondary 
structural elements; 2) predict the contact map and combine this with the predicted secondary structure to 
construct a de novo 3D model using the ‘Crystallography & NMR System’ (CNS) Suite; and 3) predict the membrane 
topology and insert the model into a lipid membrane using an adapted ‘Positioning of Proteins in Membranes’ 
(PPM) method. [Figure adapted from (52)]. 
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The Deep Transfer Learning method significantly improves the quality of the de novo 3D model via 
increased accuracy when predicting the spatial relationship between residues (contact map), which is 
irrespective on the amount of sequence homologs available (45). To drive de novo 3D model 
construction, the RaptorX-Contact server (40) utilises the ‘Crystallography & NMR System Suite’; a 
highly-flexible platform allowing structure-determination algorithms to easily be adapted for different 
systems such as PredMP (54). Consequently, this permits the distance matrix obtained from the contact 
map and the various geometric constraints (distance, angle and bonding) determined from the 
predicted secondary structure to be implemented in to the ‘Crystallography & NMR System’ Suite and 
guide de novo structure prediction (52). Finally, to embed the de novo 3D model into the lipid 
membrane, PredMP employs an adaption of the ‘Positioning of Proteins in Membranes’ method (55) to 
optimise the membrane burial potential and positioning of the transmembrane regions.  
The output from the PredMP server generates a total of five full-length de novo 3D models, ranked 
according to their energy function from the ‘Crystallography & NMR System’ Suite (40). The estimated 
accuracy of the constructed models is defined by a confidence score. This confidence score is a measure 
of how much sequence information was available for the given protein to accurately construct a final 
3D model. Given the term Meff, a protein with a score of 1.5 or less is marked with low confidence, a 
protein with a score of 3.5 or more is marked with high confidence, while a protein with a score in 
between is marked with medium confidence (45). Therefore, a low score reflects a protein with a poor 
representation of sequence homologs in which a fragment-based, comparative modelling strategy may 
offer a more accurate method of de novo structure prediction. The top de novo 3D model output from 
PredMP for YjhB had a Meff value of 3.125, which reflects medium confidence. However, it is largely 
skewed towards a level of high confidence, suggesting there is an acceptable number of sequence 
homologs for YjhB and the model can be trusted. 
The top de novo 3D model for YjhB, presented in Figure 3.8A, displays the typical architecture for a 
member of the MFS, containing 12 transmembrane helices (supporting the TOPCONS prediction, Figure 
3.6), which are shared equally in an N- and C-terminal domain, connected through a long cytoplasmic 
linker. Although this linker (along with the N- and C-terminal regions) was predicted to be partially 
disordered, it does contain a small cytoplasmic helix (C1) that perhaps may play a role in a gating 
mechanism during translocation of the substrate. Mapping the electrostatic potential to the surface of 
the de novo model, using the Adaptive Poisson-Boltzmann Solver (56), revealed a distribution of 
negative (red) charge on both the periplasmic and cytoplasmic sides of the membrane. This feature may 
facilitate the attraction of an amino sugar or proton towards its respective translocation pore in the 
protein. Characteristically, the substrate translocation pore in members of the MFS is located at the 
interface formed between the N- and C-terminal domains (33) (Figure 3.8A). As the contact-assisted ab 
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initio folding strategy does not allow conformational sampling (48), the de novo 3D model of YjhC, 
perhaps more closely resembles an occluded or intermediate state. Consequently, the surface cutaway 
representation (membrane view) did not expose any solvent accessible regions (Figure 3.8B), however 
the maximum dimensions of the protein could still be approximated.  
 
 
Figure 3.8 | De novo structure of YjhB. A) The overall structure of YjhB contains 12 transmembrane helices, 
characteristic of MFS members, these are depicted as cylinders, numbered and coloured by rainbow. The interface 
of the N- and C-terminal domains is highlighted (black dash). The cytoplasmic helix (C1) may play a role in a gating 
mechanism. B) A cutaway representation of the surface electrostatic potential is shown, which was calculated 
using the Adaptive Poisson-Boltzmann Solver (56).  
 
 
Overall, the regions with the highest degree of sequence conservation are localised at the interface 
between the N- and C-terminal domains and therefore are likely to be involved in substrate 
translocation. To decipher regions of functional importance to YjhB, the sequence conservation of the 
top 50 homologs were mapped onto the de novo 3D model (Figure 3.9). These sequence homologs 
included NanT, which was used to generate the multiple sequence alignment in Figure 3.5, along with 
several other NanT homologs and an assortment of putative sugar-, amino acid- and metabolic-proton 
symporters, collectively with a sequence identity to YjhB of >20%. This visual representation of sequence 
conservation avoided having to interpret an extensive multiple sequence alignment and facilitated an 
ease of interpretation for consensus regions. Specifically, the motifs DGFD (transmembrane helix 1, 
residues 27-30), GxxxDK/RxGRK/R (between transmembrane helices 2 and 3, residues 70-80) and 
GWRxxF (transmembrane helix 6, residues 167-172) were highly conserved across all sequence 
homologs. The positively-charged residues of the GxxxDK/RxGRK/R motif are believed to interact with 
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the head-group of lipids, stabilising the protein in the membrane—a signature of sugar transporters (57; 
58). The GWRxxF motif likely performs a similar role due to its location, interacting with lipids through 
charged and hydrophobic residues, while the DGFD motif is centrally located on transmembrane 1 
where it may play a role in substrate binding. Interestingly, the cytoplasmic helix (C1) was identified to 
be highly variable, but without functional data and an experimentally solved structure it is difficult to 
determine if this feature is unique to YjhB.  
 
Figure 3.9 | Sequence conservation among homologs for YjhB. A multiple sequence alignment of the top 50 
sequence homologs was generated using Clustal Omega (59). This was used to map the sequence conservation 
onto the de novo 3D model for YjhB using ConSurf (60). The conservation is colour-coded onto the structure as 
follows: highly conserved residues are maroon; residues that evolve at average rates are white; and residues that 
are highly variable are turquoise. Highlighted in black dashed circles are three highly conserved motifs: 1) DGFD 
(transmembrane helix 1, residues 27-30); 2) GxxxDK/RxGRK/R (between transmembrane helices 2 and 3, residues 
70-80); and 3) GWRxxF (transmembrane helix 6, residues 167-172). 
 
As NanT is the closest sequence homolog to YjhB, it can be annotated as a sugar-proton/ion symporter 
that couples the movement of a proton/ion down an electrochemical gradient with the uphill movement 
of a sugar against an electrochemical and/ or concentration gradient in the same direction across the 
plasma membrane (33). To understand how this process may occur in YjhB, a structural similarity search 
was conducted. This method identified only a handful of structures, which was reflective on the small 
number of published structures available for major facilitator superfamily proteins. Despite these 
structural homologs having a low sequence identity and coverage (<24% identity and a query coverage 
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of 40-60%) they enabled functionally important residues to be identified and helped differentiate these 
residues between a potential substrate and proton/ion translocation pore.  
The E. coli D-xylose transporter XyIE (PDB ID - 4GBY), a sugar-proton symporter within the MFS (31) was 
one of the closet structural homologs to YjhB and hence was considered the best structural candidate 
for both YjhB and NanT (7). The substrate of XylE, D-xylose, is bound between the N- and C-terminal 
domains within a central cavity and is coordinated by both aromatic and polar residues (31). The 
presence of these aromatic residues within the substrate binding cavity is a trademark feature of 
membrane transporter proteins (61-63). Within XylE, a total of four aromatic residues are situated near 
the substrate, which include Phe24, Tyr298, Trp392 and Trp416, located on transmembrane helices 1, 
7, 10 and 11, respectively (31). In YjhB, these aromatic residues, although not explicitly conserved can 
be represented by Phe31, Phe226, Phe229, Trp233 and an additional Phe148 in the same vicinity (Figure 
3.10). Furthermore, the identification of the polar residues Ser149, Asn152, Asn232, Asn236 and Thr264 
surrounding these aromatics collectively would support the coordination of a sugar molecule at this 
location. On this basis, I propose that the substrate binding site for YjhB is located at this central cavity, 
bound by transmembrane helices 1, 5, 7 and 8 (Figure 3.10). Importantly, this places the substrate 
binding site at the interface between the N- and C-terminal domains, consistent with the characteristic 
feature of the MFS (33). 
In order to transport a sugar molecule against its electrochemical and/ or concentration gradient, 
symporters must couple this uphill movement with the translocation of a proton or ion down an 
electrochemical gradient (33). This process is typically driven by residues that can be protonated or 
deprotonated, such as Asp or Glu (64; 65). Among the homologs of YjhB, a conserved Asp on 
transmembrane helix 1 is one such residue, as mutagenesis of this residue completely abolishes 
transport (66). In YjhB, this key residue is identified as Asp27, while further structural analysis identified 
Asp30 and Glu120 as potential residues involved in proton/ion transfer. Bound by transmembrane 
helices 1, 3, 4 and 6, I propose that these residues are involved in the proton/ion translocation pore for 
YjhB (Figure 3.10).  
Despite identifying a hypothetical location of the substrate binding site and proton/ion translocation 
pore, questions about the mechanism remain: 1) how do these residues create a proton/ion relay? 2) 
how is this relay coupled to the uphill movement and release of the substrate? and 3) could sialic acid 
be recognised by YjhB? It is important to note that further experimental and computational evidence, 
such as X-ray crystallography or molecular dynamic simulations are required here to quantitatively 
address these questions and define the ion dependency for YjhB. However, a hypothesis can still be 





Figure 3.10 | Proposed substrate binding site and proton/ion translocation pore for E. coli YjhB. Based on structural 
analysis with closely related homologs, residues were identified that may be functionally important. The top panels 
highlight the aromatic and polar residues that may coordinate the preferred substrate at the proposed binding 
site. The bottom panels highlight the residues that may assist in a proton/ion relay through the translocation pore. 
The conserved Asp27 has been recognised to play this role among closely related structures (64; 66). The central 
diagram indicates the location of these proposed sites on the overall de novo model. Based on the electrostatic 
potential mapped to the surface of the model, entry and exit pores can be proposed on the basis of charge 
distribution. Figures were generated using PyMOL (67) and UCSF Chimera (68). 
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A basic residue located near the conserved Asp residue has been recognised to play an essential role in 
coupling the uphill movement of the substrate with proton translocation (64; 66). In YjhB, this is 
identified as Arg110, located on transmembrane helix 4 (Figure 3.10). In the absence of a proton, this 
basic residue is reported to form a salt bridge with the conserved Asp residue causing the transporter 
to switch to an outward-facing open conformation, where the substrate can now enter and bind in the 
central cavity (69). As an example, mutation of Asp128 in the lipophilic drug transporter LmrP 
significantly reduces its transport activity (70). It is hypothesised that protonation of the conserved Asp 
residue breaks this salt bridge causing a structural rearrangement within the N- and C-terminal domains 
and facilitating a switch to the inward-facing open conformation. As a result of this switch, translocation 
of the substrate and proton transfer between Asp and Glu residues is facilitated in what can be 
described as proton relay (69).  
The conservation of the Asp residue in the translocation pore was originally identified as a characteristic 
feature of proton symporters, although in 2013, a study by Iancu and colleagues determined that the 
chemical environment within the translocation pore was also important (66). A sequence analysis 
revealed that while glucose transporter 2 contains this conserved Asp residue, it surprisingly functioned 
as a uniporter. Subsequently, modelling revealed that glucose transporter 2 had a Ser residue in the 
vicinity, which was able to form a hydrogen bond with the conserved Asp residue as opposed to a 
surrounding basic residue. As a result, the critical salt bridge was not formed. All other symporters in 
the study had a hydrophobic residue in this location (66). In YjhC, this hydrophobic residue is conserved 
(Val113), which together with the conserved Asp residue (Asp27) and the surrounding Arg110 suggests 
that YjhB could be a cation symporter. 
Structural analysis also identified a key tyrosine residue, hypothesised to play a gating role in proton 
translocation in the phosphate transporter from Piriformospora indica (71)—this is conserved in YjhB, 
as Tyr121 (Figure 3.10). Specifically, when this tyrosine residue interacts with the substrate it leads to a 
small conformational change in transmembrane helix 4 of the phosphate transporter allowing protons 
along the proton relay to exit into the cytoplasm (71). To address if this tyrosine residue in YjhB is 
involved in the proton/ion relay, molecular dynamic simulations are required.  
YjhB has been hypothesised to transport less common derivatives of sialic acid in bacteria (13). In 
consideration of its sequence identity to NanT, which is known to transport the common forms of sialic 
acid (72; 73), perhaps YjhB supports the role of NanT by expanding the substrate specificity for E. coli in 
the human host. To test this hypothesis, an in vivo assay using gene knockouts of the respective 
transporters, along with sialic acid derivatives should be performed in the future. Furthermore, while 
the residues identified in the substrate-binding site would support the binding of a sugar, no charged 
residue was observed. This contrasts with other sugar-proton symporters (10; 74), and Proteus mirabilis 
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SiaT; a sialic acid transporter within the sodium solute symporter family, which coordinates the 
carboxylate group of Neu5Ac through a salt bridge with Arg135 (61). The only reported sugar-proton 
symporter to not employ a charged residue in substrate binding is XylE (31). Therefore, perhaps YjhB 
functions to transport uncharged sialic acid derivatives, such as the lactone (Chapter One, Figure 1.1), 
which is the second most abundant sialic acid within the human gastrointestinal and respiratory tract 
(7; 13). Biologically, this would make sense as NanT can transport the acidic Neu5Ac and is likely to 
present specifically to other closely related acidic derivatives. If the lactone is transported, further 
processing was suggested through evidence of binding to YjhC (Manuscript, Chapter Two).  
 
3.4 Chapter summary 
 
This chapter investigated the previously uncharacterised YjhB membrane protein and addressed the 
hypothesis that the functional role of this transporter is to import the less common derivatives of sialic 
acid. 
Using a protein-GFP fusion system, an overexpression protocol was developed for YjhB. This is a 
significant step towards ensuring a suitable amount of protein can be isolated for future structural and 
biophysical characterisation. Insight into the biological function of YjhB was explored through a de novo 
3D model and in silico comparison between sequence homologs.  
In brief, to summarise this in silico comparison the location of the substrate binding site and proton/ion 
translocation pore for YjhB have been proposed following interpretation among structural homologs. 
Bound by transmembrane helices 1, 5, 7 and 8, the proposed substrate binding site maintains a 
conservation of aromatic and polar residues to support the binding of a sugar-based substrate. 
Although, no charged residue was identified at this location, suggesting that YjhB does not transport 
sugar-based substrates with a net positive or negative charge. Considering the hypothesis towards the 
functional role of the yjhBC operon and the homology with NanR, this suggests that YjhB imports 
uncharged derivatives of sialic acid. An example could be the lactone derivative, identified as a 
promising lead for YjhC in Chapter Two. The conservation of acidic residues (Asp27, Asp30 and Glu120) 
and partners to form a key salt bridge (Asp27/Asp30 and Arg110) in the translocation pore suggest the 
role of YjhB as a cation symporter. Furthermore, a tyrosine residue (Tyr121) may play a gating role in 
the translocation mechanism.  
Together, this characterisation completes the investigation into the uncharacterised yjhBC operon and 
has supplied data which enhances our understanding of sialic acid degradation in bacteria, providing a 
foundation to inform rational drug design to this viable target. 
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Towards a structural and functional understanding of the RpiR-




4.1.1 RpiR family of transcriptional regulators  
 
The RpiR family of transcriptional regulators regulate the genes involved in sugar catabolic pathways (1) 
and is found in both Gram-positive bacteria, such as Bacillus subtilis, Staphylococcus aureus and 
Streptococcus pneumoniae and Gram-negative bacteria, such as Escherichia coli, Haemophilus 
influenzae and Pseudomonas spp. (2-6). These catabolic pathways include the metabolism of glucose, 
maltose and ribose sugars, the pentose phosphate pathway, inositol catabolism, N-acetylmuramic acid 
catabolism and N-acetylneuraminic acid catabolism (1; 2; 7; 8).  
Within the cell, RpiR transcriptional regulators operate as both gene activators and gene repressors for 
these catabolic enzymes (7). The first member to be identified for this family was the transcriptional 
regulator RpiR, which acts as a transcriptional repressor to negatively control the gene expression of 
rpiB in E. coli (3). This gene encodes an isomerase that catalyses the isomerisation of ribose-5-phosphate 
and ribulose-5-phosphate as part of the pentose phosphate pathway (3; 7).  
Members of the RpiR family of transcriptional regulators are structurally comprised of an N-terminal 
DNA-binding domain, which contains a helix-turn-helix motif, and a C-terminal sugar isomerase domain 
(7; 9). The helix-turn-helix motif is one of the best characterised DNA-binding motifs amongst bacterial 
transcriptional regulators and is defined by a tight tri-helical structure, where the third α-helix is often 
referred to as the “recognition helix”, as it interacts directly with the major groove of the DNA (10) 
(Figure 4.1A). This is achieved primarily through electrostatic interactions, via positively-charged amino 
acid residues that interact with the DNA bases that form the recognition sequence for the regulator 
(11). In addition, polar interactions primarily with the DNA backbone provide further stability for the 






Figure 4.1 | Cartoon overview of the helix-turn-helix motif and the sugar isomerase domain. A) The helix-turn-helix 
motif is one of the best characterised DNA binding motifs amongst bacterial transcriptional regulators. 
Structurally, this motif is comprised of a tight tri-helical architecture, where the third α-helix (α3 in red) is often 
referred to as the ‘recognition helix’, as it interacts directly with the major groove of the DNA primarily via 
electrostatic interaction. B) The sugar isomerase domain is characterised by an alpha-beta architecture comprising 
multiple α-helices (blue) flanking a β-strand (orange) core. This cartoon representation is taken from the E. coli 
arabinose-5-phosphate isomerase (PDB ID 2XHZ) as a representative structure.  
 
The sugar isomerase domain is represented across eukaryotic, archaea and prokaryotic proteins and 
usually binds a phosphorylated sugar (9). Despite sharing a low sequence identity, structurally these 
domains share an alpha-beta architecture that is characterised by multiple α-helices surrounding a β-
strand core (Figure 4.1B) (12). Commonly, these proteins serve a catalytic role and function as an 
isomerase (9), however, in the RpiR family the sugar isomerase domain has been co-opted into an 
allosteric role in the regulatory mechanism (1; 13). Here, RpiR-mediated regulation can orchestrate the 
metabolism of carbohydrate nutrients by sensing the concentration of phosphosugars within the 
cellular environment (14). Upon binding, a conformational change is propagated through the regulator, 
attenuating the specific DNA interaction or binding affinity, which causes the regulator to dissociate (2; 
15). As a result, gene expression is induced for the metabolism of the respective carbohydrate (2). The 
phosphosugar that induces this allosteric response is referred to as the effector molecule.  
There are only three crystal structures of RpiR-type transcriptional regulators. One of these is a regulator 
of sialic acid catabolism in Vibro vulnificus (PDB entry 4IVN), which is discussed below, while the other 
two are solved as part of structural genomics project and are therefore not published, where they 
contain either the N-terminal or C-terminal domains only (PDB ID 31WF and 3SHO, respectively). 




4.1.2 The RpiR-type sialoregulators   
 
Given the importance of sialic acid to the survival and persistence of bacterial pathogens (16; 17), it is 
unsurprising that its catabolic pathway is tightly regulated to ensure this alternative nutrient is utilised 
to its full potential when present in the surrounding environment. In response to this availability, the 
transcriptional regulator NanR orchestrates the gene expression of the sialic acid catabolic machinery 
in order to utilise the nutrient source (13; 14). Largely placed in the RpiR-family of transcriptional 
regulators, NanR has been identified in both Gram-positive and Gram-negative bacterial pathogens 
including Clostridium perfringens (8), H. influenzae (5), S. aureus (6), S. pneumoniae (4; 18) and V. 
vulnificus (13; 19). Given these transcriptional regulators are involved in the gene regulation of sialic 
acid catabolism, they are referred to as ‘sialoregulators’ (20).  
Work to date has focused on distinguishing the genes that are controlled by these sialoregulators and 
identifying the consensus nucleotide sequence that is recognised to facilitate regulation (4-6; 8; 13; 19). 
This research demonstrates that NanR collectively regulates the gene expression of the nanA, nanK and 
nanE genes, which encode the core catabolic enzymes, N-acetylneuraminate lyase, N-
acetylmannosamine kinase and N-acetylmannosamine 6-phosphate 2-epimerase (4; 8; 13; 18). In 
addition, NanR also regulates gene expression for various other proteins involved in the import or 
processing of sialic acid, including: 1) the specific transporters of sialic acid such as the secondary 
transporter NanT or the TRAP transporters (8); 2) several uncharacterised proteins, such as the putative 
oxidoreductase YjhC, which is investigated in Chapter Two; and 3) a sialidase (NeuA) used for scavenging 
sialic acid from glycoconjugates (4; 21). Collectively, the occurrence of the nanA, nanK and nanE genes 
are highly conserved among bacteria that can catabolise sialic acid, while the genes encoding the 
transport machinery or enzymes required to further process sialic acid can change depending on the 
species. 
Secondly, various degradation products of the sialic acid catabolic pathway have been screened in order 
to identify potential effector molecules that induce the in vivo expression of the proteins required to 
degrade sialic acid. Gualdi et al. (2012) demonstrate in vivo that the S. pneumoniae regulator is 
responsive to the pathway intermediates N-acetylmannosamine, or N-acetylmannosamine-6-
phosphate (18). In addition, Olson et al. (2013) demonstrate that in the presence of the phosphorylated 
pathway intermediate N-acetylmannosamine-6-phosphate, the S. aureus regulator exhibits a loss of 
DNA-binding affinity (6). This attenuation of DNA-binding activity in the presence of N-
acetylmannosamine-6-phosphate is also observed in NanR from V. vulnificus (13), while glucosamine-6-
phosphate is implicated as the effector molecule in H. influenzae NanR (5). Thus, the RpiR-type 
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sialoregulators are largely responsive to phosphorylated pathway intermediates, a feature that is 
facilitated by the sugar isomerase domain.  
The structural characterisation of the RpiR-type sialoregulators is limited to NanR from V. vulnificus, 
where the crystal structure has been solved to 1.9 Å in complex with its effector, N-acetylmannosamine-
6-phosphate (PDB ID 4IVN). The authors demonstrate that this NanR forms a dimeric assembly, where 
DNA is hypothesised to bind between the monomers in an arched tunnel-like cavity, mediated by 
positively charged residues (13). In addition, this structure provides the first insight into the coordination 
of the effector molecule within the sugar isomerase domain, which is primarily mediated via 
electrostatic interactions and the amino acid residue H163. However, as discussed in Chapter One, the 
dimer interface of their proposed ‘active form’ is unconvincing, as it is formed by only four hydrogen 
bonds and buries less than 3% of the accessible surface area (Figure 4.2). Thus, the true oligomeric 
assembly of the RpiR-type sialoregulators, as well as the molecular details that define the protein-DNA 
interaction are open questions. This is investigated in this Chapter.  
 
 
Figure 4.2 | Crystal structure of the V. vulnificus NanR. The left panel presents the proposed ‘active’ dimeric 
assembly for V. vulnificus RpiR-type NanR in its ‘active state’ in complex with the N-acetylmannosamine-6-
phopshate (ManNAc-6P) effector molecule (sticks). Highlighted is the arched, tunnel-like DNA-binding cavity. The 
right panel presents a top view of the transcriptional regulator, where the insert highlights the four hydrogen 
bonds that form the dimeric interface—these are formed between residues, D161-G135 and H163-ManNAc-6P. 
This figure was generated using PyMOL and the PDB ID 4IVN (13). 
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4.1.3 S. pneumoniae NanR  
S. pneumoniae is a low-GC Gram-positive bacterial pathogen of the human respiratory system and is a 
major cause of pneumonia, meningitis, bacteraemia and ear infections (otitis media) (22). To establish 
infection within the human host, S. pneumoniae have evolved the ability to utilise sialic acid as an 
alternative source of nutrition (4; 18; 23). In addition, S. pneumoniae is known to express surface-
associated sialidases that function to cleave sialic acid from the terminal of glycoconjugates. Being able 
to catabolise and recycle sialic acids assists colonisation within the host, increases pathogenicity and 
provides a fitness benefit over pathogens who rely on endogenously expressed sialidases of the host to 
scavenge sialic acid (18; 21; 24; 25). 
The gene expression of the proteins required to utilise sialic acid in S. pneumoniae is under control of 
the RpiR-type transcriptional regulator NanR. Here, NanR binds to two different operons, nan operon I, 
and nan operon II, while additionally regulating the expression of the sialidase gene, nanA—these genes 
are clustered within the genome (4). nan operon I is comprised of 10 genes that encode the essential 
catabolic enzymes NanA, NanK and NanE, as well as various hypothetical proteins and a 
phosphotransferase system. Conversely, nan operon II is comprised of six primary hypothetical proteins 
and a putative oxidoreductase. This oxidoreductase is placed in the Gfo/Idh/MocA family, as is YjhC, 
which is investigated in Chapter Two. The recognition sequence for these operons has been identified 
(4; 18) and is presented in Figure 4.3, where it is compared with other Streptococci strains from the 
RegPrecise database (26). Overall, this DNA recognition sequence for NanR is highly conserved among 
Streptococci. It is unknown if these sequences will form hairpin structures in vivo, on the basis of the 







Figure 4.3 | The DNA recognition sequence for NanR within Streptococci. Eight different DNA recognition sequences 
are presented, including S. pneumoniae (labelled with red arrow). The regions of conservation are highlighted in 
white text with a black background. Combined, these sequences were used to generate a sequence logo using 
WebLogo (27). The height of each base pair is representative of its probability or conservation among Streptococci 
strains.  
 
4.2 Chapter overview 
 
This chapter presents structural and functional studies of the RpiR-type NanR from the Gram-positive 
human pathogen, S. pneumoniae, a common inhabitant of the human respiratory tract and a significant 
cause of infection and disease (22; 28). The overall aim of this chapter is to define the biologically 
relevant quaternary structure and characterise the molecular details that govern the protein-DNA 
interaction.  
The results demonstrate that S. pneumoniae NanR binds the phosphorylated sugar N-
acetylmannosamine-6-phosphate, which is consistent with its implication as an effector molecule in vivo 
(18). A thorough investigation into the quaternary structure, stoichiometry of the protein-DNA hetero-
complex and binding kinetics is presented using analytical ultracentrifugation. This is supported by 
solution scattering data, where additionally a multiphase ab initio reconstruction provides insight into 
the orientation of the protein and DNA within the hetero-complex. Although X-ray diffraction data was 
not suitable for structure determination, the crystals obtained are appropriate for future optimisation. 
Combined, these experiments enhance our understanding of how RpiR-type sialoregulators control 
gene expression.  
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4.3 Results and Discussion  
 
4.3.1 Cloning, expression and purification of S. pneumoniae NanR 
 
The nanR gene encoding the sialoregulator from S. pneumoniae was synthesised commercially in the 
cloning vector designated pUC57 with the restriction sites BamHI and HindIII. To assist overexpression 
of the construct, the nanR gene was codon optimised for E. coli—the recombinant expression host. 
Initially, in order to use an N-terminal poly-Histidine tag (His-tag), the nanR gene was sub-cloned into 
the pET30ΔSE expression vector. However, the His-tag exhibited poor binding affinity during 
immobilised-metal affinity chromatography, with a significant portion eluting in the flow-through or 
wash. Moreover, no protein-DNA interaction was observed using this construct in preliminary DNA 
binding experiments and therefore the use of a His-Tag was not suitable for this system. To rectify this, 
PCR and In-Fusion cloning was employed to utilise the restriction sites NdeI and HindIII and sub-clone 
the nanR gene back into the pET30ΔSE expression vector, without the incorporation of the N-terminal 
His-tag. 
S. pneumoniae NanR was successfully purified using a four-step procedure, employed over two days: 
ammonium sulphate precipitation, anion exchange chromatography, heparin chromatography and size-
exclusion chromatography (Chapter Eight, Section 8.6.2.2). Following protein preparation, an initial 
ammonium sulphate precipitation step was utilised to remove nucleic acid contamination without the 
use of DNase, which may have affected DNA-binding studies following purification (29). This was verified 
by assessing the ratio of absorbance at 260/280 nm on a NanoDrop Spectrophotometer, where a ratio 
of 0.61 was obtained following this initial purification step. This ratio is consistent with a protein 
spectrum that is free of nucleic acid contamination. Without this step a 260/280 nm ratio at ~1.0 
towards a value of 2.0 was obtained, indicative of increasing nucleic acid contamination (29). SDS-PAGE 
analysis following this procedure indicated that most of the protein was retained, thus while this is 
effective at removing nucleic acid it offers little overall purification. However, as characterising the 
protein-DNA interaction is a major aim of this study, this preliminary step was necessary. Prior to 
subjecting the protein to anion exchange chromatography, the sample was buffer exchanged by dialysis 
to ensure efficient binding to the column. 
Following elution from the anion exchange column (Figure 4.4A), the protein sample was subjected to 
heparin chromatography. Here, the structure and negative charge of heparin allows it to mimic the 
polyanionic structure of DNA and serve as an affinity ligand (30). Following elution, NanR was primarily 





Figure 4.4 | A typical purification of S. pneumoniae NanR. A) A typical chromatogram from anion exchange 
chromatography. B) A typical chromatogram from heparin chromatography. The column was equilibrated with 
150 mM NaCl as the recombinant protein was deemed unstable at lower salt concentrations. The red line 
highlights the concentration of elution buffer used to elute the recombinant protein, while the grey box highlights 
the fractionation range that was pooled.  
 
As a final purification step, the fractions pooled from heparin chromatography were subjected to size-
exclusion chromatography, where initially, the column was equilibrated with a buffer containing 150 
mM NaCl. However, at this salt concentration the protein eluted as a very broad peak across a retention 
volume of 80 mL. This observation is indicative of non-specific ionic interactions with the Superdex 
matrix. To fix this, I increased the ionic strength of the buffer by using a salt concentration of 300 mM, 
where following equilibration with this new buffer, NanR eluted as a much tighter, single elution peak 
across a retention volume of approximately 10 mL (Figure 4.5A). The increasing purity of the 
recombinant protein from each chromatography technique is shown in Figure 4.5B. The final purity 
following size-exclusion chromatography was estimated to be approximately 95%, as highlighted by the 
single band (Figure 4.5B). Moreover, the theoretical monomeric molar mass of 32, 671 Da was verified 
by electrospray ionisation mass spectrophotometry, providing a molar mass of 32, 529 Da. This small 
discrepancy is consistent with the loss of the terminal methionine (149 Da). The final yield of S. 










Figure 4.5 | Purification of S. pneumoniae NanR. A) A typical chromatogram from size-exclusion chromatography. 
The grey box highlights the fractionation range that was pooled and flash-frozen for future structural and 
functional characterisation. B) SDS-PAGE analysis showing the increasing purity following each purification step. 
Lane 1, Protein ladder (kDa); lane 2, crude lysate; lane 3, pooled fractions from anion-exchange chromatography; 
lane 4, pooled fractions from heparin chromatography; and lane 5, pooled fractions following size-exclusion 
chromatography.  
 
4.3.2 The thermal stability of S. pneumoniae NanR 
 
Three effector molecules for S. pneumoniae NanR have been identified, following in vivo growth studies 
reported in the literature (18; 31). These include Neu5Ac, and two metabolites of the sialic acid 
degradation pathway: N-acetylmannosamine; and N-acetylmannosamine-6-phosphate. To verify these 
effectors bind NanR in vitro, differential scanning fluorimetry experiments were used to detect changes 
in the melting temperature of the protein, in the presence and absence of the molecules (Chapter Eight, 
Section 8.6.2.3). Effector binding can be evaluated based upon the changes in melting temperature, as 
such a positive or negative thermal shift can be used to infer whether the effector molecule is binding 
the sialoregulator.  
Initially, the thermal stability was measured for NanR in the absence of any effector molecule, 
demonstrating a melting temperature of 48.1 ± 0.1 °C (Figure 4.6). To assess the thermal stability of 
NanR in the presence of potential effector molecules, a total of six metabolites of the sialic acid 
degradation pathway were used, including: Neu5Ac; N-acetylmannosamine (ManNAc); N-
acetylmannosamine-6-phosphate (ManNAc-6P); N-acetylglucosamine (GlcNAc); and N-
acetylglucosamine-6-phosphate (GlcNAc-6P). A significant increase in thermal stability of 9.4 °C was only 
observed in the presence of ManNAc-6P (Figure 4.6). This provides strong evidence of a binding event 
for ManNAc-6P, supporting its implication as an effector molecule (18) and is consistent with the 
observation of RpiR family members generally binding phosphorylated end-products of their respective 
catabolic pathways (9). However, no significant increase in thermal stability was observed for Neu5Ac 
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or N-acetylmannosamine, contradicting the in vivo growth experiments in the literature (4; 18). Perhaps 
in vivo this interaction is either transient, or the result of degradation to ManNAc-6P when grown on 
Neu5Ac and ManNAc, both upstream metabolites in the sialic acid catabolic pathway (Chapter One, 
Figure 1.7). All other pathway metabolites presented a thermal shift of less than 1.0 °C, which was 
deemed insignificant.  
 
Figure 4.6 | Thermal stability of S. pneumoniae NanR in the presence and absence of potential effectors molecules. 
A) The mean melting temperatures determined for S. pneumoniae NanR is presented (bar). The melting 
temperature (Tm) from each triplicate measurement is shown (black cross). The red line highlights the Tm for the 
protein only. B) The thermal stability shift presented as a derivative plot. Here, the Tm is denoted as the lowest 
part of the curve. The conditions that demonstrated a significant increase in thermal stability relative to the protein 
by itself are shown. 
 
Lastly, to assess if DNA provided a change in thermal stability, the protein was also incubated with the 
respective DNA recognition sequence (Chapter Eight, Table 8.4). Here, an increase of 2.1 °C was 
observed, providing evidence of DNA binding. DNA-binding activity is investigated in further detail later 
in the chapter. Together, the results from these thermal shift experiments are summarised in Table 4.1.  









S. pneumoniae NanR 
Protein only 48.1 ± 0.1 
+ Neu5Ac 47.9 ± 0.5 
+ ManNAc 48.1 ± 0.2 
+ ManNAc-6P 57.5 ± 0.1 
+ GlcNAc 48.0 ± 0.1 
+ GlcNAc-6P 46.71 ± 0.1 
+ DNA Recognition Sequence 50.2 ± 0.1 
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4.3.3 Sequence comparison with other RpiR-type sialoregulators  
 
To elucidate potential amino acid residues that may be functionally important for the binding of the 
effector and interaction with DNA, a multiple sequence alignment was generated between S. 
pneumoniae NanR and the RpiR-type sialoregulators from C. perfringens, H. influenzae, S. aureus, and 
V. vulnificus using Clustal Omega (32). By comparing the V. vulnificus crystal structure (PDB ID 4IVN), 
potential amino acid residues that are functionally important were assigned based on conservation 
between sequences. These proteins share a sequence identity of 20-30%.  
Within the N-terminal DNA-binding domain, the majority of amino acid residues that show high 
sequence conservation have positively-charged side chains or polar uncharged side chains (Figure 4.7, 
highlighted red). Within the V. vulnificus structure, these residues are primarily clustered together on 
the surface of the protein where they are poised for electrostatic or polar interaction with the DNA base 
pairs and backbone. A combination of arginine, lysine and threonine side chains is a common feature in 
the helix-turn-helix motif (10; 33). In addition, other conserved amino acid residues or chemically similar 
amino acid residues likely play a structural role, maintaining the correct fold of the helix-turn-helix motif 
and overall N-terminal domain.  
Conversely, within the C-terminal sugar isomerase domain, the amino acid residues that coordinate the 
phosphate oxygens atoms of the effector molecule N-acetylmannosamine-6-phosphate in V. vulnificus 
are highly conserved (Figure 4.7, highlighted in blue; residues S182, S184 T187 in V. vulnificus sequence) 
(13). This amino acid conservation is consistent with the evidence from differential scanning fluorimetry 
experiments where only a phosphorylated sugar provided a significant increase in thermal stability 
(Section 3.3.3). In addition, other amino acids highlighted in Figure 4.7 provide additional coordination 
to the effector molecule, primarily through a water-mediated hydrogen-bonding network. In particular, 
proline at position 231 in V. vulnificus is observed to form a hydrogen bond with the carbonyl oxygen of 
the N-acetyl moiety in N-acetylmannosamine-6-phosphate (13). This proline is conserved in S. 
pneumoniae NanR at position 227. Conversely, H. influenzae NanR, which is predicted to bind 
glucosamine-6-phosphate (5) has a lysine at this position. As glucosamine-6-phosphate lacks the N-








Figure 4.7 | Multiple sequence alignment of RpiR-type sialoregulators from five bacterial pathogens. Species include 
C. perfringens, H. influenzae, S. aureus, S. pneumoniae and V. vulnificus. Strictly conserved residues (*), 
conservation between residues with strongly similar properties (:) and conservation between residues with weakly 
similar properties (.) are shown. Highlighted in red are residues that may be functionally important for DNA 
interaction. Highlighted in blue are residues that may be functionally important for binding the effector. These 
assignments are based upon the V. vulnificus structure (PDB ID - 4IVN). Labelled with black arrows is the N-terminal 
DNA-binding domain and the C-terminal sugar isomerase domain.  
 
Overall, this multiple sequence alignment identified amino acid residues that are likely to coordinate 
the effector and highlighted their conservation with the V. vulnificus structure, providing further 








4.3.4 The quaternary structure of S. pneumoniae NanR 
 
Sedimentation velocity experiments were carried out to characterise the quaternary structure of S. 
pneumoniae NanR. In order to extract this information, the purified protein was subjected to a 
centrifugal force field causing separation of the components within the sample based on their size and 
shape (34). This process can be monitored by absorbance optics to measure the sedimentation and 
diffusion behaviour of the macromolecules in solution. In addition, this solution behaviour can be 
evaluated across a wide range of concentrations and buffer conditions (35).  
Sedimentation data was collected for NanR at a concentration of 0.25 and 0.5 mg mL-1 (Chapter Eight, 
Section 8.6.2.5) and fitted to a continuous sedimentation coefficient distribution [c(s)] model, resulting 
in a single, symmetrical peak. Peak integration within the c(s) distribution gave a sedimentation 
coefficient of 4.31 S for S. pneumoniae NanR (Figure 4.8, Panel A). The frictional ratio (f/f0), which is a 
measure of shape asymmetry suggested that NanR (f/f0 = 1.28) has a slightly elongated shape in 
solution, as a sphere would have a f/f0 of 1.0.  
 
Figure 4.8 | Sedimentation velocity analysis of S. pneumoniae NanR using analytical ultracentrifugation. Data was 
collected at 280 nm, 42 000 rpm and 20 °C using purified NanR at a concentration of 0.5 mg mL-1. Panel A) The c(s) 
model displaying the sedimentation distribution. Shown in bold is the sedimentation coefficient, following peak 
integration. Panel B) The c(M) model displaying the molar mass distribution. Shown in bold is the apparent molar 
mass, following peak integration. Panel C) The raw data (open circles) and best fit (lines) is presented. For clarity, 
every third absorbance scan is shown. The randomly distributed residuals are shown below. All data was analysed 
using SEDFIT (36). Figures were produced using PRISM (version 7.00) and GUSSI (developed by Dr Chad Brautigam).  
 
Further fitting to a continuous mass distribution [c(M)] model gave an apparent molar mass of 62.9 kDa, 
consistent with the theoretical dimeric mass of 65.3 kDa (Figure 4.8, Panel B). The observation of a 
dimeric assembly is a common feature amongst bacterial transcriptional regulators (37; 38). Although a 
smaller species was observed in the sedimentation data at ~2.5 S, the ratio between this smaller peak 
and the predominant peak did not change with concentration. This is consistent with the conclusion 
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that NanR is not in a self-association and suggested that this peak is likely to be a contaminant or an 
incompetent monomer of NanR. However, it could be a very slow self-association.  
Combined, these sedimentation velocity data confirmed that NanR adopts a dimeric architecture in 
solution, which is consistent with the reported oligomeric structure of V. vulnificus NanR (13). Moreover, 
the observation of a predominant, symmetrical peak demonstrated NanR is stable in solution. Validation 
of this analysis was supported by the randomly distributed residuals and a low root-mean-square 
deviation (Figure 4.8, Panel C). 
 
4.3.5 Electrophoretic mobility shift assays demonstrate DNA binding activity 
 
Electrophoretic mobility shift assays (EMSA) were conducted using a nanomolar titration range of 
protein against a set concentration of fluorescently end-labelled DNA as described in Chapter Eight, 
Section 8.6.2.7, in order to identity DNA-binding activity. This double-stranded oligonucleotide contains 
the DNA recognition sequence found within the operator site of the S. pneumoniae nan operon I (Figure 
4.3) and is labelled with fluorescein at the 5’ terminal. In addition, these experiments were replicated 
in the presence of N-acetylmannosamine-6-phosphate to further investigate the role of this 
phosphorylated sugar as the effector molecule for S. pneumoniae NanR.  
Visualised using a fluorescent scanner, the addition of NanR resulted in a concentration-dependent gel 
shift, relative to the DNA probe. This single observed band, which increases in signal intensity is 
consistent with the formation of a single protein-DNA hetero-complex (Figure 4.9A). However, as the 
protein concentration was increased further, this band disappeared leaving a smear in the EMSA gel 
(Figure 4.9A, Lanes 9-11). Instead, the sample was observed at the bottom of the well suggesting that 
the species has significantly increased in size and is now unable to enter the EMSA gel. In addition, a 
reduced signal intensity of the DNA probe was observed in lanes 9-11, respectively (Figure 4.9A). 
Together, these features suggest the formation of non-specific DNA-binding within this titration range. 
It should be noted that the intensity of the retarded band for the hetero-complex was relatively low 








Figure 4.9 | Electrophoretic mobility shifty assays in the presence and absence of N-acetylmannosamine-6-
phosphate. A) Titration range of NanR in the presence of 50 nM DNA. B) Titration range of NanR in the presence 
of 50 nM DNA and 5 mM N-acetylmannosamine-6-phosphate (ManNAc-6P). In both gels each lane contains as 
follows: Lane 1 – 12.5 nM NanR; Lane 2 – 25 nM NanR; Lane 3 – 50 nM NanR; Lane 4 – 60 nM NanR; Lane 5 – 70 
nM NanR; Lane 6 – 80 nM NanR; Lane 7 – 90 nM NanR; Lane 8 – 100 nM NanR; Lane 9 – 200 nM NanR; Lane 10 – 
300 nM NanR; Lane 11 – 400 nM NanR; and Lane 12 – DNA only. Labelled is the DNA probe, the protein-DNA 
hetero-complex and evidence of sample stuck in the wells.  
 
Interestingly, when N-acetylmannosamine-6-phosphate was included in the binding assay, a complete 
loss of activity was observed (Figure 4.9B). This feature provides strong evidence to reinforce that this 
phosphorylated sugar is the effector molecule as its presence has significantly attenuated the DNA-
binding affinity for NanR towards its recognition sequence. Although, relative to the previous 
experiment, more sample was observed at the bottom of the well, without a clear reduction in signal 
for the DNA probe (Figure 4.9B, Lanes 7-11). Intriguingly, this may reflect aggregated protein as opposed 
to non-specific binding to DNA as no clear retardation of DNA was present.  
Nonetheless, these EMSA experiments demonstrate that NanR can actively bind DNA and illustrate that 
in the presence of N-acetylmannosamine-6-phosphate this DNA binding activity is lost or significantly 
attenuated. To further unravel the molecular determinants for this attenuation, a crystallographic 
analysis in the presence and absence of N-acetylmannosamine-6-phosphate is required. This would 
enable any effector-induced conformational changes to be mapped, in order to understand the 






4.3.6 Defining the stoichiometry of the S. pneumoniae NanR-DNA hetero-complex  
 
The stoichiometry of protein-DNA hetero-complexes is crucial to developing a molecular understanding 
of the DNA-binding mechanism. As mentioned earlier, sedimentation velocity experiments conducted 
using an analytical ultracentrifugation provide access to the sedimentation and diffusion behaviour of 
macromolecules in solution (35). In addition, analytical ultracentrifugation has long been recognised as 
the gold-standard technique to quantitatively analyse complex interactions in solution, since 
experiments can be performed in conditions that closely match the physiological environment (39; 40). 
Thus, sedimentation velocity experiments can provide a qualitative assessment of EMSA assays, which 
can be limited in terms of measuring the dissociation of the complex due to a non-equilibrium 
environment. Furthermore, EMSA assays do not provide accurate determination of the molecular mass 
for the complexes, as the gel-based technique is influenced by several other factors (41). 
To investigate the nature of the S. pneumoniae NanR-DNA interaction, sedimentation velocity 
experiments were conducted using different titrations of the sialoregulator against a set concentration 
of fluorescently end-labelled DNA (Chapter Eight, Section 8.6.2.6) This double-stranded oligonucleotide 
is identical to what was in the EMSA experiments above. By measuring the emission wavelength of 
fluorescein (495 nm) the sedimentation profile of DNA can be monitored as each titration is subjected 
to a centrifugal force field. Thus, this not only enables detection of free DNA but also provides the ability 
to evaluate the formation of protein-DNA hetero-complex, indicated by a positive shift in the 
sedimentation coefficient.  
To accurately determine the molecular weight of each species in solution and therefore gain access to 
the stoichiometry of this interacting system, three key pieces of information must be obtained, 
including: 1) sedimentation coefficient; 2) diffusion coefficient; and 3) partial specific volume. To 
precisely acquire the sedimentation and diffusion coefficients, sedimentation velocity experiments can 
be collected at two different speeds. A high speed enables the macromolecules within a complex 
mixture (such as protein and DNA) to be separated with increased resolution, resulting in an accurate 
sedimentation coefficient. Conversely, a lower speed allows more time for macromolecules to diffuse 
in solution, providing a more precise diffusion coefficient. However, each speed must be optimised for 
each experiment. This is dependent on the number of samples being collected and the approximate 
molar mass range of the macromolecules in solution. In this study, both 50 000 rpm and 32 000 rpm 
were selected. Lastly, the partial specific volume of the protein-DNA hetero-complex was estimated as 
a weight-average of the protein and DNA components (Chapter Eight, Equation 8.4). The values used in 
this study are presented in Table 4.2.  
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Following data collection, the sedimentation data was evaluated by the two-dimensional spectrum 
analysis (2DSA) (42) and further refined by 50 Monte Carlo iterations using the state-of-the-art software, 
Ultrascan (43). Using peak integration, the hydrodynamic information was extracted from both the high 
and low speed experiments and was used to define the stoichiometry. This revealed that upon 
increasing protein concentration, S. pneumoniae NanR coordinates DNA as a dimer with a 2:1 binding 
stoichiometry to form a dimeric NanR-DNA hetero-complex (Figure 4.10).  
 
 
Figure 4.10 | Single-wavelength sedimentation velocity analysis of NanR from S. pneumoniae. A) 2DSA-Monte Carlo 
model displaying the sedimentation coefficient (S) distribution from the 50 000 rpm experiment, where each 
colour represents a different titration sample, collected independently (see legend). To illustrate the identity of 
the two main species in solution, a cartoon depiction of DNA and the NanR-DNA hetero-complex is presented. B) 
van Holde-Weischet plot provides a graphical transformation of the sedimentation data allowing the proportional 
contributions of each species to be interpreted. C) Pseudo-3D plot presenting the global solute distribution, across 




Across the seven different NanR-DNA titrations measured in this experiment, all displayed a positive 
shift in the sedimentation coefficient, relative to the DNA signal at 2.14 S (Figure 4.10A). This shift can 
clearly be observed in the van Holde-Weischet plot (Figure 4.10B), which provides a graphical 
transformation of the sedimentation data allowing the proportional contributions of each species to be 
interpreted. Moreover, upon increasing NanR concentration a new peak at approximately 5 S appears 
and a decrease in the relative DNA signal was observed—this is indicative of protein-DNA hetero-
complex formation. The measured molar mass of this complex (reported in Table 4.2) was consistent 
with the theoretical molar mass of a NanR dimer and its DNA recognition sequence forming a dimeric 
NanR-DNA hetero-complex (77.4 kDa). Validation of this stoichiometry was supported by the small 
difference in molar mass between these values with an error of less than 10% (Table 4.2).  
 
Table 4.2 | Summary of sedimentation velocity data collection and analysis from NanR S. pneumoniae   
Data collection parameters  
Buffer density (g/cm3) 1.0059 
Buffer viscosity (cp) 1.0211 
Partial specific volume (mL/g)  
S. pneumoniae NanR 0.7354 
DNA oligonucleotide 0.5550 
Dimeric NanR-DNA hetero-complex 0.7065 



















DNA only 2.14 10.35 12.5 - 12.1 3.3 
0.25:1 5.19 5.55 77.3 Dimeric 77.4 0.1 
0.5:1 5.15 5.44 78.3 Dimeric 77.4 0.5 
1:1 5.08 5.33 78.8 Dimeric 77.4 1.8 
2:1 4.93 5.47 74.5 Dimeric 77.4 3.7 
3:1 4.97 5.71 72.0 Dimeric 77.4 6.9 
4:1 5.07 5.97 70.1 Dimeric 77.4 9.4 
5:1 5.53 4.71 90.5 Dimeric + DNA  89.5 1.1 
 
However, at a protein-DNA ratio of 5:1, a new peak was observed with a small positive shift in the 
sedimentation coefficient. Following further analysis, the measured molar mass of this species was 
consistent with the theoretical molar mass of the dimeric NanR-DNA hetero-complex with an additional 
DNA oligonucleotide, as opposed to a second NanR dimer. This observation suggests that non-specific 
binding may occur between neighbouring DNA oligonucleotides at high concentration, or upon 
saturating conditions of the hetero-complex. A similar observation at this protein-DNA molar ratio was 
observed in the EMSA experiment, where the hetero-complex did not enter the gel and remained at 
the bottom of the well (Figure 4.9A, Lanes 9-11). Further optimisation, with respect to ionic strength or 
pH of the buffer system used in the experiment may reduce the appearance of the non-specific binding. 
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The global distribution of the components in this experiment can be visualised using a Pseudo-3D plot 
(Figure 4.10C). Here, a spot is representative of a solute, where upon increasing concentration the 
intensity of that spot changes. For this experiment, three populations were visualised: 1) free DNA; 2) 
NanR-DNA complex; and 3) non-specific binding. While the frictional ratio was seen to vary for the 
protein-DNA hetero-complex, this was likely due to the presence of a reaction boundary during complex 
formation.  
To determine the binding kinetics, the ratio of bound and unbound DNA was determined by peak 
integration within the sedimentation coefficient distribution. The data was best fit to a single-site model 
in Prism (Figure 4.11) and gave a dissociation constant of 0.91 µM (95% confidence interval of 0.64, 1.29 
µM) for the NanR-DNA interaction. This demonstrated that NanR has a low micromolar affinity for its 
DNA recognition sequence.  
 
Figure 4.11 | The DNA binding isotherm for S. pneumoniae NanR. The binding isotherm from the sedimentation 
data, best fit to a single-site model provides a dissociation constant (KD) of 0.91 µM (black dash). 
 
Taken together, these sedimentation velocity experiments have defined the stoichiometry of NanR-DNA 
hetero-complex formation in S. pneumoniae, supported by the small difference between measured and 
theoretical molar mass values, and have determined that this system displays high affinity for its DNA 
recognition sequence. Overall, this demonstrated the precision of analytical ultracentrifugation to 
accurately provide hydrodynamic information in order to characterise macromolecules in solution and 
reinforces why it is regarded as the gold-standard technique to quantitatively analyse complex 





4.3.7 Crystallisation studies of S. pneumoniae NanR  
 
To gain insight into the molecular mechanism of gene regulation, S. pneumoniae NanR was subjected 
to crystallisation studies, following purification, with the aim of obtaining a crystal structure. Here, 
crystallisation trials were conducted using the sitting-drop vapor-diffusion method, as described in 
Chapter Eight, Section 8.6.2.8, across multiple crystallisation screens from Molecular Dimensions, 
including JCSG-plus, PACT-premier, Shotgun, Morpheus and the Clear Strategy Screens (I and II). In 
addition, the effector molecule, N-acetylmannosamine-6-phosphate (Section 4.3.3) was included in the 
protein-buffer solution and subjected to co-crystallisation trials in parallel. Here, the aim was to gain 
functional insight into coordination of this phosphorylated sugar. Collectively, these crystallisation 
screens were incubated at two temperatures (8 °C and 20 °C) and were frequently monitored for any 
signs of crystal growth. 
Over several weeks, various wells across the crystallisation trials presented the appearance of 
precipitation, phase separation and spherulites, while very few showed signs of promising crystal 
development. However, following a further incubation, crystals that were suitable for diffraction 
screening were identified at 20 °C. Collectively, these crystals were obtained from very different 
conditions, where one grew in Shotgun condition C6 (2.0 M ammonium sulphate, 0.1 M sodium acetate, 
pH 4.6), while the other developed in PACT-premier condition C9 (0.2 M lithium chloride, 0.1 M HEPES, 
pH 7.0, 20 % (w/v) PEG 6000). In both cases, the protein-buffer solution contained 10 mM N-
acetylmannosamine-6-phosphate. No crystal growth was seen in conditions without this 
phosphorylated sugar.  
Figure 4.12A and 4.12B show the difference in crystal morphology between Shotgun condition C6 and 
PACT-premier condition C9, respectively. When observed under a polarising filter, both crystal 
morphologies were birefringent, suggesting each crystal was protein. Excitingly, when collected using 
the MX2 beamline at the Australian Synchrotron, these crystals diffracted to 3.30 Å and 3.72 Å, 









Figure 4.12 | Crystal images and X-ray diffraction images of S. pneumoniae NanR. A) Crystal obtained from Shotgun 
condition C6 that diffracted to 3.29 Å. B) Crystal obtained from PACT-premier condition C9 that diffracted to 3.72 
Å. The red crosshair highlights the crystal mounted within a cryo-loop on the MX2 beamline. A scale bar is included 
to give an indication on the size of each crystal. The blue ring indicates where the highest diffraction was observed 
in each crystal.  
 
Table 4.3 | Data collection statistics from S. pneumoniae NanR crystallisation trials* 
 
 Shotgun condition C6 PACT-premier condition C9 
Data collection statistics   
Spacegroup  H32 P21 
Unit cell a, b, c (Å) 124.94, 124.94, 193.62 126.58, 218.58, 127.55 
Unit cell α, β, γ (°) 90, 90, 120 90, 93.68, 90 
Resolution range (Å) 47.23-3.55 (3.29-3.29) 49.43-3.80 (3.72-3.72) 
No. of total reflections 46, 285 (8, 984) 249, 764 (13, 822) 
No. of unique reflections 8, 889 (1, 817) 71, 405 (3, 950) 
I/σ 7.6 (1.8) 3.2 (0.6) 
Completeness (%) 98.4 (99.6) 98.4 (85.4) 
CC1/2 (%) 99.3 (70.2) 77.6 (9.0) 
Rmerge  0.154 (0.709) 0.689 (5.606) 
Rpim 0.078 (0.400) 0.509 (4.400) 
*Values in parentheses are for the highest resolution shell 
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Unfortunately, both these datasets were not suitable for structure determination of S. pneumoniae 
NanR for several reasons. Firstly, both were susceptible to radiation damage during data collection. This 
was significant in the PACT-premier condition C9, indicated by the poor correlation coefficient (CC1/2) 
and high Rmerge value. Moreover, these crystals were very thin on one axis and hence were difficult to 
centre, which contributed to the reduced level of completeness and poor I/σ value. Secondly, molecular 
replacement models for these proteins are limited as there are only three RpiR-like transcriptional 
regulators in the PDB, which all have a sequence identity less than 21%. This low identity is largely due 
to the sugar isomerase domain as suggested in Figure 4.7. When combined with a lower resolution 
dataset, this makes phasing the data increasingly difficult. Further, neither an ensemble-based 
molecular replacement strategy, nor an automated crystal structure determination platform, such as 
Auto-Rickshaw (44) or MrBUMP (45), were successful at phasing the diffraction data. 
However, these two conditions are perfectly suited to optimisation in the future. This can be achieved 
by screening the salt, buffer, or precipitant around each condition. Moreover, crystal seeding would 
provide an initial nucleation event to encourage larger crystal growth, with the aim of reducing 
sensitivity to radiation damage and simplifying the alignment of crystals. Lastly, the protein could be 
labelled with selenomethionine to provide an alternative phasing strategy by single-wavelength 
anomalous diffraction (46). Most importantly, obtaining this diffraction data from an initial 
crystallisation screen, combined with the level of resolution observed, demonstrates that optimisation 
and ultimately structure determination is feasible for this protein.  
 
4.3.8 Small angle X-ray scattering of S. pneumoniae NanR 
 
In the absence of an atomic resolution structure, I employed an alternative strategy, small-angle X-ray 
scattering (SAXS) to gain a structural understanding of the RpiR-type sialoregulators. Although low-
resolution (10-50 Å), SAXS can provide insight into the size and shape of biological macromolecules in 
solution and enable measurement of the molar mass and the molecular envelope of proteins, DNA or 
complexes (47; 48). Together, this information can be used to complement hydrodynamic information 
from analytical ultracentrifugation or alternatively the crystal packing within an atomic resolution 
structure to provide confirmation of the biologically relevant quaternary structure (48; 49). In addition, 
SAXS can provide a gauge on the flexibility or disorder of biological macromolecules and allow 
interpretation of conformational changes that may occur upon addition of a ligand (such as DNA) (49).  
Since the total solution scattering is a feature of all species within the sample, including the buffer the 
presence of aggregates or contaminants can have a significant effect on the overall quality (50). Thus, 
to help mitigate these effects, all samples were subjected to in-line size-exclusion chromatography prior 
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to SAXS data collection using the SAXS/WAXS beamline at the Australian Synchrotron as described in 
Chapter Eight, Section 8.6.2.9. Here, the solution structure of S. pneumoniae NanR was determined 
(Figure 4.13). In addition, SAXS experiments were conducted in the presence of DNA (Figure 4.14), in 
order to investigate any conformational changes and visualise the hetero-complex through multiphase 
modelling (Figure 4.16). Together, these solution-scattering experiments are discussed below.  
 
4.3.8.1 The solution structure of S. pneumoniae NanR 
 
SAXS data collected for the S. pneumoniae sialoregulator was consistent with a dimeric assembly in 
solution. This supports the sedimentation velocity data obtained in Section 4.3.5, verifying the 
quaternary structure. The scattering data is presented below in Figure 4.13, while a summary of the 
data analysis is provided in Table 4.4. Guinier analysis produced a linear plot (Figure 4.13A, insert) with 
a radius of gyration (Rg) of 34.56 Å and a forward scattering value (I0) of 0.024 (Table 4.4). The linearity 
of the Guinier plot further supports the observation of a single monodisperse species in solution, free 
of any significant amount of aggregation or inter-particle interference. The maximum inter-particle 
dimension (Dmax) was calculated as 112 Å by an in-direct Fourier transform of the scattering data (Figure 
4.13C). Kratky analysis presented a bell-shaped curve (Figure 4.13D), which indicated the protein was 
folded in solution and provided evidence of some flexibility. The molecular weight determined via the 
Porod volume was 77.6 kDa, which was consistent with a dimeric assembly in solution, albeit slightly 
larger than the theoretical dimeric mass (65.3 kDa). However, the molecular weight determined used 
the online server SAXS-MoW2 (51) was 91.2 kDa, which was closer to the theoretical trimeric mass (98.0 
kDa). As there was no sign of aggregation in the Guinier plot or indication of a trimeric species during 
sedimentation velocity experiments (Section 4.3.5, 4.3.7), this discrepancy in molecular weight is likely 
attributable to several features: 1) the low resolution of SAXS data (52); 2) the flexibility observed in 
NanR, as supported by the Kratky analysis; and 3) the elongated shape of NanR in solution. This is 
supported by the frictional ratio of 1.28, calculated during sedimentation velocity experiments (Section 
4.3.5) and the positively-skewed tail of the pairwise distribution plot (Figure 4.13C).  
 
Table 4.4 | Summary of SAXS data analysis for S. pneumoniae sialoregulator, DNA and the hetero-complex 
SAXS data analysis S. pneumoniae NanR DNA only NanR-DNA Complex 
Guinier analysis    
I(0) (cm-1) 0.0240 ± 0.0004 0.0030 ± 0.00002 0.0260 ± 0.0001 
Rg (Å)  34.56 ± 0.94 17.44 ± 1.33 38.78 ± 0.71 
P(r) analysis    
I(0) (cm-1) 0.024 ± 0.002 0.0030 ± 0.00004 0.0260 ± 0.0002 
Rg (Å)  34.75 ± 0.22 17.21 ± 0.15 39.45 ± 0.41 
Dmax (Å) 112 50 133 
Porod volume (Å-3) 132 000 11 900 127 000 
Molecular Mass (MM) estimation, kDa    
MM SAXS-MoW2a 91.2 9.8 90.3 
MM Porod volume  77.6 7.0 74.7 




Figure 4.13 | SAXS data for the S. pneumoniae sialoregulator. A) Solution scattering data presented as an intensity 
plot. The Guinier plot shown as an insert, highlights linearity at low q—this provides confidence that the data is 
free of any significant amount of aggregation or inter-particle interference. B) Plot showing the forward scattering 
value I(0) (black line) and radius of gyration (Rg) (red squares) as a function of time. The grey box highlights the 
frames that were selected for averaging to produce the plot shown in A. C) Pairwise distribution plot displaying 
the maximum inter-particle dimension (Dmax) as 112 Å. D) The Kratky plot presents a bell-shaped curve, which 
indicates protein is folded and provides evidence of some flexibility in the structure, due to deviation from the 
baseline (grey dash) between 0.1 and 0.2 q.  
 
4.3.8.2 The solution structure of the S. pneumoniae NanR-DNA hetero-complex 
 
Having characterised the solution structure of the S. pneumoniae sialoregulator and defined the 
stoichiometry of the NanR-DNA hetero-complex through analytical ultracentrifugation, further SAXS 
experiments were conducted in the presence of DNA in order to characterise the solution structure of 
this hetero-complex. Here, protein and DNA were mixed at a molar ratio of 2:1 and injected onto the 
in-line size-exclusion chromatography column prior to data collection. This allowed separation of the 
NanR-DNA hetero-complex from the interaction partners, any non-specific binding, which was observed 
in the EMSA experiments (section 4.3.6) and the presence of any aggregation within the sample, while 
ensuring the sample was buffer matched. To illustrate this process, Figure 4.14 presents the UV trace 
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from the in-line size exclusion column and associated forward scattering intensity/ Rg plot for NanR, 
DNA and the hetero-complex. Here, a positive shift to the left was observed in the presence of DNA 
compared with NanR by itself, indicating a larger species. Moreover, this shifted peak had a higher 
absorbance at 260 nm (beige line) than 280 nm (red line). Taken together, this demonstrates protein-
DNA hetero-complex formation. The solution scattering data for the NanR-DNA hetero-complex and the 
DNA interaction partner is presented in Figure 4.15, while all data analysis is summarised in Table 4.4.  
 
Figure 4.14 | SAXS data of S. pneumoniae NanR, the NanR-DNA complex, and DNA from the in-line size exclusion 
column. A) UV trace from the in-line size exclusion column. The absorbance at 280 nm (red line), 260 nm (beige 
line) and 214 nm (blue line) is shown. B) Plot showing the forward scattering value I(0) (black line) and radius of 
gyration (Rg) (red squares) as a function of time. The grey box highlights the frames that were selected for 






Figure 4.15 | SAXS data for the S. pneumoniae sialoregulator in the presence of DNA. A) Solution scattering data 
presented as an intensity plot for NanR only (red), DNA only (blue) and the NanR-DNA hetero-complex (beige). 
Shown below is a residuals plot to highlight the difference in solution scatter between the protein only (red) and 
complex (orange). This difference between the experimental I(q) values is divided by the associated experimental 
standard deviation (S.D.) and plotted as a function of q. The two horizontal red lines indicate ± 2 S.D., which is 
used as limits for a good fit within the program US-SOMO (53). B) Pairwise distribution plot displaying the 
difference in maximum inter-particle dimension (Dmax) between the complex and each interacting partner. C) The 
Guinier plot for the DNA and hetero-complex data is shown as an insert, highlights linearity at low q—this provides 
confidence that the data is free of any significant amount of aggregation or inter-particle interference. D) 
Dimensionless Kratky plot suggests that the complex has a slightly more elongated shape than NanR, as the peak 
maximum has shifted to further to the right. A typical globular protein has a peak maximum at 1.1 as highlighted 
by the grey dashes. E) The Kratky plot for the DNA highlights the inherent flexibility of the oligonucleotide in 
solution having lost the bell-shaped curve of a globular particle and not having convergence to the baseline (grey 




A comparison between the SAXS data of NanR and the NanR-DNA hetero-complex demonstrated that 
in the presence of DNA, NanR undergoes a conformational change in solution. This was indicated by 
several features including: 1) subtle changes to the solution scatter through the mid q range (0.1-0.2); 
2) an increase in Rg from 34.56 Å to 38.78 Å; and 3) a more elongated particle in solution, suggested by 
the larger inter-particle dimension (Dmax) of 133 Å, as opposed to 112 Å (Figure 4.15B), and the right-
shifted peak maximum in the dimensionless Kratky plot (Figure 4.15D).  
The molecular weight determined via the Porod volume was 74.7 kDa, which was consistent with a 
theoretical dimeric NanR-DNA hetero-complex mass (77.4 kDa). In addition, the molecular weight 
determined by the online server SAXS-MoW2 (51) was 90.3 kDa, which was also consistent with a 
dimeric NanR-DNA hetero-complex in solution, albeit slightly larger than the theoretical mass .  
Conversely, DNA was much smaller with a molecular weight determined by the online server SAXS-
MoW2 (9.8 kDa) and the Porod volume (7 kDa) that was consistent with the theoretical mass (12.1 kDa) 
for the double-stranded oligonucleotide. In solution, this oligonucleotide displayed a significant amount 
of flexibility, as suggested by the large rise and lack of a bell-shaped curve in the Kratky plot (Figure 
4.15E). This observation is understandable, as in solution the oligonucleotide would sample multiple 
different conformations and twists of the double helix. While the UV absorbance at 260 nm for the DNA 
sample was relatively high compared with the other samples, due to the aromaticity of the nucleic acid 
base pairs, its respective forward scattering intensity was much lower (Figure 4.14A and B, respectively). 
This is because the oligonucleotide has a much smaller molar mass and partial specific volume compared 
with NanR, or the hetero-complex and hence a smaller scattering length, leading to a reduced scattering 
amplitude.  
 
4.3.8.3 Multiphase ab initio model of the S. pneumoniae NanR-DNA hetero-complex 
 
To provide further structural insight into the NanR-DNA hetero-complex, I reconstructed a 3D ab initio 
model (Figure 4.16) from the scattering curves of the complex, along with the interaction partners, 
protein and DNA using the multiphase modelling software MONSA (54). This process uses densely 
packed beads and multiple rounds of simulated annealing to find the best fit between the experimental 
scattering and the theoretical scattering of the ab initio model being built. Although, as these 3D ab 
initio models are derived from a 1D scattering profile they are inherently ambiguous, meaning models 
of very similar conformations can all be generated from the same experimental data, thus one model 
alone is not expected to provide a realistic structure at this resolution (54). This ambiguity can be 
reduced by reconstructing an ensemble of models and then averaging these using DAMAVER (55) to 
find the model that is the best representation of the scattering data. Moreover, each model generated 
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from multiple runs can be compared with each other using SUPCOMB to determine the level of 
consistency. The mean normalised spatial discrepancy (NSD) for reconstructions of the S. pneumoniae 
NanR-DNA hetero-complex was 0.70 ± 0.03. This low value demonstrates a good level of consistency 
between each independent model. As a result, the averaged reconstruction presented in Figure 4.16B 
provides qualitative evidence on the relative orientation of the protein and DNA when bound to each 
other in solution.  
 
Figure 4.16 | Multiphase ab initio model of the S. pneumoniae NanR-DNA hetero-complex. A) The scattering profiles 
of the protein (red spheres), DNA (blue spheres) and protein-DNA complex (beige spheres) with MONSA generated 
fits (black line). The respective chi2 value for each fit is shown B) The multiphase ab initio model of the NanR-DNA 
hetero-complex. Highlighted is the predicted sugar isomerase (SIS) domain, which is known to bind the effector 
molecule and the DNA-binding domain. Here, the DNA (in blue) appears to bind within a cavity formed by these 
DNA-binding domains (in red).  
 
This ab initio model suggests that NanR binds DNA between two ‘arms’. These are likely the DNA-binding 
domains from each monomer of the dimeric assembly, which interact with opposite sides of the DNA in 
order to accommodate the double helix within a binding cavity. The exact conformation of the DNA 
does seem implausible, as it would make sense for it to bind perpendicular rather than parallel to the 
protein, in order to accommodate the genomic DNA within the cell. However, this model is a low-
resolution reconstruction and requires further structural evidence at higher resolution to verify the 
correct binding conformation. This can be explored in future experiments through X-ray crystallography 
or through cryo-electron microscopy in the presence of DNA. Nonetheless, this low-resolution model 
still provides qualitative insight into the relative orientation of DNA and binding between the DNA-
binding domains, which is consistent with the function of the helix-turn-helix motif within this domain.  
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Combined, these SAXS experiments define the solution structure of S. pneumoniae NanR and provide 
insight into the conformational changes that occur upon DNA binding. While experiments in the 
presence of an effector molecule would help deduce any conformational changes that occur upon 
effector binding, these were not performed as making enough effector-supplemented buffer was not 
feasible for the in-line size exclusion SAXS experiments.  
 
4.3.8.4 Comparison with Vibrio vulnificus NanR structure  
 
To investigate if the solution structure of S. pneumoniae NanR is similar to the reported dimer of V. 
vulnificus NanR (13), a homology model was initially constructed for S. pneumoniae NanR by using the 
crystal structure of V. vulnificus NanR (PDB ID – 4IVN) as a template. CRYSOL (56) was subsequently used 
to generate a theoretical scattering profile of the homology model and then fit this to the experimental 
scattering profile of S. pneumoniae NanR in the presence and absence of DNA.  
The architecture observed in the crystal lattice of V. vulnificus fit the experimental scatter of S. 
pneumoniae NanR with a chi2 value of 2.0 (Figure 4.17A). This value supports that V. vulnificus is 
surprisingly similar to S. pneumoniae NanR in terms of oligomeric state, consistent with a dimeric 
architecture. In addition, this comparison suggests that S. pneumoniae NanR adopts a similar extended 
conformation in solution to V. vulnificus NanR, when in the absence of DNA. This is where the N-terminal 
DNA binding domains orient in opposing directions, while the C-terminal sugar isomerase domain serves 
as the oligomeric interface (Figure 4.17A, insert).  
 
Figure 4.17 | Comparison of the solution structure for the S. pneumoniae and V. vulnificus sialoregulators. A) Small-
angle X-ray scattering data of S. pneumoniae NanR (black sphere) is consistent with the theoretical scattering 
profile (red line, chi2 value of 2.0) of the V. vulnificus crystal lattice architecture (insert). B) Small-angle X-ray 
scattering data of the S. pneumoniae NanR-DNA hetero-complex (black sphere) is inconsistent with the theoretical 
scattering profile (red line, chi2 value of 8.3) of the V. vulnificus proposed ‘active form’ (insert). The q range with 
the main difference in the fit is highlighted (grey box). Each dimeric model is depicted as a surface representation. 
126 
 
This fit was repeated using a homology model of the authors proposed ‘active form’ of V. vulnificus 
NanR (13) using the experimental scatter of S. pneumoniae NanR-DNA hetero-complex, providing a chi2 
value of 8.3 (Figure 4.17B). In this model, the N-terminal DNA-binding domains are now oriented much 
closer together to create a DNA-binding cavity (Figure 4.17B, insert). However, the fit of this homology 
model suggested that S. pneumoniae NanR adopts an alternative shape in solution owing to differences 
in the mid q range (57). Despite this difference, both S. pneumoniae NanR and V. vulnificus NanR were 
largely consistent with a dimeric architecture in solution.  
Overall, this comparison supports that S. pneumoniae NanR adopts a very similar conformation in 
solution to the crystal structure of V. vulnificus NanR, when in the absence of DNA. However, the poor 
fit of the proposed ‘active form’ of V. vulnificus NanR to the scattering profile of the S. pneumoniae 
NanR-DNA hetero-complex provides evidence to support that the model of V. vulnificus NanR is 
incorrect. Importantly, this evidence reinforces that the dimeric interface of the ‘active form’, which 
was interpreted from negative stain transmission electron microscopy data is unconvincing. To 
understand this further, it is important to note that the crystal structure of V. vulnificus NanR did not 
contain sufficient electron density to resolve the linker region between the N- and C-terminal domains, 
thus these domains are disconnected in the final model (PDB ID - 4IVN). This lack of density indicates 
this region is highly flexible and suggests it may play a role in facilitating the large conformational change 
of the N-terminal domain that is required to accommodate DNA within a binding cavity.  
 
4.4 Chapter summary and model mechanism of regulation for S. 
pneumoniae NanR 
 
This chapter developed a structural and functional understanding of the RpiR-type NanR from S. 
pneumoniae—the gene regulator of bacterial sialic acid catabolism.  
Taken together, the stoichiometry, binding kinetics and solution structure for S. pneumoniae NanR, lead 
to a model mechanism for the NanR-mediated gene regulation of sialic acid catabolism in S. pneumoniae 
(Figure 4.18). Here, three key states can be defined, including 1) free protein; 2) DNA-bound; and 3) 








Figure 4.18 | Model mechanism of regulation for S. pneumoniae NanR. Briefly, the dimeric assembly of S. 
pneumoniae NanR (red) adopts an extended conformation in solution, when in the absence of DNA. In the 
presence of its DNA recognition sequence, NanR can coordinate DNA with low micromolar affinity forming a 
dimeric NanR-DNA hetero-complex. This DNA coordination is between the DNA-binding domains of NanR, as 
opposed to being oriented parallel to NanR. In this state, the expression of the sialic acid catabolic machinery is 
repressed. The binding of the sialic acid pathway catabolite N-acetylmannosamine-6-phosphate (ManNAc-6P) 
promotes a loss of DNA binding affinity. By consequence, a proposed conformational change leads to the 
upregulation of sialic acid catabolic machinery to promote glycolytic activity through the degradation of Neu5Ac.  
 
Free protein. In the absence of a crystal structure, sedimentation velocity data demonstrated that S. 
pneumoniae NanR adopts a dimeric assembly in solution. Further SAXS experiments and evaluation of 
the solution structure with the theoretical scatter of V. vulnificus NanR supported that S. pneumoniae 
NanR adopts an extended conformation in solution. In this conformation, the N-terminal DNA-binding 
domains are oriented in opposing directions, mediated by a flexible linker, while the C-terminal sugar 
isomerase domain serves as the oligomeric interface.  
DNA-bound. Sedimentation velocity studies demonstrated that S. pneumoniae NanR in the presence of 
DNA, coordinates DNA as a dimer with a 2:1 binding stoichiometry upon increasing protein 
concentration. Further analysis revealed a low micromolar DNA-binding affinity for its DNA recognition 
sequence.  Structural studies using SAXS verified this stoichiometry and enabled a multiphase ab initio 
model to be reconstructed from the complex scattering data, along with the scattering data of the 
interaction partners (protein and DNA). Although low resolution, this model provided qualitative 
evidence to inform how NanR and DNA interact and suggested a conformational rearrangement of the 
N-terminal domains had occurred. This rearrangement is likely facilitated by the flexible linker region 
between the N- and C-terminal domains. A further comparison of this multiphase model to the 
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proposed ‘active form’ of V. vulnificus NanR highlighted an alternative shape in solution, supporting that 
the dimeric model of V. vulnificus NanR is incorrect.  
Effector-bound. Differential scanning fluorimetry experiments verified the identity of the effector 
molecule, N-acetylmannosamine-6-phosphate following an increase in thermal stability. EMSA 
experiments demonstrated NanR can actively bind DNA, although in the presence of N-
acetylmannosamine-6-phosphate this activity was significantly attenuated, further supporting its role 
as the effector molecule for S. pneumoniae NanR. Unfortunately, while diffraction data was collected 
for S. pneumoniae NanR in the presence of N-acetylmannosamine-6-phosphate to a resolution of 3.29-
3.72 Å, this was not suitable for structure determination. These crystals should be optimised in the 
future in order to identify the residues that coordinate the effector molecule and subsequently map any 
conformational changes that have occurred as a result of effector binding.  
Taken together, these data enhance our understanding for the RpiR-like sialoregulators and provide a 
platform for future structural characterisation at the atomic level to investigate effector binding and 
deduce specific protein-DNA contacts following crystallisation trials in the presence of DNA.  
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Defining the DNA-binding mechanism of the GntR-type 
sialoregulator from Escherichia coli – Part One 
 
 
The work presented in this chapter was a collaborative project with both Professor Borries Demeler at 
the University of Lethbridge, Canada and Dr Hariprasad Venugopal at the Clive and Vera Ramaciotti 
Centre for Cryo-Electron Microscopy, Monash University, Australia. Over a total of five weeks I visited 
the University of Lethbridge to conduct novel multi-wavelength sedimentation velocity experiments to 
study the interactions between Escherichia coli NanR and its DNA recognition sequence in the solution 
state. With guidance from Professor Borries Demeler, I developed an understanding towards the 
experimental design, data analysis, and result interpretation for this novel biophysical technique. This 
research was funded by a grant from the Maurice Wilkins Centre as this advanced analytical 
ultracentrifugation instrumentation is not available in New Zealand. Secondly, I visited the Clive and 
Vera Ramaciotti Centre for Cryo-Electron Microscopy several times, where I undertook the work 
presented in this chapter with guidance from Dr Hariprasad Venugopal. Specifically, I assisted in the 
sample preparation and initial screening of the cryo-electron microscopy data, while Hariprasad 
processed the data and successfully reconstructed the structure of the NanR-DNA hetero-complex. This 

















5.1.1 GntR family of transcriptional regulators 
 
First discovered in Bacillus subtilis, GntR is a protein that acts as a transcriptional repressor of the 
gluconate (gnt) operon (44) and is the defining member of the GntR superfamily. Today, the GntR 
superfamily is one of the most widespread groups of bacterial transcriptional regulators, which regulate 
a variety of key biological processes within bacteria (45). 
Members of this regulatory superfamily are structurally comprised of an N-terminal DNA-binding 
domain, which contains a winged helix-turn-helix motif, and a C-terminal effector-binding domain (46; 
47). As described in Chapter One, the helix-turn-helix motif of GntR members is characterised by an 
additional ‘wing’ that interacts with the minor groove of DNA to provide additional specificity. This ‘wing’ 
is formed by a small loop with two short β-strands following the canonical tri-helical structure (48). 
Together, the architecture of this DNA-binding motif is highly conserved among GntR members. 
Although surprisingly, the sequence similarity of the DNA-binding motif between GntR members is low 
(~25%). In contrast, the C-terminal domain exhibits a variety of different structural folds (45), although 
they share a common function in effector binding and forming the oligomerisation interface. These 
structural folds can be divided into seven subfamilies based on shared structural features: AraR; DevA; 
FadR; HutC; MocR; PlmA; and YtrA, (45; 49-53). Together, these seven subfamilies regulate an array of 
biological processes in bacteria, including various metabolic or biosynthetic pathways, the activity of the 
ABC transport systems, and as environmental sensors that respond to sources of nutrition (45-47). All 
subfamilies, except DevA and PlmA have representative structures in the PDB, presented in Figure 5.1. 
Between these subfamilies, the FadR subfamily is the biggest, comprising about 40% of all GntR family 
members (47). The first member to be identified in this subfamily was the repressor FadR, which 
regulates the genes responsible for fatty acid metabolism (54). In addition, this repressor is also 
considered a model protein of the GntR superfamily with numerous crystal structures determined from 
E. coli and V. cholerae. Notably, these include the apo transcriptional regulator (55) and hetero-complex 





Figure 5.1 | The structural architecture of the GntR subfamilies. The domain architecture of the largest subfamily, 
FadR is presented. Shown is the homodimer (PDB ID - 1HW1) with one monomer colour-coded and labelled, while 
the other is coloured grey. Representative homo-dimeric structures of the remaining subfamilies are presented: 
HutC subfamily (PDB ID - 4U0V); MocR subfamily (PDB ID - 4N0B); AraR subfamily (PDB ID - 5DEQ); and the YtrA 
subfamily (PDB ID - 2EK5). For each, one monomer is coloured in blue, while the other is coloured in grey. The 
topology of the N-terminal DNA-binding domain is very similar, while the C-terminal domain architecture is very 
different between subfamilies.  
Structurally, FadR members are characterised by an all α-helical C-terminal domain, which forms a tight 
antiparallel bundle. Depending on the number of α-helices in this helical array, the subfamily can be 
further classified into two subgroups: VanR, which is comprised of six α-helices; and FadR, which is 
comprised of seven α-helices. This additional helix serves as a flexible linker connecting the N-terminal 
DNA-binding domain to the C-terminal effector-binding domain, as opposed to a short loop in the VanR 
subgroup (45). In some cases, this additional helix can facilitate a domain swap through the C-terminal 
domain (59).  
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Interestingly, members of this subfamily, such as TM0439 from Thermotoga maritima (51) are metal-
dependent, coordinating various metal ions such as zinc, through three conserved histidine residues 
buried deep within the C-terminal domain (51; 59). Although, the role these metal ions play is currently 
unclear. Do metal ions play a structural role and facilitate the binding of the effector molecule or do 
they mediate oligomerisation? Alternatively, are these metal-sensing transcriptional regulators? 
Further structural insight is required to fully understand the physiological role these metal ions provide 
select repressors, whom some authors believe should form a new subgroup within the FadR subfamily 
(51).  
 
5.1.2 Interaction of GntR family members with DNA 
 
Identified through protein-DNA co-crystal structures, GntR members are known to interact with DNA as 
dimers, where the recognition helix (α3) of the winged helix-turn-helix motif binds within the major 
groove, perpendicular to the double-stranded DNA axis. Here, residues at the end of the recognition 
helix can directly interact with specific bases through electrostatic interaction, or by forming a 
hydrogen-bonding network (56; 60; 61). For example, the identification of a conserved arginine residue 
present on the recognition helix of the winged helix-turn-helix motif interacts directly with a guanine 
base through hydrogen bonding (46). Conversely, the ‘wing’ of the DNA-binding motif interacts with the 
minor groove of DNA. Interestingly, a conserved glycine residue present at the tip of the ‘wing’ has been 
identified as a key interaction within the minor groove. Mutation of this key glycine residue to introduce 
steric bulk or charge significantly affects the ability of the repressor to bind DNA (62). Consequently, this 
glycine residue is a trademark of this protein family.  
The point of interaction for each monomer can be described as a half-site, which typically represents a 
perfect- or pseudo-palindromic sequence that is rich in adenine and thymine bases (47). The centre of 
these palindromic half-sites is highly conserved, while the periphery is divergent and thus contributes 
to specificity of the repressor (63). Although, in contrast some GntR members recognise inverted or 
direct repeats that offer no symmetry (45; 60). This is the case for the GntR-type NanR from Escherichia 
coli. Unfortunately, protein-DNA hetero-complex structures have only been solved for GntR members 
that bind palindromic sequences (56; 60; 64). The interaction with a direct repeat has yet to be 
characterised at the molecular level. However, the structural data available still provides invaluable 
insight into the molecular recognition at the DNA interface. A representative model of the DNA bound 




Figure 5.2 | The interaction of the N-terminal DNA-binding domain with DNA. The structure of the E. coli FADR N-
terminal DNA-binding domain is presented (PDB 1HW2) as a representative model of the GntR superfamily. All 
other solved complex structures bind DNA in a similar manner. One monomer is coloured blue and the other is 
coloured grey. Highlighted is the ‘wing’, which interacts with the minor groove of DNA and the recognition helix, 
which interacts with the major groove of DNA.  
 
Additionally, the distance between the half-sites is crucial for presenting the binding site in the correct 
orientation for the repressor and therefore contributes to the DNA binding mechanism. This process 
can be intimately associated with the flexibility of the linker region between the N- and C-terminal 
domains (47) (Figure 5.1, top panel). Here, small distances facilitate tight and compact interaction with 
DNA, while much longer distances can facilitate DNA looping (45). Additional features that may influence 
DNA binding are yet to be discovered.  
 
5.1.3 Allosteric regulation mechanism of GntR family members 
 
Within the GntR superfamily, the allosteric mechanism of regulation has been characterised in E. coli 
FadR (55), Vibrio cholerae FadR (58), and Bacillus subtilis HutC (61; 65). Here, upon effector-binding, a 
large displacement of the N-terminal DNA-binding domains leads to an attenuation of DNA binding 
activity, a process mediated by the flexible linker that connects the N- and C-terminal domains. 
Interestingly, this displacement of the DNA-binding domains has been likened to a ‘jumping-jack’ motion 
in B. subtilis HutC in which the entire domain moves an astonishing 44 Å (65). This movement is similar 
in both FadR repressors, although less pronounced (58; 61).  
To fully understand the allosteric behaviour of these transcriptional regulators, further structural data 
is required, along with a greater understanding of molecular dynamics that are involved. As a result, this 
may uncover the potential for these regulators to serve as viable drug targets, such as the tetracycline 
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repressor in E. coli (66). Here, effector-screening has identified novel compounds, aside from their 
natural effector that can enhance the DNA-binding affinity and some that can reduce the affinity (67). 
This feature may provide insight to specifically engineer repressors for therapeutic application (68; 69). 
 
5.1.4 Regulation of sialic acid catabolism in Escherichia coli 
 
Given the importance of sialic acid to the survival and persistence of bacteria (as discussed in Chapter 
One), it comes as no surprise that its catabolic pathway is regulated to ensure an efficient metabolic 
return of this alternative source of nutrition. In E. coli, gene regulation of the core catabolic operon, 
nanATEK-yhcH operon is controlled by the GntR-type transcriptional repressor NanR (70).  
To achieve regulation, NanR binds a conserved operator site that contains three exact repeats of the 
DNA sequence GGTATA (non-palindromic). This hexanucleotide sequence, defined as the N-
acetylneuraminic acid (Nan) box is located within the intergenic region between the nanR gene and 
nanATEK-yhcH operon (71). In addition to regulating the core catabolic machinery for sialic acid, E. coli 
NanR regulates the gene expression of the nanCMS operon, encoding the proteins responsible for outer-
membrane transport and periplasmic processing of sialic acid (see Chapter One, Section 1.5.1), and the 
yjhBC operon, which was investigated in Chapter Two and Three. Together, these operons also contain 
three exact or near-exact repeats of the DNA sequence GGTATA (72).   
Collectively, these ten genes that are regulated by NanR form the sialoregulon. Interestingly, this 
coordinated regulation is only present in E. coli, Shigella dysenteriae and select strains of Shiga-toxin-
producing E. coli (73). This unique feature has made E. coli a model organism for understanding sialic 
acid catabolism, among bacteria who utilise this alternative source of nutrition (74). An overview of the 
E. coli sialoregulon along with the DNA-binding sequence for each regulated operon is presented below 
in Figure 5.3. While none of these operons are clustered together in the genome, the yjhBC (Base pair 
4503624-4506405) and nanCMS (Base pair 4540216-4536614) operons are localised much closer to 




Figure 5.3 | The E. coli Sialoregulon. A) Together the nanATEK-yhcH, yjhBC and nanCMS operons define the 
sialoregulon, regulated by the transcriptional regulator NanR. B) The NanR DNA-binding sequence for each operon 
is presented. This is located at the operator site for each respective operon. C) A sequence logo of each respective 
operator site, where the overall height indicates the sequence conservation at that position. This highlights that 
NanR binds a conserved operator site that contains three exact or near-exact repeats of the DNA sequence 
GGTATA. Figure generated using WebLogo (75).  
 
5.1.5 Previous studies on E. coli NanR. 
 
The current understanding of E. coli NanR in the literature has largely been influenced by the studies of 
Kalivoda and colleagues (71; 72). Notably, through DNA footprint analysis this has included the 
identification that the sequence GGTATA is the motif recognised by NanR, and when subjected to an 
electrophoretic mobility shift assay (EMSA), three concentration-dependent complexes are formed. It 
is believed that the discrete complexes represent the binding of sequential NanR promoters to the 
operator site on DNA and not conformational isomers. However, evidence from a Ferguson analysis, a 
gel-based technique to estimate the size of macromolecules was largely inconsistent (72), therefore the 
stoichiometry of this interaction is poorly understood. This is likely reflective on the inherent limitations 
with EMSA, such as the exposure to a non-equilibrium environment and unnatural stabilisation in the 
gel—a phenomenon that is poorly understood, but hypothesised to be the result of macromolecular 
crowding (76). Moreover, the use of extrinsic labels to detect complexes by EMSA may affect DNA-
binding activity (76; 77). 
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Neu5Ac is implicated as an effector molecule in vivo following a 10-fold induction of nan genes using a 
lacZ translational fusion assay. This however, has not been demonstrated in vitro using EMSA, but the 
presence of Neu5Ac is reported to dissociate NanR promoters into monomers (72). This feature is 
believed to be intimately linked with the regulation mechanism (72). In addition, DNA methylation is 
believed to contribute to the full induction of the sialoregulon, as located immediately upstream of the 
first direct GGTATA repeat is a DAM methylase GATC consensus motif (74). Here, it is hypothesised that 
once NanR dissociates from the operator site, DAM methylation may reduce the repressors ability to 
rebind as the effector concentration decreases in the cell, leading to complete catabolism of sialic acid 
(78; 79).  
Despite this largely genetic characterisation for E. coli NanR, the biggest gap in the field is the paucity of 
structural or biophysical data to dissect the allosteric mechanism, identify how the effector molecule 
coordinates the C-terminal, and elucidate how the GntR-type NanR binds DNA.  
 
5.2 Chapter overview  
 
The main aim of this chapter is to develop a mechanistic understanding of how E. coli NanR regulates 
gene expression. Reported as a manuscript, this body of work quantitatively defines the stoichiometry 
of the E. coli NanR DNA complexes, label-free and in solution using multi-wavelength sedimentation 
velocity experiments. The binding kinetics report a nanomolar DNA binding constant and reveal novel 
cooperative behaviour between the promoters that bind the DNA. The first crystal structure of a GntR-
type sialoregulator is reported, solved in complex with Neu5Ac and zinc, identifying a metal-ligand 
binding pocket. Excitingly, using single particle cryo-electron microscopy I report a structure of the 
NanR-DNA hetero-complex, which provides novel insight into how NanR binds DNA and additionally 
provide structural evidence to support the stoichiometry that was observed during multi-wavelength 
sedimentation velocity experiments. 
Combined, this analysis provides the first molecular insight into GntR-type sialoregulators and enhances 
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Bacteria carefully regulate metabolic processes to efficiently colonize and persist within the human host. 
One mechanism bacteria employ is gene regulation. In Escherichia coli, the catabolism of sialic acid is 
controlled by the GntR-type transcriptional regulator NanR, but the mechanism of gene regulation is 
unknown. We first demonstrate that NanR binds as a dimer to a total of three GGTATA direct repeats 
that make up the DNA recognition site, forming a hexameric assembly. Interestingly, we found this 
binding is cooperative and demonstrate it is mediated by a unique N-terminal extension, likely through 
protein-protein interactions. To understand how DNA-binding is attenuated by the effector, we solve 
the co-crystal structure of E. coli NanR in the presence of N-acetylneuraminic acid to 2.1 Å, supporting 
the hypothesis that this is the effector molecule, and identify a metal-binding motif that coordinates 
zinc. The structure is asymmetrical with N-acetylneuraminic acid and zinc only present in one monomer, 
informing the molecular details of the conformational change that occurs following binding to attenuate 
DNA-binding activity. Notably, we report the structure of the NanR-DNA hetero-complex to 3.9 Å using 
cryo-electron microscopy, and the first structural evidence of a multimeric assembly process within the 
GntR superfamily. Together, our results give the first molecular insight into the mechanism of the NanR-
DNA interaction in E. coli, which enhances our understanding of sialic acid gene regulation in bacteria.  
 
Significance Statement:  
To gain a competitive advantage in the human host, pathogenic bacteria scavenge and degrade sialic 
acid as an alternative source of carbon, nitrogen and energy. The expression of the genes, responsible 
for the utilization of this amino sugar are controlled by the repressor protein, NanR. How NanR interacts 
with DNA to regulate this process is poorly understood at a molecular level. Here, we report a structural 
and functional characterization of NanR and define how the protein-DNA complex is formed. Based on 
these data, we propose a model for regulation, showing that NanR binds DNA cooperatively and 










The human gastrointestinal tract is one of the most heavily populated niches occupied by bacteria (1). 
This environment is largely glucose-limited (2; 3) and gain a competitive advantage, bacteria must 
rapidly adapt to nutrient changes, a response that is facilitated by transcriptional regulators at the 
molecular level (4; 5). In Escherichia coli, the NanR repressor regulates the expression of genes 
responsible for sialic acid uptake and catabolism (6) (Fig. 1). Sialic acids are a family of negatively-
charged, nine-carbon amino monosaccharide units located at the terminal end of glycoconjugate 
structures found in the mucosal epithelia of the mammalian respiratory and gastrointestinal tract (7; 8). 
Although there are more than 50 naturally occurring and structurally distinct sialic acid variants, the 
most ubiquitous form across all organisms is N-acetylneuraminic acid (or Neu5Ac) (Fig. 1A) (9; 10). In 
the human host, Neu5Ac serves as a source of carbon, nitrogen and energy for pathogenic and 
commensal bacteria that have evolved catabolic machinery to utilize this alternative source of nutrition 
(10; 11).  
As a negative regulator, E. coli NanR binds with high affinity to a conserved DNA recognition site 
containing three exact (or near exact), GGTATA direct repeats (6; 12). This hexanucleotide motif, 
designated the N-acetylneuraminic acid (Nan) box is present in three distinct operons (Fig. 1B-C): 1) 
nanATEK-yhcH, the core catabolic pathway (6; 11); 2) nanCMS, responsible for outer-membrane 
transport and periplasmic processing (13-15); and 3) yjhBC, encoding proteins of unknown function, yet 
hypothesized to process less common variants of sialic acid (11). Collectively, the coordinated regulation 
of these 10 genes by NanR is referred to as the sialoregulon, and has only been identified in E. coli, 
Shigella dysenteriae and some Shiga-toxin-producing E. coli strains (11; 12). E. coli NanR belongs to the 
GntR superfamily of transcriptional regulators. These proteins are composed of an N-terminal DNA-
binding domain, which contains a winged-helix-turn-helix (wHTH) motif, and a C-terminal effector-
binding domain. While the architecture of the wHTH DNA-binding domain is highly conserved (16), the 
C-terminal effector-binding exhibits a wide variety of structural folds—these can be divided into seven 
subfamilies based on shared structural features (17). To attenuate repression, an effector molecule 
binds to GntR regulators, causing a conformational change that alters DNA binding affinity (18). This 
allosteric regulation is a trademark of bacterial transcriptional regulators allowing them to function as 
molecular switches to turn gene expression on or off as required (19). In E. coli NanR, Neu5Ac is thought 
to be the effector molecule and inducer of the sialocatabolic pathway in vivo, converting NanR oligomers 
to monomers in solution (19). However, the molecular mechanism that facilitates this allosteric 
regulation in vitro is poorly understood, with no direct biophysical or structural evidence confirming that 




Fig. 1 | The transcriptional repressor NanR binds a conserved operator site in three distinct operons, collectively 
referred to as the sialoregulon, to coordinate the catabolism of sialic acid in E. coli. (A) The most common sialic 
acid, Neu5Ac is shown in chair conformation. Red indicates the stereochemical difference at the C2 position, 
generated the α- or thermodynamically favorable β-anomer. (B) nanATEK-yjhcH, yjhBC and nanCMS operons 
within the sialoregulon. (C) Sequence alignment of the operator sites present in each operon. Conserved 
nucleotides are marked with an asterisk. (D) Based on this alignment, this sequence logo, generated using 
WebLogo (20) highlights the conservation of the DNA bases within these operator sites.  
 
Here, we demonstrated that complex formation is cooperative and mediated by protein-protein 
interactions. We then defined the stoichiometry of the protein-DNA hetero-complex, label-free and in 
solution, via multi-wavelength sedimentation velocity experiments. We also report a 2.1 Å co-crystal 
structure of E. coli NanR in the presence of Neu5Ac, which reveals a metal-ligand binding pocket. Using 
cryo-electron microscopy, we present a 3.9 Å structure of the NanR-DNA hetero-complex (70.5 kDa) 
and provide structural insight to support the formation of the higher-order hetero-complex. Taken 
together, our biophysical and structural data give the first molecular insight into the mechanism of the 
NanR-DNA interaction in E. coli and enhance our understanding of how GntR-type regulators control 
gene expression. 
 
Results and Discussion 
NanR binds DNA cooperatively with nanomolar affinity. 
The presence of multiple binding sites suggests the mechanism for gene regulation involves 
cooperativity, as observed for the well-known lac (21) and ara (22) repressors through DNA-looping and 
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in other GntR family members such as CitO (23) and PhnF (24). To determine whether E. coli NanR 
exhibits cooperative behavior, we titrated NanR against fluorescently-labelled DNA oligonucleotides 
that mimic the full recognition site, by employing both an electrophoretic mobility shift assay (EMSA) 
(Fig. 2A) and analytical ultracentrifugation (Fig. 2B). As shown in Fig. 2C, NanR binds three repeats of the 
GGTATA sequence with nanomolar affinity, displaying cooperative behavior, as shown by the sigmoidal 
dependency and fit to the Hill model. EMSA experiments were conducted using a nanomolar titration 
range of NanR against a set concentration of fluorescently end-labelled DNA. As visualized using a 
fluorescent scanner, three concentration-dependent complexes were formed. Densitometry analysis of 
the observed bands then revealed the ratio of bound and unbound DNA. Fitting this data to the Hill 
equation gave a sigmoidal binding isotherm (Fig. 2C), with a Hill coefficient of 2.5 ± 0.3, which is 
characteristic of cooperativity. The apparent dissociation constant (KD) of 36.3 ± 1.8 nM is consistent 
with previous reports (6; 12) and is within range of the reported KD values of other regulators within the 
GntR superfamily (25). At high protein concentrations, we observed the development of non-specific 
binding, a feature also detected in the poly-AT oligonucleotide control, where specific binding was 
abrogated (SI Appendix, Fig. S1A). This non-specific binding is likely associated with large protein-DNA 
hetero-complexes, mediated by the localized concentration of NanR, as these species are very poorly 
resolved in the gel shift assay and do not substantially affect the signal of the DNA probe. For clarity we 
also assessed DNA binding by EMSA with oligonucleotides containing one or two GGTATA repeats (SI 
Appendix, Fig. S1B-C). In these experiments, complex formation was only observed by EMSA with two 
GGTATA repeats. This observed loss of DNA binding activity with only one GGTATA repeat further 
supports the hypothesis that the mechanism of regulation for NanR depends on cooperative binding, 
because multiple GGTATA repeats appear essential to both initiate complex formation and drive the 
formation of the higher-order assemblies. 
We also sought to assess the DNA binding kinetics of NanR more quantitatively and without the 
limitations of a gel-based technique by employing analytical ultracentrifugation. Here, using 
fluorescence optics, sedimentation velocity experiments were conducted by using an identical NanR 
titration range against the fluorescently-labeled DNA and measurement at an emission wavelength of 
495 nm. This enabled detection of free DNA and an evaluation of protein-DNA complex formation 
indicated by a positive shift in the sedimentation coefficient. When fitted to a c(s) model, three 
populations of concentration-dependent complexes (C1-3) were visualized in the c(s) distribution across 
the NanR titration range (Fig. 2B)—this mirrors what we observed by EMSA (Fig. 2A). To determine the 
binding kinetics, the ratio of bound and unbound DNA was determined by peak integration within the 
c(s) distribution. When plotted and fit to the Hill model, the binding isotherm also exhibited a sigmoidal 
shape (Fig. 2C), with a Hill coefficient of 1.9 ± 0.2 and an apparent KD of 19.7 ± 1.3 nM, consistent with 
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cooperative binding. Collectively, these DNA-binding studies support the hypothesis that the 
coordinated regulation of the E. coli sialocatabolic pathway is driven by nanomolar affinity and mediated 
by positive cooperativity. Insight into what drives this cooperativity will be discussed later in this study.  
 
Fig. 2 | E. coli NanR binds DNA with nanomolar affinity and displays positive cooperativity. (A) Using fluorescently 
labelled DNA and titration of NanR, an electrophoretic mobility shift assay highlights that NanR binds DNA, 
resulting in three concentration-dependent complexes (C1–3). (B) Sedimentation velocity data was fitted to a 
continuous mass [c(s)] distribution. With increasing NanR concentration, the DNA signal at ~3 S slowly shifts, 
consistent with complex formation. The three populations of concentration-dependent complexes (C1–3), 
analogous to the EMSA experiment, are highlighted. The pure protein control, run separately, is shown for 
reference (grey dashed line). (C) The binding isotherm from the EMSA (black) and AUC (red) data was best fit to 
the Hill equation. 
 
E. coli NanR remains dimeric in solution, regardless of Neu5Ac. 
Validation of the oligomeric assembly is essential for developing a functional understanding of how 
transcriptional regulators operate. Most members of the GntR superfamily function as a dimer in 
solution to control gene expression, although tetrameric assemblies have been characterized for some 
members (26; 27). Moreover, it has been reported than Neu5Ac, implicated as the effector molecule of 
E. coli NanR in vivo, induces a dramatic dissociation in SDS-PAGE analysis, converting NanR oligomers to 
monomers (12). Together, these observations led us to evaluate the oligomeric state of E. coli NanR and 
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investigate Neu5Ac-induced dissociation in solution using single-wavelength sedimentation velocity and 
small angle X-ray scattering (SAXS) experiments. Both demonstrated that E. coli NanR is a dimer in 
solution, regardless of Neu5Ac.  
Sedimentation velocity data were fitted to a continuous mass distribution [c(M)] model, resulting in a 
single, monodisperse peak for both samples. The c(M) distribution indicated an apparent molar mass 
for NanR with (55.6 kDa) and without (54.5 kDa) Neu5Ac that were consistent with the calculated 
dimeric mass of 59 kDa for NanR (SI Appendix, Fig. S2A). Further fitting to a continuous sedimentation 
coefficient distribution [c(s)] model was also consistent with a single oligomeric species in solution for 
both samples (SI Appendix, Table S1). SAXS data were also consistent with a dimeric NanR assembly in 
solution when analyzed using SAXS-MoW2 (28). The predicted molar mass values for NanR with (63.6 
kDa) and without (70.6 kDa) Neu5Ac were consistent with the calculated dimeric mass, despite the 
slightly larger size of NanR in the absence of Neu5Ac. In addition, both samples presented an analogous 
scattering profile (SI Appendix, Fig. S1B), further supporting a single oligomeric species in solution. Taken 
together, these data propose a dimeric assembly of NanR in solution that is not perturbed by the 
presence of Neu5Ac, contradicting reports that Neu5Ac-induced dissociation is intimately linked with 
the mechanism of regulation. All data collection and data analysis statistics for these experiments are 
summarized in SI Appendix, Table S1. 
Stoichiometry of the NanR-DNA complex.  
Understanding the stoichiometry of protein-DNA hetero-complexes is crucial to elucidating the DNA- 
binding mechanism. In this system, DNase footprint analysis, conducted by Kalivoda et al. revealed that 
NanR accommodates the full recognition site by overlapping individual GGTATA repeats, whereby one 
NanR promoter provides coverage of one GGTATA repeat, as well as partial coverage of a neighboring 
GGTATA repeat, approximately a half turn away on the DNA helix (6). Furthermore, initial binding has 
been postulated to involve a homotrimer of NanR, with full coverage achieved by six monomers over a 
region of approximately 30 bp, or three turns of the DNA helix (6; 12). This is inconsistent with both our 
single-wavelength sedimentation velocity and small angle X-ray scattering (SAXS) experiments, which 
proposed a dimeric species of NanR in solution (SI Appendix, Fig. S2).  
Thus, we investigated the nature of the NanR-DNA interaction, label-free and in solution by multi-
wavelength sedimentation velocity (MWL-SV) experiments. This emerging analytical ultracentrifugation 
strategy couples a novel multi-wavelength detector with high-performance computing to characterize 
complex mixtures by deconvoluting the spectral signals of the interaction partners into separate 
sedimentation profiles. As an intrinsic extinction profile of each interaction partner is used to achieve 
decomposition, the separate sedimentation profiles are scaled to molar concentration. This is facilitated 
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by employing the non-negatively-constrained least-squares algorithm (29; 30). This feature allows the 
stoichiometry of the complex to simply be extracted by integrating the molar ratio of the co-migrating 
peaks (31). In addition, the separated datasets can then be further analyzed to extract hydrodynamic 
information as is traditionally achieved using single-wavelength experiments. Thus, this new approach 
provides both hydrodynamic and spectral characterization of an interacting system to define the 
stoichiometry of association, and grant access to properties such as the mass and frictional ratio of each 
species. Together, this enables interacting species to be characterised with high resolution. 
Using the DNA oligonucleotide with three GGTATA repeats as a model of the full operator site, we 
observed three concentration-dependent complexes (Fig. 2). However, this suggests a complex system 
involving multiple interaction partners. While our overarching aim is to define the stoichiometry of 
protein-DNA complex formation in the full recognition site, we first characterized the assembly process 
with only two GGTATA repeats present. EMSA revealed the formation of only two complexes (SI 
Appendix, Fig. S1C), thus simplifying the system. For the two-binding-site model, protein-DNA loading 
titrations ratios of 1:1, 2:1, 4:1, 6:1 and 10:1 were employed, analogous to the approach used in Zhang 
et al. (31). In addition, single-wavelength sedimentation velocity experiments were conducted 
individually on purified NanR and pure DNA using wavelengths of 280 nm and 260 nm, respectively (SI 
Appendix, Fig. S4A). Together, these served as the controls for the experiment, where any observation 
of a positive shift in sedimentation coefficient upon mixing supports the formation of a protein-DNA 
complex.  
Following data analysis, the spectral profiles of NanR and DNA were deconvoluted into individual 
sedimentation coefficient distributions for each titration performed (SI Appendix, Fig. S4B–F). With 
increases in the protein concentration, we clearly observed co-migration relative to the individual NanR 
and DNA controls (SI Appendix, Fig. S4A), which is consistent with complex formation. Peak integration 
of these co-migrating species suggested that NanR initially binds at a 2:1 molar ratio, forming a dimeric 
protein-DNA hetero-complex comprising one NanR dimer bound to DNA with a sedimentation 
coefficient of ~4.4 S. As shown in SI Appendix, Fig. S4B, the co-migrating peaks overlaid perfectly. As the 
concentration of NanR was increased, we observed the formation of a broad reaction boundary. This 
phenomenon indicates sub-saturation of the complex, representing multiple and dynamic intermediate 
species that are mediated by mass action, similar to the observations made in Zhang et al. (31). As a 
result, peak integration at these mixing concentrations serves as an average of the species present and 
therefore gives rise to non-integral molar ratios. Integration of the co-migrating regions revealed molar 
ratios of 4:1 and 6:1, with measured sedimentation coefficients of ~6.4 S and ~ 8.6 S. These values are 
consistent with tetrameric and hexameric protein-DNA hetero-complexes, comprising two or three 
NanR dimers bound to DNA, respectively. A further increase in protein concentration led to a narrowing 
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of this reaction boundary towards the 6:1 molar ratio and the appearance of a new peak, corresponding 
to free protein. The presence of excess protein, free of any co-migrating DNA, indicated that complex 
formation had reached saturation. This assembly process is presented as a model in SI Appendix, Fig. 
S4G. In addition to characterizing the assembly process of these interacting partners, we also examined 
their hydrodynamic properties to provide validation of the observed complexes. Combining these 
properties with a weight-averaged partial specific volume for each oligomeric assembly provided a way 
of calculating the molar mass for each respective complex. We determined that the dimeric and 
tetrameric protein-DNA hetero-complexes were both in excellent agreement with their theoretical 
molar mass values (SI Appendix, Table S2). However, the formation of a hexameric complex that is 
consistent with three bound NanR dimers was unexpected considering we only observed two species 
by EMSA (SI Appendix, Fig. S1C). We hypothesize that because NanR can accommodate overlapping 
binding sites, the label-free oligonucleotide used in these assays may be sterically unhindered, forming 
protein-mediated bridges since NanR can accommodate the full recognition site by overlapping 
individual GGTATA repeats (6; 12).  
Having characterizing the assembly process with two binding sites, we repeated the MWL-SV 
experiment using the full recognition site with three GGTATA repeats, employing protein-DNA titrations 
ratios of 1:1, 3:1, 6:1, and 10:1. Fig. 3A–E shows the deconvoluted sedimentation coefficient 
distributions for the titration series and the pure protein and DNA controls. Here, analogous to the 
previous model, we observed a clear co-migration of the NanR and DNA signals, which proceeded 
through several assembly steps and involved a broad reaction boundary. Initially, integration of the peak 
with a sedimentation coefficient of ~5.52 S gave a 2:1 molar ratio, consistent with the formation of a 
dimeric protein-DNA hetero-complex. In addition, integration of the peak with a sedimentation 
coefficient of ~7.39 S gave a 4:1 molar ratio, consistent with a tetrameric protein-DNA hetero-complex 
(Fig. 3B–C). Together, these two peaks were located within a broad reaction boundary, as was observed 
in the MWL-SV experiments using the two-binding-site model (SI Appendix, Fig. S4B–F). This indicated 
that the system was still at sub-saturation and contained multiple intermediate species mediated by 
mass action effects. As the concentration of NanR was increased further, the reaction boundary 
remained, although a shift to a higher sedimentation coefficient of ~8.27 S was observed. Integration of 
this peak gave a 6:1 molar ratio, consistent with a hexameric protein-DNA hetero-complex (Fig. 3D). 
Upon increasing the concentration of NanR even further, the 6:1 molar ratio remained unchanged. 
However, a slight increase in sedimentation coefficient was observed, and the co-migrating peak 
became more defined. In addition, we also observed the presence of free protein (Fig. 3E). Together, 
these features indicated that the system had reached saturation. Further analysis of the hydrodynamic 
properties gave measured molar mass values for the 1:1 and 6:1 molar ratio that were consistent with 
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the theoretical molar masses of the dimeric and hexameric protein-DNA hetero-complexes, respectively 
(SI Appendix, Table S3). Because the 4:1 molar ratio lies within the broad reaction boundary, an accurate 




Fig. 3 | The stoichiometry of the NanR-DNA hetero-complex. The deconvoluted sedimentation coefficient 
distributions for the titration series are shown. (A) Separate controls of NanR (blue), NanR33-263 (orange) and full 
operator site (3rDNA, black). (B) 0.5 µM NanR. (C) 1.5 µM NanR. (D) 3.0 µM NanR. (E) 5.0 µM NanR. (F) 0.6 µM 
NanR33-263. (G) 6.0 µM NanR33-263. A clear shift in the sedimentation coefficient is observed with increasing protein 
concentration, consistent with the formation of higher order hetero-complexes. The broad reaction boundary 
indicates tight binding and represents multiple, dynamic intermediate species that are mediated by mass action. 
This is only apparent in full-length NanR, as N-terminally truncated NanR33-263 appears to reach saturation at the 
lower order (dimeric) hetero-complex. The presence of excess protein, free of any co-migrating DNA indicates that 
complex formation has reached saturation. All plots are presented as g(s) distributions using the molar 
concentration of monomeric NanR. (H) A model to illustrate the differences in complex assembly between NanR 
(blue) and NanR33-263 (orange).  
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Taken together, these results indicate that we successfully characterized the stoichiometry of the NanR-
DNA hetero-complex, in which NanR dimers sequentially bind DNA to ultimately form a hexameric 
complex bound to one DNA molecule. A model of the assembly process is presented in Fig. 3H. The 
analysis is complemented by the hydrodynamic information from each interacting partner, providing 
accurate molar mass measurements for the majority protein-DNA complexes across the two MWL-SV 
experiments (SI Appendix, Tables S2–3). Further, we found that complex formation is concentration-
dependent, supporting EMSA experiments (6; 12) (Fig. 2) and conclude that the initial assembly of the 
dimeric NanR-DNA hetero-complex plays an integral role in the formation of the higher-order hetero-
complexes, which proceeds through a broad reaction boundary before reaching saturation. This 
reaction boundary is indicative of a reversibly associating system with multiple intermediates, as 
opposed to the presence of discrete, non-interacting species. We note that DNA was always present in 
sub-stoichiometric amounts, and therefore was consumed by NanR binding as dimers to the DNA, hence 
free DNA was never observed in these experiments. This suggests that the KD for this assembly process 
is very low, supporting the nanomolar affinity defined in this study (Fig. 2).  
N-terminally truncated NanR derivatives bind DNA with significantly reduced affinity. 
 
Cooperative binding of transcriptional regulators to DNA is typically driven by protein-protein 
interactions between neighboring protomers (32)—a process critical to gene regulation. Our EMSA and 
analytical ultracentrifugation binding experiments both demonstrated that NanR exhibits positive 
cooperative behavior, as shown by the sigmoidal dependency of the binding isotherm (Fig. 2C). To 
investigate what drives this cooperativity, we performed a sequence homology search within the PDB. 
We identified that NanR possesses a predominantly disordered 32-residue N-terminal extension of the 
DNA-binding domain (SI Appendix, Fig. S5), which is considerably longer than those of similar structures 
in closely related GntR transcriptional regulators.  Notably, this extension contains four serine residues 
(at positions 9, 14, 15 and 24), four arginine residues (at positions 20, 23, 25 and 29), and 11 
hydrophobic residues spread throughout. To assess the role of this extension in cooperativity, we 
deleted the 32 N-terminal residues to generate a truncated version of NanR, designated NanR33-263. 
Using MWL-SV experiments with the full recognition site and protein-DNA mixing titrations of 3:1 and 
10:1, we observed a significant change in the assembly process (Fig. 3F–G) compared with that of the 
full-length protein (Fig. 3B–E). Following peak integration of the co-migrating regions, we determined 
that the N-terminally truncated NanR bound DNA with a 2:1 molar ratio and a sedimentation coefficient 
of ~4.39 S, which is consistent with formation of a dimeric protein-DNA hetero-complex and values 
observed with that of the full-length NanR. However, we also observed the presence of free protein 
(Fig. 3F), unlike the full-length NanR at this titration, which therefore indicates weaker binding. Upon 
increasing concentration of NanR, the co-migrating peak for the dimeric protein-DNA hetero-complex 
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became more defined with a sedimentation coefficient of ~4.46 S, and the signal corresponding to free 
DNA disappeared, indicating that the system had reached saturation. The measured molar mass of this 
dimeric protein-DNA hetero-complex was in excellent agreement with its theoretical molar mass (SI 
Appendix, Table S4), providing further confidence in the 2:1 protein-DNA molar ratio. Interestingly, while 
we showed that full-length NanR bound DNA and ultimately formed a hexameric protein-DNA hetero-
complex, N-terminally truncated NanR was only capable of binding as a single protomer, forming a 
dimeric protein-DNA hetero-complex at the titration range tested.  
Therefore, removal of the 32-residue N-terminal extension appears to perturb the ability of the 
repressor to form higher-order hetero-complexes via a concentration-dependent assembly. 
Consequently, we propose that this N-terminal extension is the driving force of the positive cooperative 
behavior, facilitated by protein-protein interaction. We also hypothesize that the initial binding to DNA 
causes a conformational change of NanR that facilitates a favorable interaction with neighboring 
protomers through a cooperative process mediated by the N-terminal extension. As this extension is 
significantly larger than those found in closely related GntR members (SI Appendix, Fig. S5), we believe 
this cooperative mechanism is unique to E. coli NanR, among characterized GntR family members, and 
is required to maintain tight, coordinated control of the sialoregulon. 
 
The structure of the NanR Neu5Ac complex reveals a metal-binding site. 
 
To gain insight into the molecular mechanism of regulation, we solved the structure of E. coli NanR in 
complex with Neu5Ac and a zinc ion (Fig. 4A–B). This intrinsically bound zinc ion was identified through 
inductively coupled plasma mass spectrometry and X-ray absorption spectroscopy, then used to phase 
the structure using a combined single-wavelength anomalous dispersion and molecular replacement 
strategy to a maximum resolution of 2.1 Å (SI Appendix, Table S5). This discovery places NanR in a small 
and distinct family of GntR transcriptional regulators, including TM0439, that contain a metal-binding 










Fig. 4 | Overall structure of E. coli NanR in complex with Neu5Ac and zinc. (A) Cartoon representation of the 
domain-swapped dimeric structure. NanR comprises an N-terminal DNA-binding domain, with the characteristic 
winged helix-turn-helix motif, and a C-terminal effector binding domain, analogous to other GntR members. The 
effector-bound and the effector-free are shown in beige and cyan, respectively, and all secondary structure 
elements are labelled. Prime denotes the effector-free monomer. (B) The effector-binding site is located within 
the large polar cavity of the C-terminal domain. The direct or water-mediated (black dashes) hydrogen bonding 
residues (grey sticks) that coordinate Neu5Ac in its β-anomeric form and support zinc in an octahedral geometry 
are indicated, while water molecules are depicted as yellow spheres. The omit map corresponding to Neu5Ac 
(black sticks) and zinc (grey sphere) is shown as an insert. Here, the 2Fo-Fc electron density map (1.0 σ, blue mesh) 
and the mFo-Fc omit electron density map (3.0 σ, green mesh) is shown. (C) An overlay of the effector-bound 
monomer (beige) and effector-free monomer (cyan) illustrates effector-induced conformational changes, 
including: 1) a restriction of the all-α-helical bundle of the effector-binding domain (EBD); and 2) a hinging motion 
between α5 and α4 causing a displacement of the DNA-binding domain (DBD) by 7.7° and 3.5 Å. Superimposition 
of a dimeric model for each distinct state, depicting helices as cylinders, further illustrates these changes. (D) The 
experimental scattering profile for NanR33–263 (black dots) is consistent with the theoretical scattering of the atomic 
structure (red line, X2 value of 0.32). The Guinier plot shown as an insert, highlights linearity at low q, providing 
confidence that the data is free of significant aggregation or inter-particle interference. (E) SDS-PAGE analysis 
showing protein molecular weight ladder (Lane 1), and purified E. coli NanR (Lane 2) and NanR33–263 (Lane 3) 




Analogous to other GntR members of the superfamily, NanR has a two-domain architecture comprising 
an N-terminal DNA-binding domain (α1–α3, β1–β2), and an all α-helical C-terminal effector-binding 
domain (α4 to α10) (Fig. 4A). The antiparallel two-stranded β-sheet defines the "wing" of the 
characteristic wHTH motif—a trademark of the GntR family (18). The presence of seven α-helices in the 
C-terminal domain identifies NanR as member of the FadR subfamily (17). Helices α5–α10 are arranged 
into an antiparallel bundle and play a role in both effector binding and dimerization, while helix α4 
serves as a flexible linker connecting the N-terminal domain to the all α-helical bundle of the C-terminal 
domain. Moreover, this linker is believed to play a role in the allosteric mechanism (18). Our structure 
of NanR contains two monomers (Chain A, Lys31–Asn246; Chain B, Lys31–His244) of NanR in the 
asymmetric unit, which is consistent with the observation of a dimer in solution (SI Appendix, Fig. S2). 
Remarkably, while we were unsuccessful in collecting diffraction data suitable for determining the apo 
structure, the structure presented in the current study captures the effector-bound conformation in 
one monomer (Chain A), while the opposing monomer (Chain B) is effector-free. Superimposition of 
these asymmetric monomers revealed a root-mean-square deviation (RMSD) of 4.55 Å over 207 
equivalent Cα atoms, indicating that a conformational change had occurred between monomers (Fig. 
4C). The 30 N-terminal residues, which define the N-terminal domain extension (SI Appendix, Fig. S5), 
the 17 C-terminal residues in chain A and the 19 C-terminal residues in chain B were not included in the 
final model because we did not observe any corresponding electron density. These regions, which we 
believe to be highly flexible were likely cleaved during incubation with chymotrypsin during 
crystallization, which was essential for structure determination.  
Interestingly, the dimeric assembly of NanR showed a domain-swapped architecture. Mediated by the 
flexible α4 helix, this was achieved through an exchange of the N-terminal domain between monomers 
(Fig. 4A). This feature is conserved in FadR and LldR, which are involved in the regulation of fatty acids 
(35) and L-lactate (34), respectively. Using the PDBePISA server (36), we determined that approximately 
2004 Å2 of accessible surface area was buried upon dimerization, while the total estimated ΔGint value 
of the dimer interface was approximately −25.9 kcal mol-1, corresponding to 15% of the total surface 
area of each monomer. Primarily, this dimer interface was formed via the helical bundle of each C-
terminal domain, facilitated by a hydrophobic core along helices α4, α5, and α8. However, polar and 
salt bridge interactions helped stabilize the dimer interface, most notably between the N- and C-
terminal domains of opposing monomers. Interestingly, we discovered that polyethylene glycol (PEG) 
was buried in this dimer interface. We initially hypothesized that this electron density fitted a bacterial 
phospholipid. However, following lipid extraction of the purified protein and subsequent quadrupole 
time-of-flight mass spectrometry, no lipid signals were detected. Thus, considering PEG was present in 
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the crystallization buffer, it was modelled into the density. PEG above 5 kDa has been reported to exhibit 
more amphiphilic characteristics, permitting such an interaction (37).  
To verify that the dimeric assembly in the crystal structure is biologically relevant in solution, we 
conducted SAXS experiments with the N-terminally truncated NanR construct. As shown in Fig. 4D, the 
theoretical scattering profile generated from the crystal structure of NanR was in excellent agreement 
with the experimental scattering profile of NanR33-263, with a reduced X2 value of 0.32, suggesting that 
the dimeric assembly observed in the crystal structure is shared globally in solution. This fit was 
facilitated using SREFLEX, which enabled flexible refinement of the atomic model to accommodate 
conformational rearrangement in solution (38). In addition, Kratky analysis demonstrated that NanR is 
flexible in solution, as although a bell-shaped curve was observed, the plot did not converge to the q 
axis (SI Appendix, Fig. S3B). This feature is likely associated with the flexible linker between the N- and 
C-terminal domains and provides justification for the higher overall B-factor observed for NanR (SI 
Appendix, Table S5).  
 
Insight into the effector-binding allosteric mechanism. 
 
The C-terminal domain has a large polar cavity buried within the all-α-helical bundle that forms the 
effector-binding site. In the current study, electron density of Neu5Ac was unambiguously observed in 
its β-anomeric form (Fig. 4B). This observed stereochemistry is consistent with reports that bacteria who 
scavenge host-derived Neu5Ac in the α-anomeric form from glycoconjugates possess a mutarotase that 
rapidly converts the amino sugar to the more thermodynamically stable β-anomer (11) (Fig. 1A). 
However, this evidence contradicts the hypothesis that the α-anomer of Neu5Ac is the physiological 
inducer of the sialocatabolic system (6).  
The stereochemistry is defined by Arg128, which forms a salt bridge with the negatively-charged 
carboxylate group of Neu5Ac (Fig. 4B). The presence of a basic residue within the effector-binding site 
is a common feature amongst repressors who preferentially bind negatively-charged effector molecules 
(25), as well as the sialic acid-binding protein SiaP, found in the periplasm (39). Further coordination 
was predominantly provided by direct or water-mediated hydrogen bonding involving Asn165, Asp172, 
His176, Arg203, His214, Asn215, Ser218, Gln221, and His244, as well as hydrophobic interactions with 
Phe168, Ile200, and Leu245 (Fig. 4B and SI Appendix, Fig. S6). In addition to Neu5Ac, the zinc ion was 
also buried within the cavity through an octahedral geometry with a refined B-factor of 36.7 Å2, which 
is consistent with a bound metal ion.  Specifically, this coordination involved OD1 of Asp172, NE2 of 
His176, His222, and His244, and the O1 carboxyl and O2 hydroxyl moieties of Neu5Ac (Fig. 4B and SI 
Appendix, Fig. S6). In each case, the bond distance was in the range of 2.0–2.2 Å. Collectively, these 
154 
 
residues are part of a conserved fingerprint motif (Arg-X3-Glu-X40-Asp-X4-His-X~50-His-X~20-His) that is 
present in GntR transcriptional regulators that bind metal ions, where the histidine residues form a 
triangular, propeller-like architecture (33). To ensure these histidine residues can coordinate the zinc 
ion via their NE2 atoms, residues Glu132 and Gln221 stabilize the Nδ1 protonated tautomer through 
hydrogen bonds of 2.6 and 2.9 Å, respectively.  
As mentioned above, our structure captures NanR in both effector-bound and effector-free (apo) states. 
This discovery allows us to probe the conformational changes that occur following effector binding. We 
found that effector binding triggers a conformational change, compacting the all-α-helical bundle, which 
in turn causes an Arg128-mediated shift of helix α5 towards the helical linker, α4. This propagation of 
the allosteric signal results in the displacement of the DNA-binding domain by 7.7° over 3.5 Å, which we 
believe would disrupt DNA binding. To illustrate this conformational change, we constructed a model of 
the dimeric effector-free and effector-bound structures (Fig. 4C). We observed that the displacement 
of the N-terminal DNA-binding domain occurred in opposing directions, supporting our hypothesis that 
this change would decrease the binding affinity for DNA. The conformational change was further 
supported by our solution studies where we observed a small change in shape (SI Appendix, Fig. S1 & 
Table S1). However, EMSA experiments did not show a significant change in affinity in the presence of 
Neu5Ac and zinc (SI Appendix, Fig. S1D–E). This suggests that perhaps multiple ligands are required to 
bind the effector or a complex interplay between additional proteins is required. . 
 
Conformation of DNA-bound NanR. 
 
Next, we conducted single-particle cryo-electron microscopy (cryo-EM) experiments to investigate the 
DNA-bound conformation of NanR. Experiments were performed using a protein-DNA ratio titration of 
2:1 after the observation of a stable dimeric protein-DNA hetero-complex, in solution, comprising one 
NanR dimer bound to DNA during MWL-SV experiments with the two-binding-site model (SI Appendix, 
Fig. S4C). To further reduce any sample heterogeneity and remove any aggregates, the complex was 
purified using size-exclusion chromatography (SI Appendix, Fig. S7A). Once imaged, micrographs 
revealed an even particle distribution (Fig. 5A), while two-dimensional (2D) class averages showed 
defined secondary structural elements and the presence of DNA, supporting complex formation (Fig. 
5B). Despite the size of the dimeric NanR-DNA hetero-complex (70.5 kDa), a volta phase plate was not 
utilized in this experiment. Following 3D classification, ~140K particles were used for 3D refinement, 
producing a 3.9 Å resolution electron scattering potential map, as determined by the ‘gold standard’ 
Fourier shell correlation criterion (=0.143) (Fig. 5C).Using  the crystal structure of NanR as a reference, 
we constructed an atomic model of the dimeric NanR-DNA hetero-complex, fit the model to the cryo-




Fig. 5 | The DNA-bound conformation of E. coli NanR. (A) Electron micrograph of the dimeric NanR-DNA complex 
(scale bar, 40 nm). Insert: complex particle (white arrow). (B) The 2D class averages of the dimeric protein-DNA 
hetero-complex depict secondary structure elements and the presence of DNA in projection. (C) Fourier shell 
correlation plots indicate an estimated resolution of 3.9 Å for the masked (green line) and corrected (blue line) 
initial 3D map, and 4.3 Å for the unmasked (red) initial 3D map. (D) 3D electron scattering potential map and 
docked model of the dimeric NanR-DNA hetero-complex. The N-terminal DNA-binding domains (DBD), the C-
terminal effector binding domains (EBD) and density are consistent with the N-terminal extension of NanR, 
perpendicular to the DNA. (E) Multiphase ab initio model reconstructed from the scattering profiles of NanR, DNA 
and the dimeric NanR-DNA hetero-complex in solution. Despite its low resolution, this model supports the binding 
orientation observed in the electron scattering potential map. (F) A model of the NanR N-terminal DNA binding 
domain (blue) superimposed on the structure of the FadR-DNA complex [PDB ID: 1HW2, in beige]. For clarity, only 
one N-terminal domain is shown. The wing is shown to bind in the minor groove, whereas the HTH motif binds in 
the major groove. The NanR amino acid residues predicted to be involved in DNA binding based on sequence 
conservation are shown as sticks and labelled. The sequence alignment for this region is shown in the lower panel 






The 2D class averages (Fig. 5B) and refined 3D model, docked to the electron scattering potential map 
(Fig. 5D) present the DNA-bound conformation for E. coli NanR. We observed that NanR binds DNA 
between the N-terminal DNA-binding domains, making contact in the major groove with the recognition 
α3 helix (Fig. 5D). The distance between the N-terminal DNA-binding domains was ~20 Å, forming a 
positively-charged DNA-binding cleft to accommodate the diameter of the DNA double helix (~18 Å) (SI 
Appendix, Fig. S8). In the absence of DNA, these domains were separated by ~30 Å (Fig. 4A), This 
conformation change, between each state, was facilitated by the flexible linker, helix α4. 
To verify the orientation of NanR and DNA in solution, we collected SAXS data for the dimeric NanR-
DNA hetero-complex (SI Appendix, Fig. S3C) and reconstructed a multiphase ab initio model using 
MONSA (41) (Fig. 5E). This complex was assembled in an identical manner to the single-particle cryo-
EM experiments using the two-binding-site model and NanR. Using SUPCOMB (42), the atomic structure 
of NanR and an atomic model of the DNA oligonucleotide were superimposed with the multiphase 
model with normalized spatial discrepancies of 3.3 and 1.6, respectively. Although low resolution, this 
ab initio model supported the binding conformation observed in the cryo-EM map, where the C-
terminal domain of NanR is primarily orientated in parallel with the helical axis of DNA. 
Together, the 3D cryo-EM model (Fig. 5D) and the multiphase ab initio model (Fig. 5E) present the DNA-
bound conformation of the dimeric protein-DNA hetero-complex. However, the resolution of the 
structural data restricted our ability to elucidate the specific amino acid residues that are responsible 
for DNA binding. Therefore, we superimposed the N-terminal DNA-binding domain of NanR onto the 
structural coordinates of the GntR-type transcriptional regulator FadR-DNA hetero-complex (PDB ID – 
1HW2 (43)) to generate a NanR-DNA model (Fig. 5F). The results showed that, the N-terminal domain 
of NanR and FadR aligned well, with an RMSD of 0.984 Å, with the recognition α3 helix bound within the 
major groove, and the wing motif interacting with the minor groove of DNA. This was consistent with 
our cryo-EM model (Fig. 5D). However, as the recognition sites vary between NanR and FadR in both 
direction and length, this analysis only provides a foundation to examine the role of conserved residues 
that are likely to play a functional role in DNA-binding. 
Based on sequence comparisons (Fig. 5F), nine putative DNA-binding amino acid residues were 
identified. Firstly, residue Ser31 in helix α1, residue Glu58 in helix α2, residues Gly68 and Ser71 of helix 
α3, and residue Glu91 in the wing motif may form hydrogen bonds with the phosphate backbone. 
Secondly, residue Arg59 in helix α2, residues Arg69 and Arg73 in helix α3, and residue Asn89 in the wing 
motif are likely to make sequence-specific contacts with one of the DNA bases within the recognition 
sequence (Fig. 1D). Furthermore, these four residues that are implicated in specific base contacts all 
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map to the most positive electrostatic surface of the N-terminal domain (SI Appendix, Fig. S8), and hence 
support a role in DNA binding within E. coli NanR.  
Structural insight into multimeric protein-DNA hetero-complex assembly.  
Having characterised the stoichiometry of the NanR-DNA complex and demonstrated that NanR 
ultimately forms a hexameric protein-DNA hetero-complex, comprising three NanR dimers bound to 
DNA, we conducted further single-particle cryo-EM experiments to investigate this multimeric assembly 
process. Because a stable hexameric protein-DNA hetero-complex was observed during MWL-SV 
experiments, further single particle cryo-EM imaging was performed using a protein-DNA titration ratio 
of 10:1 with the full-length operator site (Fig. 3). The hexameric protein-DNA hetero-complex was 
purified using size-exclusion chromatography (SI Appendix, Fig. S7B). Once imaged, 2D class averages 
clearly identified the helical axis of DNA and revealed the presence of multiple NanR protomers 
assembling along this oligonucleotide (Fig. 6). Further classification and interpretation allowed us to 
construct a 3D model for the multimeric protein-DNA hetero-complex assembly process using our 
refined cryo-EM structure of the dimeric protein-DNA hetero-complex (Fig. 5D). As observed previously, 
NanR was primarily oriented parallel to the helical axis of DNA (Fig. 6). Upon formation of the higher-
order complexes, each additional NanR dimer appeared to bind very closely to each other. This 
observation is consistent with NanR accommodating the full recognition site by overlapping individual 
GGTATA repeats (6). In addition, the proximity of NanR supports the involvement of protein-protein 















Fig. 6 | Structural insight into multimeric NanR-DNA hetero-complex assembly. (A) 2D class averages showing a 
single NanR dimer bound to DNA in projection (left).and a model of the dimeric NanR-DNA hetero-complex using 
these 2D classes (right). (B) 2D class averages showing two NanR dimers bound to DNA in projection (left) and a 
model of the tetrameric NanR-DNA hetero-complex (right). (C) 2D class averages showing three NanR dimers 
bound to DNA in projection (left) and a Cryo-EM structure of the hexameric NanR-DNA hetero-complex (right). All 
models are shown as surface representations using the DNA-bound cryo-EM structure (Fig. 6D). Together, these 




In this study, we report the biophysical and structural characterization of the GntR-type transcriptional 
regulator NanR from E. coli. Our binding studies demonstrate NanR exhibits nanomolar affinity and 
binds DNA as sequential dimers, ultimately saturating at a hexameric protein-DNA hetero-complex with 
three NanR dimers coordinating DNA. The MWL-SV data provide an excellent case study for analysis of 
protein-DNA interactions. In addition, we think it likely that the potential of this emerging approach 
could be expanded to other complex systems, provided that the spectral properties of the interacting 
partners can be exploited (29). Using full-length NanR we define this assembly process is facilitated by 
positive cooperativity. Removal of a 32-residue, N-terminal extension to the DNA-binding domain 
perturbs this cooperative binding, suggesting this feature, is the driving force for this behavior. We 
hypothesize that this extension plays a fundamental role in both the recruitment of additional NanR 
dimers and towards anchoring the NanR dimers to maintain a high-order hetero-complex, likely through 
protein-protein interactions. Using crystallography, we solved the structure of NanR in complex with 
Neu5Ac and zinc, which provided the first evidence of a metal ion playing a direct role in the binding of 
an effector molecule, expanding our understanding of the metal-binding transcriptional regulators of 
the GntR family. This structure also illustrated the conformational changes that occur as part of the 
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allosteric mechanism to reorient the N-terminal DNA-binding domains. This provided novel insight into 
the allosteric mechanism to attenuate gene expression and strong evidence to support the suggestion 
that Neu5Ac is the effector molecule in vivo. In addition, we report the structure of the dimeric protein-
DNA hetero-complex by single particle cryo-EM, and structurally verified the multimeric protein-DNA 
hetero-complex assembly process that was observed in our MWL-SV experiments.  
 
Materials and Methods 
 
All reagents, media and consumables were purchased from Thermo Fisher Scientific and Sigma-Aldrich, 
unless otherwise stated. A detailed description of the protein cloning, expression and purification of E. 
coli NanR, double-stranded DNA preparation, SAXS analysis, single- and multi-wavelength 
sedimentation velocity analysis, EMSA assays, determination of the KD, protein crystallization, phase 
determination and X-ray structure refinement, and single-particle cryo-EM sample preparation, data 
acquisition and data processing are described in SI Appendix. X-ray coordinates have been deposited in 
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Protein cloning and expression. 
Escherichia coli nanR (UniProt accession-P0A8W0) was commercially synthesized by GenScript and sub-
cloned into expression vector pET28a. A truncated nanR fragment (NanR33-263) was amplified using 
specific primers (forward: 5’-AAGGAGATATACATATGCTCTCCGAAATGGTGGAAGAAG-3’; reverse:5’-
GTGCGGCCGCAAGCTTTTATTTCTTTTTGTTGGTGGTCTG-3’) and cloned into pET28a using an In-Fusion HD 
Cloning Kit (Takara Bio USA) as per the manufacturer’s instructions.  The resulting recombinant plasmid 
was transformed into chemically-competent E. coli BL21(DE3) cells, which were then cultured in Luria-
Bertani growth medium supplemented with kanamycin (30 µg mL-1) at 37 °C with shaking at 220 rpm to 
an OD600 of ~0.6. Protein expression was induced by the addition of isopropyl β-D-1-
thiogalactopyranoside to 1 mM and the temperature was lowered to 26 °C for incubation overnight.  
Protein purification. 
All purification steps for NanR and NanR33-263 were conducted at 4 °C. Cells were harvested by 
centrifugation (Sorvall LYNX 4000 Superspeed) at 7,000 x g for 10 min. Cell pellets were resuspended in 
buffer A (20 mM Tris−HCl (pH 8.0), 150 mM NaCl), supplemented with Complete protease cocktail 
inhibitor (Roche), and lysed by sonication (Hielscher UP200S Ultrasonic Processor). Cell debris and 
insoluble material was pelleted by centrifugation at 32,000 x g for 30 min. As an initial purification step, 
protein was precipitated with 40% ammonium sulphate for 1 h at 4 °C. Protein was pelleted at 11,000 x 
g for 15 min and resuspended in buffer B (20 mM Tris−HCl (pH 8.0), 50 mM NaCl), while the supernatant 
was discarded. The resuspended sample was dialyzed overnight in buffer B. NanR was then purified 
using a three-step procedure: anion exchange, heparin affinity and size-exclusion chromatography using 
the ÄKTApure chromatography system (GE Healthcare). First, the dialyzed sample was applied to a 
HiTrap Q FF column (GE Healthcare) and washed with buffer B. Bound protein was eluted using a 
continuous gradient of buffer C (20 mM Tris−HCl (pH 8.0), 1 M NaCl). Fractions containing protein were 
identified by SDS-PAGE and subsequently pooled. The pooled sample was then applied to a HiTrap 
Heparin HP column (GE Healthcare), and the bound protein was eluted using a continuous gradient of 
buffer C. Following concentration to approximately 500 µL using Vivaspin 6 30 kDa molecular weight 
cutoff centrifugal concentrators (Sartorius), the pooled sample was applied to a Superdex 200 Increase 
10/300 GL column (GE Healthcare) in buffer A, and NanR eluted as a single peak. The final purity was 
estimated to be approximately 95%, as highlighted by a single band in SDS-PAGE (Fig. 4C). Protein that 




Double-stranded DNA formation. 
Complementary DNA oligonucleotides (Integrated DNA Technologies) were resuspended in a buffer 
consisting of10 mM Tris−HCl (pH 8.0), and 100 mM NaCl, mixed at equimolar concentrations, and then 
hybridized by heating to 95 °C for 5 min, followed by cooling slowly to room temperature. DNA 
oligonucleotides used in EMSA and single-wavelength AUC experiments were 5’-FAM fluorescently- 
labelled on both strands to improve sensitivity. Double-stranded DNA oligonucleotides were stored at 
−20 °C until use.  
Small-angle X-ray scattering (SAXS) analysis. 
SAXS data were collected on the SAXS/WAXS beamline equipped with a Pilatus 1M detector (170 × 170 
mm, effective pixel size 172 × 172 μm) at the Australian Synchrotron using a wavelength of 1.0332 Å. 
The sample detector distance was 1600 mm, providing a q range of 0.006−0.5 Å−1. 80 µL aliquots of 
purified NanR and NanR33-263 proteins at 10 mg mL-1 (340 µM) were injected onto an inline Superdex 
S200 5/150 Increase (GE Healthcare), equilibrated with buffer A, and supplemented with the radical 
scavenger 0.1% (w/v) sodium azide, using a flow rate of 0.45 mL min-1. Protein-DNA complex was 
prepared by incubating NanR (340 µM) and two-binding-site DNA (170 µM) on ice for 30 min prior to 
injection. DNA alone was injected at the same concentration. To investigate the effect of Neu5Ac, the 
inline S200 column was re-equilibrated in buffer A and supplemented with 20 mM Neu5Ac. All scattering 
data was collected in 1-s exposures over a total of 500 frames using a 1.5-mm glass capillary at 12 °C. 
Coflow SAXS was used to minimize sample dilution and maximize signal-to-noise (1). 2D intensity plots 
were radially averaged, normalized against sample transmission, and background-subtracted using the 
Scatterbrain software package (Australian Synchrotron).  
All scattering data was analyzed using the ATSAS software package (version 2.8.4) (2). PrimusQT (3) was 
used to perform the Guinier analysis. The pairwise distribution function P(r) and the maximum 
interparticle dimension (Dmax) of the scattering samples were calculated using an indirect Fourier 
transformation. The molecular mass of each sample was estimated using the SAXS-MoW2 package (4) 
and from the Porod volume. To generate a multiphase ab initio reconstruction of the dimeric NanR-DNA 
hetero-complex, 10 independent MONSA (5) runs were performed and then averaged using DAMAVER 
(6). Each model was further evaluated using SUPCOMB (7) to determine the level of consistency. The 
resulting averaged model was visualized in PyMOL (8) by increasing the solvent density radius. The 
scattering data for all samples, excluding DNA alone, were deposited into the Small Angle Scattering 




Single-wavelength sedimentation velocity experiments. 
Sedimentation velocity experiments were performed using a Beckman Coulter Model XL-I analytical 
ultracentrifuge at University of Canterbury to analyze the oligomeric structure of NanR and the effect 
of Neu5Ac in solution. NanR at a concentration of 17 µM (0.5 mg mL-1) in buffer A and in the presence 
of 20 mM Neu5Ac were loaded into a An-60 Ti four-hole rotor, using double sector epon-charcoal 
center-pieces, fitted with sapphire windows. Data were collected at 50,000 rpm and at 20 °C, where 
sedimentation was monitored using the absorbance optical system at 280 nm.  
To assess protein-DNA interaction, sedimentation velocity experiments were performed in a Beckman 
Coulter Model XL-A analytical ultracentrifuge at University of Melbourne using double sector epon-
charcoal center-pieces fitted with quartz windows in an An-50 Ti eight-hole rotor at 20 °C. NanR was 
titrated against a 5’-FAM fluorescently-labelled oligonucleotide at 11 protein concentrations (2-fold 
dilutions from 794–0.78 nM) in buffer A. The DNA oligonucleotide contained three repeats of the motif 
GGTATA (full recognition site). Data were collected at 50,000 rpm, where sedimentation was monitored 
using the fluorescence emission optical system (AVIV Biomedical). To generate an artificial bottom, 50 
µL of FC43 fluorinert oil were loaded into the bottom of each cell. A radial calibration was performed 
prior to each experiment at 3,000 rpm using a calibration cell containing 10 µM fluorescein in 10 mM 
Tris–HCl (pH 7.8) and 100 mM KCl. Photo-multiplier tube (PMT) voltage and gain were adjusted for each 
cell, while an appropriate focusing depth was selected to maximize the signal and minimize the inner 
filter effect for the highest NanR concentration. A PMT voltage and gain setting of 58% was used.  
All data were analyzed using SEDFIT (9). Sedimentation data was fitted to either a continuous size 
distribution [c(s)] or a continuous mass distribution [c(M)] model. The buffer density, buffer viscosity 
and an estimate of the partial specific volume of the protein sample based on the amino acid sequence 
were also determined using SEDNTERP.  
Electrophoretic mobility shift assays. 
Double stranded 5’-FAM-labelled DNA oligonucleotides were diluted to 10 nM in gel shift buffer (10 mM 
MOPS (pH 7.5), 50 mM KCl, 5 mM MgCl2, and 10% (v/v) glycerol). Twelve-well Novex 6% Tris-glycine gels 
(Invitrogen) were pre-run in 0.5× Tris-Borate-EDTA (TBE) buffer (40 mM Tris-HCl (pH 8.3), 45 mM boric 
acid, and 1 mM EDTA) at 200 V for 30 min at 4 °C. Protein and DNA oligonucleotides were mixed and 
incubated at room temperature for 30 min to allow samples to reach equilibrium. Electrophoresis was 
performed immediately on the pre-run gels in 0.5× TBE buffer at 200 V for 20 mins at 4 °C. Following 
electrophoresis, gels were rinsed in distilled water and imaged using a Typhoon FLA 9500 Biomolecular 
Imager (GE Healthcare) with a 473 nm excitation source and a long-pass (LPB) emission filter.  
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Determining the dissociation constant of the NanR-DNA interaction. 
The apparent affinity of the interaction between NanR and its DNA recognition sequence was measured 
by comparing the ratio of bound and unbound oligonucleotides in both the EMSA and analytical 
ultracentrifugation experiments. This ratio was determined from the fluorescent sedimentation velocity 
data by the integration of the peaks in the c(s) distribution, where a shifted species relative to the DNA 
signal represented complex formation. In the EMSA, the ratio of free versus bound fluorescently-
labelled DNA was determined by densitometry using ImageJ (10). Together, the fraction containing 
bound DNA was plotted against the concentration of NanR in each experiment. The dissociation 
constant was calculated by fitting the data to the Hill equation using Prism 7 (GraphPad Software Inc.). 
The standard error of the best fit parameters was then calculated for the model (Fig. 2).  
Multi-wavelength sedimentation velocity (MWL-SV) experiments.  
To define the stoichiometry of the NanR-DNA complex, MWL-SV experiments were performed in a 
Beckman Coulter Optima AUCTM using double sector epon-charcoal center-pieces fitted with sapphire 
windows in an An-60 Ti four-hole rotor at 20 °C. Samples were prepared with increasing loading 
concentrations of NanR with respect to DNA (1:1; 2:1; 3:1; 4:1; 6:1; 10:1 (protein:DNA)) in 50mM sodium 
phosphate (pH 7.4), and 50mM NaCl. Data were collected in intensity mode at either 50,000 or 60,000 
rpm and sedimentation was monitored using the UV absorption system in intensity mode. This system 
allowed the acquisition of full UV-vis intensity spectra from 190–800 nm. In this experiment, radial 
sedimentation velocity scans were recorded in the range of 220–300 nm with 2 nm increments, 
providing 41 individual datasets for each loading concentration. All data were analyzed using UltraScan 
4.0, release 2578 (11), and fit using the UltraScan LIMS cluster.  
Initially all MWL-SV datasets were analysed using a two-dimensional spectrum analysis (2DSA) (12). This 
analysis method allows the sedimentation coefficient and frictional ratio (f/f0) to be floated 
independently in an unbiased hydrodynamic model. In addition, both time-invariant and radially in-
variant noise components are removed, while accurate fitting of the meniscus position is provided. All 
datasets were further refined using the 2DSA Monte Carlo (2DSA-MC) analysis, which determines the 
confidence intervals for each parameter that define each solute (13). These include the sedimentation 
and diffusion coefficients. The partial specific volume for NanR was predicted based on the amino acid 
sequence using UltraScan, while the buffer density and viscosity were determined based on the 
composition (50mM sodium phosphate (pH 7.4), 50mM NaCl) using UltraScan. 
Absorbance spectra for NanR and DNA were obtained by performed a dilution series of each pure 
component across the spectral range of interest (220-300 nm) using a Genesys 10s benchtop 
spectrophotometer (Thermo Scientific). The dilution series of absorbance spectra were fitted to intrinsic 
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extinction profiles as described previously (14). The resulting intrinsic extinction profiles were scaled to 
molar concentration using an extinction coefficient of 13 980 M-1 cm-1 at 280 nm for full-length NanR 
and for NanR32-263 as calculated by ExPASy ProtParam (15) from the amino acid sequence. For the DNA 
oligonucleotides, and extinction coefficient of 276 816 M-1 cm-1 at 260 nm for 2rDNA, and 567 112 M-1 
cm-1 at 260 nm for 3rDNA as determined by the nearest-neighbour method (16; 17). The vector angle 
between these spectral profiles was found to be 60.2° and 63.3°, respectively for NanR and the 2rDNA 
or 3rDNA oligonucleotides. These vector angles represent good orthogonality between spectra and 
therefore ensure separability, as an angle of 0° reflects linear dependence or perfect overlap, while an 
angle of 90° indicates perfect orthogonality or no spectral overlap. Next, the profiles scaled to molar 
concentration were subsequently used to decompose the noise-corrected MWL-SV datasets into 
separate datasets for the protein and DNA components using the non-negatively constrained least 
squares algorithm (18) as previously described (14; 19). The resulting decomposed datasets were 
individually analysed by a two-dimensional spectrum analysis using UltraScan. The resulting amplitudes 
of the decomposed species involved in hetero-complex formation can be integrated to directly provide 
the molar stoichiometry of the protein-DNA hetero-complexes. A summary of the integration results 
from the MWL-SV analysis is shown in SI Appendix Table S3-5.   
In order to accurately determine the molecular weight of each species in solution, a weight-averaged 





Here, the molar mass, measured in Daltons is required for the protein (𝑀1) and DNA (𝑀2) components, 
along with the partial specific volume of the protein (?̅?1 ) and the DNA (?̅?2 ). A molar mass of 59 kDa, 
118 kDa and 177 kDa was used for the dimeric (oneNanR protomer), tetrameric (two NanR protomers) 
and hexameric (threeNanR protomers) protein components, respectively. A molar mass of 11.5 kDa and 
21.5 kDa was used for the 2r- and 3r-DNA components, respectively. The partial specific volume of the 
protein (?̅?1 ) was 0.7295 mL g
-1, while the partial specific volume of the DNA (?̅?2 ) was 0.55 mL g
-1. 
Crystallization, phase determination, and structure refinement. 
Initial crystallisation conditions were identified using the sitting-drop vapour-diffusion method by mixing 
400 nL of protein (20 mg mL-1 NanR in 20 mM Tris-HCl (pH 8.0), 150 mM containing 20 mM Neu5Ac) 
with 400 nL of reservoir solution equilibrated at 20 °C. However, following data collection at the 
Australian Synchrotron MX2 beamline, using an EIGER x 16M detector (Dectris), these crystals were not 
suitable for structure determination, diffracting to ~5 Å resolution. To overcome this, we performed in 
situ proteolysis (20) with the addition of 10 µg mL-1 chymotrypsin following identification of the 
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predominately disordered N-terminal extension (SI Appendix, Fig. S5). We decided against surface-
entropy reduction as this strategy utilises site-directed mutagenesis on charged residues (21). Since 
transcriptional regulators employ positive amino acids in DNA binding, we wanted to conserve these 
residues for modelling purposes.  
Prior to crystallisation, the protein solution/protease mixture was incubated on ice for 30 min. After 
four weeks growth at 8 °C, crystals were produced, which diffracted to 2.10 Å using the sitting-drop 
vapor-diffusion method and in situ proteolysis by mixing 400 nL of NanR (20 mg mL-1) NanR in buffer 
containing 20 mM Tris-HCl (pH 8.0), 150 mM , and 20 mM Neu5Ac) with 400 nL of reservoir solution 
(0.1 M sodium HEPES (pH 7.5), 0.2 M sodium acetate trihydrate, and 25% (w/v) PEG 3350), equilibrated 
at 8 °C. Crystals were flash-frozen in liquid nitrogen, and X-ray diffraction data were collected on the 
MX2 beamline at the Australian Synchrotron, using an EIGER × 16M detector (Dectris). A single dataset 
was collected at a wavelength of 0.9537 Å over 180° and was processed in XDS (22) displaying P21 
symmetry, with cell dimensions of a = 39.77, b = 87.85, c = 73.87 Å. However, we were unable to phase 
the data using molecular replacement because the sequence identity of potential molecular 
replacement templates was low. To determine a phasing strategy, we performed X-ray absorption 
spectroscopy on the MX2 beamline to identify metal ions present in the crystal and obtained a distinct, 
yet weak, anomalous signal from zinc. The presence of an intrinsically-bound zinc ion was further 
supported using inductively-coupled plasma mass spectrometry. With the aim of increasing the 
anomalous signal, NanR was expressed in the presence of 100 µM ZnCl2, purified, and subjected to 
further screening as described using in situ proteolysis. Crystals were obtained from a reservoir solution 
containing 0.1 M Tris-HCl (pH 8.5), 0.2 M magnesium chloride hexahydrate, and 30% (w/v) PEG 4000, 
flash-frozen, and then cryoprotected in the same reservoir solution supplemented with 15% (w/v) 
glycerol/ ethylene glycol. A MAD scan was performed on the crystal around the zinc absorption edge. 
At a wavelength of 1.2782 Å (slightly remote from the edge), 22 datasets were collected using an EIGER 
× 16M detector at a detector distance of 245–255 mm from a single crystal at five different positions 
where diffraction ranged from 2.62–2.29 Å. For each dataset, 3600 frames were collected with an 
exposure of 0.1 sec per frame, with an X-ray beam attenuation of 50%. These datasets were processed 
in XDS (22) displaying I212121 symmetry and were then analyzed with XDS_NONISOMORPHISM (23) to 
identify the most isomorphous datasets. Based on this analysis, eight isomorphous datasets were 
selected, merged and scaled using XSCALE (22), in order to improve the zinc anomalous signal. The unit 
cell dimensions of the merged and scaled dataset were a = 75.46, b = 78.35, c = 88.72 Å, α=β=γ=90°. 




The crystal structure of the C-terminal domain (residues 120–251) was solved using the SAD protocol in 
the Auto-Rickshaw pipeline (24).Input diffraction data were prepared and converted for use in Auto-
Rickshaw using programs within the CCP4 suite (25). FA values were calculated using the program 
SHELXC (25). Based on an initial analysis of the data, the maximum resolution for substructure 
determination and initial phase calculation was set to 2.70 Å. Both heavy atoms requested were found 
using the program SHELXD (26). The correct hand for the substructure was determined using the ABS 
program (27), while initial phases of 162 were calculated following density modification using SHELXE 
(26). The initial phases were improved using density modification and phase extension to 2.29 Å 
resolution using RESOLVE (28). 50.00% of the model was built using the program ARP/wARP (29). This 
partial model, along with the 2.10 Å dataset, were used in a MRSAD protocol in Auto-Rickshaw (30) for 
phase enhancement and model completion. The resulting model was improved by iterative manual 
building in COOT (31) and refinement against the 2.10 Å dataset using PHENIX (32). No density was 
visible for residues 1–30 and 247–263 in chain A, or for residues 1–30 and 245–263 in chain B. The final 
refined model had Rwork and Rfree values of 18.2% and 23.0%, respectively. This model was validated using 
MOLPROBITY (33). Structure refinement statistics are summarized in Table SI Appendix, Table S5. The 
dimer interface was analyzed using PDBePISA (34). All structural graphics were prepared using PyMOL 
(8). The coordinates and structure factors for NanR in complex with Neu5Ac and zinc have been 
deposited in the PDB under the ID code 60N4. 
 
Single-particle cryo-electron microscopy sample preparation, data acquisition and data processing. 
Sample preparation: 
Dimeric NanR-DNA hetero-complex was prepared by mixing NanR and the two-binding-site model DNA 
oligonucleotide a loading concentration of 2:1. Hexameric NanR-DNA hetero-complex was prepared by 
mixing NanR and the full recognition site DNA oligonucleotide at a loading concentration of 10:1. 
Following equilibration for 1 h at 4 °C, the sample was loaded onto a Superdex 200 Increase 10/300 GL 
column (GE Healthcare), pre-equilibrated with buffer A . Fractions consistent with complex formation 
were pooled and diluted to a final concentration of 0.5 mg mL-1. Frozen-hydrated samples were 
prepared on plasma-cleaned Quantifoil R1.2/1.3 holey carbon EM grids (Quantifoil) using a Vitrobot 
Mark III vitrification robot (FEI) with a 3 sec blotting time, 100% humidity and -3 mm blotting offset.  
Data collection:  
Automated data acquisition of the dimeric NanR-DNA hetero-complex was performed using a Titan 
Krios™ electron microscope (FEI) at 300 keV, which was equipped with a K2 Summit™ direct detector 
(Gatan) and a GIF- Quantum energy filter (Gatan) using EPU software (ThermoFisher Scientific). Cryo-
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EM imaging were performed using nanoprobe EFTEM imaging mode, a C2 Condenser aperture size of 
50 µM, an objective aperture size of 70 µM, and at a nominal magnification of 215,000×, which provided 
a magnified pixel size of 0.68 Å. Movies comprising 32 frames, an exposure time of 12.8 sec, and a total 
dose of 60e- Å-2 were collected using a K2 Summit™ direct detector (Gatan) in counting mode, using a 
dose rate of 4e- pixel-1 sec-1 and a defocus range from -0.5 µm to -2.5 µm. Automated data acquisition 
of the hexameric NanR-DNA hetero-complex was performed using a Talos Artica™ electron microscope 
(FEI) at 200 keV, which was equipped with a Falcon III ™ direct detector (FEI).   
Data processing:  
Correction for beam-induced motion were performed using MotionCor2, which provided dose weighted 
corrected averages. CTF parameters were estimated on the corresponding non-dose weighted averages 
using Gctf v1.06 (35). Both steps were performed using RELION v3.0-stable wrapper. Automated 
particle-picking were performed using Gautomatch v0.53 on a subset of images with a sphere diameter 
of 8 nm. These particles were then subjected to 2D classification, where the 2D classes that showed 
secondary structural features were used as a template for further automated particle-picking using the 
entire dataset. This generated 1.2m particles. Further 2D classification resulted in 270k particles with 
good signal-to-noise. These particles were then used to generate the initial 3D model using ab initio 
reconstruction in CRYOSPARC v2 (36). Further 3D classifications in RELION 3.0 teased out a homogenous 
set of 140k particles corresponding to the DNA bound dimer population. Multiple rounds of masked 
refinement resulted in teasing out the signal of 70kDa NanR-DNA hetero-complex at a resolution of 3.9 
Å (gold standard FSC 0.143 criteria). The 3D structure of the DNA oligonucleotide was modelled using 













SI Appendix Fig S1 | Electrophoretic mobility shift assay (EMSA) of NanR and fluorescently-labelled DNA oligonucleotides. (A) Specific DNA binding is abrogated in the poly 
adenine/ thymine (poly-AT) control. At high concentration, non-specific binding is observed. (B) Poor DNA binding activity is observed when only one GGTATA repeat is 
present suggesting the regulation mechanism is dependent on cooperative binding. (C) Two concentration-dependent complexes are observed when two GGTATA repeats are 
present. (D) A small change in DNA binding affinity is observed in the presence of 20 mM Neu5Ac when compared with the EMSA gel in the absence of Neu5Ac (C). (E) The 
binding isotherm from the two-binding-site model with NanR (black) and in the presence of Neu5Ac (red). The data was best fit to a Hill equation due to the signal 
dependency. A small decrease in affinity is observed (~20 nM). (F) The sequence of the DNA oligonucleotides used in EMSA experiments. The fluorescent fluorescein (FAM) 




SI Appendix Fig. S2 | E. coli NanR remains as an exclusive dimer in solution with (red) or without (black) the presence 
of Neu5Ac. (A) Sedimentation velocity data at a protein concentration of 17 μM and with the addition of 20 mM 
Neu5Ac were fitted to a continuous mass [c(M)] distribution. The data were both best fit to a dimeric species with 
a calculated mass of 59 kDa. (B) Small angle X-ray scattering data present an analogous scattering profile with and 
without Neu5Ac (20 mM), demonstrating no oligomeric change has occurred in solution. The residuals (shown 
below) highlights the q region where a minor difference is observed—this may be reflective of a small Neu5Ac-
induced conformational change. The linearity of the Guinier plot (insert) further supports the observation of a 










SI Appendix Fig. S3 | SAXS for E. coli NanR and the NanR-DNA hetero-complex. (A) Pairwise distribution plot displaying the maximum interparticle dimension (Dmax) for NanR 
(111 Å, red), NanR33-263 (84 Å, red), two binding site DNA (64 Å, blue) and the dimeric NanR-DNA hetero-complex (98 Å, orange). (B) Kratky plot for NanR33-263 presents a bell-
shaped curve, which indicates the protein is folded in solution. In addition, the Kratky analysis provided evidence of flexibility in the structure as the plot does not converge with 
the baseline (black dash). (C) The scattering profiles for NanR (red), DNA (blue) and the dimeric NanR-DNA hetero-complex (orange). The MONSA generated fits (black line) and 
chi2 value are shown for each. (D) The Guinier plot for DNA (blue) and the dimeric NanR-DNA hetero-complex (orange) highlights linearity at low q—this provides confidence 
that the data is free of any significant amount of aggregation or interparticle interference. (E) The SEC-SAXS data for the dimeric NanR-DNA hetero-complex. Using US-SOMO 
(39), three Gaussian functions were fitted to the data to deconvolute the scattering profile for the dimeric NanR-DNA hetero-complex (peak 2, grey) from free DNA and aggregate 
(peak 1 and 3, diagonal line).  The radius of gyration (Rg) value across peak 2 is shown as black dots. The lower panel presents the UV trace for the SEC-SAXS data collected at 
260 nm (grey dot), and 280 nm (black line). The NanR-DNA hetero-complex and free DNA are highlighted.  
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SI Appendix Fig S4 | The stoichiometry of the NanR-DNA hetero-complex. The deconvoluted sedimentation 
coefficient distributions for the titration series are presented. (A) Separate controls of NanR (blue) and the two-
binding-site DNA model (2rDNA, black). (B) 1.2 µM NanR. (C) 2.4 µM NanR. (D) 4.8 µM NanR. (E) 7.2 µM NanR. 
(F) 12 µM NanR33-263. Upon increasing protein concentration, a clear shift in the sedimentation coefficient is 
observed, consistent with the formation of higher order hetero-complexes. The broad reaction boundary is 
indicative of tight binding and represents multiple, dynamic intermediate species that are mediated by mass 
action. The presence of excess protein, free of any co-migrating DNA indicates that hetero-complex formation 
has reached saturation. All plots are presented as g(s) distributions. (G) A model of the hetero-complex assembly 












SI Appendix Fig S5 | Multiple sequence alignment performed using Clustal Omega (40) and generated using 
ESPript 3.0 (41). The top five hits from a sequence homology search within the PDB were used in the sequence 
alignment. The red background highlights identical residues, while the yellow background indicates chemically 
similar residues. Secondary structure elements depicted above the alignment were generated from the crystal 
structure of E. coli NanR (Fig. 4A). The dots above the aligned sequences are the amino acid numbers respective 
to NanR. The N-terminal DNA-binding domain (blue box), the linker region, and the C-terminal effector-binding 










SI Appendix Fig S6 | Schematic representation of the NanR-Neu5Ac-Zn interaction network. The hydrogen 
bonded network is presented (black dashed lines) and the distance between partners are labelled. Key 
interacting water molecules (yellow spheres) and hydrophobic contacts (red arcs with spokes) are shown. Figure 












SI Appendix Fig S7 | Cryo-EM sample preparation. Prior to vitrification, dimeric (A) and hexameric (B) NanR-DNA 
hetero-complex was purified using size exclusion chromatography to remove free DNA and aggregates. The 
pooled fraction is highlighted (grey box). The size exclusion chromatogram for NanR (blue dashed lines) in the 
absence of DNA is presented in (A). 
 
SI Appendix Fig S8 | The electrostatic surface map for NanR. The electrostatic surface map was generated using 
APBS (43) and coloured by the electrostatic potential distribution with negatively and positively charged regions 
displayed in red and blue, respectively (range -5kT to 5kT). Located between the N-terminal DNA-binding 
domains is a positively-charged cleft that is proposed to be the DNA binding site. The distance between the N-
terminal domains is ~20 Å. The most positive electrostatic surface (shown as an insert) is mapped to recognition 
helix (α3) and the ‘wing’ of the winged helix-turn-helix motif.  
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SI Appendix Table S1 | Data collection and analysis statistics from solution studies.  
Sedimentation velocity analysis NanR 
NanR 
(+ 20 mM Neu5Ac) 
 
  
Sedimentation coefficient (×10−13 S) 3.65 3.55    
Frictional ratio (f/f0) 1.34 1.31    
Molecular weight (from c(M), kDa) 54.5 55.6    
Partial specific volume of NanR (mL g-1) 0.7295    
Buffer density (g/cm3) 1.006 1.009    
Buffer viscosity (cp) 1.027 1.086    
SAXS data analysis NanR 
NanR 




I(0) (cm-1) (from Guinier analysis) 0.021 ± 5.7e-05 0.032 ± 8.7e-03 0.057 ± 6.2e-05 0.006 ± 4.2e-05 0.013 ± 6.7e-05 
Rg (Å) (from Guinier analysis)  32.3 ± 0.3 31.4 ± 0.2 28.9 ± 0.1 19.7 ± 0.5 33.4 ± 0.6  
I(0) (cm-1) (from  P(r)  analysis) 0.021 ± 0.1e-03 0.033 ± 0.1e-03 0.057 ± 0.9e-04 0.006 ± 0.8e-04 0.013 ± 0.1e-03 
Rg (Å) (from P(r) analysis) 31.8 ± 0.2 32.3 ± 0.2 28.50 ± 0.4 19.8 ± 0.3 32.9 ± 0.3 
Dmax (Å)  111 116 84 64 98 
Porod volume (Å-3) 112 000 107 000 83 000 16 000 114 000 
Molar mass (from Porod Volume, kDa) 65.9 62.9 48.8 9.4 67.1 
Molar mass (from SAXSMoW2*, kDa) 70.6 63.6 57.7 10.6 82.5 
Calculated dimer MM from sequence (kDa) 59.0 59.0 51.3 11.5 70.5 
SASBDB ID SASDFJ5 SASDFK5  -  
SAXS data-collection parameters      
Instrument Australian Synchrotron SAXS/WAXS beamline 
Detector PILATUS 1M (Dectris) 
Wavelength (Å) 1.0332 
Maximum flux at sample 8 x 1012 photons per second at 12 keV 
Camera length (mm)  1600 
q range (Å-1)  0.006-0.5 
Exposure time Continuous 1 second frame measurements 
Sample configuration SEC-SAXS with co-flow 
Sample temperature (°C) 12 
a http://saxs.ifsc.usp.br/ (4)     
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Measured molar ratio ‡ n/a n/a 2.10 2.84 2.58 4.02 4.23 6.33 6.48 
Weight-averaged  ?̅? (mL g-1) § 0.730 0.55 0.700 0.700 0.700 0.714 0.714 0.719 0.719 





86 73.1 79.4 N/D† N/D† 148.6 178.6 
Theoretical molar mass (kDa) # 59 11.5 70.5 70.5 70.5 129.5 129.5 188.5 188.6 
Oligomeric state of hetero-
complex 
n/a n/a Dimeric Dimeric Dimeric Tetrameric Tetrameric  Hexameric Hexameric 
* These are the sedimentation and diffusion coefficients observed following 2DSA-Monte Carlo analysis. Parameters are obtained from integration of pseudo-3D plots within the UltraScan 
software. All measured values represent the mean from the Monte Carlo analysis. The values in parentheses are the 95% confidence intervals from the Monte Carlo analysis.  
† N/D = not determined as species were present within a reaction boundary.  
‡ Partial concentration is determined from peak integration of the co-migrating species in both the NanR and DNA datasets. As the data is scaled to molar concentration these concentrations 
can be used directly to infer the molar ratio and thus stoichiometry of the complex.  
§ Partial specific volume (?̅?) of the complex, estimated from the weight-average of the protein and DNA components. A ?̅? of 0.7295 mL g-1 was used for NanR, while a ?̅? of 0.55 mL g-1 was used 
for DNA. The equation used to calculate the weight-averaged ?̅? is presented in SI Methods.  
¶ The measured molar mass is estimated based upon the hydrodynamic parameters (sedimentation and diffusion coefficient) and the weighted-averaged ?̅?, predicted based on the measured 
molar ratio. The values in parentheses are the 95% confidence intervals from the Monte Carlo analysis for the pure components.  
# The theoretical mass is predicted based upon the amino acid or nucleic acid sequence within UltraScan. The mass of each complex is predicted based on the observed molar ratio.  
179 
 




































(7.35, 8.61)  
8.31 
(7.95, 8.68) 















Measured molar ratio ‡ n/a n/a 2.45 4.25 2.37 3.63 4.65 6.44 6.21 
Weight-averaged  ?̅? (mL g-1) § 0.730 0.550 0.682 0.702 0.682 0.702 0.702 0.710 0.710 




 (17.9, 24.8) 
98.9 N/D† 97.6 N/D† N/D† 211.8 204.8 
Theoretical molar mass (kDa) # 59.0 21.5 80.5 139.5 80.5 139.5 139.5 198.5 198.5 
Oligomeric state of hetero-
complex 
n/a n/a Dimeric Tetrameric Dimeric Tetrameric Tetrameric Hexameric Hexameric 
* These are the sedimentation and diffusion coefficients observed following 2DSA-Monte Carlo analysis. Parameters are obtained from integration of pseudo-3D plots within the UltraScan 
software. All measured values represent the mean from the Monte Carlo analysis. The values in parentheses are the 95% confidence intervals from the Monte Carlo analysis.  
† N/D = not determined as species were present within a reaction boundary.  
‡ Partial concentration is determined from peak integration of the co-migrating species in both the NanR and DNA datasets. As the data is scaled to molar concentration these 
concentrations can be used directly to infer the molar ratio and thus stoichiometry of the complex.  
§ Partial specific volume (?̅?) of the complex, estimated from the weight-average of the protein and DNA components. A ?̅? of 0.7295 mL g-1 was used for NanR, while a ?̅? of 0.55 mL g-1 was 
used for DNA. The equation used to calculate the weight-averaged ?̅? is presented in SI Methods.  
¶ The measured molar mass is estimated based upon the hydrodynamic parameters (sedimentation and diffusion coefficient) and the weighted-averaged ?̅?, predicted based on the 
measured molar ratio. The values in parentheses are the 95% confidence intervals from the Monte Carlo analysis for the pure components.  
# The theoretical mass is predicted based upon the amino acid or nucleic acid sequence within UltraScan. The mass of each complex is predicted based on the observed molar ratio.  
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Measured molar ratio ‡ n/a n/a 2.44 2.24 
Weight-averaged  ?̅? (mL g-1) § 0.730 0.55 0.677 0.677 




 (17.9, 24.8) 
66.3 66.4 
Theoretical molar mass (kDa) # 51.3 21.5 72.8 72.8 
Oligomeric state of hetero-
complex 
n/a n/a Dimeric Dimeric 
* These are the sedimentation and diffusion coefficients observed following 2DSA-Monte Carlo analysis. Parameters are obtained from integration of pseudo-3D plots within the UltraScan 
software. All measured values represent the mean from the Monte Carlo analysis. The values in parentheses are the 95% confidence intervals from the Monte Carlo analysis.  
‡ Partial concentration is determined from peak integration of the co-migrating species in both the NanR and DNA datasets. As the data is scaled to molar concentration these 
concentrations can be used directly to infer the molar ratio and thus stoichiometry of the complex.  
§ Partial specific volume (?̅?) of the complex, estimated from the weight-average of the protein and DNA components. A ?̅? of 0.7295 mL g-1 was used for NanR, while a ?̅? of 0.55 mL g-1 was 
used for DNA. The equation used to calculate the weight-averaged ?̅? is presented in SI Methods.  
¶ The measured molar mass is estimated based upon the hydrodynamic parameters (sedimentation and diffusion coefficient) and the weighted-averaged ?̅?, predicted based on the 
measured molar ratio. The values in parentheses are the 95% confidence intervals from the Monte Carlo analysis for the pure components.  
# The theoretical mass is predicted based upon the amino acid or nucleic acid sequence within UltraScan. The mass of each complex is predicted based on the observed molar ratio. 
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Dataset name  NanR-Zn  NanR 
Data collection   
X-ray wavelength (Å) 1.2781 0.9537 
Crystal-to-detector distance (mm) 245 200 
Space group I 21 21 21 P 21 
Unit cell a, b, c (Å) 75.46/78.35/88.72 39.77, 87.85, 73.87 
Unit cell α, β, γ (°) 90, 90, 90 90, 103, 90 
Resolution range (Å) 44.36-2.29 43.9-2.10 (2.17-2.10) 
No. of total reflections 12209 96673 
No. of unique reflections 7465 28482 
Completeness (%) 99.6 (97.9) 98.1 (88.3) 
Rmerge (%) 5.4 (36.9) 4.4 (53.5) 
CC1/2 (%) 99.9 (94.9) 99.9 (69.4) 
I/σ (I) 4.23 15.3 (1.6) 
Refinement statistics   
Resolution (Å)  43.9-2.10 
No. of reflections used  26874 
No. of reflection used in test set  1368 
Rwork/Rfree (%)  18.12/22.95 
Total non-H atoms  3653 
Protein/ Water  3586 
Ligands/ Ion  67 
Mean B factor (Å2)  56.65 
Geometric RMSD    
Bond (Å)  0.009 
Angle (°)  1.27 
MolProbity statistics†   
Rotamer outliers (%)  3.88 
Clashscore  9.17 
Ramachandran plot   
Favoured/allowed regions (%)  98.36/1.64 
PDB ID   60N4 
* Values in parentheses are for the highest resolution shell 
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5.4 Chapter Summary 
 
 
This chapter presents a thorough structural and functional investigation of the GntR-type NanR from E. 
coli. Solution studies in the presence of Neu5Ac were inconsistent with the literature as no Neu5Ac-
induced dissociation was observed. The binding kinetics reported a nanomolar affinity for DNA, which 
was consistent with the literature and revealed novel cooperative behaviour. The stoichiometry of the 
NanR-DNA interaction was defined using multi-wavelength sedimentation velocity experiments, 
demonstrating that NanR binds as a dimer to a total of three direct GGTATA repeats that constitute the 
DNA recognition site, forming a hexameric NanR-DNA hetero-complex. A sequence analysis revealed a 
unique 32 residue N-terminal extension. Through mutagenesis this extension was hypothesised to 
facilitate the positive cooperativity, following observation of a perturbed ability to form high order 
hetero-complexes. Excitingly, the crystal structure of E. coli NanR was solved in complex with sialic acid 
and a zinc ion. This is the first known structure of a GntR-type sialoregulator to be reported, providing 
insight into the allosteric mechanism of regulation and novel evidence of a metal ion interacting with 
an effector molecule.  Single particle cryo-EM experiments reported a structure of the NanR-DNA 
hetero-complex and provided structural evidence to support the multimeric hetero-complex assembly 
process. This is the first known structure of a NanR gene regulator in complex with DNA. Together, this 
characterisation of the GntR-type NanR from E. coli enhances our understanding of bacterial 
sialoregulation at a molecular level.  
 
 




44. Reizer, A., Deutscher, J., Saier, M. H., Jr., & Reizer, J. (1991). Analysis of the gluconate (gnt) operon of Bacillus 
subtilis. Molecular Microbiology, 5, 1081-1089. 
45. Rigali, S., Derouaux, A., Giannotta, F., & Dusart, J. (2002). Subdivision of the Helix-Turn-Helix GntR Family of 
Bacterial Regulators in the FadR, HutC, MocR, and YtrA Subfamilies. Journal of Biological Chemistry, 277, 
12507-12515. 
46. Jain, D. (2015). Allosteric control of transcription in GntR family of transcription regulators: A structural 
overview. IUBMB Life, 67, 556-563. 
47. Suvorova, I. A., Korostelev, Y. D., & Gelfand, M. S. (2015). GntR Family of Bacterial Transcription Factors and 
Their DNA Binding Motifs: Structure, Positioning and Co-Evolution. Public Library of Science One, 10, 
e0132618-e0132618. 
48. Brennan, R. G. (1993). The winged-helix DNA-binding motif - another helix-turn-helix takeoff. Cell, 74, 773-776. 
49. Hoskisson, P. A., Rigali, S., Fowler, K., Findlay, K. C., & Buttner, M. J. (2006). DevA, a GntR-Like Transcriptional 
Regulator Required for Development in Streptomyces coelicolor. Journal of Bacteriology, 188, 5014. 
50. Franco, I. S., Mota, L. J., Soares, C. M., & de Sa-Nogueira, I. (2007). Probing key DNA contacts in AraR-mediated 
transcriptional repression of the Bacillus subtilis arabinose regulon. Nucleic Acids Research, 35, 4755-
4766. 
51. Zheng, M., Cooper, D. R., Grossoehme, N. E., Yu, M., Hung, L. W., Cieslik, M., Derewenda, U., Lesley, S. A., 
Wilson, I. A., Giedroc, D. P., & Derewenda, Z. S. (2009). Structure of Thermotoga maritima TM0439: 
implications for the mechanism of bacterial GntR transcription regulators with Zn2+-binding FCD 
domains. Acta Crystallographica, Section D, Biological Crystallography, 65, 356-365. 
185 
 
52. Lee, M. H., Scherer, M., Rigali, S., & Golden, J. W. (2003). PlmA, a new member of the GntR family, has plasmid 
maintenance functions in Anabaena sp. strain PCC 7120. Journal of Bacteriology, 185, 4315-4325. 
53. Bramucci, E., Milano, T., & Pascarella, S. (2011). Genomic distribution and heterogeneity of MocR-like 
transcriptional factors containing a domain belonging to the superfamily of the pyridoxal-5'-phosphate 
dependent enzymes of fold type I. Biochemical and Biophysical Research Communications, 415, 88-93. 
54. DiRusso, C. C., Heimert, T. L., & Metzger, A. K. (1992). Characterization of FadR, a global transcriptional 
regulator of fatty acid metabolism in Escherichia coli. Interaction with the fadB promoter is prevented by 
long chain fatty acyl coenzyme A. Journal of Biological Chemistry, 267, 8685-8691. 
55. van Aalten, D. M., DiRusso, C. C., Knudsen, J., & Wierenga, R. K. (2000). Crystal structure of FadR, a fatty acid-
responsive transcription factor with a novel acyl coenzyme A-binding fold. EMBO Journal, 19, 5167-5177. 
56. van Aalten, D. M., DiRusso, C. C., & Knudsen, J. (2001). The structural basis of acyl coenzyme A-dependent 
regulation of the transcription factor FadR. EMBO Journal, 20, 2041-2050. 
57. Fujihashi, M., Nakatani, T., Hirooka, K., Matsuoka, H., Fujita, Y., & Miki, K. (2014). Structural characterization of 
a ligand-bound form of Bacillus subtilis FadR involved in the regulation of fatty acid degradation. Proteins-
Structure Function and Bioinformatics, 82, 1301-1310. 
58. Shi, W., Kovacikova, G., Lin, W., Taylor, R. K., Skorupski, K., & Kull, F. J. (2015). The 40-residue insertion in Vibrio 
cholerae FadR facilitates binding of an additional fatty acyl-CoA ligand. Nature Communications, 6, 6032. 
59. Gao, Y. G., Suzuki, H., Itou, H., Zhou, Y., Tanaka, Y., Wachi, M., Watanabe, N., Tanaka, I., & Yao, M. (2008). 
Structural and functional characterization of the LldR from Corynebacterium glutamicum: a 
transcriptional repressor involved in L-lactate and sugar utilization. Nucleic Acids Research, 36, 7110-
7123. 
60. Jain, D., & Nair, D. T. (2013). Spacing between core recognition motifs determines relative orientation of AraR 
monomers on bipartite operators. Nucleic Acids Research, 41, 639-647. 
61. Fillenberg, S. B., Grau, F. C., Seidel, G., & Muller, Y. A. (2015). Structural insight into operator dre-sites 
recognition and effector binding in the GntR/HutC transcription regulator NagR. Nucleic Acids Research, 
43, 1283-1296. 
62. Raman, N., Black, P. N., & DiRusso, C. C. (1997). Characterization of the fatty acid-responsive transcription 
factor FadR. Biochemical and genetic analyses of the native conformation and functional domains. 
Journal of Biological Chemistry, 272, 30645-30650. 
63. Weickert, M. J., & Adhya, S. (1992). A family of bacterial regulators homologous to Gal and Lac repressors. 
Journal of Biological Chemistry, 267, 15869-15874. 
64. Franco, I. S., Mota, L. J., Soares, C. M., & de Sa-Nogueira, I. (2006). Functional domains of the Bacillus subtilis 
transcription factor AraR and identification of amino acids important for nucleoprotein complex assembly 
and effector binding. Journal of Bacteriology, 188, 3024-3036. 
65. Resch, M., Schiltz, E., Titgemeyer, F., & Muller, Y. A. (2010). Insight into the induction mechanism of the 
GntR/HutC bacterial transcription regulator YvoA. Nucleic Acids Research, 38, 2485-2497. 
66. Saenger, W., Orth, P., Kisker, C., Hillen, W., & Hinrichs, W. (2000). The Tetracycline Repressor-A Paradigm for 
a Biological Switch. Angewandte Chemie, 39, 2042-2052. 
67. Goeke, D., Kaspar, D., Stoeckle, C., Grubmuller, S., Berens, C., Klotzsche, M., & Hillen, W. (2012). Short peptides 
act as inducers, anti-inducers and corepressors of Tet repressor. Journal of Molecular Biology, 416, 33-
45. 
68. Kanwar, M., Wright, R. C., Date, A., Tullman, J., & Ostermeier, M. (2013). Protein switch engineering by domain 
insertion. Methods Enzymology, 523, 369-388. 
69. Hardy, J. A., & Wells, J. A. (2004). Searching for new allosteric sites in enzymes. Current Opinion In Structural 
Biology, 14, 706-715. 
70. Plumbridge, J., & Vimr, E. (1999). Convergent pathways for utilisation of the amino sugars N-
acetylglucosamine, N-acetylmannosamine, and N-acetylneuraminic acid by Escherichia coli. Journal of 
Bacteriology, 181, 47-54. 
71. Kalivoda, K. A., Steenbergen, S. M., Vimr, E. R., & Plumbridge, J. (2003). Regulation of sialic acid catabolism by 
the DNA binding protein NanR in Escherichia coli. Journal of Bacteriology, 185, 4806-4815. 
72. Kalivoda, K. A., Steenbergen, S. M., & Vimr, E. R. (2013). Control of the Escherichia coli sialoregulon by 
transcriptional repressor NanR. Journal of Bacteriology, 195, 4689-4701. 
73. Vimr, E. R. (2013). Unified theory of bacterial sialometabolism: how and why bacteria metabolise host sialic 
acids. International Scholarly Research Notices in Microbiology, 2013, 816713. 
74. Vimr, E. R., Kalivoda, K. A., Deszo, E. L., & Steenbergen, S. M. (2004). Diversity of microbial sialic acid 
metabolism. Microbiology & Molecular Biology Reviews, 68, 132-153. 
186 
 
75. Crooks, G. E., Hon, G., Chandonia, J. M., & Brenner, S. E. (2004). WebLogo: a sequence logo generator. Genome 
Res., 14, 1188-1190. 
76. Schuck, P. (2007). Protein interactions: biophysical approaches for the study of complex reversible systems (Vol. 
5). New York, NY, Springer. 
77. Hellman, L. M., & Fried, M. G. (2007). Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic 
acid interactions. Nature Protocols, 2, 1849-1861. 
78. Westphal, L. L., Sauvey, P., Champion, M. M., Ehrenreich, I. M., & Finkel, S. E. (2016). Genomewide Dam 
Methylation in Escherichia coli during Long-Term Stationary Phase. mSystems, 1. 
79. Chu, D., Roobol, J., & Blomfield, I. C. (2008). A theoretical interpretation of the transient sialic acid toxicity of 









Defining the DNA-binding mechanism of the GntR-type 
sialoregulator from Escherichia coli – Part Two 
 
6.1 Chapter overview 
 
This chapter provides additional and supporting information to Chapter Five. Combined, the overall aim 
of this body of work is to develop a mechanistic understanding of how the GntR-type NanR from E. coli 
regulates gene expression of sialic acid catabolism.  
The thermal stability of E. coli NanR is investigated using nano-differential scanning fluorimetry 
experiments and confirms an increase in thermal stability in the presence of sialic acid and its DNA 
recognition sequence. In addition, electrophoretic mobility shift assays (EMSA) investigate the effect on 
DNA-binding activity when the spacing between the GGTATA binding motif is increased. A thorough 
investigation into the stoichiometry of the protein-DNA complex is presented using single-wavelength 
sedimentation velocity experiments. These experiments provide the foundation for the multi-
wavelength sedimentation velocity analysis presented in Chapter Five. As this is an emerging strategy, 
the data analysis of multi-wavelength sedimentation velocity experiments is detailed in this chapter. 
The C-terminal domain sub-structure used to solve the X-ray structure of E. coli NanR using a combined 
molecular replacement and single wavelength anomalous dispersion strategy is presented. Although 
crystallisation trials conducted in the presence of DNA were not suitable for structure determination, 




















6.2 Results and Discussion  
 
6.2.1 The thermal stability of E. coli NanR  
To investigate the thermal stability of E. coli NanR, differential scanning fluorimetry (DSF) experiments 
were employed. Initially, these experiments were conducted using SYPRO Orange, a fluorescent dye 
that binds hydrophobic residues and reports during protein unfolding (1). However, a high background 
fluorescence was observed from the start of the melt curve, despite using a low final concentration of 
SYPRO Orange (as per the manufacturer’s instructions). This indicated that the fluorescent dye was 
binding the protein before it has unfolded. To investigate this, circular dichroism (CD) spectroscopy was 
performed to check the protein was folded in solution (Figure 6.1A) as described in Chapter Eight, 
Section 8.6.3.2.  
 
Figure 6.1| CD spectra and disorder plot of E. coli NanR. A) The negative peaks at 208 nm and 222 nm are 
characteristic of α-helices and suggests that NanR is folded in solution. Experiment was conducted using 0.05 mg 
mL-1 NanR in 20 mM Tris-HCl (pH 8.0) using a 1 cm pathlength quartz cuvette. The data was converted to mean 
residue ellipticity (MRE) and plotted as a function of wavelength (nm). B) The disorder probability estimated from 
RONN (https://www.strubi.ox.ac.uk/RONN) and PrDOS (http://prdos.hgc.jp/cgi-bin/top.cgi) online servers. The 
regions of disorder are highlighted (grey with dot).  
The CD spectra for NanR displayed negative peaks at 208 nm and 222 nm, which is characteristic for a 
protein comprised of α-helices (2). This observation was consistent with the crystal structure presented 
in Chapter Five, where the C-terminal domain displayed an all α-helical architecture. Taken together, 
this supports that NanR is folded in solution. Consequently, the cause of the high background 
fluorescence observed when using SYPRO® Orange is likely attributed to the 32 residue N-terminal 
extension of the DNA binding domain, which was predicted to be disordered (Figure 6.1B) by the online 
servers RONN and PrDOS. In addition, its composition is primarily comprised of hydrophobic residues 




As an alternative strategy, the Prometheus NT.48 instrument (NanoTemper Technologies) was 
employed to determine the thermal stability of NanR without the use of environmentally sensitive 
fluorescent dyes. This was achieved by monitoring the intrinsic fluorescence of tryptophan residues 
upon introduction of a thermal gradient. Here, as the tertiary structure of the protein unfolds, the 
intrinsic tryptophan fluorescence changes as the chemical environment of these residues is altered (3). 
These changes are monitored by dual-UV detection at emission wavelengths of 350/330 nm, where the 
ratio of these signals can be used to infer the unfolding temperature of the protein with high resolution 
(4). Furthermore, these experiments can be conducted across any buffer system and require a sample 
volume of only 10 µL. Thus, this technology is referred to as Nano-DSF.  
Nano-DSF experiments were carried out using a NanR concentration of 1 mg mL-1 in 20 mM Tris-HCl (pH 
8.0), 150 mM NaCl. Here, NanR displayed biphasic unfolding behaviour with the identification of two 
unfolding transitions in the first derivative plot (Figure 6.2, blue). The first transition (Tm1) gave a melting 
temperature of 52.04 ± 0.01 °C, with an onset melting temperature (Tonset) of 48.8 ± 0.04 °C (Table 6.1). 
The second transition (Tm2) although visible (~67 °C), was not distinguished as an inflection point in the 
PR.ThermControl software (NanoTemper Technologies) so no melting temperature was recorded. This 
is likely due to only a minor difference in the 350/330 nm emission wavelengths. When supplemented 
with Neu5Ac, a similar biphasic unfolding was observed (Figure 6.2, red), where the Tm1 gave a melting 
temperature of 53.97 ± 0.08 °C, with a Tonset of 50.04 ± 0.82 °C, while Tm2 gave a melting temperature of 
68.1 ± 0.1 °C (Table 6.1). The height of these transition peaks suggested almost a 50:50 population of 
species unfolding at Tm1 versus Tm2. Conversely, when NanR was supplemented with its DNA recognition 
site, this biphasic unfolding was lost, as only one transition peak was observed. This transition gave a 






Figure 6.2| Thermal stability of E. coli NanR using nano-DSF. A) The change in the ratio of intrinsic tryptophan 
fluorescence at the emission wavelengths of 350 and 330 nm. The onset melting temperature (Tonset) is highlighted. 
B) The first derivative of the fluorescence ratio curve. The peak maximum corresponds to the melting temperature 
(Tm) of the protein/ transition, derived from the inflection point of the ratio curve above. Transitions Tm1 and Tm2 
are highlighted. Nano-DSF experiments were performed with 1 mg mL-1 (33 µM) protein in 20mM Tris-HCl (pH 
8.0), 150 mM NaCl and additionally supplemented with either 10 mM Neu5Ac or 300 µM DNA. Thermal unfolding 
was monitored from 20 to 95 °C at a at a ramp rate of 1 °C per min for NanR (blue), NanR + Neu5Ac (red) and NanR 
+ DNA (black).  
 
Interestingly, all samples displayed a decrease in the fluorescent ratio (350/330 nm), which is consistent 
with a blue shift (Figure 6.2A). This feature indicates that the tryptophan residues are solvent exposed 
and begin to accommodate a more hydrophobic environment upon heating. Conversely, an increase in 
the fluorescent ratio would be consistent with a red shift, where a buried tryptophan residue slowly 
becomes solvent exposed upon heating (5). In the structure of E. coli NanR, the two tryptophan residues 
(residues 198 and 252) are located near the dimer interface and towards the C-terminus, respectively. 
Both these residues are solvent exposed, supporting the observed blue shift.  
 
Table 6.1 | Summary of data analysis from nano-DSF experiments. The Tonset and Tm values represent averages along 
with the standard deviation from duplicates.  
Sample Tonset (°C) Tm1 (°C) Tm2 (°C) 
NanR 48.8 ± 0.04 52.04 ± 0.01 - 
NanR + Neu5Ac 50.04 ± 0.82 53.97 ± 0.08 68.1 ± 0.1 
NanR + DNA 61.41 ± 0.07 - 69.9 ± 0.01 
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Combined, these data demonstrated that NanR displays biphasic unfolding in the presence and absence 
of Neu5Ac, although this behaviour was altered in the presence of DNA. However, all data exhibited a 
blue shift with a decrease in the fluorescent ratio (350/330 nm). This feature suggests that the first 
transition (Tm1) observed in the presence and absence of Neu5Ac corresponds to a partial denaturation 
of the protein, while the second transition (Tm2) observed in all samples corresponds to complete 
denaturation of the protein. Although, a second interpretation would be that each transition reflects 
the two domains of NanR unfolding at different temperatures.  
To further understand this thermal denaturation process, it is important to consider NanR is comprised 
of two domains; an N-terminal DNA-binding domain and a C-terminal effector-binding domain. 
Interestingly, when in the presence of Neu5Ac, both melting temperatures (Tm1 and Tm2), as well as the 
onset melting temperature had increased by approximately 2 °C relative to NanR alone—this is 
consistent with an increase in thermal stability. Furthermore, the second transition peak was more 
pronounced in the presence of Neu5Ac compared to NanR alone (Figure 6.2A and B, respectively in red). 
This suggests that the second transition represents denaturation of the C-terminal domain, where the 
increase in signal with Neu5Ac is consistent with effector binding, while the first transition represents 
denaturation of the N-terminal domain. Conversely, in the presence of DNA, only a single melting 
temperature was measured, with a significant increase in the onset melting temperature by 10-12 °C. 
This demonstrates that when bound to DNA, NanR is sustainably more stable in solution.  
 
6.2.2 Analysing the distance between GGTATA binding repeats using 
electrophoretic mobility shift assays 
 
To achieve regulation, E. coli NanR binds a conserved operator site that contains three direct repeats of 
the DNA sequence GGTATA. This results in the formation of three concentration-dependent complexes 
or discrete bands by EMSA (Figure 6.2A). Separating these direct binding repeats are the base pairs ACA 
between direct repeats one and two (spacer region 1), and base pairs AA between direct repeats two 
and three (spacer region 2). Collectively, these base pairs are conserved in the promoter region of the 
three operons NanR regulates as part of the sialoregulon (6). However, the biological relevance of 
maintaining a third GGTATA repeat is currently unresolved and thus an open question. To address this 
and investigate whether spacing of the repeats is crucial for DNA binding, the number of base pairs was 
progressively increased by three and subsequently assessed using EMSA. A total of six mutant DNA 
oligonucleotides were designed and tested below, each with an increasingly larger distance between 
the GGTATA direct repeat (Figure 5.2B-G). An identical titration range for NanR and a constant 




Figure 6.2 | Analysing the distance between binding repeats using EMSA. A) Wild-type sequence. Three 
concentration dependent complexes are visualised, labelled C1, C2 and C3. The DNA probe is labelled DNA. The 
spacer region between GGTATA repeats one and two is labelled 1, while the spacer region between GGTATA 
repeats two and three is labelled 2. Both are highlighted blue. B to G) EMSA gel for mutant oligonucleotides 1-6. 
The left side of the figure presents the DNA sequence for each mutant. Highlighted in red is the addition base pairs 
within the spacer.  
 
It is evident that the distance between spacer region 2 is significantly more important for the assembly 
of higher order complexes, than the distance between spacer region 1. In mutant oligonucleotide one, 
where the distance had increased by three base pairs, the appearance of a hexameric NanR-DNA hetero-
complex species was still observed, with a retarded band at the same height as C3 in the wild type gel 
(Figure 6.2B). Conversely, the data for mutant oligonucleotide two primarily demonstrated hetero-
complex formation that was consistent with C1, or a dimeric NanR-DNA hetero-complex species. There 
was little appearance of bands that were consistent with a higher-order hetero-complex, suggesting 
that the DNA-binding affinity was reduced with this nucleotide sequence (Figure 6.2C). This supported 
the notion that the third GGTATA repeat is important to promote the cooperative assembly of the 
hexameric NanR-DNA hetero-complex. In mutant oligonucleotide three, both spacer regions have been 
increased by three base pairs, where a significant loss in binding affinity is observed, and a further 
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decrease in signal for the retarded bands that correspond to complex formation (Figure 6.2C). This is 
consistent with a combined effect of what is observed in mutant oligonucleotide one and two. Mutant 
oligonucleotide four and five have been increased by a further three base pairs at spacer region 1 and 
2, respectively. In these gel shift assays, a similar assessment can be made as to what was observed in 
Figure 6.2A and 6.2B. This observation is similar in mutant oligonucleotide five, which shows the DNA 
probe being retarded just as quickly (Figure 6.2F). Lastly, when the distance between the GGTATA 
repeats was increased to a total of six base pairs, very little complex formation was visualised (Figure 
6.2G). While the last or most right-hand lane in each gel was a DNA only control, the inside two to three 
lanes showed a significant shift with respect to the DNA probe. Moreover, these lanes appeared more 
smeared than others. As this was also a feature in the wild type, these bands are likely the result of non-
specific binding leading to a heterogeneous population of protein-DNA intermediates that would fail to 
produce a discrete shift.  
Combined, these mutated oligonucleotides explored what effect distance has on DNA-binding affinity 
for NanR. Here, it was discovered that when this distance was increased between spacer region 2, as 
opposed to the first spacer region, a significant loss in DNA binding affinity can be observed. This 
demonstrates that the third GGTATA repeat is crucial for the assembling the higher order hetero-
complex. Interestingly, this data also shows that the pairs of direct GGTATA repeats are not equivalent, 
suggesting that cooperativity of the system is mediated by only one of these pairs. As higher order 
hetero-complex assembly was perturbed when spacer region 2 was mutated, perhaps GGTATA repeats 
2 and 3 mediate the cooperative behaviour of the system. However, it is unclear if the binding of NanR 
occurs sequentially to these repeats or through a random ordered process.  
 
6.2.3 Sedimentation velocity analysis on the E. coli NanR-DNA interaction 
 
Prior to this study, the stoichiometry of the E. coli NanR-DNA interaction was poorly understood. This is 
because the gel-based technique used to estimate the size of macromolecules gave largely inconsistent 
results. However, in Chapter Five, analytical ultracentrifugation was employed to quantitatively 
demonstrate that E. coli NanR coordinates its DNA recognition as dimers, forming a hexameric NanR-
DNA hetero-complex. This was achieved using novel multi-wavelength sedimentation velocity 
experiments, conducted at the University of Lethbridge, Canada as this advanced analytical 
ultracentrifugation instrumentation was not available in New Zealand.  
However, prior to these experiments, single-wavelength sedimentation velocity experiments were 
initially performed using a titration range of E. coli NanR against a fixed concentration of fluorescently 
end-labelled DNA, as described in Chapter Eight (Section 8.6.3.4). Here, by measuring the emission 
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wavelength of the fluorescein tag at 495 nm, I could detect free DNA, and evaluate protein-DNA 
complex formation, indicated by a positive shift in the sedimentation coefficient. Furthermore, in order 
to accurately determine the molecular weight of the species in solution, the experiment was repeated 
at two velocities as this enables the hydrodynamic information to be extracted with increased precision.  
 
6.2.3.1 Single-wavelength sedimentation velocity analysis using two GGTATA binding sites 
 
Initially, experiments were conducted with an oligonucleotide containing only two GGTATA binding sites 
in order to simplify the system, as by EMSA only two concentration-dependent hetero-complexes are 
visualised (Figure 6.3A).  
 
Figure 6.3 | EMSA gel of the two binding site model for E. coli NanR. A) When only two GGTATA repeats are present, 
NanR forms two concentration-dependent hetero-complexes, labelled C1 and C2. B) When three GGTATA repeats 
are present, NanR forms three concentration-dependent hetero-complexes, labelled C1-3. The free DNA probe 
for each is labelled and the DNA sequence is shown below each respective EMSA gel.  
 
In this experiment, a total of seven individual samples were collected at 60 000 rpm and 28 000 rpm, 
where one was a DNA only control, while the remaining six samples included a micromolar titration 
range of E. coli NanR. Following data collection at each speed, the sedimentation data was evaluated 
using a two-dimensional spectrum analysis (2DSA) (7) and further refined by 50 Monte Carlo iterations 
using the state-of-the-art software, Ultrascan (8). Here, upon increasing concentration two new peaks 
could be observed, both displaying a larger sedimentation coefficient relative to the DNA only control 
of 2.19 S (Figure 6.4A). In addition, the free DNA signal slowly decreased upon increasing concentration 
of NanR. Combined, these observations were consistent with the formation of a protein-DNA hetero-
complex of two different sizes. Interestingly, the small peak at a sedimentation coefficient of 
approximately 1 S, which was consistent with a low concentration of single-stranded DNA, did not 
change during the NanR titration. This showed that only the double-stranded DNA interacted with and 





Figure 6.4 | Single-wavelength sedimentation velocity analysis of E. coli NanR and two GGTATA binding sites. A) 
2DSA-Monte Carlo model displaying the sedimentation coefficient (S) distribution from the 60 000 rpm 
experiment. Each colour represents a different titration sample, collected independently (see legend). To illustrate 
the identity of the three main species in solution, a cartoon depiction of DNA and each NanR-DNA hetero-complex 
is presented. For clarity the sedimentation coefficient distribution for E. coli NanR collected independently is 
shown. B) van Holde-Weischet plot provides a graphical transformation of the sedimentation data allowing the 
proportional contributions of each species to be interpreted. C) Pseudo-3D plot presenting the global solute 
distribution, across all sedimentation data shown in (A) as a function of frictional ratio and sedimentation 








Table 6.2 | Summary of single-wavelength sedimentation velocity data collection and analysis from E. coli NanR   
Data collection parameters  
Buffer density (g cm3) 1.0059 
Buffer viscosity (cp) 1.0211 
Partial specific volume (mL g-1)  
E. coli NanR 0.7327 
DNA oligonucleotide (Two binding site model) 0.5550 
Dimeric NanR-DNA hetero-complex 0.7030 

















% Error  
(Molar mass) 
DNA only 2.19 10.34 11 - 11.5 1 
0.5:1* 4.75 6.06 64 Dimeric 70.5 10 
1:1 4.73 5.15 75 Dimeric 70.5 6 
2:1 4.73 5.26 73 Dimeric 70.5 4 
3:1 4.77 5.54 71 Dimeric 70.5 1 
4:1 6.23 4.23 127 Tetrameric 129.5 2 
5:1 6.61 4.33 131 Tetrameric 129.5 1 
*Protein:DNA ratio 
 
Following peak integration of these species, the measured molar mass of the complex at approximately 
4.7 S (reported in Table 6.2) was consistent with the theoretical molar mass of a single NanR dimer and 
its DNA recognition sequence forming a dimeric NanR-DNA hetero-complex (70.5 kDa). Conversely, the 
measured molar mass of the hetero-complex at approximately 6.4 S (reported in Table 6.2) was 
consistent with the theoretical molar mass of two NanR dimers and its DNA recognition sequence 
forming a tetrameric NanR-DNA hetero-complex (129.5 kDa). Validation of this stoichiometry was 
supported by the small difference in molar mass between these values with an error less than 10% 
(Table 6.2). The accuracy of these measured molar masses is increased when a stable species is 
observed, as opposed to an equilibrium between two species that lie within a reaction boundary. This 
can be observed in the van Holde-Weischet plot (Figure 6.4B), which provides a graphical 
transformation of the sedimentation data allowing the proportional contributions of each species to be 
interpreted. A stable species can be visualised by a predominately straight line, which indicates the 
sample is primarily homogenous. For example the 2:1 (protein:DNA) sample is primarily a single species 
(hetero-complex), with a small amount of DNA. This distribution was also observed in the multi-
wavelength data in Chapter Five and further reinforces why this protein-DNA ratio was selected for 
single-particle cryo-EM experiments in order to investigate the DNA bound conformation of NanR. In 
addition, the van Holde-Weischet plot provides insight into the kinetics of the NanR-DNA hetero-
complex assembly process. In this study, the formation of the dimeric NanR-DNA hetero-complex 
appeared much slower, while the transition to the higher order hetero-complex or tetrameric NanR-
DNA hetero-complex was much faster (Figure 6.4B). This difference in DNA binding kinetics was also 
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observed by EMSA (Figure 6.3A) and can be supported by the cooperative behaviour of the system, 
which was demonstrated in Chapter Five.  
Furthermore, these species were combined to create a global model and then further refined by utilising 
genetic algorithms as part of the UltraScan software. This strategy removed regions with very low signal 
(false positives) from the model, which were generated by stochastic noise in the data and in turn 
emphasised the signal of the primary solutes or components that were present in solution (9). The result 
of this global refinement is presented as a Pseudo-3D plot, which allows hydrodynamic parameters such 
as the sedimentation coefficient, diffusion coefficient or frictional ratio to be compared. Figure 6.4C 
presents this plot as a function of frictional ratio and sedimentation coefficient, highlighting the free 
DNA, dimeric and tetrameric NanR-DNA hetero-complexes. Here, an increasing trend in the frictional 
ratio was observed as the sedimentation coefficient become larger. Since the frictional ratio is a 
measure of shape asymmetry, this feature was expected, since during complex assembly, the addition 
of successive NanR dimers would create an increasingly asymmetric molecule.  
Taken together, these sedimentation velocity experiments demonstrated that when two GGTATA 
binding sites were present, two protein-DNA hetero-complexes of different sizes were formed. Further 
analysis defined the stoichiometry of these protein-DNA complexes, as a dimeric and tetrameric NanR-
DNA hetero-complex, respectively. This was supported by the small difference between measured and 
theoretical molar mass values. In addition, van Holde-Weischet analysis illustrated the difference in DNA 
binding kinetics during this hetero-complex assembly process.  
 
6.2.3.2 Single-wavelength sedimentation velocity analysis using three GGTATA binding sites 
 
Next, to investigate the assembly process with the full operator site, sedimentation velocity experiments 
were repeated using three GGTATA binding sites, which produces three concentration-dependent 
complexes in EMSA (Figure 6.3B). In this experiment the initial velocities were adjusted to 50 000 rpm 
and 32 000 rpm since larger species were expected than previously, owing to the extra GGTATA repeat. 
However, the data was analysed and refined using UltraScan (8) in an analogous process. The 2DSA-
Monte Carlo model displaying the sedimentation coefficient distribution from the 50 000 rpm 








Figure 6.5 | Single-wavelength sedimentation velocity analysis of E. coli NanR and three GGTATA binding sites. A) 
2DSA-Monte Carlo model displaying the sedimentation coefficient (S) distribution from the 50 000 rpm 
experiment. Each colour represents a different titration sample, collected independently (see legend). To illustrate 
the identity of the three main species in solution, a cartoon depiction of DNA and each NanR-DNA hetero-complex 
is presented. B) van Holde-Weischet plot provides a graphical transformation of the sedimentation data allowing 
the proportional contributions of each species to be interpreted. C) Pseudo-3D plot presenting the global solute 
distribution, across all sedimentation data shown in (A) as a function of frictional ratio and sedimentation 
coefficient. Highlighted are the three predominant species in solution.   
 
In this experiment, upon increasing concentration of NanR, two prominent shifts in sedimentation 
coefficient were observed (Figure 6.5A). This was consistent with protein-DNA hetero-complex 
formation via a multistep assembly process. Following peak integration of these species, the measured 
molar mass of the peak centred at approximately 3 S (reported in Table 6.3) was consistent with the 
theoretical molar mass of the full operator site with three GGTATA binding sites (22.5 kDa). This small, 
yet positive shift in sedimentation coefficient relative to the two binding site model, is a result of the 
additional 18 base pairs, which includes the third GGTATA repeat (Figure 6.3). Upon titration of NanR, 
this peak slowly decreased and initially shifted to a peak centred at a sedimentation coefficient of 
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approximately 7 S. The measured molar mass of this species was consistent with the theoretical molar 
mass of two NanR dimers and its DNA recognition sequence forming a tetrameric NanR-DNA hetero-
complex (139.5 kDa). Upon increasing the concentration further, this peak shifted to a peak centred at 
a sedimentation coefficient of approximately 8.6 S. Following peak integration, the measured molar 
mass of this species was consistent with the theoretical molar mass of three NanR dimers and its DNA 
recognition sequence forming a hexameric NanR-DNA hetero-complex (198.5 kDa). Having formed this 
high-order assembly, the system appears to saturate as no free DNA remains to be complexed. The 
proportional contributions of each species during this multistep assembly process can be visualised in 
the van Holde-Weischet plot (Figure 6.5B). In addition, the frictional ratio of these species can be 
visualised in the Pseudo-3D plot following further refinement with a genetic algorithm in UltraScan 
(Figure 6.5C).  
 
Table 6.3 | Summary of single-wavelength sedimentation velocity data collection and analysis from E. coli NanR   
Data collection parameters  
Buffer density (g cm3) 1.0059 
Buffer viscosity (cp) 1.0211 
Partial specific volume (mL g-1)  
E. coli NanR 0.7327 
DNA oligonucleotide (Full operator site) 0.5550 
Tetrameric NanR-DNA hetero-complex 0.7034 

















% Error  
(Molar mass) 
DNA only 2.97 6.93 23 - 22.5 1 
   1:1* 7.46 4.33 142 Tetrameric 139.5 2 
2:1 7.51 4.21 146 Tetrameric 139.5 4 
4:1 7.70 4.02 156 Tetrameric 139.5 11 
6:1 8.49 3.39 211 Hexameric 198.5 6 
8:1 8.77 3.36 219 Hexameric 198.5 10 
*Protein:DNA ratio 
 
Interestingly, in comparison to the two binding site model, no prominent peak was visible at a 
sedimentation coefficient of 5 S, which would be consistent with the formation of a dimeric NanR-DNA 
hetero-complex. However, as a tetrameric and hexameric NanR-DNA hetero-complex was observed, 
this highlighted that when the full promoter site is present, NanR can rapidly associate to form the 
higher order hetero-complexes. Thus, despite their presence in the multistep assembly process the 
signal concentration for the dimeric NanR-DNA hetero-complex was so low that it fell outside the 
detectable range for this experiment. This feature was also visualised by EMSA (Figure 6.3B). 
Furthermore, this assembly process was consistent with a cooperative system, as demonstrated in 
Chapter Five.  
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6.2.3.3 An introduction to multi-wavelength sedimentation velocity analysis 
 
The data from the single-wavelength sedimentation velocity experiments presented above demonstrate 
the stoichiometry of the NanR-DNA hetero-complex. However, to provide a more definite answer to 
this complex system I employed a new analytical ultracentrifugation strategy, which is denoted multi-
wavelength sedimentation velocity analysis. This emerging strategy offers a significant improvement in 
resolution by coupling a novel multi-wavelength detector (10) with high-performance computing. 
Furthermore, data collection involves an additional spectral dimension, providing the ability to 
distinguish between dissimilar macromolecules (such as protein and DNA) by exploiting the differences 
in their respective absorbance profiles (10; 11). Overall, this feature provides the capacity to 
characterise the assembly process of interacting components within a complex mixture, without any 
detection labels. The steps necessary to facilitate data analysis of multi-wavelength experiments are 
summarised below.  
Initially, an absorbance profile for each interacting component must be collected using a dilution series 
over a range of wavelengths. This range must be tailored for each experiment based upon the spectral 
properties of the interacting components. In this study, a wavelength range of 220-320 nm was chosen 
as this encompasses the spectral profiles of both protein and DNA. Next, using an extinction coefficient 
of each interacting component, the dilution series is globally fitted in the software UltraScan to obtain 
an intrinsic extinction profile for the entire wavelength range measured (12). This profile is later used 
to scale the sedimentation data to molar concentration and subsequently decompose the absorbance 
signal of the interacting components into separate profiles. However, in order to accurately achieve 
spectral decomposition, two key factors must be assured, including: 1) an accurate extinction coefficient 
when fitting the intrinsic extinction profile; and 2) the intrinsic extinction profile of the individual 
components must be sufficiently different or ‘orthogonal’. To determine orthogonality, the vector angle 
between the two spectral profiles can be measured using UltraScan, where an angle of 90 ° reflects no 
spectral overlap and a vector angle of 0 ° indicates perfect overlap. In this study, the spectral profiles 
for E. coli NanR and DNA, presented in Figure 6.6, gave a vector angle of 60 °. This indicated that they 








Figure 6.6 | Intrinsic extinction profiles for the interacting partners. A) Intrinsic extinction profiles for E. coli NanR 
B) Intrinsic extinction profiles for DNA (Two binding site model). Together, these profiles provide an extinction 
coefficient for the entire wavelength range measured. A vector angle of 60 ° between these profiles, supports that 
they are ‘orthogonal’—this feature is essential to achieve spectral decomposition (12).  
 
In the next step, sedimentation velocity data is collected across the wavelength range of interest within 
a two-sector cell. In Chapter Five, protein-DNA titrations of 1:1, 2:1, 4:1, 5:1, 6:1 and 10:1 (µM ratios) 
were employed to simulate and further expand the single-wavelength experiments above. Moreover, 
sedimentation velocity data were collected individually on purified NanR and pure DNA using a 
wavelength of 280 nm and 260 nm, respectively. Together, these serve as the controls for the 
experiment, thus any observation of a positive shift in sedimentation coefficient supports an interaction 
between NanR and DNA.  
By introducing the spectral dimension (or alternatively, a fourth dimension) to this new approach, the 
volume of data over traditional methods is significantly increased when combined with data collection 
over a range of wavelengths (10). As a result, multi-wavelength sedimentation velocity experiments 
offer a substantial improvement in spectral resolution over single-wavelength approaches (12), which 
comprise a three-dimensional (3D) dataset that includes time, radius and absorbance (13). An example 
of this new multi-wavelength sedimentation velocity data is presented in Figure 6.7. Following data 
collection, each wavelength can be analysed independently. While this process is computationally 
demanding, the analysis is manageable via access to high-performance computing and use of the 









Figure 6.7 | 3D visualisation of the multi-wavelength sedimentation velocity data. Presented is a single time point 
from the 2:1 (protein:DNA) loading titration. Here, an absorbance maximum is visible below 230 nm, which is 
contributed by the peptide backbone of the protein, while the maximum between 260-280 nm is contributed by 
both the DNA and the aromatic amino acid residues of the protein.  
 
Once analysed, the intrinsic extinction profile of the individual components can be used to decompose 
the multi-wavelength sedimentation velocity data into separate sedimentation profiles, which are 
scaled to molar concentration—this is achieved by employing the non-negatively constrained least-
squares algorithm (12; 14). An example of these separated signals is presented in Figure 6.8 where a 
clear difference can be visualised in the sedimentation boundaries between DNA and protein. Following 
decomposition, the formation of a hetero-complex can be identified by observing a co-migrating peak 
(or signal) between the individual sedimentation distributions.  
 
 
Figure 6.8 | 2D visualisation of the E. coli NanR and DNA sedimentation profiles following spectral decomposition. 
Presented is the separated signals from the 2:1 (protein:DNA) titration, where the data has been scaled to molar 
concentration as a function of radius. Here, a clear difference can be visualised in the sedimentation boundaries 
between DNA and E. coli NanR. While NanR is primarily one large boundary, thus a single species, DNA has multiple 
boundaries or several species. 
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Finally, the stoichiometry of the hetero-complex can simply be extracted by integrating the molar ratio 
of the co-migrating peaks (11). Moreover, these separated datasets can now be analysed further to 
extract hydrodynamic information as is traditionally achieved using single-wavelength experiments. 
Thus, this new approach can provide both hydrodynamic and spectral characterisation of an interacting 
system to define the stoichiometry of association, and additionally grant access to properties such as 
the mass and frictional ratio of each species—together this enables interacting species to be 
characterised with high resolution. 
Overall, the multi-wavelength sedimentation velocity analysis presented in Chapter Five verifies the 
stoichiometry that was defined in the single-wavelength experiments above. This demonstrates the 
precision of analytical ultracentrifugation and reinforces its recognition as the gold-standard technique 
to quantitatively analyse complex interactions in solution (12; 15). However, most importantly it 
showcases what multi-wavelength sedimentation velocity analysis can achieve with the additional 
information that the spectral dimension can offer.  
 
6.2.4 The C-terminal domain sub-structure of E. coli NanR used to phase the native 
structure 
 
Chapter Five reports the crystal structure of E. coli NanR solved in complex with Neu5Ac and a zinc ion 
to a maximum resolution of 2.1 Å. To phase this structure, a combined single-wavelength anomalous 
dispersion and molecular replacement strategy was employed, using zinc as the anomalous scatterer. 
This experimental phasing approach was implemented following identification of a zinc ion through 
inductively coupled plasma mass spectrometry and X-ray absorption spectroscopy.  
Initially when this anomalous signal for zinc was detected, the reported value was low in both the 
fluorescence scan and multiple anomalous dispersion scan, suggesting poor occupancy. To address this 
problem, NanR was expressed in 10 µM zinc chloride, purified and subjected to further crystallisation 
trials. This resulted in the growth of a large orthorhombic crystal that diffracted to a maximum 
resolution of 2.29 Å (Figure 6.9A-B). Due to the size, multiple datasets could be collected along the 
length of the crystal at a wavelength of 1.278 Å (9.7 keV), which is slightly off centre from the absorption 
edge of zinc (1.284 Å). Upon merging these datasets, a significant anomalous signal was observed for 
zinc. This anomalous signal was suitable for experimentally phasing the merged data using Auto-






Figure 6.9 | E. coli NanR substructure. A) Image of the crystal in the loop (top) and within the crystallisation plate 
(lower). A scale bar for each image is shown as a black line. B) X-ray diffraction image. Blue ring highlights maximum 
resolution of 2.29 Å. C) Cartoon representation of the substructure, where the N- and C-terminals are labelled. D) 
The strong electron density for zinc and partial ligand density. Figures produced using PyMOL and COOT.  
 
Following further refinement, the final model only showed density for the C-terminal domain (residues 
119 to 244) (Figure 6.9C). This suggests that the N-terminal domain has been cleaved due to proteolysis, 
as chymotrypsin was included in the crystallisation condition. However, most importantly, strong 
density was observed for the zinc atom, coordinated by three histidine residues and a glutamic acid 
residue (Figure 6.9D). Partial density was also observed for a ligand that appears to be interacting with 
the zinc atom. In the native dataset this ligand was unambiguously identified as Neu5Ac. Although not 
a complete model, this substructure was fundamental in solving the native dataset as molecular 
replacement alone was not viable as a phasing strategy. This is because the C-terminal domain among 




6.2.5 Crystallisation trials of E. coli NanR in the presence of DNA  
 
Following sedimentation velocity experiments to define the stoichiometry of the NanR-DNA hetero-
complex (Chapter Five and Section 6.2.3), E. coli NanR was subjected to crystallisation trials in the 
presence of DNA with the aim of obtaining a crystal structure to elucidate the specific DNA contacts. 
Here, trials were conducted using the sitting-drop vapor-diffusion method across the crystallisation 
screens Shotgun and MIDASplus, a screen optimised for macromolecular complexes (Molecular 
Dimensions).  
 
6.2.5.1 Crystallisation trials with full-length NanR  
 
In an initial strategy, full-length protein was pre-equilibrated with either two or three binding site 
oligonucleotides (label-free) and then subjected to co-crystallisation trials. The mixing ratios for each 
oligonucleotide were selected based on the appearance of a stable species in the multi-wavelength 
sedimentation velocity experiments (Chapter Five). Unfortunately, these trials were largely 
unsuccessful, despite some appearance of precipitation and phase separation, which was likely due to 
heterogeneity in the sample.  
To address this heterogeneity, I chose to focus on the two binding site model, which is a simpler system. 
In addition, the protein-DNA hetero-complex was isolated from free protein and DNA, by subjecting the 
sample to size exclusion chromatography prior to setting up the co-crystallisation trials. This was 
facilitated by utilising the multi-wavelength detection on the ÄKTA pure (GE Healthcare), which enabled 
a few mixing ratios to be screened that were optimised for the dimeric or tetrameric NanR-DNA hetero-
complexes. Furthermore, the DNA oligonucleotide was redesigned to have sticky ends, as opposed to 
blunt ends (Figure 6.10A). These additional base pairs are believed to encourage head-to-tail 
polymerisation of the DNA to form an extended chain and assist crystal packing (17). Following several 
weeks of growth, small crystals were obtained for NanR with this new oligonucleotide at a mixing ratio 
of 2:1 (protein:DNA) in Shotgun condition B11 (0.2 M Ammonium chloride, 20 % (w/v) PEG 3350). When 
data was collected at the MX2 beamline (Australian Synchrotron), these crystals diffracted to 
approximately 13 Å (Figure 6.10B-C), but the data was unable to be processed, and thus no spacegroup 







Figure 6.10 | E. coli NanR-DNA crystallisation trials. A) Two binding site model with ‘sticky ends’. Highlighted in blue 
are the two GGTATA binding sites. B) Image of the crystals within the crystallisation drop. C) X-ray diffraction 
image. Blue ring indicates the estimated resolution of ~13 Å.  
 
6.2.5.2 Crystallisation trials with the N-terminal DNA-binding domain 
 
While optimisation of the crystallisation conditions is ongoing with the full-length protein and DNA, an 
alternative, parallel strategy was employed utilising just the N-terminal DNA-binding domain of E. coli 
NanR. Briefly, this was achieved through PCR and In-Fusion cloning of the E. coli nanR gene in order to 
produce a template that encoded only the N-terminal domain (residues 1-95) and also incorporate an 
N-terminal His-tag by utilising the restriction sites NdeI and XhoI in the expression vector pET28a 
(Chapter Eight, Section 8.6.3.6). Following In-Fusion cloning, the NanR construct was transformed into 
E. coli BL21 (DE3) bacterial cells and overexpressed in Luria Bertani media. As the construct contained 
an N-terminal His-tag, a two-step purification procedure was employed, which included immobilised 
metal affinity chromatography and size-exclusion chromatography (as described in Chapter Eight, 
Section 8.6.3.7). As this truncated construct does not contain any aromatic residues, protein elution 
during each chromatography technique was monitored via the peptide backbone absorbance at a 
wavelength of 220 nm. Alternatively, a Bradford assay was used to estimate protein concentration. The 
increasing purity of the truncated protein, following each chromatography technique is shown in Figure 





Figure 6.11 | E. coli NanR N-terminal DNA-binding domain truncation. A) SDS-PAGE analysis showing the increasing 
purity following each purification step. Lane 1, Protein ladder (kDa); lane 2, crude lysate; lane 3, pooled fractions 
from immobilised-metal affinity chromatography; and lane 4, pooled fractions following size-exclusion 
chromatography. B) The c(M) model displaying the molar mass distribution. Shown in bold is the apparent molar 
mass, following peak integration. C) The raw data (open circles) and best fit (lines) is presented. For clarity, every 
third absorbance scan is shown for each dataset. The randomly distributed residuals for each fit are shown below. 
D) 2DSA-Monte Carlo model displaying the sedimentation coefficient (S) distribution from the 55 000 rpm 
experiment, where each colour represents a different titration sample, collected independently (see legend). 
Samples with DNA were collected at 495 nm, while protein alone (black dash) was collected at 280 nM. E) Cartoon 
representation of the N-terminal DNA-binding domain (residues 1-95) based off the atomic structure in Chapter 
Five. Highlighted is the N-terminal extension (disordered), and the key features of the winged helix-turn-helix 
(HTH) motif.  
 
To characterise the stability of the N-terminal DNA-binding domain in solution, sedimentation velocity 
experiments were conducted, using analytical ultracentrifugation (Chapter Eight, Section 8.6.3.4). When 
fitted to a continuous mass distribution [c(M)] model, the data gave an apparent molar mass of 12 kDa, 
consistent with the theoretical monomeric mass of 12.9 kDa (Figure 6.11B). Validation of this analysis 
was supported by the randomly distributed residuals and a low root-mean-square deviation (Figure 
6.11C). Further fitting to a continuous sedimentation coefficient distribution [c(s)] model, displayed a 
single peak with a sedimentation coefficient of 1.34 S (Figure 6.11D), supporting a homogeneous species 
in solution. The frictional ratio (f/f0) of 1.4 suggests this truncated construct has an elongated shape in 
solution. This is a feature of the disordered N-terminal extension and His-tag (Figure 6.11E).  
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To confirm the activity of the N-terminal DNA-binding domain, prior to crystallisation trials, further 
sedimentation velocity experiments were conducted using 10:1 ratio of protein to fluorescently end-
labelled DNA at 495 nm (Chapter Eight, Section 8.6.3.4). Following data collection at 55 000 rpm, a 
positive shift in sedimentation coefficient relative to the individual interaction partners was observed 
(Figure 6.11D). This was consistent with hetero-complex formation, and thus provides confirmation of 
DNA-binding activity. 
Having confirmed the N-terminal DNA-binding domain was active, crystallisation trials were conducted 
using the two binding site model with ‘sticky ends’ (Figure 6.10A) at a protein:DNA ratio of 10:1. 
Following several weeks growth, small crystals were observed in four different conditions (Figure 6.12). 
These include: A) Shotgun condition D9 (0.2 M Ammonium sulfate, 0.1 M sodium acetate, pH 4.6, and 
30 % (w/v) PEG 2000 MME); B) Shotgun condition F3 (0.2 M Ammonium sulfate, 20 % (w/v) PEG 3350); 
C) MIDASplus condition H12 (0.1 M Tris, pH 8.0, 15 % (w/v) Polyvinylpyrrolidone, and 25 % (w/v) PEG 
5000 MME; and D) Shotgun condition B11 (0.2 M Ammonium chloride, and 20 % (w/v) PEG 3350). 
Although small, the crystals all appeared to have a similar oval morphology with more rounded edges. 
Overall, these crystals are suitable for optimisation. One strategy that would be useful to employ in the 
future is crystal seeding, with the aim of increasing the size of the crystal.  
 
Figure 6.12 | E. coli NanR N-terminal DNA-binding domain-DNA crystallisation trials. A) Shotgun condition D9. B) 
Shotgun condition F3. C) MIDASplus condition H12. D) Shotgun condition B11. Sitting-vapour diffusion drops were 
visualised using a Leica benchtop microscope. A polarising filter was used for both C and D.  
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6.3 Chapter Summary 
 
This chapter provided supplementary structural and biophysical data, to both support the evidence 
presented in Chapter Five, and enhance our understanding of the GntR-type transcriptional regulator 
NanR from E. coli.  
Nano-DSF experiments demonstrated that in the presence of Neu5Ac, an increase in thermal stability 
was observed. This showed that Neu5Ac can actively bind NanR in solution, supporting the hypothesis 
that this is the effector molecule in E. coli. In the presence of DNA, a significant increase in thermal 
stability was observed, supporting hetero-complex formation.  
Although the DNA binding kinetics were explored in Chapter Five, this chapter investigated if the 
distance between the direct GGTATA repeats was crucial for binding, by progressively increasing the 
number of base pairs. EMSA experiments illustrated that mutating the distance between direct repeats 
two and three promote a significant decrease in DNA-binding affinity. This suggested that the third 
GGTATA repeat was crucial for the assembly of higher order hetero-complexes. 
Single-wavelength sedimentation velocity studies with DNA demonstrated that when two GGTATA 
binding sites are present, a dimeric and tetrameric NanR-DNA hetero-complex was formed. In the 
presence of the full operator site, a tetrameric and hexameric NanR-DNA hetero-complex was formed. 
This was verified by an excellent agreement between the apparent molar mass of these hetero-
complexes and their respective theoretical molar mass. Interestingly, the dimeric NanR-DNA hetero-
complex was not definitely resolved with the full operator site, despite being observed in the two 
binding site experiment. This illustrated that NanR rapidly assembles into the higher order hetero-
complexes, and although present in solution, the signal concentration of the dimeric NanR-DNA hetero-
complex fell outside the detectable range of the instrument. Therefore, multi-wavelength 
sedimentation velocity experiments were carried out, as the additional spectral dimension allowed this 
hetero-complex to be resolved, when using the full operator site. Nonetheless, the single-wavelength 
experiments presented in this chapter provided the foundation to design the multi-wavelength 
experiment.  
The C-terminal domain sub-structure that was used to phase the native dataset and solve the final 
model of NanR was presented. Analogous to this final model, the sub-structure also displayed density 
for the ligand Neu5Ac, which interacts with the zinc ion. Following preliminary crystallisation trials, 
crystals were obtained for NanR in the presence of DNA with ‘sticky ends’, which was used to encourage 
crystal packing. Unfortunately, while diffraction data was collected for these complex crystals, the 
maximum resolution of the diffraction was ~13 Å. In addition, various crystals were obtained with the 
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N-terminal DNA-binding domain and DNA, following the cloning, purification and preliminary 
characterisation of this domain construct. Together, these crystals should be optimised in the future.  
Overall, these data complement the characterisation presented in Chapter Five, enhance our 
understanding of the GntR-type NanR from E. coli, and provide a platform for future structure 
determination of the protein-DNA hetero-complex at an atomic level. This would allow the specific 
amino acid residues that interact with DNA to be deduced and may additionally provide further insight 
into the mechanistic role of the N-terminal extension in mediating the cooperative binding to DNA.  
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Chapter Seven  
 
Conclusion and future perspectives 
 
7.1 The interplay between gene regulation and metabolism in 
pathogenic bacteria  
 
Within the human host, the variety of environments that pathogenic bacteria infect (e.g. gastrointestinal 
or respiratory tract) present different nutrient availability (1; 2). To gain a competitive advantage, 
pathogens must adapt to these unfavourable environments by upregulating the expression of genes 
that are essential to metabolise the available nutrient source. This response is facilitated by 
transcriptional regulation. Here, in the absence of said nutrient, expression of the associated metabolic 
machinery is switched off by the binding of a transcriptional regulator to the operator region of the 
metabolic operon (3)—this blocks the activity of RNA polymerase. Although when sufficient levels of 
said nutrient are present, signalling molecules called effectors can bind to the transcriptional regulator 
and mediate a conformational change through an allosteric mechanism (4; 5)—as a result of this 
environmental cue, gene expression is switched on. Together, this complex interplay between gene 
expression and the metabolic network is critical for efficient growth and to establish infection within 
the human host. Furthermore, as this coordination provides pathogenic bacteria the ability to propagate 
and persist in new niches, these nutrient sources can act as virulence factors and thus play an integral 
role in pathogenesis (6; 7).  
Sialic acid is an example of such nutrient that acts as a virulence factor in pathogenic bacteria (8-10). 
Found at the terminal of glycoconjugates within the human respiratory and gastrointestinal tract (10; 
11), the utilisation of sialic acid provides bacteria with an alternative source of carbon, nitrogen and 
energy (9; 12). The expression of the molecular machinery to catabolise sialic acid is controlled by the 
transcriptional regulator, NanR. However, the mechanism of this gene regulation is poorly understood 
at a molecular level. Using protein biophysics and structural biology, I addressed this gap by investigating 
two types of NanR sialoregulators, including the RpiR-type sialoregulator from the Gram-positive 
pathogen S. pneumoniae and the GntR-type sialoregulator from the Gram-negative pathogen E. coli. In 
addition, I also investigated the uncharacterised yjhBC operon, which is hypothesised to play a role in 
sialic acid metabolism. Together, this knowledge provides a foundation to dissect the regulatory 
mechanism of NanR at a molecular level, and most importantly enhance our understanding of sialic acid 
catabolism to assist in the development of novel antimicrobial therapeutics that aim to prevent bacterial 
colonisation and persistence. 
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7.2 The first molecular insight into the yjhBC operon  
 
Within bacteria, the catabolism of host-derived sialic acid primarily refers to Neu5Ac, the most 
ubiquitous form of sialic acid in the human host (9; 13). Aside from Neu5Ac, the 9-O-acetylated 
derivative and the hydroxylated derivative, N-glycolylneuraminic acid are reported as nutrient sources. 
These sialic acid derivatives are processed by the periplasmic esterase NanS (14; 15) and the epimerase 
YhcH (16), respectively. In addition, as part of the NanR coordinated regulation in E. coli, a putative 
oxidoreductase YjhC and a putative permease YjhB have since been identified, which are hypothesised 
to uptake and process less common forms of sialic acid (9). Prior to this thesis, structural and functional 
data to support this involvement in sialic acid catabolism was lacking.  
Excitingly, I presented the first molecular insight into the previously uncharacterised yjhBC operon. The 
high-resolution structure of E. coli YjhC to 1.35 Å, solved in complex with NAD(H) verifies its role as an 
oxidoreductase/dehydrogenase from the Gfo/Idh/MocA family. Despite a low sequence identity, YjhC 
shares a similar tertiary fold to family members that catalyse redox reactions with carbohydrate-based 
substrates. This annotation was supported through in vivo knockout studies. Thermal shift experiments 
and in silico docking simulations, identified several promising leads, including the sialic acid 1,7 lactone 
derivative and Neu5Ac. In terms of relative distribution, the lactone derivative is the second most 
abundant sialic acid in the human gastrointestinal tract with respect to Neu5Ac (9; 17). Unfortunately, 
soaking experiments failed to observe any density for either ligand when using the NAD(H) co-crystals. 
In the native structure a mysterious density was observed that was localised around the proposed 
catalytic site. This feature mostly likely represents a bound substrate and provides a possible 
explanation as to why ligand density was not observed following soaking experiments. Nonetheless, 
these results are consistent with an oxidoreductase/dehydrogenase functionality for YjhC and provide 
evidence to suggest YjhC is involved in sialic acid catabolism, directed towards Neu5Ac derivatives. 
Importantly, the derivatives identified as promising leads have abundance levels in the human host that 
are comparable to Neu5Ac. If these levels were considerably different, it would question the fitness 
benefit towards coordinating the gene regulation of these enzymes in E. coli.  
I also investigated the permease YjhB, and optimised an overexpression protocol, using a protein-GFP 
fusion system. This is a critical step towards purifying the membrane protein for future structural and 
biophysical studies. A de novo 3D reconstruction and subsequent in silico characterisation suggested 
YjhC is a sugar-ion symporter and identified amino acid residues that may be of functional importance. 
Interestingly, in contrast with other sugar-ion symporters, such as the fructose transporter (18) or the 
Proteus mirabilis SiaT (19), YjhB does not contain a charged amino acid residue at the substrate binding 
site. This observation suggests YjhB does not transport a charged substrate, such as Neu5Ac. Given that 
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yjhB is transcribed from the same operon as yjhC, perhaps this symporter facilities the transport of the 
lactone derivative, as NanT in E. coli is reported to transport Neu5Ac (20; 21). An in vivo growth assay 
to test this test substrate specificity, as well as molecular dynamic simulations to further validate the 
model and assess the involvement of amino acid residues in the function of YjhB, would be an interesting 
avenue to explore for future research. 
 
7.3 Structural and functional insight into the RpiR-type sialoregulator 
from S. pneumoniae  
 
While RpiR-type NanR have been investigated across several bacterial pathogens including: C. 
perfringens (22); H. influenzae (23); S. aureus (24); S. pneumoniae (25; 26); and V. vulnificus (27; 28); the 
focus of this research was primarily aimed at determining the DNA sequence that is recognised by NanR 
and identifying which molecules can induce gene expression in vivo. As such, this research does not 
address the molecular mechanism of how RpiR-type sialoregulators control gene expression, except for 
NanR from V. vulnificus.  
To address this, I investigated the RpiR-type NanR from S. pneumoniae using protein biophysics and 
structural biology. Through sedimentation velocity experiments and fluorescently end-labelled DNA that 
replicated the recognition site, a 2:1 binding stoichiometry and the first dissociation constant for S. 
pneumoniae NanR were reported. This DNA-binding affinity was consistent with the reported 
dissociation constant for NanR from V. vulnificus (28), which was determined using isothermal titration 
calorimetry. While both these techniques can analyse the interaction in solution, isothermal titration 
calorimetry is a laborious method and requires a considerably larger amount of sample than 
sedimentation velocity experiments. Furthermore, the signal in isothermal titration calorimetry is 
proportional to the binding enthalpy of the interaction, thus if the protein-DNA interaction exhibits a 
small-binding enthalpy this will result in low signal-to-noise (29). Conversely, sedimentation velocity 
experiments using an analytical ultracentrifuge present a more convenient method, which can provide 
access to both thermodynamic and hydrodynamic properties, simply by analysing the sedimentation 
and diffusion behaviour of macromolecules in solution (30).  
Small angle X-ray scattering demonstrated that S. pneumoniae NanR adopts an extended dimeric 
architecture in solution, mediated by a flexible linker region, complementing sedimentation velocity 
experiments. This conformation changed when forming the protein-DNA hetero-complex. Using 
multiphase modelling, an ab initio model was reconstructed for the NanR-DNA hetero-complex from 
the individual scattering profiles. Despite its low resolution, this model demonstrated the relative 
orientation of the interacting partners, placing DNA between the N-terminal DNA-binding domains of 
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the protein. Together, these solution studies were used to investigate the ambiguous oligomeric 
assembly of V. vulnificus NanR by comparing the experimental data to the theoretical scattering profile, 
which was generated from the published atomic structure (PDB ID – 4IVN). Interestingly, this 
comparison supported that S. pneumoniae NanR adopts a similar dimeric assembly in solution to the 
crystal structure of V. vulnificus NanR, when in the absence of DNA. However, the poor fit of the 
proposed ‘active form’ of V. vulnificus NanR, to the scattering profile of the S. pneumoniae NanR-DNA 
hetero-complex, suggested that the model of V. vulnificus NanR is incorrect. 
Lastly, using thermal shift experiments, various effector molecules were screened to investigate binding 
in vitro. These experiments identified the sialic acid pathway metabolite N-acetylmannosamine-6-
phosphate, which was consistent with previous in vivo analysis of S. pneumoniae NanR (25; 26). The 
consequence of this binding event was investigated in the presence of DNA. Interestingly, this resulted 
in a complete attenuation of DNA binding, strongly supporting that N-acetylmannosamine-6-phosphate 
is the effector molecule. Further structural analysis is necessary to verify this conclusion and allow any 
effector-induced conformational changes to be mapped. While attempts to solve the crystal structure 
of S. pneumoniae NanR were unsuccessful, diffraction data was collected between 3 Å and 4 Å. Those 
crystallisation conditions are perfectly suited for optimisation and should be explored in the future. 
Nonetheless, this characterisation permitted a model mechanism for S. pneumoniae NanR-mediated 
gene regulation to be proposed. 
 
7.4 The cooperative assembly of the GntR-type NanR from E. coli  
 
I also conducted a thorough structural and functional investigation of the GntR-type NanR from E. coli. 
In contrast to the RpiR-type sialoregulators, which function as a simple system, the GntR-type NanR 
from E. coli is significantly more complex. Using novel multi-wavelength sedimentation velocity analysis, 
I demonstrated that E. coli NanR binds DNA as a dimer to a total of three direct GGTATA repeats, forming 
a hexameric NanR-DNA hetero-complex, with a 6:1 stoichiometry. This is the first application of this 
emerging technique with protein and DNA as interaction partners in solution. Further binding analysis 
demonstrated this assembly process was cooperative and reported a nanomolar dissociation constant. 
Although cooperativity among bacterial transcriptional regulators has long been established, in such 
examples as the well-known lac repressor (31) or ara repressor (32), this behaviour has not been 
reported for any other NanR gene regulator of sialic acid catabolism. The mechanisms that drive 
cooperativity are diverse, facilitated by protein-protein interaction, the presence of DNA or through 
indirect processes that occur locally or over a considerable distance (33). To address the driving force 
of this cooperativity in E. coli NanR, I initially conducted a sequence analysis. This identified a 32 residue 
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N-terminal extension, which is considerably longer than closely related structures of GntR 
transcriptional regulators and therefore unique to E. coli. Using mutagenesis, the involvement of this N-
terminal extension in DNA binding was assessed. Curiously, these experiments revealed that the ability 
to form higher-order hetero-complexes was perturbed when using this truncated construct of NanR. 
This provided strong evidence that the N-terminal extension mediates the positive cooperativity of the 
E. coli sialoregulator, a process that is likely facilitated by protein-protein interactions. 
The DNA recognition site for E. coli NanR is unique among all characterised members of the GntR 
superfamily. Although some members of the FadR and HutC subfamilies are reported to contain 
inverted or direct repeats, these recognition sites contain a maximum of two repeats (4; 34), whereas 
E. coli NanR contains three exact (or near-exact) direct repeats of the hexanucleotide sequence GGTATA 
(35). Combined with the positive cooperativity observed for this sialoregulator, perhaps this feature is 
the result of evolution in order to maintain robust control over the gene expression of sialic acid 
catabolic machinery. This is because the binding to a single GGTATA repeat exhibited poor DNA-binding 
affinity. However, the presence of multiple GGTATA sites demonstrated a dynamic hetero-complex 
assembly process. To investigate the importance of the distance between the direct repeats, I designed 
mutant oligonucleotides and conducted EMSA experiments. Interestingly, this data showed that the 
pairs of direct GGTATA repeats are not equivalent and suggested that cooperativity of the system is 
mediated by direct GGTATA repeats one and two. However, it is unclear if the binding of NanR occurs 
sequentially to these repeats or through a random-ordered process. This is a question that should be 
explored in future experiments.  
Excitingly, this thesis reported the crystal structure of E. coli NanR to 2.1 Å, solved in complex with 
Neu5Ac and a zinc ion. This coordination supports the role of Neu5Ac as the effector molecule, while 
additionally providing the first report of a metal ion playing a direct role in the binding of an effector 
molecule, within the GntR superfamily. Mutated variants would allow the residues that were involved 
in the coordination of Neu5Ac and zinc to be probed, which I plan to do in the future. Using single-
particle cryo-EM, the structure of the dimeric NanR-DNA hetero-complex was refined to a resolution of 
3.9 Å, providing the first structural insight into the protein-DNA conformation for a NanR gene 
regulation. In addition, this conformation illustrated the significant rearrangement of the N-terminal 
DNA-binding domains, which was facilitated by the flexible α4 linker of NanR. Remarkably, given the 
molar mass of the complex (70.5 kDa), this experiment did not employ a phase plate for data collection. 
A search through the Electron Microscopy Data Bank (EMDB) identified this protein-DNA hetero-
complex as the highest resolution model to data, given its size, lack of symmetry and dynamic nature. 
All the high-resolution structures below 100 kDa are rigid, homogeneous proteins, such as: haemoglobin 
(54 kDa, C2 symmetry reconstruction, resolved to 3.2 Å) (36); and isocitrate dehydrogenase (93 kDa, C2 
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symmetry, resolved to 3.8 Å) (37). Further cryo-EM experiments of the higher order hetero-complex 
provided structural evidence to support the multimeric assembly process and highlighted how close 
each NanR dimer are to each other, when bound to DNA. This proximity reinforces the notion that 
protein-protein interactions are the driving force of cooperativity, where perhaps the N-terminal 
extension helps to tether the sequential dimers together. While DNA-mediated interactions cannot be 
ruled out, no apparent distortion in the DNA was visible, nor any suggestion of DNA looping. Higher 
resolution cryo-EM models of the higher order hetero-complexes may provide further insight towards 
how the N-terminal extension is interacting with the protein and DNA.  
Although this detailed characterisation permits a model mechanism for regulation to be proposed, one 
unresolved question remains—what are the molecular determinants that facilitate the allosteric 
regulation of NanR? I identified zinc as an additional effector molecule and surprisingly captured the 
structure of NanR in an effector-bound and effector-free (apo) state. Superimposition of these states 
provided insight into the molecular choreography that occurs upon binding of Neu5Ac and zinc. 
However, only a small attenuation of DNA-binding activity can be observed in vitro with these molecules. 
This insignificant change shows that the allosteric mechanism involves additional elements that have 
yet to be elucidated in vitro. One hypothesis is DNA methylation, which although presents broad 
functionality in bacteria, the activity of DNA adenine methyltransferase (Dam) has been reported to 
influence the transcription of virulence factors and thus play a role in pathogenesis (38). Located 
immediately upstream of all three regulated operons in E. coli is the sequence GATC, which serves as a 
consensus site for Dam (10; 39). Interestingly, one study reported a decrease in expression of sialic acid 
catabolism in a Dam mutant (40). By consequence, it is hypothesised that methylation over time may 
reduce the ability for NanR to rebind in the presence of Neu5Ac (10; 39), although this has yet to be 
confirmed experimentally. An alternative hypothesis is an interplay between the cAMP receptor protein 
(CRP), which facilitates the binding of RNA polymerase to the promoter region of DNA through protein-
protein interaction (41). In E. coli, ~60 bp upstream of the nanATEK operon there is a CRP binding site 
(42), which is commonly observed in carbon catabolite operons (41). 
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Chapter Eight  
 
Methods and Materials  
 
8.1 Experimental consumables  
 
8.1.1 Chemical consumables  
 
Unless otherwise stated, general chemicals, including antibiotics were purchased from Sigma-Aldrich 
and AppliChem. Chemicals used to prepare growth media, including Luria Bertani broth base were 
purchased from Invitrogen, while agar was obtained from Oxoid. Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was sourced from Bioline. Sialic acid and all other N-acetyl derivatives were purchased from 
Carbosynth. cOmplete™ mini protease inhibitor tablets were purchased from Roche.  
 
8.1.2 Biological consumables  
 
Plasmid constructs harbouring genes of interest were purchased from GenScript or GenArt (Thermo 
Fisher Scientific). DNA oligonucleotides, primers and any associated chemical modification were 
purchased from Integrated DNA Technologies (IDT). All restriction enzymes were obtained from New 
England Biolabs. Agarose gel DNA extraction kits were supplied by Roche. DNA-Spin™ Plasmid DNA 
Purification Kits (miniprep) were obtained from iNtRon Biotechnology. T4 DNA Ligase and In-Fusion® HD 
cloning kits, including chemically competent Stellar cells™ were purchased from TaKaRa Bio USA. 
Bradford dye reagent was obtained from BioRad. DNA HyperLadder marker was supplied by Bioline. 
Novex® Sharp Pre-stained Protein Ladder, Novex® Tris-Glycine SDS sample buffer, Benchmark™ Protein 
Ladder and BOLT™ running buffer were purchased from Invitrogen. SYBR® Safe DNA gel strain and 
SYPRO® Orange dye were also obtained from Invitrogen. IF-0a inoculating fluid, tetrazolium dye mix and 
carbon utilisation plates (PM1 and PM2A) were all purchased from BiOLOG Inc. (Harvard, CA, USA).   
 
8.1.3 General consumables 
 
Precast gels required for sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and 
electrophoretic mobility shift assays (EMSA) were purchased from Thermo Fisher Scientific. All 
prepacked chromatography columns, including molecular weight standards were purchased from GE 
Healthcare. Syringe filters (0.22 and 0.45 µm), including eppendorf sized spin concentrators (various 
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molecular weight cut-off) were supplied by Merck Millipore. Large volume spin concentrators with 
varying molecular weight cut-off were purchased from Sartorius. Crystallisation screens, sitting-drop 
crystallisation plates, UV-transmissible plate seals and cryo-protection solutions were purchased from 
Molecular Dimensions. Cryo loops were obtained from Hampton Research. 24 deep-well growth blocks 
were purchased from Thermo Fisher. Breathable sealing film was purchased from Axygen. 96 well 
microplates and optical adhesive film were purchased from Applied Biosystems. QUANTAFOIL® R1.2/1.3 
carbon support films and UltrAuFoil® R 1.2/1.3 gold support films were purchased from Quantifoil Micro 
Tools (Germany). Glass capillaries used for nano-differential scanning fluorimetry and microscale 
thermophoresis were obtained from NanoTemper.  
 
8.2 General Methodology 
 
8.2.1 Mass spectrometry 
 
To accurately analyse the molecular masses of purified proteins, mass spectrometry was carried out 
using a Bruker MaXis 3G ultra high-resolution time of flight mass spectrometer, equipped with an 
electrospray ionisation source. Proteins to be analysed were diluted to approximately 1 mg mL-1 in MilliQ 
water or Tris-buffered saline. Analysis was performed by Dr. Marie Squire of the Chemistry Department 
at the University of Canterbury. 
 
8.2.2 DNA sequencing 
 
Newly cloned pET-based constructs were sequenced using next generation sequencing by Macrogen 
Inc., South Korea. Purified plasmids (>50 ng μL-1) were supplied and used directly in the sequencing 
reaction, along with the appropriate primers for the forward and complementary strands, respectively. 
Sequencing results were aligned with the gene sequence using the software GENEIOUS (Biomatters, 
https://www.geneious.com).  
 
8.2.3 pH measurement 
 
The pH of buffers and other solutions was measured using an Ultrabasic Benchtop pH meter (Denver 
Instrument). Initially the meter was calibrated with appropriate pH standards surrounding the target pH 






All centrifugation was performed using a Sorvall LYNX 4000 Superspeed (Thermo Fisher), Sorvall RC 6 




All media and glassware for bacterial growth were autoclaved in-house for 15 min at 121 °C. 
 
8.2.6 Visualisation of macromolecular structures 
 
All interactive visualisation and analysis of macromolecule structures, including proteins, DNA and ab 




















8.3.1 Bacterial strains  
 
Four bacterial strains of E. coli were used throughout this research, as described in Table 8.1.  
 
Table 8.1 | Bacterial strains used throughout this thesis. The strain name and associated genotype is presented. 
E. coli strain Application Cloning vector 
DH5α Cloning 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 
Δ(lacZYA-argF) U169, hsdR17(rK- mK+), λ– 
StellarTM In-Fusion 
Cloning 
F- endA1 supE44, thi-1, recA1, relA1, gyrA96, phoA, Φ80dlacZΔM15 
Δ(lacZYA-argF) U169, Δ(mrr -hsdRMS -mcrBC), ΔmcrA, λ– 
BL21 (DE3) Expression 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ΔhsdS λ DE3 = λ sBamHIo ΔEcoRI-
B int::(lacI::PlacUV5::T7 gene1) i21 Δnin5 
Lemo21 (DE3) Expression 
fhuA2 [lon] ompT gal (λ DE3) [dcm] hsdS/pLemo(CamR) λ DE3 = λ 
sBamHIo ΔEcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 Δnin5 pLemo = 
pACYC184-PrhaBAD-lysY 
 
8.3.2 Constructs used in this thesis  
 
A list of constructs used throughout this thesis are listed in Table 8.2. 
 
Table 8.2 | Constructs used routinely throughout this thesis. The protein, species of origin, cloning vector, 












EcYjhC E. coli pET30ΔSE* 37 930 43 048 N-term His-tag 
EcYjhB E. coli pWarf(-)† 70 820 
44 103 (YjhB) 
73 400 (Fusion) 
N-term His-tag/GFP 
SpNanR S. pneumoniae pET30ΔSE 27 390 32 671 - 
EcNanR E. coli pET28a 13 980 29 524 - 
EcNanR (33-263) E. coli pET28a 13 980 25 625 - 
EcNanR-DBD (1-95) E. coli pET28a N/D‡ 12 863 N-term His-tag 
* Kindly supplied by Dr. Hironori Suzuki 
† Kindly supplied by Assoc. Prof. Rosemarie Friemann  
‡ N/D = Not determined as there are no aromatic residues for this construct 
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8.3.3 Media  
 
8.3.3.1 Luria-Bertani media 
 
Luria-Bertani (LB) media was prepared by reconstitution from a commercial powdered stock, containing 
10 g L-1 tryptone, 5 g L-1 yeast extract and 5 g L-1 sodium chloride. For every 1 L of LB medium required, 
20 g of powder was resuspended in MilliQ water. This media was subsequently sterilised by autoclave 
and stored at room temperature until further use.  
 
8.3.3.2 Terrific Broth media 
 
Terrific Broth (TB) media was prepared by resuspending 20 g tryptone, 24 g yeast extract, 9.4 g 
dipotassium phosphate, 2.2 g monopotassium phosphate, and 4 mL glycerol in 1 L of MilliQ water. Prior 
to be being sterilised by autoclave, the pH of the media was adjusted to 7.2 using concentrated sodium 
hydroxide. TB media was stored at room temperature until further use.  
 
8.3.3.3 LB agar 
 
For every 1 L of LB agar required, 20 g of LB powder was mixed with 12 g of agar and resuspended in 
MilliQ water. This media was subsequently sterilised by autoclave. To prepare LB agar plates, freshly 
autoclaved media was supplemented with filter sterilised appropriate antibiotic, gently swirled and 
poured into sterile petri dishes under aseptic conditions. Once cooled, LB agar plates were sealed with 
plastic wrap and stored at 4 °C for up to two to three weeks.  
 
8.3.3.4 Super optimal broth with catabolite repression media 
 
Super optimal broth with catabolite repression (SOC) medium was prepared by the addition of 5 g of 
yeast extract, 20 g tryptone, 0.5 g sodium chloride, 2.5 mL 1 M potassium chloride, 10 mL magnesium 
chloride and 10 mL 1 M magnesium sulfate to 900 mL of MilliQ water. The pH of the SOC media was 
adjusted to 7.0 with the drop-wise addition of concentrated sodium hydroxide and sterilised by 
autoclave. Once cooled 20 mL of a sterile 1 M glucose was added and the final volume adjusted to 1 L 
with sterile MilliQ water. SOC media was then aliquoted into 1.7 mL eppendorf tubes under aseptic 






Antibiotics were prepared as stock solutions and filter sterilised through a 0.22 µm syringe filter. The 
appropriate filter sterilised antibiotic was subsequently used to supplement autoclaved media; these 
are described in Table 8.3.  
 
Table 8.3 | Antibiotic solutions used throughout this thesis. The stock concentration, final working concentration 
and solvent used to resuspend the antibiotic are presented.  
Antibiotic Stock concentration Final working concentration Solvent 
Ampicillin 100 mg mL-1 100 µg mL-1 MilliQ water 
Chloramphenicol 100 mg mL-1 34 µg mL-1 Ethanol 
Kanamycin 50   mg mL-1 50 µg mL-1 MilliQ water 
 
 
8.3.5 Preparation of competent cells 
 
All strains of chemically competent E. coli cells used throughout this research were initially prepared 
and supplied commercially. Cloning and expression strains used routinely were prepared in-house using 
a calcium chloride-based method. Firstly, commercial stocks were streaked onto LB agar plates without 
antibiotic and incubated overnight at 37 °C. The following morning, a single colony was inoculated into 
10 mL sterile LB medium and incubated overnight at 37 °C, without antibiotic. The following morning, 1 
mL starter culture was added to 100 mL of LB and left to grow at 37 °C until an OD600 of 0.35-4 was 
reached. When the optimal OD600 was reached, cells were immediately put on ice and cooled for 30 
min, swirling occasionally to ensure even cooling. Once cool, cells were centrifuged for 5 min at 6000 
rpm. The supernatant was decanted and gently resuspended in 10 mL sterile, ice cold 0.1 M calcium 
chloride before a further 30 min incubation on ice. Following incubation, cells were centrifuged for 5 
min at 6000 rpm. The supernatant was discarded, and cells were gently resuspended in 5 mL sterile, ice 
cold 0.1 M calcium chloride, 15% (v/v) glycerol. Chemically competent cells were aliquoted into sterile 
1.7 mL eppendorf tubes under aseptic conditions, flash-frozen and stored at -80 °C until further use. 
 
8.3.6 Transformation of competent cells 
 
The heat-shock method of transformation was used to incorporate exogenous plasmid DNA into 
chemically competent E. coli cells. Competent cells were initially thawed on ice for 20 min. For each cell 
transformation, approximately 100 ng of plasmid DNA was added to 50 µL of competent cells and mixed 
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gently by stirring. Cells were incubated on ice for 20 min before being subjected to heat shock at 42 °C 
for 45 seconds. Cells were incubated for a further 5 min on ice. The transformed cells were recovered 
by adding 500 µL of SOC media and incubating cells at 37 °C for 1 hr at 250 rpm. Cells were subsequently 
spread onto LB agar plates with appropriate antibiotic selection and left to incubate overnight at 37 °C.  
 
8.3.7 Preparation of glycerol stocks 
 
A single transformed colony was selected to inoculate a 10 mL LB starter culture, supplemented with 
an appropriate antibiotic. Left to incubate at 37 °C overnight, an aliquot was added to a fresh 10 mL LB 
culture and left to grow at 37 °C, with shaking at 220 rpm, until an OD600 of 0.4-5 was reached. When 
the optimal OD600 was reached, an aliquot of culture was added to a sterile 1.7 mL eppendorf tube and 
glycerol was added to final concentration of 15% (v/v). Tubes were subsequently flash-frozen in liquid 
nitrogen and stored at -80 °C until further use.  
 
8.4 Biomolecular techniques  
 
8.4.1 Determination of protein and DNA concentrations 
 
8.4.1.1 Bradford protein assay  
 
Protein concentration was measured using the Bradford assay (3) where no aromatic residues were 
present in the sequence or when protein was in complex with DNA. To prepare a 1x dye solution, one 
part of concentrate Bradford dye reagent was diluted in four parts MilliQ water and left to equilibrate 
at room temperature. In order to construct a calibration curve, bovine serum albumin was serially 
diluted from 0.5 mg/mL to 0.016 mg/mL in the same buffer that the protein sample was in. Samples 
were prepared in triplicate by thoroughly mixing 10 µL protein with 200 µL 1x Bradford dye reagent in 
a 96 well microplate. A blank was prepared using 10 µL of MilliQ water in place of protein. Prior to 
measurement of the absorbance at 595 nm, triplicates were incubated for 5 min at room temperature. 
Measurements were taken using a SpectraMax M5 microplate spectrophotometer (Molecular Devices). 
Unknown protein samples were diluted in accordance with the midpoint of the calibration curve, where 





8.4.1.2 Quantitation of proteins using ultra-violet spectroscopy  
 
The concentration of all protein and DNA in this study was determined by ultra-violet (UV) spectrometry. 
UV absorbance at a wavelength of 280 nm was measured using a NanoDrop™ 1000 spectrometer 
(Thermo Fisher). The concentration of protein was calculated using Beer-Lambert Law (Equation 8.1).   
 
                               𝐴 =  ε c l     (8.1) 
 
Where  A is the absorbance at 280 nm (A.U) 
ε is the wavelength-dependent extinction coefficient (M-1 cm-1) 
c is the concentration of protein (mg mL-1)  
l is the pathlength (cm)  
 
The extinction coefficient for each protein was predicted from the sequence using ExPASy ProtParam 
(https://web.expasy.org/protparam/) based on the content of the aromatic residues, tryptophan and 
tyrosine (4). The extinction coefficients of each protein used in this research are listed in Table 8.2.  
 
8.4.1.3 Quantitation of DNA using ultra-violet spectroscopy  
 
The concentration of DNA was determined by the Nucleic Acid module on the NanoDrop™ 1000 
spectrometer. UV absorbance at a wavelength of 260 nm was used for DNA quantitation. Furthermore, 
the relative purity or contamination could be assessed using the 260/280 nm absorbance ratio. A ratio 
of approximately 1.8 is generally accepted as ‘pure’ for DNA, while a ratio of approximately 0.6 is 
generally accepted as ‘pure’ for protein. 
 
8.4.2 DNA preparation 
 
Complementary DNA oligonucleotides (IDT) were resuspended in annealing buffer (10 mM Tris-HCl, pH 
8, 100 mM NaCl), mixed at equimolar concentrations, and hybridised by heating to 95 °C for 5 min in a 
heat block, followed by cooling slowly to room temperature.  Double stranded DNA (dsDNA) 
oligonucleotides were stored at -20 °C until use. All DNA oligonucleotides used in this study are listed 




Table 8.4 | DNA oligonucleotides used throughout this thesis. The sequence and application are presented.  
6-carboxyfluorescein (FAM) was used as a fluorescent tag for fluorescent detection.  
 
 
8.4.3 Plasmid preparation  
 
Plasmid DNA were purified using a DNA-Spin™ Plasmid DNA Purification Kit (iNtRon Biotechnology). For 
initial DNA amplification, the plasmid interest was transformed into chemically competent E. coli cells 
(DH5α strains) by heat-shock (Section 2.3.5). A single transformed colony was selected to inoculate a 10 
mL LB starter culture and was incubated at 37 °C overnight. Following incubation, the cells were 
centrifuged, and plasmid DNA was purified according to the manufacturer’s instructions. Plasmid DNA 
was sequence verified by next-generation sequencing (Section 8.2.2).  
 
8.4.4 In-Fusion cloning  
 
In-Fusion cloning is a ligation-independent cloning method and was employed in the later stages of this 




Primers for the gene of interest were designed using the online design tool 
(https://www.takarabio.com/). When supplied with the vector and target gene sequence the tool 
designs primers that maintain three characteristics: 1) 15 base-pair extension at the 5’ end that is 
Construct Sequence Application 
Two binding site model 
with 5’FAM (EcNanR) 
 
          FAM-5’-TGGTATAACAGGTATAA-3’ 
              3’-ACCATATTGTCCATATT-5’-FAM 
EMSA/AUC 




    3’-AACTAGACCATATTGTCCATATTTCCATATAGCAA-5’-FAM 
 
EMSA/AUC 
Two site model 
(EcNanR) 
 
             5’-TGGTATAACAGGTATAA-3’ 
             3’-ACCATATTGTCCATATT-5’ 
 
AUC/Cryo-EM 
Full operator site 
(EcNanR) 
 
    5’–TTGATCTGGTATAACAGGTATAAAGGTATATCGTT-3’ 
    3’-AACTAGACCATATTGTCCATATTTCCATATAGCAA-5’ 
 
AUC/Cryo-EM 
Two binding site model 
(sticky end) (EcNanR) 
 
            5’- CTGGTATAACAGGTATAA -3’ 
            3’-  ACCATATTGTCCATATTC-5’ 
 
Crystallisation 
Full operator site with 
5’FAM (SpNanR) 
 
          FAM-5’-TCTGAAAGTACTTTTAGA-3’ 





complementary to the end of the digested vector to which it will be joined; 2) 3’ end of the primer must 
be gene-specific, be between 20-25 base pairs in length, maintain a GC content between 40-60% and 
have a melting temperature between 50-65 °C; and 3) complementarity within each primer must be 
avoided in order to prevent hairpin structures. Once designed, these DNA oligonucleotide primers were 
commercially synthesised through IDT. Lyophilised primers were resuspended to a final concentration 
of 100 µM in nuclease-free MilliQ water (Thermo Fisher) and were stored at -20 °C until further use. 
 
8.4.4.2 Polymerase Chain Reaction 
 
The polymerase chain reaction (PCR) was performed using In-Fusion primers and CloneAmp HiFi PCR 
Premix, according to manufacturer’s instructions (TaKaRa Bio USA). Briefly, the PCR reaction contained 
12.5 µL of the CloneAmp HiFi PCR Premix (CloneAmp HiFi Polymerase, dNTPs and optimised buffer), 5 
µL of a primer master mix (Forward and Reverse at a concentration of 5-7 pmol), 2 µL original vector 
(containing target gene) and 5.5 µL nuclease-free MilliQ water (Thermo Fisher). The PCR amplification 
was performed as per conditions in Table 8.5 using a Verti 96-well thermal cycler (Applied Biosystems). 
 
Table 8.5 | PCR amplification reaction. 
Temperature (°C) Time (sec) Cycles 
98 30 1 
98 10 
30    x *  15 
72 30-60 per kb 
72 120 1 
4 ∞ 1 
* Melting temp is primer dependent (~50-65 °C) 
 
8.4.4.3 Restriction enzyme digest 
 
Preparation of DNA for downstream cloning is dependent upon restriction digests to cut DNA at specific 
recognition sites to produce linearized vector. Restriction enzymes were purchased from New England 
BioLabs and used to obtain an empty plasmid vector or extract a target gene with compatible ends. The 
components of a typical restriction double digest are shown in Table 8.6, where reactions were 
incubated for 3 h at 37 °C. The specific 5’ and 3’ restriction enzyme used to sub-clone each target gene 




Table 8.6 | Restriction enzyme double digest reaction. Reagents are listed for a 50 µL reaction volume. 
Reagent Amount 
Plasmid DNA Approximately 2000 ng DNA 
Restriction enzyme (5’) 1 µL 
Restriction enzyme (3’) 1 µL 
10x CutSmart® buffer 5 µL 
Nuclease-free MilliQ water x µL 
Total volume  50 µL 
 
8.4.4.4 DNA gel extraction 
 
Following restriction enzyme digest or PCR, fragmented DNA products were separated by agarose gel 
electrophoresis (Section 8.5.2). Once mapped, the DNA band of interest was excised from the gel using 
a razor blade and extracted from the gel using an agarose gel DNA extraction kit, according to the 
manufacturer’s instructions (Roche). Purified DNA was used immediately or stored at -20 °C.  
 
8.4.4.5 Ligation-independent recombination  
 
The final step in the In-Fusion cloning workflow is a ligation-independent recombination reaction 
between the linearized target vector and the PCR product with 15 base pair extensions complementary 
to the vector. The components of a typical cloning reaction include: 0.5 µL 5× In-Fusion HD Enzyme 
Premix, 4 µL linearized vector and 2 µL PCR product in a total reaction volume of 6.5 µL. This reaction 
was then incubated at 50 °C for 15 min using a Verti 96-well thermal cycler (Applied Biosystems). The 

























8.5.1 Electrophoresis buffer solutions 
 
Buffer solutions used for either agarose gel or sodium dodecyl sulfate polyacrylamide gel 
electrophoresis is listed in Table 8.7.  
 
Table 8.7 | Buffer solutions for gel electrophoresis. The solution and composition are presented.  
Solution Composition 
1× Tris-acetate-EDTA (TAE) buffer 40 mM Tris-HCl pH 8.0, 0.11 % (v/v) glacial acetic acid, and 1 mM EDTA 
6× DNA loading buffer 
0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol FF, and 30% (v/v) 
glycerol 
4× Gel loading buffer 
200 mM Tris-HCl pH 6.8, 8% (w/v) sodium dodecyl sulfate, 0.4% (w/v) 
bromophenol blue, and 100 mM DTT (added just prior to use) 
 0.5× Tris-Borate-EDTA (TBE) buffer  40 mM tris, pH 8.3, 45 mM boric acid, and 1 mM EDTA 
20x Bolt™ MES SDS running buffer 
50 mM 2-(N-morpholino)ethanesulfonic acid (MES), 50 mM Tris-HCl pH 7.3, 
0.1% SDS, and 1 mM EDTA                     
1× Tris-Glycine SDS Running Buffer 25 mM Tris-HCl, pH 8.6, 192 mM glycine, and 0.1% SDS 
SimplyBlue™ SafeStain 80 mg L-1 Coomassie Brilliant Blue G-250, 35 mM HCl 
 
 
8.5.2 Agarose gel electrophoresis 
 
Agarose gel electrophoresis was used to separate and visualise DNA fragments. Agarose gels were 
prepared by dissolving 1% (w/v) agarose in 1× Tris-acetate-EDTA (TAE) buffer, followed by heating and 
the addition of SYBR® Safe DNA Gel Stain to a final concentration of 1×. Once poured and set, DNA 
samples were mixed with 6× DNA loading buffer to a final concentration of 1× and loaded into the 
solidified agarose gel. For molecular mass confirmation, HyperLadder™ 1 kb was run alongside the 
sample DNA fragments. The agarose gel cassette was set up in a mini electrophoresis tank, submersed 
in 1× TAE buffer and subjected to electrophoresis for 40 min at 120 volts. DNA bands within the gel 





8.5.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate proteins 
and assess the level of purity after different chromatography techniques. Sodium dodecyl sulfate is an 
anionic detergent that binds to the surface of polypeptides, allowing them to migrate towards the anode 
of an electric field. The rate of movement of the polypeptide is proportional to its respective molecular 
mass. Therefore, protein samples can be separated on the basis on molecular mass within the gels into 
discrete bands.  
SDS-PAGE was performed using Bolt™ 4-12% Bis-Tris plus precast protein gels in 1× Bolt™ 2-(N-
morpholino)ethanesulfonic acid SDS running buffer. Protein samples were prepared by mixing with 4x 
gel loading buffer to a final concentration of 1×, heated at 80 °C for 5 min and loaded into the precast 
protein gel alongside Novex™ Sharp Pre-stained Protein Standard. Electrophoresis was performed at 
200 volts for 22 min and gels were stained using SimplyBlue™ SafeStain. Gels were visualised and imaged 
using a Bio-5000 Plus digital imaging system (Microtek).  
 
8.6 Experimental methods  
 
All methodology affiliated with each respective chapter is presented below except for Chapter Two and 
Chapter Five—this is included within the chapter as part of the manuscript. All general methodology is 
described above, while all constructs used in this research are presented in Table 8.2.  
 
8.6.1 Experimental methods for Chapter Three 
 
8.6.1.1 Cloning and expression trials of the Escherichia coli YjhB construct 
 
The gene encoding YjhB from E. coli was synthesised commercially by Genscript and sub-cloned into the 
pWarf(-) expression vector (kindly supplied by Assoc. Prof. Rosmarie Friemann, University of 
Gothenburg, Sweden) using the restriction sites XhoI and BamHI to generate pWarf(-)yjhB. This 
expression construct was then transformed into E. coli Lemo21(DE3) cells (New England BioLabs) and 
plated onto LB-Agar supplemented with kanamycin (50 μg mL-1) and chloramphenicol (34 μg mL-1). For 
the expression trials, a single colony was used to inoculate 50 mL of TB media supplemented with 
kanamycin (50 μg mL-1) and chloramphenicol (34 μg mL-1). This preculture was incubated overnight at 
37 °C. The following day, 2 mL of preculture was used to inoculate 250 mL of freshly prepared TB media 
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along with the antibiotics, kanamycin (50 μg mL-1) and chloramphenicol (34 μg mL-1). Once inoculated 
this media was aliquoted (4 mL) into two 24 deep-well blocks (Thermo Fisher), where each row explored 
a different L-rhamnose (Sigma) concentration (0, 100, 250, 500, 100, and 2000 µM) and each column 
explored a different IPTG (Bioline) concentration (0.1, 0.4, 0.7, and 1 mM). These compounds were 
freshly prepared, and filter sterilised prior to addition. Initially, each L-rhamnose concentration was 
aliquoted individually (200 µL), then each 24 deep-well block was sealed using a breathable sealing film 
(Axygen) and left to grow at 37 °C with shaking at 220 rpm. To monitor the OD600 the remaining TB 
media was aliquoted into a third and fourth 24 deep-well block so the expression trial would not be 
disturbed. Expression was then induced at an OD600 ≈ 1.5-2.0 by the addition of each respective IPTG 
concentration (200 µL). Here, one block was transferred to 26 °C, while the other was transferred to 18 
°C. In addition, the supplementary deep-well blocks were transferred to each growth temperature to 
serve as a non-induced sample, respectively. All blocks were left to grow overnight with shaking at 220 
rpm. As a negative control, empty pWarf(-) was grown in parallel, as a target gene is required for GFP 
to be expressed (5). Following 14-16 h incubation, the OD600 of each well was measured and the cell 
pellet was harvested by centrifugation at 8 000 rpm for 5 min before being flash-frozen for storage at 
-20 °C. 
 
8.6.1.2 Whole-cell fluorescence 
 
Cell pellets were resuspended in 200 µL Phosphate-Buffered Saline (PBS) and left to incubate on ice for 
30 min. Following incubation on ice, each resuspended sample was transferred to a Corning® 96 Well 
Black Polystyrene Microplate. Here, the whole cell fluorescence from the green fluorescent protein 
(GFP) fusion tag was measured at an excitation wavelength of 485 nm and an emission wavelength of 
512 nm using a SpectraMax® M5 Microplate Spectrophotometer (Molecular Devices). To calculate the 
whole-cell fluorescence, the data was analysed according to the protocol in Hsieh et al. (2010) using 
Equation 8.2 and 8.3 (5). Firstly, the fluorescent readings (F) for each well were normalised (FN) against 
the OD600 reading using Equation 8.2. Secondly, this normalised fluorescence was (FN1) was divided by 
the normalised fluorescence of the non-induced sample at the respective temperature (FN2) to account 
for the inherent fluorescence of E. coli using Equation 2.3. The final whole-cell fluorescence reading was 
reported in relative fluorescence units (RFU).  
                                                                           𝐹𝑁 =
𝐹
𝑂𝐷600
      (8.2) 
 
                                                                          RFU =
𝐹𝑁1
𝐹𝑁2
      (8.3) 
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8.6.1.3 In-gel fluorescence  
 
Following whole-cell fluorescence measurements, the top six samples with respect to RFU were 
sonicated on ice using a sonication bath for 30 min. Once sonicated, samples were mixed with 1× Novex® 
Tris-Glycine SDS Sample Buffer (Thermo Fisher), loaded into a 10-well Novex® 4-12% Tris-Glycine 
precast gel and subjected to electrophoresis for 1.5 hr at 125 volts using 1× Tris-Glycine SDS Running 
Buffer (25 mM Tris-HCl, pH 8.6, 192 mM glycine, 0.1% SDS). To provide an indication of the molecular 
weight for each sample, a Benchmark™ Fluorescent protein standard was run alongside. After 
electrophoresis, the gel was rinsed in MilliQ water and imaged with a Typhoon FLA 9500 (GE Healthcare) 
using a 489 nm excitation source and an LPB emission filter. 
 
8.6.1.4 Bioinformatic analysis of E. coli YjhB 
 
To search and compare protein sequences for E. coli YjhB, the basic local alignment search tool (BLAST) 
program and BLASTp (6) was used. The amino acid sequence for the top five search hits were sourced 
from the UniProt database (7). Multiple sequence alignments of YjhB homologues were generated using 
Clustal Omega (8). Membrane topology was predicted using the TOPCONS server (topcons.cbr.su.se/).  
 
8.6.1.5 De novo 3D structure prediction 
 
To construct a 3D de novo structure of YjhB, the PredMP server (9) was employed. Initially, when 
supplied an amino acid sequence, secondary structural elements were predicted using RaptorX-
Property (10). Secondly, the spatial relationship between residues was predicted using RaptorX-Contact 
and deep transfer learning (11). Using the Crystallography & NMR System, this information was used to 
construct the 3D de novo model before being embedded into a membrane using an adapted ‘Positioning 
of Proteins in Membranes’ method. 
 
8.6.2 Experimental methods for Chapter Four 
 
8.6.2.1 Cloning of the Streptococcus pneumoniae NanR expression construct 
 
The gene encoding NanR from S. pneumoniae was synthesised commercially in the cloning vector 
designated pUC57 with the restriction sites BamHI and HindIII. In order to use a N-terminal His-tag, the 
nanR gene was digested from pUC57 using the high-fidelity restriction enzymes BamHI and HindIII (New 
England Biolabs), gel purified and ligated with T4 DNA ligase (Takara) for 30 min at room temperature 
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to generate pET30ΔSE/SpNanR_His. The pET30ΔSE expression vector, conferring kanamycin resistance 
was kindly supplied by Dr Hironori Suzuki. However, following an initial purification and DNA binding 
experiment this His-tag was not suitable. For removal, In-Fusion primers were designed (Forward-5’-
AAG GAG ATA TAC ATA TGG ACA AAC CAG ATA TCG CAA CT-3’, Reverse-5’-GCT CGA GCT AGG ATT TTC 
TTA CAC GTT TTT GT-3’) to utilise the restriction enzyme sites NdeI and HindIII and ensure an ~15 base 
pair extension that is complementary to the pET30ΔSE expression vector. Briefly, the target gene was 
amplified using PCR and the CloneAmp™ DNA polymerase. Next, the expression vector was linearized 
with the restriction enzymes NdeI and HindIII and subjected to agarose gel electrophoresis alongside 
the PCR product. Once the integrity of the components was verified using DNA sequencing (Macrogen), 
both were purified using a DNA-Spin™ Plasmid DNA Purification Kit (iNtRon Biotechnology). Following 
plasmid preparation, In-Fusion cloning was then conducted according to the manufacture’s protocol 
(Takara). This cloning reaction was then incubated for 15 min at 50 °C before being transformed into 
Stellar™ competent cells (Takara) to generate pET30ΔSE/SpNanR. A diagnostic restriction endonuclease 
digestion was used to verify positive clones before the identity of the final construct was confirmed by 
DNA sequencing (Macrogen).  
 
8.6.2.2 Expression and purification of S. pneumoniae NanR 
 
The pET30ΔSE/SpNanR construct was transformed into E. coli BL21(DE3) competent cells (Agilent) and 
grown in LB media with 30 mg mL-1 kanamycin at 37 °C and shaking at 220 rpm. Expression of SpNanR 
was induced mid-log phase (OD600 ≈ 0.6) by the addition of IPTG to a final concentration of 1 mM and 
incubated overnight (14-16 h) at 26 °C with shaking at 220 rpm. Cells were harvested by centrifugation 
(Sorvall LYNX 4000 Superspeed) at 8 000 rpm for 10 min. Following centrifugation, the supernatant was 
discarded, and the cell pellet was flash-frozen in liquid nitrogen for storage at -20 °C until needed.  
To prepare the protein for purification, the cell pellet was resuspended in lysis buffer (20 mM Tris-HCl, 
pH 8.0, 150 mM NaCl), supplemented with cOmplete™ mini protease cocktail inhibitor (Roche), and 
lysed by sonication (Hielscher UP200S Ultrasonic Processor) on ice. Cell debris and insoluble material 
was pelleted by centrifugation at 16 000 rpm for 30 min. The resulting cell lysate was then saturated to 
50 % ammonium sulphate and left to equilibrate for 1 h at 4 °C. Following precipitation, protein was 
pelleted at 10 000 rpm for 15 min and resuspended in 20 mM Tris-HCl, pH 8.0, 100 mM NaCl (buffer A), 
while the supernatant was discarded. This resuspended sample was dialysed overnight in buffer A at 4 
°C. Purification of S. pneumoniae NanR was conducted via a three-step procedure: anion exchange 
chromatography; heparin affinity chromatography; and size-exclusion chromatography, using an 
ÄKTApure (GE Healthcare). The dialysed sample was applied to a HiTrap Q FF column (GE Healthcare), 
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pre-equilibrated in buffer A. Weakly-associated or positively-charged proteins were removed by 
washing the column for three column volumes of buffer A. Subsequently, the bound protein was eluted 
using a continuous gradient of buffer B (20 mM Tris-HCl, pH 8.0, 1 M NaCl) over 60 min. Fractions 
containing protein were identified by SDS-PAGE and then pooled. The pooled sample was then applied 
to a HiTrap Heparin HP column (GE Healthcare), pre-equilibrated in buffer A. Next, the column was 
washed using three column volumes of buffer A, while the bound protein was eluted using a continuous 
gradient of buffer B over 20 min. Following concentration to <500 µL using ultrafiltration (Sartorius), the 
pooled sample was applied to a Superdex 200 Increase 10/300 GL column (GE Healthcare) in buffer C 
(20 mM Tris–HCl, pH 8.0, 300 mM NaCl) where NanR eluted as a single peak. The absorbance at 280 nm 
of the purified protein was measured using a NanoDrop spectrophotometer and the concentration was 
estimated using a molar extinction coefficient of 27 390 M-1 cm-1 at 280 nm, as calculated by ProtParam 
(4). All purification steps were carried out at 4 °C. Protein that was not immediately used in experiments 
was flash-frozen in liquid nitrogen and stored at -80 °C. 
 
8.6.2.3 Ligand screening using differential scanning fluorimetry 
 
A QuantStudio 3 real-time PCR system (ThermoFisher Scientific) was used to record the thermal stability 
of the purified protein with and without potential substrates. Reactions consisted of 0.5 mg mL-1 (15 
µM) protein, 5× SYPRO® Orange (prepared as a 50× stock) and 10 mM effector or DNA in a final reaction 
volume of 25 µL. Once prepared these were loaded into a 96-well microplate (Applied Biosystems). To 
prevent any evaporation during measurement an optical adhesive film (Applied Biosystems) was applied 
to the microplate prior to data collection. Samples were heated from 4 °C to a 95 °C at a ramp rate of 
0.05 °C, taking fluorescent readings at each time point. Triplicate measurements were performed for 
each sample. To validate the experiment, one positive control with a well-characterised melting curve 
(lysozyme at 15 µM) and two negative controls (protein only and dye only) were conducted. Data 
analysis was performed using Protein Thermal Shift software (version 1.3–Applied Biosystems) where 
an apparent melting point (Tm) of each sample in °C was obtained from the lowest point of the first 
derivative plot. 
 
8.6.2.4 Bioinformatic analysis with other RpiR-type sialoregulators 
 
To compare the protein sequence of S. pneumoniae NanR with other RpiR-type NanR, amino acid 
sequences of NanR from Clostridium perfringens, Haemophilus influenzae, Staphylococcus aureus, and 
Vibrio vulnificus were sourced from the UniProt database (7). A multiple sequence alignment was then 
generated using Clustal Omega (8). The DNA recognition site for NanR from Streptococci strains were 
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sourced from the RegPrecise database (12) and used to make a sequence logo via WebLogo (13). A 
homology model of S. pneumoniae NanR was generated using RaptorX (10). 
 
 8.6.2.5 Analytical ultracentrifugation of S. pneumoniae NanR  
 
Sedimentation velocity experiments were performed with a XL-I Analytical Ultracentrifuge (Beckman 
Coulter) using 12 mm double-sector quartz cells and epon centrepieces in an An-60 Ti 4-hole rotor. Data 
was obtained at 42 000 rpm using 380 µL protein at a concentration of 0.5 mg mL-1 (15 µM) in size 
exclusion buffer (20 mM Tris–HCl, pH 8.0, 300 mM NaCl) and 400 µL of size exclusion buffer as a 
reference. A total of 300 scans were collected at 20 °C using radial absorbance scans at 280 nm and a 
step size of 0.003 cm. Data  was fit to either a continuous sedimentation distribution [c(s)]  or a 
continuous mass distribution [c(M)] model using SEDFIT (14). The buffer density, buffer viscosity and an 
estimate of the partial specific volume of the protein sample, based on the amino acid sequence, were 
determined using SEDNTERP (15).  
 
8.6.2.6 Analytical ultracentrifugation of S. pneumoniae NanR in the presence of DNA 
 
Sedimentation velocity experiments in the presence of DNA were performed with a XL-I Analytical 
Ultracentrifuge (Beckman Coulter) at 20 °C. Protein-DNA titrations were prepared in binding buffer (20 
mM Tris–HCl, pH 8.0, 150 mM NaCl) and left to equilibrate at room temperature for 30 min before being 
loaded (450 µL per sector) into 12 mm double-sector quartz or sapphire cells with epon centre-pieces, 
and then mounted into an An-50 Ti 8-hole or An-60 Ti 4-hole rotor. Data was obtained at 50 000 rpm 
and 32 000 rpm in intensity mode at 495 nm.  The optical density of each sample at 495 nm was 0.5 to 
ensure a balanced gain setting.   
All data were analysed using UltraScan 4.0, release 2578 (16). Sedimentation data were evaluated by 
the two-dimensional spectrum analysis (2DSA) (17), which affords an unbiased hydrodynamic model, 
where the sedimentation coefficient and frictional ratio (f/f0) can be floated independently. In addition, 
50 Monte-Carlo iterations were performed on the 2DSA data set providing further refinement. All fitting 
procedures were completed using the UltraScan LIMS cluster. Each 2DSA-Monte Carlo model was 
visually assessed to ensure a good fit and a low RMSD using the FE Model Viewer utility in UltraScan. 
Peak integration of sample components was performed using the Genetic Algorithm Initialisation Utility 
in UltraScan. The buffer density, buffer viscosity and an estimate of the partial specific volume of the 




In order to accurately determine the molecular weight of each species in solution, a weight-averaged 
partial specific volume was estimated for each protein-DNA hetero-complex using the following 
equation. The values used in this study are presented in Chapter Four, Table 4.2. 
 
?̅? =
𝑀1?̅?1 + 𝑀2?̅?2  
𝑀1+ 𝑀2
     (8.4) 
 
 
Where   𝑀1 is the molar mass of the protein component (Da) 
  𝑀2 is the molar mass of the DNA component (Da) 
  ?̅?1 is the partial specific volume of the protein (mL g
-1) 
  ?̅?2  is the partial specific volume of the DNA (mL g
-1) 
 
8.6.2.7 Electrophoretic mobility shift assay with S. pneumoniae NanR 
 
Double stranded 5’FAM labelled DNA oligonucleotides (IDT) were diluted to 50 nM in binding buffer (20 
mM Tris–HCl pH 8.0, 150 mM NaCl, 5% Glycerol). This buffer was supplemented with 5 mM N-
acetylmannosamine-6-phosphate to investigate the role of the phosphorylated sugar. 12-well Novex 6% 
Tris-Glycine gels (Invitrogen) were pre-run in 0.5× Tris-Borate-EDTA (TBE) buffer (40 mM Tris-HCl, pH 
8.3, 45 mM boric acid, 1 mM EDTA) for 30 min at 200 V and 4 °C. Protein and DNA oligonucleotides were 
mixed and incubated at room temperature for 30 min to allow samples to reach equilibrium. 
Electrophoresis was performed immediately on the pre-run gels in 0.5× TBE buffer for 20 min at 200 V 
and 4 °C.  After electrophoresis, the gel was rinsed in MilliQ water and imaged with the Typhoon FLA 
9500 (GE Healthcare) using a 473 nm excitation source and an LPB emission filter.  
 
8.6.2.8 Crystallisation and data collection of S. pneumoniae NanR 
 
Crystallisation trials for S. pneumoniae NanR were performed in-house using the JCSG-plus, PACT-
premier, Shotgun, Morpheus and the Clear Strategy Screens (I and II) from Molecular Dimensions. Trials 
were conducted using the sitting-drop vapour-diffusion method at 8 °C and 20 °C with droplets 
consisting of 400 nL protein solution and 400 nL reservoir solution. Purified NanR was concentrated to 
10 mg mL-1 in 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, or alternatively a buffer supplemented with 10 
mM N-acetylmannosamine-6-phosphate. Conditions that produced crystals suitable for diffraction 
screening were mounted onto cryo-loops (selected based on the size of crystal), and cryo-protected by 
soaking in 85% reservoir solution and 15% glycerol-ethylene glycol (50:50 mix) prior to being flash-
238 
 
frozen in liquid nitrogen. Once flash-frozen, these crystals were then mounted onto the MX2 Beamline 
at the Australian Synchrotron. Diffraction data were collected (λ = 0.9537 Å) with the EIGER × 16M 
detector. Data was processed and scaled using XDS (18) and AIMLESS from the CCP4 program suite (19).   
8.6.2.9 Small angle X-ray scattering of S. pneumoniae NanR 
 
Small angle X-ray scattering (SAXS) data was collected on the SAXS/WAXS beamline equipped with a 
Pilatus 1M detector (170 mm × 170 mm, effective pixel size, 172 μm × 172 μm) at the Australian 
Synchrotron. A sample detector distance of 1600 mm was used, providing a q range of 0.006-0.5 Å-1. 
Here, 50 µL of purified S. pneumoniae NanR at 8 mg mL-1 (250 µM) was injected onto an inline Superdex 
S200 Increase 5/150 GL SEC column (GE Healthcare), equilibrated with 20 mM Tris–HCl, pH 8.0, 300 mM 
NaCl, and supplemented with 0.1% (w/v) sodium azide, using a flow rate of 0.35 mL min-1. To 
characterise the solution structure of the protein-DNA hetero-complex, protein (250 µM) and DNA 
oligonucleotides (125 µM) were mixed and incubated at room temperature for 30 min to allow samples 
to reach equilibrium. DNA was collected separately at the same concentration. Co-flow SAXS was used 
to minimise sample dilution and maximise signal to noise (20). Scattering data was collected in one 
second exposures (λ = 1.0332 Å) over a total of 500 frames, using a 1.5 mm glass capillary, at 12 °C.  
Analysis of the scattering data was performed using the ATSAS software package (version 2.8.4)(21). 2D 
intensity plots were radially averaged, normalised to sample transmission, and background subtracted 
using CHROMIXS. PrimusQT (22) was used to perform the Guinier analysis, perform the Kratky analysis 
and to generate the pairwise distribution function P(r), which was calculated using an indirect Fourier 
transform. The molecular mass of the samples was estimated using the SAXS-MoW2 package (23), or 
from the Porod volume. To generate a multiphase ab initio reconstruction of the protein-DNA hetero-
complex, 10 independent MONSA (24) runs were performed and then averaged using DAMAVER (25). 
Each model was further evaluated using SUPCOMB (26) to determine the level of consistency. The 
resulting averaged model was visualised in PyMOL by increasing the solvent density radius.  
 
8.6.3 Experimental methods for Chapter Six 
 
8.6.3.1 Thermal stability of E. coli NanR  
 
Differential scanning fluorimetry experiments with E. coli NanR were performed using the Prometheus 
NT.48 instrument (NanoTemper Technologies). Protein was prepared at 1 mg mL-1 in 20 mM Tris–HCl 
,pH 8.0, 150 mM. This buffer was supplemented with Neu5Ac (10 mM) or DNA (300 µM) when the 
thermal stability of ligands was investigated. Protein samples (10 µL) were loaded into glass capillaries 
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and placed into the sample holder. Detection was achieved through excitation of tryptophan residues 
within the protein at 280 nm, while the intrinsic fluorescence intensity was recorded at 330 nm and 350 
nm. The laser intensity was adjusted to 16%, based upon the number of tryptophan residues in NanR 
(two per monomer). Samples were heated from 20 °C to a 95 °C at a ramp rate of 1 °C per min, taking 
fluorescent readings at each time point. Duplicate measurements were performed for each sample. 
Data analysis was performed using PR.ThermControl software (NanoTemper Technologies) where an 
apparent melting point (Tm) of each sample in °C was obtained by taking the first derivative of the 
350/330 nm ratio.  
 
8.6.3.2 Circular dichroism spectroscopy 
 
A Jasco-J815 circular dichroism (CD) spectrophotometer was used to record CD spectra of purified NanR. 
Wavelength scans between 200 and 260 nm were performed on protein samples at a concentration of 
0.05 mg mL-1 in a 1 mm pathlength quartz cuvette. Protein stock was diluted in 20 mM Tris-HCl, pH 8.0. 
Data was collected at 20 °C in 0.2 nm steps. To reduce the signal-to-noise ratio, three scans were 
collected and then averaged. The data was converted to mean residue ellipticity by using the optical 
conversion tool within the Spectral Analysis software (Jasco) by supplying the molar concentration and 
cell pathlength. 
 
8.6.3.3 Electrophoretic mobility shift assay with E. coli NanR 
 
Double stranded 5’FAM labelled DNA oligonucleotides were diluted to 10 nM in gel shift buffer (10 mM 
MOPS, pH 7.5, 50 mM KCl, 5 mM MgCl2, 10% glycerol). 12-well Novex 6% Tris-Glycine gels (Invitrogen) 
were pre-run in 0.5× TBE buffer (40 mM Tris-HCl, pH 8.3, 45 mM boric acid, 1 mM EDTA) for 30 min at 
200 V, and 4 °C. Protein and DNA oligonucleotides were mixed and incubated at room temperature for 
30 min to allow samples to reach equilibrium. Electrophoresis was performed immediately on the pre-
run gels in 0.5× TBE buffer for 20 min at 200 V, and 4 °C.  After electrophoresis, the gel was rinsed in 
MilliQ water and imaged with the Typhoon FLA 9500 (GE Healthcare) using a 473 nm excitation source 
and an LPB emission filter.  
 
8.6.3.4 Analytical ultracentrifugation of E. coli NanR and the N-terminal DNA-binding domain in 
the presence of DNA 
 
Sedimentation velocity experiments in the presence of DNA were performed with a XL-I Analytical 
Ultracentrifuge (Beckman Coulter) at 20 °C. Protein-DNA titrations were prepared in binding buffer (20 
mM Tris–HCl, pH 8.0, 150 mM NaCl) and left to equilibrate at room temperature for 30 min before being 
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loaded (450 µL per sector) into 12 mm double-sector quartz or sapphire cells with epon centre-pieces, 
and then mounted into an An-50 Ti 8-hole or An-60 Ti 4-hole rotor. Data was obtained at both a high 
and low speed in intensity mode at 495 nm.  The optical density of each sample at 495 nm was 0.5 to 
ensure a balanced gain setting.   
All data were analysed using UltraScan 4.0, release 2578 (16). Sedimentation data were evaluated by 
the two-dimensional spectrum analysis (2DSA) (17), which affords an unbiased hydrodynamic model, 
where the sedimentation coefficient and frictional ratio (f/f0) can be floated independently. In addition, 
50 Monte-Carlo iterations were performed on the 2DSA data set providing further refinement. All fitting 
procedures were completed using the UltraScan LIMS cluster. Each 2DSA-Monte Carlo model was 
visually assessed to ensure a good fit and a low RMSD using the FE Model Viewer utility in UltraScan. 
Peak integration of sample components was performed using the Genetic Algorithm Initialisation Utility 
in UltraScan. The buffer density, buffer viscosity and an estimate of the partial specific volume of the 
protein sample, based on the amino acid sequence, were determined using UltraScan.  
 
8.6.3.5 Crystallisation and data collection of E. coli NanR in the presence of DNA 
 
Crystallisation trials for E. coli NanR were performed in-house using the Shotgun and MIDASplus screens 
from Molecular Dimensions. Trials were conducted using the sitting-drop vapour-diffusion method at 8 
°C and 20 °C with droplets consisting of 400 nL protein solution and 400 nL reservoir solution. Purified 
NanR was initially concentrated to 20 mg mL-1 in 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, mixed with DNA  
and left to equilibrate for 30 min on ice prior to laying screens. Trials were later adapted to include a 
size-exclusion chromatography step following equilibration to purify the hetero-complex from free 
protein and free DNA. Initially, a Superdex S-200 Increase 10/300 GL column (GE Healthcare) was pre-
equilibrated in 20 mM Tris-HCl pH 8.0, 150 mM NaCl, prior to injection of the sample. Multi-wavelength 
detection at 220 nm, 260 nm and 280 nm was employed to identify the hetero-complex. In addition, 
trials with a two binding site DNA model with sticky ends (Table 8.4) were performed in parallel. 
Conditions that produced crystals suitable for diffraction screening were mounted onto cryo-loops 
(selected based on the size of crystal) and were then flash-frozen in liquid nitrogen. If required, crystals 
were cryo-protected by soaking in 85% reservoir solution and 15% glycerol-ethylene glycol (50:50 mix) 
prior. Once flash-frozen, these crystals were mounted on the MX2 Beamline at the Australian 
Synchrotron. Diffraction data were collected (λ = 0.9537 Å) with the EIGER × 16M detector. Data was 





8.6.3.6 Cloning of the E. coli NanR N-terminal DNA-binding domain 
The gene encoding the N-terminal DNA-binding domain of E. coli NanR was amplified from the 
pET28a/EcNanR construct using In-Fusion cloning, in order to utilise an N-terminal His-tag with the 
restriction sites NdeI and XhoI. In-Fusion primers were designed (Forward-5’-AGG AGA TAT ACC ATG 
CTC TCC GAA ATG GAA GAG-3’, Reverse-5’-GGT GGT GGT GCT CGA GTT AGA CGC GAG CGC GTT CG-3’) 
to ensure a ~15 base pair extension was complementary to the pET28a expression vector. Briefly, the 
target gene was amplified using PCR and the CloneAmp™ DNA polymerase. Next, the expression vector 
was linearized with the restriction enzymes NdeI and XhoI and subjected to agarose gel electrophoresis 
alongside the PCR product. Once the integrity of the components was verified, both were purified using 
a DNA-Spin™ Plasmid DNA Purification Kit (iNtRon Biotechnology). Following plasmid preparation, In-
Fusion cloning was then conducted according to the manufacturer’s protocol (Takara). This cloning 
reaction was then incubated for 15 min at 50 °C, before being transformed into Stellar™ competent 
cells (Takara) to generate pET28a/EcNanR-DBD (DNA-binding domain). A diagnostic restriction 
endonuclease digestion was used to verify positive clones before the identity of the final construct was 
confirmed by DNA sequencing (Macrogen).  
 
8.6.3.7 Expression and purification of the E. coli NanR N-terminal DNA-binding domain 
 
The pET28a/EcNanR-DBD construct was transformed into E. coli BL21 (DE3) competent cells (Agilent) 
and grown in LB media, supplemented with 30 mg mL1 kanamycin at 37 °C and shaking at 220 rpm. 
Expression of EcNanR-DBD was induced mid-log phase (OD600 ≈ 0.6) by the addition of IPTG to a final 
concentration of 1 mM and incubated overnight (14-16 h) at 26 °C, with shaking at 220 rpm. Cells were 
harvested by centrifugation (Sorvall LYNX 4000 Superspeed) at 8 000 rpm for 10 min. Following 
centrifugation, the supernatant was discarded, and the cell pellet was flash-frozen in liquid nitrogen for 
storage at -20 °C until needed.  
To prepare the protein for purification, the cell pellet was resuspended in lysis buffer (20 mM Tris-HCl, 
pH 8.0, 500 mM NaCl), supplemented with cOmplete™ mini protease cocktail inhibitor (Roche), and 
lysed by sonication (Hielscher UP200S Ultrasonic Processor) on ice. Cell debris and insoluble material 
was pelleted by centrifugation at 16 000 rpm for 30 min. Purification of EcNanR-DBD was conducted via 
a two-step procedure: immobilised-metal affinity chromatography; and size-exclusion chromatography 
using an ÄKTApure (GE Healthcare). The dialysed sample was applied to a HisTrap FF crude column (GE 
Healthcare), pre-equilibrated in buffer A (20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 40 mM imidazole). 
Weakly-associated or non-specific proteins were removed by washing the column with three column 
volumes of buffer A. Subsequently, bound protein was eluted using a continuous gradient of buffer B 
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(20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 400 mM imidazole) over 60 min. As EcNanR-DBD does not 
contain any aromatic residues, the protein was monitored via the peptide backbone at a wavelength of 
220 nm, while the Bradford assay (3) was used to estimate protein concentration.  Fractions containing 
the protein of interest were identified by SDS-PAGE analysis and then pooled. Following concentration 
to <500 µL using ultrafiltration (Sartorius), the pooled sample was applied to a Superdex 200 Increase 
10/300 GL column (GE Healthcare) in buffer C (20 mM Tris–HCl, pH 8.0, 300 mM NaCl), where EcNanR-
DBD eluted as a single peak. All purification steps were carried out at 4 °C. The final purity was estimated 
to be approximately 90-95%, with only a minor contaminant at 10 kDa. This was verified by electrospray 
ionisation mass spectrophotometry with molar masses of 12 863 Da and 8 607 Da, respectively. Protein 
that was not immediately used in experiments was flash-frozen in liquid nitrogen and stored at -80 °C. 
 
8.6.3.8 Crystallisation of E. coli NanR N-terminal DNA-binding domain in the presence of DNA 
 
Crystallisation trials for the E. coli NanR N-terminal DNA-binding domain were performed in-house using 
Shotgun and MIDAS-plus screens from Molecular Dimensions. Trials were conducted using the sitting-
drop vapour-diffusion method at 8 °C and 20 °C with droplets consisting of 400 nL protein solution and 
400 nL reservoir solution. Purified protein was initially concentrated to 20 mg mL-1 in 20 mM Tris-HCl, 
pH 8.0, 150 mM NaCl, mixed with DNA and left to equilibrate for 30 min on ice prior to laying screens. 
Trials were performed using a two binding site DNA model with sticky ends (Table 8.4) at a protein:DNA 
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